data_1bzk_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1bzk _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.474 ' OG ' ' HB ' ' A' ' 18' ' ' VAL . 8.0 t . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -92.9 -69.32 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.704 1 C-N-CA 126.207 4.605 . . . . 0.0 110.299 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -58.17 -50.89 71.95 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.318 -0.864 . . . . 0.0 108.723 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.474 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 98.4 t -59.34 -22.42 22.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 15' ' ' SER . 13.4 tp -60.17 -57.55 12.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.063 -1.023 . . . . 0.0 108.832 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.68 -51.1 61.75 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.328 -0.858 . . . . 0.0 109.343 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.86 -55.38 11.86 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.69 0.757 . . . . 0.0 109.561 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.6 t -50.39 -34.46 11.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 121.807 -0.558 . . . . 0.0 109.535 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mt -71.46 -37.88 66.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.336 -0.852 . . . . 0.0 108.78 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -57.08 -41.03 78.11 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 35.3 mt -73.74 -32.96 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.468 ' HA ' ' HB2' ' A' ' 30' ' ' LEU . 32.8 t80 -63.84 -22.38 66.89 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -90.11 -31.79 16.95 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.57 -72.07 0.5 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.215 0.531 . . . . 0.0 111.339 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.83 -51.61 9.49 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.163 -0.961 . . . . 0.0 111.781 -177.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.468 ' HB2' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -78.13 24.57 0.24 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.38 -0.825 . . . . 0.0 111.167 -178.207 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.552 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -65.79 -49.56 58.74 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 120.96 -1.087 . . . . 0.0 110.477 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 31' ' ' SER . 43.2 Cg_endo -90.91 -21.45 0.72 Allowed 'Trans proline' 0 N--CA 1.503 2.033 1 C-N-CA 126.553 4.835 . . . . 0.0 111.54 -178.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.724 0 O-C-N 120.941 -1.099 . . . . 0.0 110.244 -179.211 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.523 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 3.6 t . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 120.708 0.289 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.523 ' HD3' ' N ' ' A' ' 15' ' ' SER . 41.9 Cg_endo -86.26 -48.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.773 1 C-N-CA 125.98 4.454 . . . . 0.0 110.091 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -59.79 -43.41 94.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.201 -0.937 . . . . 0.0 108.772 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.46 ' O ' ' HB1' ' A' ' 21' ' ' ALA . 73.6 t -71.6 -49.03 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.528 ' O ' ' CD1' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -44.95 -42.76 8.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.106 -0.996 . . . . 0.0 108.358 179.309 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.92 -48.71 77.63 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 18' ' ' VAL . . . -52.87 -56.82 13.04 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.682 0.754 . . . . 0.0 109.927 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 43.8 t -54.37 -25.21 13.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.446 -0.784 . . . . 0.0 109.201 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.553 HD11 ' N ' ' A' ' 23' ' ' ILE . 1.6 mp -82.26 -31.73 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.476 -0.765 . . . . 0.0 109.081 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -52.12 -50.98 60.61 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.1 mt -67.88 -34.87 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.574 ' CD2' HD13 ' A' ' 30' ' ' LEU . 3.4 t80 -61.84 -19.44 62.59 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.458 ' HA ' ' HB2' ' A' ' 30' ' ' LEU . 1.8 t80 -85.65 -40.05 16.61 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.5 ' O ' ' OG ' ' A' ' 31' ' ' SER . . . -46.86 -53.07 12.9 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.89 -42.45 81.2 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.969 0.89 . . . . 0.0 109.515 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.574 HD13 ' CD2' ' A' ' 26' ' ' TYR . 73.0 mt -70.44 15.33 0.1 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.63 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.583 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.9 OUTLIER -39.25 -48.24 4.38 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 120.872 -1.143 . . . . 0.0 111.17 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 31' ' ' SER . 39.0 Cg_endo -87.0 -23.47 1.55 Allowed 'Trans proline' 0 N--CA 1.502 2.003 1 C-N-CA 126.388 4.725 . . . . 0.0 111.421 -178.63 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.536 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.756 0 O-C-N 121.069 -1.019 . . . . 0.0 109.882 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.419 ' OG ' ' HB ' ' A' ' 18' ' ' VAL . 2.9 t . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -86.35 -53.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.704 1 C-N-CA 126.094 4.53 . . . . 0.0 110.136 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -57.56 -20.22 30.67 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.104 -0.998 . . . . 0.0 109.201 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.419 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 3.4 t -90.12 -57.17 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.448 -0.783 . . . . 0.0 109.425 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 18' ' ' VAL . 29.6 mt -47.22 -46.99 24.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.997 -1.064 . . . . 0.0 108.5 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.5 ' O ' ' C ' ' A' ' 21' ' ' ALA . . . -59.27 -56.39 22.72 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 20' ' ' ALA . . . -37.46 -49.66 1.04 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 122.192 0.996 . . . . 0.0 109.267 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.8 t -57.26 -66.56 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.749 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.582 ' O ' ' N ' ' A' ' 25' ' ' ILE . 0.7 OUTLIER -69.1 -55.29 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 120.947 -1.096 . . . . 0.0 110.276 -179.096 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.538 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 2.4 t80 -28.72 -38.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.35 0.595 . . . . 0.0 109.68 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.582 ' N ' ' O ' ' A' ' 23' ' ' ILE . 25.5 mt -77.32 -54.66 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.529 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.8 OUTLIER -61.26 -66.9 0.46 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.19 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.539 ' O ' ' CB ' ' A' ' 31' ' ' SER . 0.1 OUTLIER -39.2 -41.9 0.91 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.472 0.653 . . . . 0.0 109.244 177.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 24' ' ' PHE . . . -53.9 -51.44 63.71 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.626 0.727 . . . . 0.0 110.931 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.427 ' HB2' HD13 ' A' ' 30' ' ' LEU . . . -52.17 -58.06 7.75 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.537 -0.727 . . . . 0.0 110.849 -178.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.427 HD13 ' HB2' ' A' ' 29' ' ' ALA . 2.6 mp -106.07 38.86 1.92 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 0.0 110.736 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.607 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -90.93 -56.79 0.25 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.985 -1.072 . . . . 0.0 110.786 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.607 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 45.2 Cg_endo -93.36 -17.3 0.66 Allowed 'Trans proline' 0 N--CA 1.501 1.964 1 C-N-CA 126.279 4.652 . . . . 0.0 111.882 -177.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.006 -1.059 . . . . 0.0 110.916 -178.511 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 4.6 t . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.466 ' O ' ' HB3' ' A' ' 19' ' ' LEU . 45.7 Cg_endo -92.59 -69.52 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.733 1 C-N-CA 126.353 4.702 . . . . 0.0 109.845 179.579 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -57.45 -49.37 76.49 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.411 ' O ' HG11 ' A' ' 18' ' ' VAL . 97.3 t -61.04 -23.49 30.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' A' ' 15' ' ' SER . 6.2 tp -58.69 -54.16 50.18 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.88 -1.137 . . . . 0.0 108.63 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.0 -54.59 44.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.427 -0.795 . . . . 0.0 109.8 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.14 -55.69 7.97 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.881 0.848 . . . . 0.0 110.042 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.494 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 28.8 t -55.2 -41.01 58.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 O-C-N 121.802 -0.562 . . . . 0.0 109.875 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 19' ' ' LEU . 46.7 mm -72.11 -22.1 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.416 -0.802 . . . . 0.0 110.201 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -63.61 -52.31 61.45 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.5 mt -74.62 -26.99 20.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.549 ' O ' ' CG ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -70.15 -20.19 63.16 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.075 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.48 ' HA ' ' HB2' ' A' ' 30' ' ' LEU . 10.0 t80 -83.23 -44.37 15.07 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.29 -51.94 30.75 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.023 0.916 . . . . 0.0 108.676 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.507 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -74.1 -41.24 61.95 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.772 0.796 . . . . 0.0 109.955 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.56 ' CD1' ' HB1' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -60.63 -0.03 0.24 Allowed 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.152 -178.51 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.565 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -35.35 -49.0 1.24 Allowed Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.028 -1.045 . . . . 0.0 110.547 -179.629 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 31' ' ' SER . 44.4 Cg_endo -91.48 -23.67 0.44 Allowed 'Trans proline' 0 N--CA 1.502 1.992 1 C-N-CA 126.533 4.822 . . . . 0.0 111.363 -179.422 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.56 ' HB1' ' CD1' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.198 -0.939 . . . . 0.0 110.847 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.47 ' OG ' ' HB ' ' A' ' 18' ' ' VAL . 1.5 t . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -86.91 -61.24 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.781 1 C-N-CA 125.986 4.457 . . . . 0.0 110.062 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.09 -31.07 62.9 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.388 -0.82 . . . . 0.0 109.128 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.47 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 5.5 t -89.33 -40.31 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.441 -0.787 . . . . 0.0 110.491 -179.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 15' ' ' SER . 33.6 tp -57.73 -56.28 23.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.574 -1.329 . . . . 0.0 108.488 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.434 ' O ' ' C ' ' A' ' 21' ' ' ALA . . . -55.24 -55.23 33.69 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.494 -0.754 . . . . 0.0 109.429 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 20' ' ' ALA . . . -42.24 -52.66 4.37 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.944 0.878 . . . . 0.0 109.692 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.7 t -48.65 -55.0 3.71 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 121.173 0.511 . . . . 0.0 110.377 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 25' ' ' ILE . 45.7 mm -63.49 -54.46 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.097 -1.002 . . . . 0.0 110.778 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.523 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -32.71 -36.08 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.643 -0.661 . . . . 0.0 109.661 -179.552 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.528 ' N ' ' O ' ' A' ' 23' ' ' ILE . 43.4 mt -76.5 -53.98 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.405 -0.809 . . . . 0.0 109.058 178.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.479 ' O ' ' N ' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -57.58 -64.9 0.74 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.521 ' O ' ' OG ' ' A' ' 31' ' ' SER . 0.1 OUTLIER -39.33 -29.3 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.715 0.769 . . . . 0.0 109.236 177.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.495 ' HB1' ' O ' ' A' ' 24' ' ' PHE . . . -63.65 -62.27 1.77 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.538 -0.726 . . . . 0.0 111.202 -178.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.62 -66.76 0.9 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.179 -0.951 . . . . 0.0 112.883 -177.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.15 36.96 0.92 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.132 -0.98 . . . . 0.0 110.557 -177.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.649 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -47.09 -62.79 1.75 Allowed Pre-proline 0 C--N 1.295 -1.788 0 O-C-N 121.199 -0.938 . . . . 0.0 110.878 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.649 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 49.7 Cg_endo -98.88 -0.48 1.03 Allowed 'Trans proline' 0 N--CA 1.501 1.968 1 C-N-CA 126.347 4.698 . . . . 0.0 111.337 -178.337 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.008 -1.057 . . . . 0.0 110.541 -178.774 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -91.69 -66.97 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.755 1 C-N-CA 126.374 4.716 . . . . 0.0 110.645 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.36 -42.26 86.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -0.903 . . . . 0.0 109.466 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.0 t -73.11 -19.09 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.372 -0.83 . . . . 0.0 109.155 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 15' ' ' SER . 0.4 OUTLIER -65.36 -47.11 77.56 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.069 -1.02 . . . . 0.0 108.81 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.86 -53.35 18.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.388 -0.82 . . . . 0.0 109.132 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.53 -55.77 10.17 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.895 0.855 . . . . 0.0 109.532 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.7 t -51.73 -47.92 38.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 O-C-N 121.789 -0.569 . . . . 0.0 109.519 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.493 ' O ' ' HB2' ' A' ' 27' ' ' PHE . 22.9 mm -64.54 -26.32 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 110.114 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -64.58 -36.49 84.41 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 120.515 -1.366 . . . . 0.0 108.141 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.3 mt -74.82 -41.88 46.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.497 ' O ' ' N ' ' A' ' 28' ' ' ALA . 6.4 m-85 -60.62 -64.22 1.03 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.608 ' HA ' ' CB ' ' A' ' 31' ' ' SER . 0.8 OUTLIER -37.07 -31.33 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.97 0.89 . . . . 0.0 109.099 177.087 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 26' ' ' TYR . . . -75.24 -53.83 8.14 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.7 -89.38 0.18 Allowed 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.875 -1.141 . . . . 0.0 113.633 -175.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.37 35.26 3.12 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.505 -0.747 . . . . 0.0 112.802 -175.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.608 ' CB ' ' HA ' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -71.14 -48.2 13.59 Favored Pre-proline 0 C--N 1.293 -1.866 0 O-C-N 120.665 -1.272 . . . . 0.0 109.614 179.152 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 31' ' ' SER . 40.3 Cg_endo -86.29 16.76 1.89 Allowed 'Trans proline' 0 C--N 1.303 -1.819 1 C-N-CA 126.307 4.671 . . . . 0.0 110.498 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.444 0 O-C-N 121.221 -0.925 . . . . 0.0 109.258 179.681 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.545 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.545 ' HD3' ' N ' ' A' ' 15' ' ' SER . 43.5 Cg_endo -91.01 -65.09 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.765 1 C-N-CA 126.13 4.553 . . . . 0.0 109.88 179.694 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -60.47 -27.01 67.21 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.367 -0.833 . . . . 0.0 109.056 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.2 t -73.39 -26.82 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.326 -0.859 . . . . 0.0 109.554 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.04 -52.81 37.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.058 -1.026 . . . . 0.0 108.32 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.09 -47.16 61.95 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.88 -54.59 27.49 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.608 0.718 . . . . 0.0 109.362 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.423 ' O ' HG11 ' A' ' 22' ' ' VAL . 89.7 t -48.93 -31.22 3.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.524 -0.735 . . . . 0.0 109.28 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.502 ' HA ' ' HB2' ' A' ' 26' ' ' TYR . 82.0 mt -78.47 -36.17 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.408 -0.807 . . . . 0.0 109.565 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.63 -43.33 97.64 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mt -76.0 -31.29 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.502 ' HB2' ' HA ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -67.55 -19.15 65.25 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.284 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -85.75 -38.59 18.07 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.507 ' O ' ' OG ' ' A' ' 31' ' ' SER . . . -51.17 -50.53 58.82 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.585 0.707 . . . . 0.0 109.749 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.481 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -76.34 -47.79 22.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.606 -0.684 . . . . 0.0 110.642 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.539 ' CD1' ' HB2' ' A' ' 33' ' ' ALA . 4.4 mm? -66.08 3.71 0.81 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.614 -0.679 . . . . 0.0 112.042 -178.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.558 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -45.99 -53.98 18.98 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 120.445 -1.41 . . . . 0.0 111.068 -179.083 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.558 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 42.9 Cg_endo -92.48 -17.7 0.82 Allowed 'Trans proline' 0 N--CA 1.501 1.914 1 C-N-CA 126.397 4.731 . . . . 0.0 111.751 -178.319 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.539 ' HB2' ' CD1' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.68 0 O-C-N 120.779 -1.201 . . . . 0.0 110.156 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.474 ' OG ' ' HB ' ' A' ' 18' ' ' VAL . 16.3 t . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -89.99 -64.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.757 1 C-N-CA 126.234 4.622 . . . . 0.0 110.034 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -55.7 -59.22 5.16 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.474 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 25.4 t -51.55 -24.96 4.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 15' ' ' SER . 0.2 OUTLIER -63.38 -53.16 56.89 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.214 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.85 -50.54 70.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.478 -0.764 . . . . 0.0 109.006 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.24 -55.59 10.12 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.752 0.787 . . . . 0.0 109.768 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.2 t -55.65 -38.73 51.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 O-C-N 121.71 -0.619 . . . . 0.0 109.601 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 19' ' ' LEU . 22.7 mt -69.19 -26.81 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.237 -0.915 . . . . 0.0 109.449 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -60.76 -41.51 95.6 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.1 mt -72.4 -41.02 64.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -61.56 -22.8 65.49 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.485 ' O ' ' HB2' ' A' ' 31' ' ' SER . 0.2 OUTLIER -84.62 -29.3 25.86 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 122.044 0.926 . . . . 0.0 108.577 179.416 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.7 -61.81 1.63 Allowed 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.802 -0.561 . . . . 0.0 111.1 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.36 -62.08 1.51 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.038 -1.039 . . . . 0.0 112.708 -177.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.4 mt -83.11 26.17 0.64 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.961 -1.087 . . . . 0.0 111.417 -177.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.576 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -58.13 -51.52 81.17 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 120.826 -1.172 . . . . 0.0 109.541 179.472 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.576 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 46.3 Cg_endo -94.45 -9.87 1.49 Allowed 'Trans proline' 0 N--CA 1.498 1.786 1 C-N-CA 126.71 4.94 . . . . 0.0 110.533 -179.375 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 32' ' ' PRO . . . . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.287 -0.883 . . . . 0.0 110.156 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.509 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.777 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -89.7 -65.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.763 1 C-N-CA 126.143 4.562 . . . . 0.0 109.752 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -55.48 -51.26 67.56 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.469 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 72.4 t -62.1 -23.4 31.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.628 -0.67 . . . . 0.0 109.303 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.509 ' HB2' ' O ' ' A' ' 15' ' ' SER . 3.9 tp -56.89 -58.02 9.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.151 -0.968 . . . . 0.0 108.694 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.77 -53.59 38.09 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -44.67 -52.48 8.2 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 122.036 0.922 . . . . 0.0 109.68 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.8 t -49.94 -49.9 20.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.235 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.6 mt -66.96 -26.87 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -0.975 . . . . 0.0 109.832 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -54.74 -42.0 71.1 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.096 -1.002 . . . . 0.0 108.743 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.72 -44.11 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.107 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.06 -19.17 29.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.905 -1.122 . . . . 0.0 108.17 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.521 ' O ' ' CB ' ' A' ' 31' ' ' SER . 0.2 OUTLIER -90.81 -34.91 15.12 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.952 0.882 . . . . 0.0 108.74 179.555 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 31' ' ' SER . . . -76.04 -67.93 0.63 Allowed 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.395 0.617 . . . . 0.0 110.4 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.28 -56.28 24.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.389 -0.819 . . . . 0.0 110.623 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.455 ' HA ' ' HB1' ' A' ' 33' ' ' ALA . 9.8 mp -85.13 25.59 0.96 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.347 -0.846 . . . . 0.0 110.547 -178.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.577 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -66.13 -49.52 55.51 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.075 -1.015 . . . . 0.0 110.046 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 31' ' ' SER . 42.8 Cg_endo -91.1 -5.76 4.1 Favored 'Trans proline' 0 C--N 1.303 -1.821 1 C-N-CA 126.557 4.838 . . . . 0.0 111.186 -179.097 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.455 ' HB1' ' HA ' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.023 -1.048 . . . . 0.0 109.647 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.516 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.397 0 CA-C-O 120.539 0.209 . . . . 0.0 111.461 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -89.77 -69.42 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.71 1 C-N-CA 126.072 4.515 . . . . 0.0 109.884 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -55.6 -46.21 77.35 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.526 ' CG1' HG21 ' A' ' 22' ' ' VAL . 47.5 t -66.72 -26.84 38.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.516 ' HB2' ' O ' ' A' ' 15' ' ' SER . 2.7 tp -52.58 -44.14 65.72 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.473 -1.392 . . . . 0.0 108.587 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.76 -50.94 61.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.511 -0.743 . . . . 0.0 109.783 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.21 -64.48 0.85 Allowed 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 122.029 0.919 . . . . 0.0 109.285 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.526 HG21 ' CG1' ' A' ' 18' ' ' VAL . 77.3 t -51.59 -33.73 15.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.865 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.487 ' O ' ' HB2' ' A' ' 27' ' ' PHE . 82.5 mt -78.96 -26.06 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.751 -1.218 . . . . 0.0 109.559 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -57.85 -53.42 58.41 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.2 mp -70.17 -36.44 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.495 ' HA ' ' HB2' ' A' ' 30' ' ' LEU . 0.5 OUTLIER -64.63 -15.58 61.44 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.588 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.487 ' HB2' ' O ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -90.18 -26.0 20.37 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.208 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.62 -79.17 0.22 Allowed 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.605 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.469 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -91.66 -56.95 2.91 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.382 -0.823 . . . . 0.0 112.83 -177.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.495 ' HB2' ' HA ' ' A' ' 26' ' ' TYR . 15.9 mt -68.93 8.91 0.46 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.142 -0.974 . . . . 0.0 112.362 -177.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.575 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.9 OUTLIER -44.35 -48.66 25.29 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 120.626 -1.296 . . . . 0.0 110.112 179.585 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 31' ' ' SER . 42.9 Cg_endo -91.84 -15.69 1.3 Allowed 'Trans proline' 0 N--CA 1.5 1.874 1 C-N-CA 126.707 4.938 . . . . 0.0 111.131 -179.198 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.43 ' HB1' ' HB3' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.69 0 O-C-N 121.063 -1.023 . . . . 0.0 110.038 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.475 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 120.775 0.321 . . . . 0.0 110.212 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.476 ' HD2' ' OE1' ' A' ' 17' ' ' GLN . 43.2 Cg_endo -89.39 -65.64 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.669 1 C-N-CA 126.236 4.624 . . . . 0.0 108.786 178.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.48 ' OE1' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -65.14 -26.53 68.22 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.669 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.48 HG21 ' OE1' ' A' ' 17' ' ' GLN . 22.0 t -78.04 -20.68 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.483 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 1.0 OUTLIER -64.66 -49.02 72.65 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.321 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 21' ' ' ALA . . . -62.73 -56.86 13.79 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 20' ' ' ALA . . . -42.06 -48.76 4.72 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.951 0.881 . . . . 0.0 109.185 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 3.4 t -44.01 -55.29 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.5 mm -54.64 -39.59 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 119.172 -1.011 . . . . 0.0 109.021 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -51.38 -40.41 59.18 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.276 -0.89 . . . . 0.0 108.755 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.456 HD11 ' HA ' ' A' ' 22' ' ' VAL . 7.1 mt -73.15 -40.22 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.313 -0.867 . . . . 0.0 108.95 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -62.84 -16.62 59.17 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.7 -36.45 15.21 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 31' ' ' SER . . . -62.08 -56.61 17.17 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.458 0.646 . . . . 0.0 110.098 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.535 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -57.21 -46.71 82.66 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.474 -0.766 . . . . 0.0 110.563 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.539 ' CD2' ' HB2' ' A' ' 33' ' ' ALA . 1.9 tm? -63.94 -1.29 1.39 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.871 -0.518 . . . . 0.0 111.675 -178.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.589 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -45.91 -57.03 8.79 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 120.832 -1.167 . . . . 0.0 112.219 -178.907 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.589 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 43.1 Cg_endo -91.1 -23.7 0.48 Allowed 'Trans proline' 0 N--CA 1.502 1.986 1 C-N-CA 126.105 4.537 . . . . 0.0 112.122 -177.408 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.539 ' HB2' ' CD2' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.554 0 O-C-N 120.745 -1.222 . . . . 0.0 109.27 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.542 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 8.2 t . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.542 ' HD3' ' N ' ' A' ' 15' ' ' SER . 44.7 Cg_endo -89.83 -64.65 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.747 1 C-N-CA 125.893 4.395 . . . . 0.0 110.074 -179.419 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -45.07 -32.52 1.77 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.196 -0.94 . . . . 0.0 109.66 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.7 t -86.44 -46.6 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 110.504 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.522 HD22 ' CD1' ' A' ' 23' ' ' ILE . 0.9 OUTLIER -57.54 -60.23 3.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.671 -1.268 . . . . 0.0 108.482 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.59 -47.31 39.87 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.472 -0.767 . . . . 0.0 109.285 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 24' ' ' PHE . . . -49.03 -55.44 12.02 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.938 0.875 . . . . 0.0 109.786 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.1 t -55.29 -51.83 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 121.648 0.737 . . . . 0.0 109.848 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.522 ' CD1' HD22 ' A' ' 19' ' ' LEU . 5.9 mt -66.92 -15.89 20.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.225 -0.922 . . . . 0.0 109.435 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.484 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -64.94 -39.75 93.97 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 179.453 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.9 mt -67.75 -45.71 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.617 ' CE1' ' HG ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -61.33 -69.94 0.21 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.599 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.552 ' HA ' ' CB ' ' A' ' 31' ' ' SER . 0.5 OUTLIER -41.34 -30.16 0.17 Allowed 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.679 0.752 . . . . 0.0 110.201 178.2 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.24 -58.04 3.59 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.449 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -91.09 -73.53 0.53 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -175.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.617 ' HG ' ' CE1' ' A' ' 26' ' ' TYR . 2.0 pt? -85.47 26.07 0.97 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.966 -1.083 . . . . 0.0 112.364 -175.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.552 ' CB ' ' HA ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -90.02 -50.6 0.36 Allowed Pre-proline 0 C--N 1.296 -1.726 0 O-C-N 120.825 -1.172 . . . . 0.0 109.919 179.108 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 31' ' ' SER . 41.7 Cg_endo -90.58 20.22 1.02 Allowed 'Trans proline' 0 C--N 1.303 -1.829 1 C-N-CA 126.565 4.844 . . . . 0.0 110.823 -179.223 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.459 0 O-C-N 121.099 -1.001 . . . . 0.0 109.706 179.918 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -92.43 -68.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.771 1 C-N-CA 126.392 4.728 . . . . 0.0 110.458 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -52.29 -56.53 14.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 108.867 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.46 ' O ' ' C ' ' A' ' 19' ' ' LEU . 71.9 t -58.63 -33.0 47.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.478 ' O ' HG13 ' A' ' 23' ' ' ILE . 4.6 tp -44.94 -43.1 8.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.664 -1.273 . . . . 0.0 108.671 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.62 -52.94 32.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.472 -0.767 . . . . 0.0 109.615 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.5 -59.99 3.78 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 121.67 0.748 . . . . 0.0 109.597 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.429 HG22 ' CG1' ' A' ' 18' ' ' VAL . 2.8 t -51.77 -39.63 24.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 O-C-N 121.68 -0.638 . . . . 0.0 109.585 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.481 ' HA ' ' HB2' ' A' ' 26' ' ' TYR . 63.7 mt -67.15 -30.13 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.967 -1.083 . . . . 0.0 109.493 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.401 ' O ' ' HB2' ' A' ' 27' ' ' PHE . 5.2 t80 -57.27 -50.48 72.78 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.5 mt -65.98 -36.97 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.481 ' HB2' ' HA ' ' A' ' 23' ' ' ILE . 3.2 m-85 -62.78 -21.09 65.6 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -81.65 -34.44 30.8 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.045 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 31' ' ' SER . . . -63.44 -56.88 12.65 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.454 0.645 . . . . 0.0 109.34 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.01 -54.95 22.39 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.535 -0.728 . . . . 0.0 110.221 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' A' ' 26' ' ' TYR . 1.9 mp -81.13 22.08 0.67 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.351 -0.843 . . . . 0.0 110.593 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.601 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -61.37 -47.63 93.29 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 120.989 -1.069 . . . . 0.0 110.01 179.722 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 31' ' ' SER . 40.8 Cg_endo -89.96 -6.1 4.9 Favored 'Trans proline' 0 N--CA 1.499 1.822 1 C-N-CA 126.609 4.873 . . . . 0.0 110.853 -179.454 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.455 ' HB1' ' HA ' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.069 -1.019 . . . . 0.0 109.541 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 1.3 t . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -94.53 -75.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 1 C-N-CA 126.342 4.695 . . . . 0.0 108.988 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -68.18 -19.05 64.75 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.488 ' O ' HG21 ' A' ' 22' ' ' VAL . 3.5 t -82.03 -20.64 10.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.487 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 0.7 OUTLIER -71.78 -50.82 26.49 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.43 -53.57 53.01 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.81 -46.18 50.78 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.099 0.952 . . . . 0.0 108.781 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.488 HG21 ' O ' ' A' ' 18' ' ' VAL . 2.1 t -45.05 -43.18 2.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.281 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.455 ' HA ' ' HB2' ' A' ' 26' ' ' TYR . 30.1 mm -68.99 -36.94 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.125 -0.984 . . . . 0.0 109.371 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.03 -50.03 70.09 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.158 -0.964 . . . . 0.0 108.419 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.8 mm -71.63 -26.54 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.469 ' O ' ' HB3' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -73.38 -15.56 61.36 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 178.553 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.441 ' HA ' HD22 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -89.76 -36.02 15.39 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.11 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.13 -56.83 8.3 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.617 0.722 . . . . 0.0 109.785 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.17 -50.22 74.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.666 -0.646 . . . . 0.0 111.009 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.576 ' O ' ' CD1' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -67.84 5.74 0.81 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.43 -0.793 . . . . 0.0 111.821 -177.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.573 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -36.91 -48.45 1.93 Allowed Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.727 -1.233 . . . . 0.0 110.875 179.756 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 31' ' ' SER . 41.2 Cg_endo -87.84 -34.06 0.12 Allowed 'Trans proline' 0 N--CA 1.502 1.977 1 C-N-CA 126.304 4.669 . . . . 0.0 111.303 -179.361 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.503 ' HB1' ' HA ' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.762 0 O-C-N 121.02 -1.05 . . . . 0.0 110.306 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -87.77 -61.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.72 1 C-N-CA 126.041 4.494 . . . . 0.0 109.565 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -54.23 -53.31 55.27 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.22 -0.925 . . . . 0.0 108.734 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -55.4 -39.26 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.505 -0.747 . . . . 0.0 109.105 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.488 ' C ' ' CD1' ' A' ' 19' ' ' LEU . 2.0 tm? -47.49 -49.17 26.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.856 -1.153 . . . . 0.0 109.024 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.85 -51.14 70.84 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.464 -0.773 . . . . 0.0 109.317 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.52 -56.13 9.17 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.769 0.795 . . . . 0.0 109.944 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 44.7 t -51.25 -37.26 17.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 O-C-N 121.708 -0.62 . . . . 0.0 110.248 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -77.23 -26.62 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.114 -0.991 . . . . 0.0 110.249 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -66.17 -34.87 79.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.064 -1.022 . . . . 0.0 108.584 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.4 mm -81.29 -31.13 11.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.508 ' O ' ' HB3' ' A' ' 30' ' ' LEU . 6.1 m-85 -67.72 -28.21 67.46 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.514 ' O ' ' CB ' ' A' ' 31' ' ' SER . 5.0 t80 -74.4 -37.04 63.49 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.4 -59.27 4.19 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.279 0.561 . . . . 0.0 110.507 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.465 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -89.38 -54.04 4.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.293 -0.879 . . . . 0.0 111.201 -178.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.541 ' HG ' ' CB ' ' A' ' 33' ' ' ALA . 1.8 tp -75.85 16.69 0.38 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.269 -0.894 . . . . 0.0 111.238 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.587 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -57.22 -47.14 99.55 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 120.785 -1.197 . . . . 0.0 110.621 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 31' ' ' SER . 42.7 Cg_endo -87.99 -31.35 0.21 Allowed 'Trans proline' 0 N--CA 1.502 1.976 1 C-N-CA 126.352 4.701 . . . . 0.0 111.186 -178.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.541 ' CB ' ' HG ' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.083 -1.011 . . . . 0.0 109.557 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.484 1.252 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -94.86 -73.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.638 1 C-N-CA 126.472 4.781 . . . . 0.0 109.933 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.518 ' HG3' ' N ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -60.39 -25.28 65.78 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.512 -0.743 . . . . 0.0 109.144 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.518 ' N ' ' HG3' ' A' ' 17' ' ' GLN . 2.7 t -84.46 -23.41 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.38 -0.825 . . . . 0.0 109.448 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 15' ' ' SER . 1.6 tt -63.29 -45.06 93.19 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.891 -1.131 . . . . 0.0 108.547 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.02 -54.91 12.65 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.441 -0.787 . . . . 0.0 109.222 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -46.16 -57.44 4.51 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.714 0.768 . . . . 0.0 109.393 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.6 t -45.24 -46.24 3.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.482 ' O ' ' N ' ' A' ' 26' ' ' TYR . 11.8 mm -61.51 -56.11 20.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.418 -0.801 . . . . 0.0 109.83 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.462 ' C ' ' O ' ' A' ' 23' ' ' ILE . 1.8 t80 -38.2 -38.62 0.36 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.24 -0.912 . . . . 0.0 109.452 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.7 mt -75.32 -45.7 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.517 ' O ' ' N ' ' A' ' 28' ' ' ALA . 4.2 m-30 -55.46 -69.9 0.12 Allowed 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.536 ' O ' ' CB ' ' A' ' 31' ' ' SER . 0.1 OUTLIER -35.24 -32.53 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.881 0.848 . . . . 0.0 109.52 177.859 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 26' ' ' TYR . . . -64.36 -60.43 3.19 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.649 -0.657 . . . . 0.0 110.498 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.23 -63.29 1.28 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.075 -1.016 . . . . 0.0 112.341 -178.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.455 ' HB2' ' CB ' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -89.68 37.05 0.86 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.021 -1.05 . . . . 0.0 110.191 -177.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.551 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -49.62 -51.07 62.58 Favored Pre-proline 0 C--N 1.297 -1.687 0 O-C-N 121.601 -0.687 . . . . 0.0 110.242 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.551 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 44.2 Cg_endo -90.62 0.18 5.15 Favored 'Trans proline' 0 N--CA 1.501 1.948 1 C-N-CA 126.533 4.822 . . . . 0.0 111.282 -178.846 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.455 ' CB ' ' HB2' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 120.988 -1.07 . . . . 0.0 109.816 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.599 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 2.3 m . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 110.524 -0.176 . . . . 0.0 110.524 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 15' ' ' SER . 41.8 Cg_endo -82.29 -47.38 0.06 OUTLIER 'Trans proline' 0 N--CA 1.5 1.885 1 C-N-CA 125.472 4.114 . . . . 0.0 109.746 -179.876 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -51.6 -34.98 39.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 0.0 109.018 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.428 ' O ' ' C ' ' A' ' 19' ' ' LEU . 52.2 t -72.95 -43.24 59.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.343 -0.848 . . . . 0.0 109.329 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 18' ' ' VAL . 4.4 tt -45.09 -49.04 11.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.143 -0.973 . . . . 0.0 108.595 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 21' ' ' ALA . . . -54.69 -51.38 65.71 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' A' ' 22' ' ' VAL . . . -44.53 -54.37 6.11 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.81 0.814 . . . . 0.0 109.016 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 41.3 t -43.47 -52.8 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.769 -0.582 . . . . 0.0 109.532 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.3 mt -56.67 -43.82 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.082 -1.011 . . . . 0.0 108.722 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.16 -37.79 16.46 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.451 HG21 ' HB2' ' A' ' 29' ' ' ALA . 74.1 mt -72.21 -43.72 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.485 ' HA ' ' HB2' ' A' ' 30' ' ' LEU . 18.5 t80 -52.58 -23.95 7.37 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.518 ' O ' ' CB ' ' A' ' 31' ' ' SER . 3.8 t80 -89.25 -34.21 16.7 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 122.021 0.915 . . . . 0.0 108.644 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.11 -70.08 0.7 Allowed 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.286 0.565 . . . . 0.0 111.478 -178.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.456 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -79.23 -60.58 2.31 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.283 -0.886 . . . . 0.0 112.29 -177.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 26' ' ' TYR . 38.9 mt -84.2 27.35 0.69 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.922 -1.111 . . . . 0.0 110.715 -178.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.566 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -81.73 -50.82 0.87 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.069 -1.019 . . . . 0.0 109.944 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.566 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 42.8 Cg_endo -91.43 -15.23 1.51 Allowed 'Trans proline' 0 N--CA 1.5 1.862 1 C-N-CA 126.57 4.847 . . . . 0.0 110.75 -179.255 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.467 ' HB1' ' HA ' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 110.163 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.488 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.003 -0.046 . . . . 0.0 111.058 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.488 ' HD3' ' CB ' ' A' ' 15' ' ' SER . 38.9 Cg_endo -82.23 -23.72 4.2 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 125.004 3.803 . . . . 0.0 110.116 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -71.4 -14.8 62.28 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.2 t -84.46 -33.11 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.464 -0.772 . . . . 0.0 109.205 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.471 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 2.3 tp -65.35 -53.67 40.2 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.17 -51.05 65.57 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.426 ' O ' ' C ' ' A' ' 22' ' ' VAL . . . -43.93 -53.86 5.82 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.868 0.842 . . . . 0.0 108.853 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 16.5 t -42.76 -47.61 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 121.782 -0.574 . . . . 0.0 109.527 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.3 mt -66.75 -38.73 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.054 -1.029 . . . . 0.0 109.568 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.82 -39.33 62.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.965 -1.085 . . . . 0.0 108.58 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.4 mt -67.75 -38.27 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -61.84 -21.13 64.39 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.581 ' CG ' HD22 ' A' ' 30' ' ' LEU . 2.0 t80 -73.62 -36.03 65.42 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 177.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.36 -49.3 78.36 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.555 ' O ' ' CD ' ' A' ' 32' ' ' PRO . . . -63.81 -44.24 93.87 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.404 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.581 HD22 ' CG ' ' A' ' 27' ' ' PHE . 0.8 OUTLIER -48.79 -12.01 0.04 OUTLIER 'General case' 0 N--CA 1.509 2.481 0 O-C-N 121.766 -0.584 . . . . 0.0 112.029 -178.503 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.486 ' C ' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -28.73 -50.55 0.25 Allowed Pre-proline 0 N--CA 1.502 2.144 0 O-C-N 121.382 -0.824 . . . . 0.0 112.709 -178.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.555 ' CD ' ' O ' ' A' ' 29' ' ' ALA . 38.0 Cg_endo -85.88 -32.17 0.28 Allowed 'Trans proline' 0 N--CA 1.501 1.958 1 C-N-CA 126.028 4.485 . . . . 0.0 110.757 -178.85 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.238 -0.914 . . . . 0.0 109.421 179.038 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.6 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 15' ' ' SER . 40.8 Cg_endo -82.23 -26.7 2.67 Favored 'Trans proline' 0 N--CA 1.502 1.987 1 C-N-CA 125.577 4.185 . . . . 0.0 109.955 -179.783 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.59 -21.24 58.0 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.281 -0.887 . . . . 0.0 109.112 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.0 t -88.75 -46.63 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.334 -0.854 . . . . 0.0 109.398 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.425 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 0.2 OUTLIER -54.27 -49.28 69.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.986 -1.071 . . . . 0.0 108.451 179.389 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 21' ' ' ALA . . . -56.22 -53.54 56.0 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 20' ' ' ALA . . . -41.01 -52.29 3.16 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.943 0.877 . . . . 0.0 109.386 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 9.4 t -47.65 -49.61 9.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.972 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.1 mt -67.5 -31.09 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.029 -1.044 . . . . 0.0 110.158 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.65 -39.39 58.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.971 -1.08 . . . . 0.0 108.995 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.9 mm -72.69 -44.97 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.267 -0.896 . . . . 0.0 108.957 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.484 ' CD1' ' O ' ' A' ' 26' ' ' TYR . 13.1 t80 -58.46 -20.61 46.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.096 -1.003 . . . . 0.0 108.349 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.461 ' O ' ' OG ' ' A' ' 31' ' ' SER . 0.2 OUTLIER -90.9 -31.0 16.58 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.84 0.828 . . . . 0.0 109.14 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.28 -71.37 0.41 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.354 0.597 . . . . 0.0 110.827 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.48 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -77.53 -50.69 12.08 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.4 -0.813 . . . . 0.0 111.007 -178.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.478 ' HA ' ' HB1' ' A' ' 33' ' ' ALA . 0.4 OUTLIER -77.39 18.57 0.4 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.401 -0.812 . . . . 0.0 111.247 -178.56 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.573 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -68.13 -52.64 22.09 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.613 -1.304 . . . . 0.0 109.996 -179.812 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.573 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 44.6 Cg_endo -93.54 -12.18 1.38 Allowed 'Trans proline' 0 N--CA 1.5 1.903 1 C-N-CA 126.561 4.841 . . . . 0.0 110.545 -179.6 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.478 ' HB1' ' HA ' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.675 0 O-C-N 121.322 -0.861 . . . . 0.0 110.06 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -82.11 -48.57 0.05 OUTLIER 'Trans proline' 0 N--CA 1.501 1.959 1 C-N-CA 125.96 4.44 . . . . 0.0 109.857 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.57 -26.14 60.69 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.34 -0.85 . . . . 0.0 108.922 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.414 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 74.5 t -87.91 -26.55 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.485 -0.759 . . . . 0.0 109.56 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 15' ' ' SER . 0.7 OUTLIER -68.32 -54.18 19.15 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.137 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.64 -49.53 72.62 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.61 -55.05 18.1 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.751 0.786 . . . . 0.0 109.979 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 64.0 t -52.71 -40.74 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.687 -0.633 . . . . 0.0 110.442 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.425 HD11 ' O ' ' A' ' 19' ' ' LEU . 4.3 mt -77.85 -20.42 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.11 -0.994 . . . . 0.0 110.262 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.84 -46.96 85.46 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.242 -0.911 . . . . 0.0 108.659 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.8 mp -72.6 -34.49 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.302 -0.873 . . . . 0.0 108.921 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.551 ' O ' ' CD2' ' A' ' 30' ' ' LEU . 2.3 m-85 -65.29 -27.54 68.7 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -74.89 -43.6 53.46 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.12 -56.33 21.08 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.442 0.639 . . . . 0.0 109.938 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.61 -56.54 5.66 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.546 -0.721 . . . . 0.0 110.987 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.574 ' O ' ' CD1' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -80.37 23.14 0.51 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.164 -0.96 . . . . 0.0 110.535 -178.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.564 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -38.22 -48.89 3.29 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.045 -1.034 . . . . 0.0 110.665 179.828 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 31' ' ' SER . 41.8 Cg_endo -89.42 -24.1 0.72 Allowed 'Trans proline' 0 N--CA 1.502 1.972 1 C-N-CA 126.546 4.831 . . . . 0.0 111.413 -179.22 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.547 ' CB ' ' HB2' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.597 0 O-C-N 120.917 -1.114 . . . . 0.0 110.055 -179.389 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.403 ' OG ' ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -91.05 -66.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.865 1 C-N-CA 126.424 4.75 . . . . 0.0 109.646 179.555 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -59.21 -41.49 88.71 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.374 -0.829 . . . . 0.0 108.776 179.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.403 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 2.5 t -65.74 -24.63 34.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.147 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.476 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 1.6 tt -58.75 -54.04 51.55 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.374 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.82 -53.59 46.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.106 -0.996 . . . . 0.0 108.607 179.131 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -44.05 -52.16 7.32 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.841 0.829 . . . . 0.0 109.32 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 38.1 t -44.0 -46.84 2.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 121.902 -0.499 . . . . 0.0 109.802 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.407 ' O ' ' C ' ' A' ' 24' ' ' PHE . 16.6 mt -61.75 -44.02 98.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.961 . . . . 0.0 109.39 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' ILE . 5.6 t80 -46.41 -45.36 17.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.935 . . . . 0.0 108.892 179.645 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.3 mm -68.9 -42.55 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.4 -0.812 . . . . 0.0 108.825 179.369 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.426 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.7 t80 -58.7 -18.81 34.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.998 -1.064 . . . . 0.0 108.349 179.028 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.82 -33.58 15.63 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.881 0.848 . . . . 0.0 108.91 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.564 ' O ' ' CD ' ' A' ' 32' ' ' PRO . . . -71.15 -62.37 1.42 Allowed 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.196 0.522 . . . . 0.0 110.743 -179.285 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.514 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -64.96 -49.74 69.14 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.417 -0.802 . . . . 0.0 111.563 -178.473 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.534 ' O ' ' CD1' ' A' ' 30' ' ' LEU . 3.4 tm? -44.02 -21.99 0.05 Allowed 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.246 -0.909 . . . . 0.0 110.932 -178.173 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.683 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -82.41 -64.16 0.26 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.522 -1.362 . . . . 0.0 110.593 -179.608 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.683 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 42.8 Cg_endo -91.25 20.74 0.88 Allowed 'Trans proline' 0 N--CA 1.498 1.787 1 C-N-CA 125.719 4.279 . . . . 0.0 110.056 179.949 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.225 -0.922 . . . . 0.0 109.536 -179.949 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.742 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.587 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 8.2 mtp180 -90.48 -102.13 0.1 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.457 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.587 ' CG ' ' O ' ' A' ' 2' ' ' ARG . 57.6 m-85 -161.55 86.32 1.64 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 120.961 -1.087 . . . . 0.0 109.454 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -87.73 -78.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.802 1 C-N-CA 126.086 4.524 . . . . 0.0 110.221 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -69.83 -28.91 66.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.243 -0.911 . . . . 0.0 109.422 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.476 ' O ' ' HB2' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -48.27 -41.24 27.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -0.838 . . . . 0.0 109.685 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.58 -39.05 84.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.961 . . . . 0.0 109.88 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.4 p -84.05 18.17 2.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.316 -0.865 . . . . 0.0 110.065 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 6' ' ' TYR . 0.9 OUTLIER -86.5 -58.56 2.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.123 -0.986 . . . . 0.0 109.802 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -28.27 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.205 -0.934 . . . . 0.0 109.439 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.459 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 73.9 p -85.27 24.18 1.18 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.365 -0.834 . . . . 0.0 110.016 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 12' ' ' ASP . 15.3 t70 -90.59 8.81 32.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.036 -1.04 . . . . 0.0 110.019 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.09 -17.62 14.43 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.021 -1.049 . . . . 0.0 109.75 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.507 ' C ' ' CD1' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -76.96 1.74 16.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.259 -0.901 . . . . 0.0 110.103 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.474 ' OG ' ' HB ' ' A' ' 18' ' ' VAL . 8.0 t -146.41 94.52 4.8 Favored Pre-proline 0 N--CA 1.487 1.399 0 O-C-N 121.12 -0.988 . . . . 0.0 110.073 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -92.9 -69.32 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.704 1 C-N-CA 126.207 4.605 . . . . 0.0 110.299 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -58.17 -50.89 71.95 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.318 -0.864 . . . . 0.0 108.723 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.474 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 98.4 t -59.34 -22.42 22.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 15' ' ' SER . 13.4 tp -60.17 -57.55 12.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.063 -1.023 . . . . 0.0 108.832 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.68 -51.1 61.75 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.328 -0.858 . . . . 0.0 109.343 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.86 -55.38 11.86 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.69 0.757 . . . . 0.0 109.561 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.6 t -50.39 -34.46 11.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 121.807 -0.558 . . . . 0.0 109.535 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mt -71.46 -37.88 66.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.336 -0.852 . . . . 0.0 108.78 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -57.08 -41.03 78.11 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 35.3 mt -73.74 -32.96 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.532 ' OH ' ' CG2' ' A' ' 34' ' ' ILE . 32.8 t80 -63.84 -22.38 66.89 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -90.11 -31.79 16.95 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.57 -72.07 0.5 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.215 0.531 . . . . 0.0 111.339 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.83 -51.61 9.49 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.163 -0.961 . . . . 0.0 111.781 -177.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.468 ' HB2' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -78.13 24.57 0.24 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.38 -0.825 . . . . 0.0 111.167 -178.207 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.552 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -65.79 -49.56 58.74 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 120.96 -1.087 . . . . 0.0 110.477 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 31' ' ' SER . 43.2 Cg_endo -90.91 -21.45 0.72 Allowed 'Trans proline' 0 N--CA 1.503 2.033 1 C-N-CA 126.553 4.835 . . . . 0.0 111.54 -178.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' A' ' 34' ' ' ILE . . . -61.78 -28.44 69.46 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.941 -1.099 . . . . 0.0 110.244 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.532 ' CG2' ' OH ' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -42.98 -63.87 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.159 -0.963 . . . . 0.0 110.758 -179.424 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.518 HG21 ' N ' ' A' ' 36' ' ' PHE . 8.8 t -74.32 -28.08 61.0 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.153 -0.967 . . . . 0.0 111.269 -178.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.518 ' N ' HG21 ' A' ' 35' ' ' THR . 0.1 OUTLIER -75.82 123.01 24.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.764 -1.21 . . . . 0.0 110.161 -179.161 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.44 128.55 2.03 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 170.09 -67.8 0.15 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.3 mt -73.6 94.35 2.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.166 -1.197 . . . . 0.0 109.604 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 pp -105.23 12.13 32.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.272 -0.893 . . . . 0.0 109.567 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -146.0 67.05 0.41 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.71 -25.57 19.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.316 -1.108 . . . . 0.0 109.278 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 43' ' ' LYS . 11.0 tttt . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.433 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.735 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.548 ' O ' ' CD2' ' A' ' 3' ' ' TYR . 21.3 mtt-85 -137.23 132.66 34.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 109.602 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.573 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER 164.93 -49.77 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.178 -0.951 . . . . 0.0 109.295 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 3' ' ' TYR . 42.7 Cg_endo -86.25 -38.22 0.09 OUTLIER 'Trans proline' 0 N--CA 1.499 1.803 1 C-N-CA 126.049 4.5 . . . . 0.0 109.708 179.479 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.42 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 48.2 t80 -81.04 -18.73 45.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.418 -0.801 . . . . 0.0 109.001 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.15 -38.57 83.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.523 -0.735 . . . . 0.0 109.986 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.434 ' HA ' HD11 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -56.35 -52.41 64.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.352 -0.843 . . . . 0.0 110.061 -179.449 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 t -51.91 -21.6 3.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.201 -0.937 . . . . 0.0 110.019 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.85 -50.27 6.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.096 -1.003 . . . . 0.0 110.049 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.566 HG21 ' CD2' ' A' ' 14' ' ' PHE . 5.2 mt -55.47 -15.55 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.044 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.535 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 7.6 p -89.16 -37.06 15.32 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.997 -1.064 . . . . 0.0 110.058 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -91.68 -66.78 0.9 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.117 -0.99 . . . . 0.0 111.494 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.09 -10.83 60.0 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.212 -0.93 . . . . 0.0 112.08 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.566 ' CD2' HG21 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -90.35 11.29 21.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.456 -1.402 . . . . 0.0 110.561 -179.1 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.523 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 3.6 t 35.49 63.0 2.37 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.479 -0.763 . . . . 0.0 110.267 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.535 ' CG ' ' O ' ' A' ' 11' ' ' THR . 41.9 Cg_endo -86.26 -48.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.773 1 C-N-CA 125.98 4.454 . . . . 0.0 110.091 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -59.79 -43.41 94.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.201 -0.937 . . . . 0.0 108.772 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.46 ' O ' ' HB1' ' A' ' 21' ' ' ALA . 73.6 t -71.6 -49.03 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.528 ' O ' ' CD1' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -44.95 -42.76 8.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.106 -0.996 . . . . 0.0 108.358 179.309 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.92 -48.71 77.63 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 18' ' ' VAL . . . -52.87 -56.82 13.04 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.682 0.754 . . . . 0.0 109.927 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 43.8 t -54.37 -25.21 13.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.446 -0.784 . . . . 0.0 109.201 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.553 HD11 ' N ' ' A' ' 23' ' ' ILE . 1.6 mp -82.26 -31.73 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.476 -0.765 . . . . 0.0 109.081 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -52.12 -50.98 60.61 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.1 mt -67.88 -34.87 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.574 ' CD2' HD13 ' A' ' 30' ' ' LEU . 3.4 t80 -61.84 -19.44 62.59 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.458 ' HA ' ' HB2' ' A' ' 30' ' ' LEU . 1.8 t80 -85.65 -40.05 16.61 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.5 ' O ' ' OG ' ' A' ' 31' ' ' SER . . . -46.86 -53.07 12.9 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.89 -42.45 81.2 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.969 0.89 . . . . 0.0 109.515 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.574 HD13 ' CD2' ' A' ' 26' ' ' TYR . 73.0 mt -70.44 15.33 0.1 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.63 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.583 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.9 OUTLIER -39.25 -48.24 4.38 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 120.872 -1.143 . . . . 0.0 111.17 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 31' ' ' SER . 39.0 Cg_endo -87.0 -23.47 1.55 Allowed 'Trans proline' 0 N--CA 1.502 2.003 1 C-N-CA 126.388 4.725 . . . . 0.0 111.421 -178.63 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.536 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . . . -68.12 -13.36 62.16 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.069 -1.019 . . . . 0.0 109.882 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.528 ' CD1' ' O ' ' A' ' 31' ' ' SER . 85.4 mt -29.69 -37.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-O 120.945 0.402 . . . . 0.0 111.037 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 33' ' ' ALA . 29.1 m -75.08 -50.42 16.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.046 -1.034 . . . . 0.0 109.809 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.437 ' C ' ' O ' ' A' ' 35' ' ' THR . 32.5 t80 -39.56 -49.11 2.14 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.575 -0.703 . . . . 0.0 109.888 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 34' ' ' ILE . . . -125.63 -170.17 12.99 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.463 ' O ' HD11 ' A' ' 40' ' ' LEU . . . 152.97 -47.74 0.55 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.42 ' C ' HD11 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -49.67 119.55 3.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.058 -1.26 . . . . 0.0 109.322 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.463 HD11 ' O ' ' A' ' 38' ' ' GLY . 0.8 OUTLIER -99.89 -40.52 7.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 109.315 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 116.0 -10.75 17.91 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.531 ' O ' ' CG ' ' A' ' 43' ' ' LYS . 47.0 tp10 -69.76 -56.25 7.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.298 -1.119 . . . . 0.0 109.728 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.531 ' CG ' ' O ' ' A' ' 42' ' ' GLU . 2.6 ptmm? . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.768 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.688 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.452 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 2.6 tpp85 -109.1 -63.9 1.3 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.237 -0.914 . . . . 0.0 109.328 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.452 ' CG ' ' O ' ' A' ' 2' ' ' ARG . 1.7 m-85 -167.02 70.81 1.02 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.235 -0.916 . . . . 0.0 109.584 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.514 ' HD2' ' CD2' ' A' ' 5' ' ' TYR . 43.2 Cg_endo -86.97 -31.43 0.25 Allowed 'Trans proline' 0 C--N 1.303 -1.838 1 C-N-CA 126.21 4.606 . . . . 0.0 110.234 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.571 ' CD1' ' N ' ' A' ' 6' ' ' TYR . 33.5 p90 -90.21 -47.93 7.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.904 . . . . 0.0 110.09 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.571 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -59.47 -48.04 83.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.23 -0.919 . . . . 0.0 109.551 -179.805 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.78 -41.97 97.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.744 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.426 ' HA ' ' CG ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -81.82 16.39 1.85 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.264 -0.898 . . . . 0.0 110.19 -179.559 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.42 ' CG ' ' O ' ' A' ' 5' ' ' TYR . 80.7 m-20 -90.19 -109.77 0.08 Allowed 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.883 -1.136 . . . . 0.0 109.641 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.481 HD11 HG21 ' A' ' 10' ' ' ILE . 0.4 OUTLIER -91.92 -38.01 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.894 -1.129 . . . . 0.0 110.085 -179.626 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.428 ' HA ' ' HB2' ' A' ' 14' ' ' PHE . 43.5 p -67.5 -0.94 4.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.48 -0.763 . . . . 0.0 110.908 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 16' ' ' PRO . 2.5 t0 -74.22 -37.15 63.92 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.704 -1.248 . . . . 0.0 110.023 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.22 9.34 34.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.123 -0.986 . . . . 0.0 110.147 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.428 ' HB2' ' HA ' ' A' ' 11' ' ' THR . 0.5 OUTLIER -90.33 -79.6 0.34 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.974 -1.079 . . . . 0.0 109.852 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.419 ' OG ' ' HB ' ' A' ' 18' ' ' VAL . 2.9 t -144.97 77.42 13.18 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.43 -0.794 . . . . 0.0 109.086 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.47 ' HG3' ' O ' ' A' ' 12' ' ' ASP . 41.6 Cg_endo -86.35 -53.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.704 1 C-N-CA 126.094 4.53 . . . . 0.0 110.136 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -57.56 -20.22 30.67 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.104 -0.998 . . . . 0.0 109.201 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.419 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 3.4 t -90.12 -57.17 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.448 -0.783 . . . . 0.0 109.425 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 18' ' ' VAL . 29.6 mt -47.22 -46.99 24.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.997 -1.064 . . . . 0.0 108.5 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.5 ' O ' ' C ' ' A' ' 21' ' ' ALA . . . -59.27 -56.39 22.72 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 20' ' ' ALA . . . -37.46 -49.66 1.04 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 122.192 0.996 . . . . 0.0 109.267 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.8 t -57.26 -66.56 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.749 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.582 ' O ' ' N ' ' A' ' 25' ' ' ILE . 0.7 OUTLIER -69.1 -55.29 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 120.947 -1.096 . . . . 0.0 110.276 -179.096 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.538 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 2.4 t80 -28.72 -38.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.35 0.595 . . . . 0.0 109.68 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.582 ' N ' ' O ' ' A' ' 23' ' ' ILE . 25.5 mt -77.32 -54.66 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.529 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.8 OUTLIER -61.26 -66.9 0.46 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.19 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.539 ' O ' ' CB ' ' A' ' 31' ' ' SER . 0.1 OUTLIER -39.2 -41.9 0.91 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.472 0.653 . . . . 0.0 109.244 177.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 24' ' ' PHE . . . -53.9 -51.44 63.71 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.626 0.727 . . . . 0.0 110.931 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.427 ' HB2' HD13 ' A' ' 30' ' ' LEU . . . -52.17 -58.06 7.75 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.537 -0.727 . . . . 0.0 110.849 -178.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.427 HD13 ' HB2' ' A' ' 29' ' ' ALA . 2.6 mp -106.07 38.86 1.92 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 0.0 110.736 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.607 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -90.93 -56.79 0.25 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.985 -1.072 . . . . 0.0 110.786 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.607 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 45.2 Cg_endo -93.36 -17.3 0.66 Allowed 'Trans proline' 0 N--CA 1.501 1.964 1 C-N-CA 126.279 4.652 . . . . 0.0 111.882 -177.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.02 -50.03 74.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.006 -1.059 . . . . 0.0 110.916 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -75.95 -39.37 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.05 -1.031 . . . . 0.0 110.943 -178.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.434 ' O ' HG21 ' A' ' 35' ' ' THR . 9.9 t -90.67 28.92 1.4 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.882 -1.136 . . . . 0.0 110.508 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.489 ' HB2' ' O ' ' A' ' 32' ' ' PRO . 3.6 t80 -89.41 103.59 16.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.983 -1.073 . . . . 0.0 109.671 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 127.89 110.04 1.55 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 117.95 -38.35 2.96 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -52.03 114.13 1.22 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.195 -1.179 . . . . 0.0 109.8 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.34 15.1 29.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.308 -0.87 . . . . 0.0 109.329 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 137.16 126.98 2.56 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -73.96 -62.63 1.43 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -1.183 . . . . 0.0 109.937 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.0 tptt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.658 -179.779 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.741 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -109.8 -71.4 0.76 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 0.0 109.505 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.579 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -175.44 59.84 0.2 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.203 -0.935 . . . . 0.0 109.476 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.579 ' HD3' ' N ' ' A' ' 3' ' ' TYR . 44.0 Cg_endo -91.89 -63.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.733 1 C-N-CA 125.991 4.461 . . . . 0.0 110.617 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.569 ' CE2' ' OD2' ' A' ' 9' ' ' ASP . 69.2 t80 -78.71 -23.81 45.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.489 -0.757 . . . . 0.0 110.319 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -74.79 -45.1 45.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.154 -0.966 . . . . 0.0 110.492 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.462 ' O ' ' CG2' ' A' ' 11' ' ' THR . 3.7 tp -84.42 -40.14 18.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.171 -0.956 . . . . 0.0 110.294 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.502 ' HA ' ' CG2' ' A' ' 11' ' ' THR . 9.9 t -83.75 25.26 0.8 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.336 -0.852 . . . . 0.0 110.492 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.569 ' OD2' ' CE2' ' A' ' 5' ' ' TYR . 0.6 OUTLIER -89.97 -68.32 0.79 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.0 -1.063 . . . . 0.0 109.958 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.7 mm -89.7 -25.13 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.113 -0.992 . . . . 0.0 110.207 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.502 ' CG2' ' HA ' ' A' ' 8' ' ' SER . 6.7 t -64.82 -32.38 74.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.096 -1.003 . . . . 0.0 110.015 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -74.35 -5.38 41.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.081 -1.012 . . . . 0.0 109.853 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.07 -59.99 2.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.211 -0.931 . . . . 0.0 109.828 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -81.45 5.71 16.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.27 -0.894 . . . . 0.0 110.043 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 4.6 t -148.38 76.17 10.19 Favored Pre-proline 0 C--N 1.305 -1.366 0 O-C-N 121.013 -1.055 . . . . 0.0 109.849 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.466 ' O ' ' HB3' ' A' ' 19' ' ' LEU . 45.7 Cg_endo -92.59 -69.52 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.733 1 C-N-CA 126.353 4.702 . . . . 0.0 109.845 179.579 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -57.45 -49.37 76.49 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.411 ' O ' HG11 ' A' ' 18' ' ' VAL . 97.3 t -61.04 -23.49 30.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' A' ' 15' ' ' SER . 6.2 tp -58.69 -54.16 50.18 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.88 -1.137 . . . . 0.0 108.63 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.0 -54.59 44.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.427 -0.795 . . . . 0.0 109.8 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.14 -55.69 7.97 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.881 0.848 . . . . 0.0 110.042 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.494 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 28.8 t -55.2 -41.01 58.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 O-C-N 121.802 -0.562 . . . . 0.0 109.875 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 19' ' ' LEU . 46.7 mm -72.11 -22.1 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.416 -0.802 . . . . 0.0 110.201 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -63.61 -52.31 61.45 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.5 mt -74.62 -26.99 20.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.549 ' O ' ' CG ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -70.15 -20.19 63.16 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.075 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.48 ' HA ' ' HB2' ' A' ' 30' ' ' LEU . 10.0 t80 -83.23 -44.37 15.07 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.29 -51.94 30.75 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.023 0.916 . . . . 0.0 108.676 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.507 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -74.1 -41.24 61.95 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.772 0.796 . . . . 0.0 109.955 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.56 ' CD1' ' HB1' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -60.63 -0.03 0.24 Allowed 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.152 -178.51 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.565 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -35.35 -49.0 1.24 Allowed Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.028 -1.045 . . . . 0.0 110.547 -179.629 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 31' ' ' SER . 44.4 Cg_endo -91.48 -23.67 0.44 Allowed 'Trans proline' 0 N--CA 1.502 1.992 1 C-N-CA 126.533 4.822 . . . . 0.0 111.363 -179.422 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.56 ' HB1' ' CD1' ' A' ' 30' ' ' LEU . . . -80.66 -4.25 53.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.198 -0.939 . . . . 0.0 110.847 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.481 HG22 ' O ' ' A' ' 31' ' ' SER . 1.1 pt -41.59 -26.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 O-C-N 121.293 -0.88 . . . . 0.0 110.514 -178.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.614 HG21 ' N ' ' A' ' 36' ' ' PHE . 11.6 t -81.87 -37.51 26.81 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.556 -1.34 . . . . 0.0 109.641 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.614 ' N ' HG21 ' A' ' 35' ' ' THR . 0.1 OUTLIER -50.72 -31.86 17.83 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.125 -0.984 . . . . 0.0 108.623 179.031 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -103.88 82.32 0.37 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -131.95 3.83 5.3 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.413 ' N ' ' CD2' ' A' ' 39' ' ' LEU . 3.9 mm? -84.74 7.93 18.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.312 -1.111 . . . . 0.0 109.774 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.13 -65.88 0.94 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.969 . . . . 0.0 109.395 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -46.64 140.0 7.01 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -73.26 -11.91 60.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -1.186 . . . . 0.0 109.386 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.468 179.956 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . 0.429 ' CH3' ' CE1' ' A' ' 3' ' ' TYR . . . . . . . . 0 C--O 1.215 -0.744 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.539 ' C ' ' CG ' ' A' ' 3' ' ' TYR . 0.3 OUTLIER -118.68 -76.84 0.57 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 109.712 . . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.539 ' CG ' ' C ' ' A' ' 2' ' ' ARG . 1.0 OUTLIER 37.59 87.08 0.12 Allowed Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.394 -0.816 . . . . 0.0 110.078 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -86.53 -71.62 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.92 1 C-N-CA 126.05 4.5 . . . . 0.0 110.626 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.49 ' O ' ' OD1' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -74.8 -33.99 62.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.199 -0.938 . . . . 0.0 110.036 -179.439 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.455 ' O ' ' OD1' ' A' ' 9' ' ' ASP . 12.2 t80 -41.66 -42.7 2.59 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.388 -0.82 . . . . 0.0 109.891 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.44 ' O ' HG22 ' A' ' 11' ' ' THR . 0.5 OUTLIER -71.24 -39.1 71.86 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.431 -0.793 . . . . 0.0 110.803 -178.84 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.79 -14.52 59.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.188 -0.945 . . . . 0.0 111.501 -178.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -90.68 -66.82 0.89 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.54 -1.35 . . . . 0.0 110.606 -179.501 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.464 ' CG2' ' N ' ' A' ' 11' ' ' THR . 1.8 tt -38.66 -40.95 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 121.484 0.659 . . . . 0.0 110.072 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.464 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 30.7 p -76.38 -42.12 45.61 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.481 -0.762 . . . . 0.0 109.914 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -79.27 5.45 12.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.079 -1.013 . . . . 0.0 109.869 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.07 -20.77 29.88 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.107 -0.996 . . . . 0.0 109.488 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.564 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -81.9 4.76 21.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.217 -0.927 . . . . 0.0 109.401 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 1.5 t -121.46 86.29 43.94 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -86.91 -61.24 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.781 1 C-N-CA 125.986 4.457 . . . . 0.0 110.062 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.09 -31.07 62.9 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.388 -0.82 . . . . 0.0 109.128 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.47 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 5.5 t -89.33 -40.31 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.441 -0.787 . . . . 0.0 110.491 -179.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 15' ' ' SER . 33.6 tp -57.73 -56.28 23.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.574 -1.329 . . . . 0.0 108.488 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.434 ' O ' ' C ' ' A' ' 21' ' ' ALA . . . -55.24 -55.23 33.69 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.494 -0.754 . . . . 0.0 109.429 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 20' ' ' ALA . . . -42.24 -52.66 4.37 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.944 0.878 . . . . 0.0 109.692 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.7 t -48.65 -55.0 3.71 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 121.173 0.511 . . . . 0.0 110.377 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 25' ' ' ILE . 45.7 mm -63.49 -54.46 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.097 -1.002 . . . . 0.0 110.778 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.523 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -32.71 -36.08 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.643 -0.661 . . . . 0.0 109.661 -179.552 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.528 ' N ' ' O ' ' A' ' 23' ' ' ILE . 43.4 mt -76.5 -53.98 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.405 -0.809 . . . . 0.0 109.058 178.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.479 ' O ' ' N ' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -57.58 -64.9 0.74 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.521 ' O ' ' OG ' ' A' ' 31' ' ' SER . 0.1 OUTLIER -39.33 -29.3 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.715 0.769 . . . . 0.0 109.236 177.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.495 ' HB1' ' O ' ' A' ' 24' ' ' PHE . . . -63.65 -62.27 1.77 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.538 -0.726 . . . . 0.0 111.202 -178.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.62 -66.76 0.9 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.179 -0.951 . . . . 0.0 112.883 -177.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.15 36.96 0.92 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.132 -0.98 . . . . 0.0 110.557 -177.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.649 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -47.09 -62.79 1.75 Allowed Pre-proline 0 C--N 1.295 -1.788 0 O-C-N 121.199 -0.938 . . . . 0.0 110.878 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.649 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 49.7 Cg_endo -98.88 -0.48 1.03 Allowed 'Trans proline' 0 N--CA 1.501 1.968 1 C-N-CA 126.347 4.698 . . . . 0.0 111.337 -178.337 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.6 -59.14 5.0 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.008 -1.057 . . . . 0.0 110.541 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.8 tt -62.32 -22.81 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 110.716 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.64 -19.8 24.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.889 -1.132 . . . . 0.0 110.129 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -90.08 149.29 22.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.131 -0.981 . . . . 0.0 109.983 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.66 123.16 4.95 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -105.11 18.35 42.74 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.2 mp -70.25 -16.36 63.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.371 -1.076 . . . . 0.0 109.703 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.88 -41.72 83.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.164 -0.96 . . . . 0.0 109.596 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 124.58 29.45 1.07 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.93 -19.98 66.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.217 -1.167 . . . . 0.0 109.294 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.7 tppt? . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.348 179.795 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.696 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -138.74 132.95 31.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.265 -0.897 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.443 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 2.6 m-30 -108.61 104.7 55.15 Favored Pre-proline 0 N--CA 1.487 1.389 0 O-C-N 121.22 -0.925 . . . . 0.0 109.441 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.477 ' O ' ' HB2' ' A' ' 8' ' ' SER . 42.0 Cg_endo -85.87 -35.4 0.14 Allowed 'Trans proline' 0 N--CA 1.5 1.866 1 C-N-CA 125.914 4.409 . . . . 0.0 110.508 -179.78 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.418 ' O ' ' HB3' ' A' ' 9' ' ' ASP . 27.6 m-85 -86.25 -19.41 29.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -0.961 . . . . 0.0 109.884 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.478 ' O ' ' OD2' ' A' ' 9' ' ' ASP . 33.8 t80 -78.12 -45.5 23.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.887 . . . . 0.0 109.716 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 12' ' ' ASP . 6.7 mt -86.59 -39.66 15.95 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.386 -0.821 . . . . 0.0 110.402 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 4' ' ' PRO . 8.4 m -81.84 16.25 1.91 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.124 -0.985 . . . . 0.0 111.046 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.478 ' OD2' ' O ' ' A' ' 6' ' ' TYR . 4.1 p30 -88.88 -107.8 0.08 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.759 -1.213 . . . . 0.0 109.276 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.3 mt -90.38 -29.46 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 120.833 -1.167 . . . . 0.0 109.274 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 58.2 p -90.26 30.94 1.04 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.324 -0.86 . . . . 0.0 109.355 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 55.8 t0 -74.6 -70.06 0.42 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.0 109.834 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.54 11.08 34.75 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.217 -0.927 . . . . 0.0 109.783 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -73.23 -65.39 0.81 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.237 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -143.21 77.6 15.66 Favored Pre-proline 0 C--N 1.299 -1.597 0 O-C-N 121.432 -0.793 . . . . 0.0 108.979 179.646 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -91.69 -66.97 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.755 1 C-N-CA 126.374 4.716 . . . . 0.0 110.645 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.36 -42.26 86.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -0.903 . . . . 0.0 109.466 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.0 t -73.11 -19.09 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.372 -0.83 . . . . 0.0 109.155 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 15' ' ' SER . 0.4 OUTLIER -65.36 -47.11 77.56 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.069 -1.02 . . . . 0.0 108.81 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.86 -53.35 18.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.388 -0.82 . . . . 0.0 109.132 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.53 -55.77 10.17 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.895 0.855 . . . . 0.0 109.532 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.7 t -51.73 -47.92 38.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 O-C-N 121.789 -0.569 . . . . 0.0 109.519 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.493 ' O ' ' HB2' ' A' ' 27' ' ' PHE . 22.9 mm -64.54 -26.32 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 110.114 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -64.58 -36.49 84.41 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 120.515 -1.366 . . . . 0.0 108.141 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.3 mt -74.82 -41.88 46.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.497 ' O ' ' N ' ' A' ' 28' ' ' ALA . 6.4 m-85 -60.62 -64.22 1.03 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.608 ' HA ' ' CB ' ' A' ' 31' ' ' SER . 0.8 OUTLIER -37.07 -31.33 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.97 0.89 . . . . 0.0 109.099 177.087 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 26' ' ' TYR . . . -75.24 -53.83 8.14 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.7 -89.38 0.18 Allowed 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.875 -1.141 . . . . 0.0 113.633 -175.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.37 35.26 3.12 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.505 -0.747 . . . . 0.0 112.802 -175.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.608 ' CB ' ' HA ' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -71.14 -48.2 13.59 Favored Pre-proline 0 C--N 1.293 -1.866 0 O-C-N 120.665 -1.272 . . . . 0.0 109.614 179.152 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 31' ' ' SER . 40.3 Cg_endo -86.29 16.76 1.89 Allowed 'Trans proline' 0 C--N 1.303 -1.819 1 C-N-CA 126.307 4.671 . . . . 0.0 110.498 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.99 -57.89 2.7 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.221 -0.925 . . . . 0.0 109.258 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.0 mt -78.03 -51.15 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.204 -0.935 . . . . 0.0 109.149 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.412 ' O ' ' C ' ' A' ' 36' ' ' PHE . 39.4 p -68.83 -5.93 23.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.131 -0.981 . . . . 0.0 109.746 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 32' ' ' PRO . 16.1 t80 -42.37 132.09 3.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.32 -0.863 . . . . 0.0 109.645 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -70.53 85.66 0.34 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -136.83 9.8 3.94 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.59 -172.84 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.217 -1.166 . . . . 0.0 109.508 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.35 37.76 2.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.23 -0.919 . . . . 0.0 109.319 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -126.19 5.31 7.76 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -41.1 27.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.216 -1.167 . . . . 0.0 109.386 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.479 ' CD ' ' O ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.409 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . 0.54 ' H1 ' ' CE2' ' A' ' 3' ' ' TYR . . . . . . . . 0 C--O 1.214 -0.776 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -122.03 81.64 1.85 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.904 . . . . 0.0 109.442 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.54 ' CE2' ' H1 ' ' A' ' 1' ' ' ACE . 0.2 OUTLIER -154.85 77.73 5.06 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.382 -0.824 . . . . 0.0 109.209 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -86.14 -57.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.499 1.809 1 C-N-CA 126.094 4.529 . . . . 0.0 110.344 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -52.81 -22.34 5.26 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.229 -0.919 . . . . 0.0 109.381 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.463 ' O ' ' CG ' ' A' ' 9' ' ' ASP . 3.6 t80 -59.1 -45.37 91.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.359 -0.838 . . . . 0.0 109.298 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.469 ' O ' ' OD1' ' A' ' 9' ' ' ASP . 0.1 OUTLIER -71.29 -32.63 68.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.2 -0.938 . . . . 0.0 109.358 179.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.503 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 0.3 OUTLIER -58.11 -9.38 1.4 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.683 -0.636 . . . . 0.0 111.24 -179.342 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 0.9 OUTLIER -53.08 -90.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.798 -1.189 . . . . 0.0 110.881 -178.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.52 -22.14 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.081 -1.012 . . . . 0.0 111.179 -178.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.503 ' OG1' ' HA ' ' A' ' 8' ' ' SER . 40.0 p -67.0 -7.49 22.87 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.549 -1.344 . . . . 0.0 109.929 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 9' ' ' ASP . 16.3 p-10 -90.96 -1.09 57.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.098 -1.001 . . . . 0.0 110.288 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.75 -19.48 21.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.077 -1.014 . . . . 0.0 110.042 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -84.26 -21.15 31.2 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.192 -0.943 . . . . 0.0 109.748 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.545 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 0.3 OUTLIER -143.75 62.25 10.6 Favored Pre-proline 0 N--CA 1.487 1.377 0 O-C-N 121.123 -0.986 . . . . 0.0 110.111 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.545 ' HD3' ' N ' ' A' ' 15' ' ' SER . 43.5 Cg_endo -91.01 -65.09 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.765 1 C-N-CA 126.13 4.553 . . . . 0.0 109.88 179.694 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -60.47 -27.01 67.21 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.367 -0.833 . . . . 0.0 109.056 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.2 t -73.39 -26.82 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.326 -0.859 . . . . 0.0 109.554 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.04 -52.81 37.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.058 -1.026 . . . . 0.0 108.32 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.09 -47.16 61.95 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.88 -54.59 27.49 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.608 0.718 . . . . 0.0 109.362 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.423 ' O ' HG11 ' A' ' 22' ' ' VAL . 89.7 t -48.93 -31.22 3.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.524 -0.735 . . . . 0.0 109.28 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.502 ' HA ' ' HB2' ' A' ' 26' ' ' TYR . 82.0 mt -78.47 -36.17 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.408 -0.807 . . . . 0.0 109.565 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.63 -43.33 97.64 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mt -76.0 -31.29 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.502 ' HB2' ' HA ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -67.55 -19.15 65.25 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.284 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -85.75 -38.59 18.07 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.507 ' O ' ' OG ' ' A' ' 31' ' ' SER . . . -51.17 -50.53 58.82 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.585 0.707 . . . . 0.0 109.749 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.481 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -76.34 -47.79 22.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.606 -0.684 . . . . 0.0 110.642 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.539 ' CD1' ' HB2' ' A' ' 33' ' ' ALA . 4.4 mm? -66.08 3.71 0.81 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.614 -0.679 . . . . 0.0 112.042 -178.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.558 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -45.99 -53.98 18.98 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 120.445 -1.41 . . . . 0.0 111.068 -179.083 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.558 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 42.9 Cg_endo -92.48 -17.7 0.82 Allowed 'Trans proline' 0 N--CA 1.501 1.914 1 C-N-CA 126.397 4.731 . . . . 0.0 111.751 -178.319 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.539 ' HB2' ' CD1' ' A' ' 30' ' ' LEU . . . -77.56 -28.13 51.71 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.779 -1.201 . . . . 0.0 110.156 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -53.67 -38.82 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.116 -0.99 . . . . 0.0 109.824 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.5 t -90.33 -19.25 24.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.973 . . . . 0.0 110.019 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.459 ' HB2' ' HA ' ' A' ' 33' ' ' ALA . 6.9 m-30 -78.84 -94.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.096 -1.003 . . . . 0.0 110.06 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -103.54 -172.68 25.84 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 126.37 82.75 0.45 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 39' ' ' LEU . 2.2 pt? -47.1 147.93 1.3 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -1.172 . . . . 0.0 109.448 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 41' ' ' GLY . 1.9 tp -86.77 -71.59 0.55 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.884 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 40' ' ' LEU . . . 44.92 -152.05 0.69 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -70.28 -13.92 62.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.026 -1.279 . . . . 0.0 109.126 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.466 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.728 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -158.75 28.12 0.22 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.554 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -70.03 -49.63 18.5 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 0.0 109.772 -179.703 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' A' ' 3' ' ' TYR . 42.2 Cg_endo -86.68 -35.17 0.12 Allowed 'Trans proline' 0 N--CA 1.501 1.913 1 C-N-CA 125.964 4.443 . . . . 0.0 110.862 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -69.14 -12.78 61.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.028 -1.045 . . . . 0.0 109.778 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.26 -64.7 0.97 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.168 -0.957 . . . . 0.0 109.721 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.433 ' O ' ' OG1' ' A' ' 11' ' ' THR . 15.3 mt -72.17 -38.19 69.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.342 -0.849 . . . . 0.0 109.941 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.479 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -81.23 21.77 0.71 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.402 -0.811 . . . . 0.0 110.426 -179.471 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.79 -65.95 0.95 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.811 -1.181 . . . . 0.0 109.676 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.487 HD11 HG23 ' A' ' 10' ' ' ILE . 5.2 tt -90.22 -38.02 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.323 -0.86 . . . . 0.0 109.873 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.468 ' OG1' HD22 ' A' ' 19' ' ' LEU . 67.7 p -82.84 23.64 0.81 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.514 -0.741 . . . . 0.0 110.393 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.479 ' HB3' ' O ' ' A' ' 8' ' ' SER . 3.5 p-10 -69.89 -48.72 57.58 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.893 -1.13 . . . . 0.0 109.672 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.419 ' N ' ' CG ' ' A' ' 12' ' ' ASP . . . -106.23 -15.67 14.79 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.109 -0.994 . . . . 0.0 110.06 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -82.98 -60.42 2.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.064 -1.022 . . . . 0.0 110.298 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.474 ' OG ' ' HB ' ' A' ' 18' ' ' VAL . 16.3 t -123.81 87.4 52.77 Favored Pre-proline 0 C--N 1.301 -1.541 0 O-C-N 121.289 -0.882 . . . . 0.0 109.774 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -89.99 -64.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.757 1 C-N-CA 126.234 4.622 . . . . 0.0 110.034 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -55.7 -59.22 5.16 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.474 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 25.4 t -51.55 -24.96 4.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.468 HD22 ' OG1' ' A' ' 11' ' ' THR . 0.2 OUTLIER -63.38 -53.16 56.89 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.214 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.85 -50.54 70.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.478 -0.764 . . . . 0.0 109.006 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.24 -55.59 10.12 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.752 0.787 . . . . 0.0 109.768 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.2 t -55.65 -38.73 51.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 O-C-N 121.71 -0.619 . . . . 0.0 109.601 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 19' ' ' LEU . 22.7 mt -69.19 -26.81 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.237 -0.915 . . . . 0.0 109.449 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -60.76 -41.51 95.6 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.1 mt -72.4 -41.02 64.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -61.56 -22.8 65.49 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.485 ' O ' ' HB2' ' A' ' 31' ' ' SER . 0.2 OUTLIER -84.62 -29.3 25.86 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 122.044 0.926 . . . . 0.0 108.577 179.416 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.7 -61.81 1.63 Allowed 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.802 -0.561 . . . . 0.0 111.1 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.36 -62.08 1.51 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.038 -1.039 . . . . 0.0 112.708 -177.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.4 mt -83.11 26.17 0.64 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.961 -1.087 . . . . 0.0 111.417 -177.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.576 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -58.13 -51.52 81.17 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 120.826 -1.172 . . . . 0.0 109.541 179.472 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.576 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 46.3 Cg_endo -94.45 -9.87 1.49 Allowed 'Trans proline' 0 N--CA 1.498 1.786 1 C-N-CA 126.71 4.94 . . . . 0.0 110.533 -179.375 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' A' ' 34' ' ' ILE . . . -42.78 -25.92 0.11 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.287 -0.883 . . . . 0.0 110.156 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.464 HG23 ' N ' ' A' ' 35' ' ' THR . 1.8 mp -38.56 -75.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.514 -0.741 . . . . 0.0 110.434 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.464 ' N ' HG23 ' A' ' 34' ' ' ILE . 1.7 t -83.93 -27.26 28.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.008 -1.058 . . . . 0.0 110.245 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -79.55 134.29 36.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.016 -1.052 . . . . 0.0 109.691 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.99 98.81 0.19 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 153.12 83.75 0.04 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 pp -83.09 137.07 34.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.351 -1.088 . . . . 0.0 109.797 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.486 ' CD1' ' C ' ' A' ' 40' ' ' LEU . 3.5 tm? -105.16 -58.44 1.89 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.302 -0.874 . . . . 0.0 108.922 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.73 148.22 16.97 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -69.27 -39.6 78.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -1.147 . . . . 0.0 109.248 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.463 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.718 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -90.0 -171.0 2.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.893 . . . . 0.0 109.384 . . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.551 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.1 OUTLIER 169.4 -50.28 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.904 . . . . 0.0 110.231 179.579 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.551 ' CD ' ' N ' ' A' ' 3' ' ' TYR . 41.5 Cg_endo -85.33 -29.6 0.61 Allowed 'Trans proline' 0 N--CA 1.501 1.963 1 C-N-CA 126.028 4.485 . . . . 0.0 111.246 -179.177 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -74.33 -12.73 60.61 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.936 -1.103 . . . . 0.0 109.733 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -68.69 -50.35 51.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 110.262 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.6 -41.31 88.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.18 -0.95 . . . . 0.0 109.93 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.63 -31.54 25.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.156 -0.965 . . . . 0.0 109.608 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -76.43 -32.98 58.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.243 -0.911 . . . . 0.0 109.712 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.8 mm -59.77 -17.37 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.15 -0.969 . . . . 0.0 110.165 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.41 ' OG1' ' N ' ' A' ' 12' ' ' ASP . 9.1 p -90.41 -58.75 2.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.101 -1.0 . . . . 0.0 110.539 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.41 ' N ' ' OG1' ' A' ' 11' ' ' THR . 1.5 t0 -59.89 -43.32 94.85 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.15 -0.969 . . . . 0.0 110.326 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.487 ' O ' ' C ' ' A' ' 14' ' ' PHE . . . -101.14 43.68 1.05 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.292 -0.88 . . . . 0.0 108.686 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.487 ' C ' ' O ' ' A' ' 13' ' ' ALA . 1.0 OUTLIER -34.88 -36.18 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.111 0.482 . . . . 0.0 109.743 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.509 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.4 OUTLIER 34.58 94.29 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.994 -0.441 . . . . 0.0 110.443 179.117 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -89.7 -65.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.763 1 C-N-CA 126.143 4.562 . . . . 0.0 109.752 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -55.48 -51.26 67.56 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.469 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 72.4 t -62.1 -23.4 31.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.628 -0.67 . . . . 0.0 109.303 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.509 ' HB2' ' O ' ' A' ' 15' ' ' SER . 3.9 tp -56.89 -58.02 9.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.151 -0.968 . . . . 0.0 108.694 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.77 -53.59 38.09 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -44.67 -52.48 8.2 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 122.036 0.922 . . . . 0.0 109.68 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.8 t -49.94 -49.9 20.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.235 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.6 mt -66.96 -26.87 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -0.975 . . . . 0.0 109.832 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -54.74 -42.0 71.1 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.096 -1.002 . . . . 0.0 108.743 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.72 -44.11 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.107 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.06 -19.17 29.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.905 -1.122 . . . . 0.0 108.17 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.521 ' O ' ' CB ' ' A' ' 31' ' ' SER . 0.2 OUTLIER -90.81 -34.91 15.12 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.952 0.882 . . . . 0.0 108.74 179.555 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 31' ' ' SER . . . -76.04 -67.93 0.63 Allowed 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.395 0.617 . . . . 0.0 110.4 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.28 -56.28 24.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.389 -0.819 . . . . 0.0 110.623 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.455 ' HA ' ' HB1' ' A' ' 33' ' ' ALA . 9.8 mp -85.13 25.59 0.96 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.347 -0.846 . . . . 0.0 110.547 -178.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.577 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -66.13 -49.52 55.51 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.075 -1.015 . . . . 0.0 110.046 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 31' ' ' SER . 42.8 Cg_endo -91.1 -5.76 4.1 Favored 'Trans proline' 0 C--N 1.303 -1.821 1 C-N-CA 126.557 4.838 . . . . 0.0 111.186 -179.097 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.455 ' HB1' ' HA ' ' A' ' 30' ' ' LEU . . . -85.88 -27.26 25.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.023 -1.048 . . . . 0.0 109.647 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.497 HG13 ' N ' ' A' ' 35' ' ' THR . 27.1 pt -67.6 -35.16 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.331 -0.855 . . . . 0.0 109.793 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.497 ' N ' HG13 ' A' ' 34' ' ' ILE . 10.3 t -86.91 13.96 8.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.188 -0.945 . . . . 0.0 109.44 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.49 ' CD1' ' C ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -89.93 -10.73 44.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.299 -0.876 . . . . 0.0 109.056 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.47 ' O ' ' CE1' ' A' ' 36' ' ' PHE . . . 87.41 88.11 1.09 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -142.94 23.98 2.27 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.502 ' N ' ' CD2' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -79.19 -70.87 0.47 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.217 -1.166 . . . . 0.0 108.853 179.584 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.7 mt -105.79 -57.49 2.03 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.257 -0.902 . . . . 0.0 109.74 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -151.14 -130.69 1.71 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.49 ' C ' ' CG ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -86.7 -75.57 0.39 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.317 -1.108 . . . . 0.0 109.647 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.49 ' CG ' ' C ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.537 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.726 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.02 151.35 21.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.235 -0.916 . . . . 0.0 109.535 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.425 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.9 OUTLIER 51.42 67.75 3.92 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.298 -0.876 . . . . 0.0 109.689 179.752 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.425 ' HD3' ' N ' ' A' ' 3' ' ' TYR . 41.8 Cg_endo -86.62 -88.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.775 1 C-N-CA 126.078 4.518 . . . . 0.0 110.186 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.477 ' O ' ' HB2' ' A' ' 9' ' ' ASP . 26.1 m-85 -68.06 -20.29 64.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -0.899 . . . . 0.0 109.743 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -66.4 -62.19 1.6 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.342 -0.849 . . . . 0.0 110.499 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.483 ' CD2' ' C ' ' A' ' 7' ' ' LEU . 6.6 tt -62.72 -54.11 44.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.336 -0.852 . . . . 0.0 110.751 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.487 ' HA ' HG23 ' A' ' 11' ' ' THR . 0.5 OUTLIER -55.82 -14.33 2.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.066 -1.021 . . . . 0.0 110.707 -179.103 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -90.17 -46.25 8.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.959 -1.088 . . . . 0.0 110.496 -179.264 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.419 HG22 HD11 ' A' ' 10' ' ' ILE . 50.0 mt -68.52 -5.43 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.136 -0.977 . . . . 0.0 110.672 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.487 HG23 ' HA ' ' A' ' 8' ' ' SER . 1.7 t -86.75 -46.89 9.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.868 -1.145 . . . . 0.0 110.838 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.25 -24.31 20.98 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.78 -1.2 . . . . 0.0 109.566 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.68 41.62 1.36 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.351 -0.843 . . . . 0.0 109.129 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.533 ' O ' ' O ' ' A' ' 15' ' ' SER . 5.3 t80 -51.76 -59.91 3.77 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.283 -0.886 . . . . 0.0 108.881 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.533 ' O ' ' O ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER 20.91 104.75 0.01 OUTLIER Pre-proline 0 N--CA 1.507 2.397 0 C-N-CA 122.255 0.222 . . . . 0.0 111.461 179.072 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -89.77 -69.42 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.71 1 C-N-CA 126.072 4.515 . . . . 0.0 109.884 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -55.6 -46.21 77.35 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.526 ' CG1' HG21 ' A' ' 22' ' ' VAL . 47.5 t -66.72 -26.84 38.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.516 ' HB2' ' O ' ' A' ' 15' ' ' SER . 2.7 tp -52.58 -44.14 65.72 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.473 -1.392 . . . . 0.0 108.587 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.76 -50.94 61.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.511 -0.743 . . . . 0.0 109.783 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.21 -64.48 0.85 Allowed 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 122.029 0.919 . . . . 0.0 109.285 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.526 HG21 ' CG1' ' A' ' 18' ' ' VAL . 77.3 t -51.59 -33.73 15.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.865 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.487 ' O ' ' HB2' ' A' ' 27' ' ' PHE . 82.5 mt -78.96 -26.06 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.751 -1.218 . . . . 0.0 109.559 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -57.85 -53.42 58.41 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.2 mp -70.17 -36.44 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.495 ' HA ' ' HB2' ' A' ' 30' ' ' LEU . 0.5 OUTLIER -64.63 -15.58 61.44 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.588 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.487 ' HB2' ' O ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -90.18 -26.0 20.37 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.208 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.62 -79.17 0.22 Allowed 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.605 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.469 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -91.66 -56.95 2.91 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.382 -0.823 . . . . 0.0 112.83 -177.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.495 ' HB2' ' HA ' ' A' ' 26' ' ' TYR . 15.9 mt -68.93 8.91 0.46 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.142 -0.974 . . . . 0.0 112.362 -177.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.575 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.9 OUTLIER -44.35 -48.66 25.29 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 120.626 -1.296 . . . . 0.0 110.112 179.585 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 31' ' ' SER . 42.9 Cg_endo -91.84 -15.69 1.3 Allowed 'Trans proline' 0 N--CA 1.5 1.874 1 C-N-CA 126.707 4.938 . . . . 0.0 111.131 -179.198 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.471 ' O ' ' C ' ' A' ' 34' ' ' ILE . . . -50.72 -21.59 1.69 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.063 -1.023 . . . . 0.0 110.038 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.471 ' C ' ' O ' ' A' ' 33' ' ' ALA . 72.6 mt -34.84 -74.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.765 -0.585 . . . . 0.0 110.755 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.7 t -70.72 -37.73 73.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.16 -0.963 . . . . 0.0 110.058 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.431 ' O ' ' O ' ' A' ' 33' ' ' ALA . 6.0 m-85 -73.75 178.09 5.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.257 -0.902 . . . . 0.0 109.827 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 54.94 62.53 6.17 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 40' ' ' LEU . . . 117.16 86.47 1.19 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -46.75 89.99 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.518 -0.99 . . . . 0.0 109.487 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.547 ' N ' ' O ' ' A' ' 38' ' ' GLY . 2.7 mp -106.22 31.1 5.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 109.858 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.37 -90.85 1.74 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -57.59 -53.03 62.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.408 -1.054 . . . . 0.0 109.728 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.644 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . 0.461 ' H1 ' ' HG3' ' A' ' 4' ' ' PRO . . . . . . . . 0 C--O 1.216 -0.698 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.81 -49.76 28.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.88 . . . . 0.0 109.449 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.568 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 4.1 p90 -162.03 59.91 1.05 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.173 -0.954 . . . . 0.0 109.914 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.568 ' HD3' ' N ' ' A' ' 3' ' ' TYR . 45.4 Cg_endo -90.9 -16.33 1.49 Allowed 'Trans proline' 0 N--CA 1.499 1.81 1 C-N-CA 126.004 4.469 . . . . 0.0 109.993 179.748 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.435 ' O ' ' OD1' ' A' ' 9' ' ' ASP . 17.8 t80 -81.94 -16.6 49.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.445 -0.784 . . . . 0.0 110.19 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -70.92 -57.03 4.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.162 -0.962 . . . . 0.0 110.197 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -70.78 -45.67 64.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.195 -0.941 . . . . 0.0 110.185 -179.279 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.455 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 8.5 m -43.71 -25.74 0.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.202 -0.937 . . . . 0.0 109.949 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 5' ' ' TYR . 59.3 m-20 -50.87 -63.7 1.04 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.13 -0.981 . . . . 0.0 110.408 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 56.0 mt -64.3 -43.92 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.124 -0.985 . . . . 0.0 110.283 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.455 ' OG1' ' HA ' ' A' ' 8' ' ' SER . 26.2 p -69.1 -3.12 12.08 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.13 -0.982 . . . . 0.0 109.944 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -64.17 -44.09 93.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.069 -1.019 . . . . 0.0 110.028 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.69 -6.98 18.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.064 -1.022 . . . . 0.0 109.941 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -89.25 -7.15 56.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.156 -0.965 . . . . 0.0 109.896 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.475 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 0.5 OUTLIER -135.88 91.87 17.17 Favored Pre-proline 0 C--N 1.306 -1.318 0 O-C-N 120.996 -1.065 . . . . 0.0 110.212 -179.612 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.476 ' HD2' ' OE1' ' A' ' 17' ' ' GLN . 43.2 Cg_endo -89.39 -65.64 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.669 1 C-N-CA 126.236 4.624 . . . . 0.0 108.786 178.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.48 ' OE1' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -65.14 -26.53 68.22 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.669 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.48 HG21 ' OE1' ' A' ' 17' ' ' GLN . 22.0 t -78.04 -20.68 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.483 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 1.0 OUTLIER -64.66 -49.02 72.65 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.321 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 21' ' ' ALA . . . -62.73 -56.86 13.79 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 20' ' ' ALA . . . -42.06 -48.76 4.72 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.951 0.881 . . . . 0.0 109.185 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 3.4 t -44.01 -55.29 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.5 mm -54.64 -39.59 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 119.172 -1.011 . . . . 0.0 109.021 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -51.38 -40.41 59.18 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.276 -0.89 . . . . 0.0 108.755 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.456 HD11 ' HA ' ' A' ' 22' ' ' VAL . 7.1 mt -73.15 -40.22 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.313 -0.867 . . . . 0.0 108.95 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -62.84 -16.62 59.17 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.7 -36.45 15.21 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 31' ' ' SER . . . -62.08 -56.61 17.17 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.458 0.646 . . . . 0.0 110.098 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.535 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -57.21 -46.71 82.66 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.474 -0.766 . . . . 0.0 110.563 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.539 ' CD2' ' HB2' ' A' ' 33' ' ' ALA . 1.9 tm? -63.94 -1.29 1.39 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.871 -0.518 . . . . 0.0 111.675 -178.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.589 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -45.91 -57.03 8.79 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 120.832 -1.167 . . . . 0.0 112.219 -178.907 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.589 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 43.1 Cg_endo -91.1 -23.7 0.48 Allowed 'Trans proline' 0 N--CA 1.502 1.986 1 C-N-CA 126.105 4.537 . . . . 0.0 112.122 -177.408 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.539 ' HB2' ' CD2' ' A' ' 30' ' ' LEU . . . -64.31 -23.9 67.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.745 -1.222 . . . . 0.0 109.27 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.518 HG21 ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -61.02 -24.42 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.562 -0.711 . . . . 0.0 110.19 -179.594 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.518 ' N ' HG21 ' A' ' 34' ' ' ILE . 1.8 m -79.48 -22.5 43.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.963 -1.086 . . . . 0.0 109.627 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -51.44 109.09 0.31 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.211 -0.93 . . . . 0.0 109.514 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -165.71 34.56 0.25 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 128.27 77.29 0.21 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.38 -75.83 0.27 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.365 -1.079 . . . . 0.0 109.742 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 41' ' ' GLY . 9.6 mt -86.72 -55.04 4.04 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.302 -0.874 . . . . 0.0 109.614 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 40' ' ' LEU . . . 61.2 129.25 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.408 ' C ' ' HD3' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -57.53 -17.56 14.45 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.241 -1.153 . . . . 0.0 109.501 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.408 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.199 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.753 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -102.29 149.45 24.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.146 -0.971 . . . . 0.0 109.636 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -79.39 121.98 83.46 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.358 -0.839 . . . . 0.0 109.501 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -85.54 -83.28 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.809 1 C-N-CA 125.638 4.225 . . . . 0.0 109.977 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -77.28 -39.33 48.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.125 -0.985 . . . . 0.0 109.306 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.471 ' O ' ' HB2' ' A' ' 9' ' ' ASP . 22.9 m-85 -50.09 -41.04 47.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.263 -0.898 . . . . 0.0 109.285 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.504 ' O ' ' OG1' ' A' ' 11' ' ' THR . 3.6 tp -58.89 -45.81 89.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.438 -0.789 . . . . 0.0 109.845 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.408 ' O ' ' OG ' ' A' ' 8' ' ' SER . 0.3 OUTLIER -82.18 24.13 0.68 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.19 -0.944 . . . . 0.0 110.571 -179.293 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 6' ' ' TYR . 3.5 m-20 -90.15 -105.08 0.09 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.864 -1.148 . . . . 0.0 110.247 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.8 mt -91.06 -1.27 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.995 -1.065 . . . . 0.0 111.106 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.504 ' OG1' ' O ' ' A' ' 7' ' ' LEU . 7.5 p -70.08 -8.46 49.6 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.802 -1.186 . . . . 0.0 110.093 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.92 -26.05 31.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.064 -1.022 . . . . 0.0 109.615 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.02 -11.58 58.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.345 -0.847 . . . . 0.0 109.684 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.467 ' O ' ' C ' ' A' ' 15' ' ' SER . 0.9 OUTLIER -87.31 -4.11 59.05 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.176 -0.953 . . . . 0.0 109.713 -179.869 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.542 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 8.2 t 36.23 59.93 3.22 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.653 -0.654 . . . . 0.0 110.063 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.542 ' HD3' ' N ' ' A' ' 15' ' ' SER . 44.7 Cg_endo -89.83 -64.65 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.747 1 C-N-CA 125.893 4.395 . . . . 0.0 110.074 -179.419 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -45.07 -32.52 1.77 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.196 -0.94 . . . . 0.0 109.66 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.7 t -86.44 -46.6 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 110.504 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.522 HD22 ' CD1' ' A' ' 23' ' ' ILE . 0.9 OUTLIER -57.54 -60.23 3.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.671 -1.268 . . . . 0.0 108.482 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.59 -47.31 39.87 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.472 -0.767 . . . . 0.0 109.285 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 24' ' ' PHE . . . -49.03 -55.44 12.02 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.938 0.875 . . . . 0.0 109.786 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.1 t -55.29 -51.83 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 121.648 0.737 . . . . 0.0 109.848 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.522 ' CD1' HD22 ' A' ' 19' ' ' LEU . 5.9 mt -66.92 -15.89 20.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.225 -0.922 . . . . 0.0 109.435 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.484 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -64.94 -39.75 93.97 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 179.453 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.9 mt -67.75 -45.71 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.617 ' CE1' ' HG ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -61.33 -69.94 0.21 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.599 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.552 ' HA ' ' CB ' ' A' ' 31' ' ' SER . 0.5 OUTLIER -41.34 -30.16 0.17 Allowed 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.679 0.752 . . . . 0.0 110.201 178.2 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.24 -58.04 3.59 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.449 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -91.09 -73.53 0.53 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -175.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.617 ' HG ' ' CE1' ' A' ' 26' ' ' TYR . 2.0 pt? -85.47 26.07 0.97 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.966 -1.083 . . . . 0.0 112.364 -175.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.552 ' CB ' ' HA ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -90.02 -50.6 0.36 Allowed Pre-proline 0 C--N 1.296 -1.726 0 O-C-N 120.825 -1.172 . . . . 0.0 109.919 179.108 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 31' ' ' SER . 41.7 Cg_endo -90.58 20.22 1.02 Allowed 'Trans proline' 0 C--N 1.303 -1.829 1 C-N-CA 126.565 4.844 . . . . 0.0 110.823 -179.223 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.27 -81.55 0.34 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.099 -1.001 . . . . 0.0 109.706 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.4 mt -67.45 -49.4 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.472 -0.767 . . . . 0.0 109.529 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 98.4 m -58.99 -20.36 52.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.899 . . . . 0.0 109.496 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.499 ' HB2' ' O ' ' A' ' 32' ' ' PRO . 2.0 t80 -51.03 106.19 0.12 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.301 -0.874 . . . . 0.0 109.574 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 175.41 -64.53 0.1 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 126.99 74.35 0.2 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.49 -120.0 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.167 -1.196 . . . . 0.0 109.04 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 41' ' ' GLY . 10.9 tp -66.71 -63.63 1.03 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.638 -1.289 . . . . 0.0 109.164 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 40' ' ' LEU . . . 43.59 92.27 0.01 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -55.63 -18.96 8.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.284 -1.127 . . . . 0.0 109.587 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.501 179.958 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.751 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.86 166.77 21.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 109.431 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.549 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 4.3 m-85 44.92 61.37 11.86 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 109.768 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.549 ' HD3' ' N ' ' A' ' 3' ' ' TYR . 43.6 Cg_endo -89.86 -52.16 0.02 OUTLIER 'Trans proline' 0 N--CA 1.5 1.897 1 C-N-CA 126.008 4.472 . . . . 0.0 110.282 180.0 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -45.8 -36.36 5.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -0.843 . . . . 0.0 110.086 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -89.91 -46.07 8.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.116 -0.99 . . . . 0.0 110.164 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 8' ' ' SER . 0.5 OUTLIER -76.59 -63.71 1.28 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.181 -0.95 . . . . 0.0 110.27 -179.319 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.434 ' O ' ' CG ' ' A' ' 12' ' ' ASP . 74.2 m -42.13 -29.74 0.25 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.261 -0.899 . . . . 0.0 109.951 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.5 -80.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.163 -0.96 . . . . 0.0 109.99 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.52 -30.55 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.236 -0.915 . . . . 0.0 110.037 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.405 ' OG1' ' HA ' ' A' ' 8' ' ' SER . 16.7 p -90.32 34.21 0.88 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.144 -0.973 . . . . 0.0 109.334 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.434 ' CG ' ' O ' ' A' ' 8' ' ' SER . 8.8 m-20 -78.39 -74.64 0.26 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.353 -0.842 . . . . 0.0 109.994 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.4 -22.01 12.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 110.694 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.56 -3.6 15.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.01 -1.056 . . . . 0.0 110.239 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -149.86 72.29 9.58 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 120.991 -1.068 . . . . 0.0 109.839 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -92.43 -68.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.771 1 C-N-CA 126.392 4.728 . . . . 0.0 110.458 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -52.29 -56.53 14.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 108.867 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.46 ' O ' ' C ' ' A' ' 19' ' ' LEU . 71.9 t -58.63 -33.0 47.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.478 ' O ' HG13 ' A' ' 23' ' ' ILE . 4.6 tp -44.94 -43.1 8.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.664 -1.273 . . . . 0.0 108.671 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.62 -52.94 32.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.472 -0.767 . . . . 0.0 109.615 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.5 -59.99 3.78 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 121.67 0.748 . . . . 0.0 109.597 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.429 HG22 ' CG1' ' A' ' 18' ' ' VAL . 2.8 t -51.77 -39.63 24.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 O-C-N 121.68 -0.638 . . . . 0.0 109.585 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.481 ' HA ' ' HB2' ' A' ' 26' ' ' TYR . 63.7 mt -67.15 -30.13 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.967 -1.083 . . . . 0.0 109.493 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.401 ' O ' ' HB2' ' A' ' 27' ' ' PHE . 5.2 t80 -57.27 -50.48 72.78 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.5 mt -65.98 -36.97 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.481 ' HB2' ' HA ' ' A' ' 23' ' ' ILE . 3.2 m-85 -62.78 -21.09 65.6 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -81.65 -34.44 30.8 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.045 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 31' ' ' SER . . . -63.44 -56.88 12.65 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.454 0.645 . . . . 0.0 109.34 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.01 -54.95 22.39 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.535 -0.728 . . . . 0.0 110.221 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' A' ' 26' ' ' TYR . 1.9 mp -81.13 22.08 0.67 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.351 -0.843 . . . . 0.0 110.593 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.601 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -61.37 -47.63 93.29 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 120.989 -1.069 . . . . 0.0 110.01 179.722 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 31' ' ' SER . 40.8 Cg_endo -89.96 -6.1 4.9 Favored 'Trans proline' 0 N--CA 1.499 1.822 1 C-N-CA 126.609 4.873 . . . . 0.0 110.853 -179.454 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.455 ' HB1' ' HA ' ' A' ' 30' ' ' LEU . . . -77.62 -31.34 52.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.069 -1.019 . . . . 0.0 109.541 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.5 pt -90.51 -29.7 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 109.496 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -22.4 57.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.124 -0.985 . . . . 0.0 109.183 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -46.4 -65.54 0.54 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 109.017 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 61.54 68.63 1.58 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 178.6 32.03 0.05 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mp -90.24 85.82 6.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.209 -1.171 . . . . 0.0 109.83 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.77 -31.76 40.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.118 -0.989 . . . . 0.0 109.571 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 56.88 168.92 0.1 OUTLIER Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 43' ' ' LYS . 6.7 mt-10 -76.1 -23.57 54.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.326 -1.102 . . . . 0.0 109.703 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 42' ' ' GLU . 1.5 tmmt? . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.645 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.756 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.492 ' O ' ' N ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -127.61 -48.93 1.39 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.875 . . . . 0.0 109.563 . . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.447 ' C ' ' O ' ' A' ' 2' ' ' ARG . 2.2 m-30 -40.03 96.89 0.12 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.504 -0.748 . . . . 0.0 110.054 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.492 ' N ' ' O ' ' A' ' 2' ' ' ARG . 43.0 Cg_endo -88.5 -25.34 0.74 Allowed 'Trans proline' 0 C--N 1.304 -1.806 1 C-N-CA 126.24 4.627 . . . . 0.0 110.26 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -90.47 -11.31 40.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.275 -0.891 . . . . 0.0 109.494 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.47 ' O ' ' OD2' ' A' ' 9' ' ' ASP . 2.6 t80 -89.81 -43.32 10.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 110.117 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.416 ' N ' HD21 ' A' ' 7' ' ' LEU . 2.0 mm? -87.74 -38.23 15.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 110.455 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 4' ' ' PRO . 19.3 m -83.12 19.97 1.34 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.208 -0.933 . . . . 0.0 110.945 -178.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.47 ' OD2' ' O ' ' A' ' 6' ' ' TYR . 6.3 p30 -90.54 -109.48 0.09 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.726 -1.234 . . . . 0.0 109.557 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.1 mm -90.96 -25.93 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.795 -1.191 . . . . 0.0 109.987 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.458 ' HA ' ' HB3' ' A' ' 14' ' ' PHE . 76.4 p -56.39 -29.86 62.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 110.109 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 9' ' ' ASP . 5.2 p-10 -47.19 -37.35 10.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.064 -1.022 . . . . 0.0 109.417 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -97.91 -27.18 14.39 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.226 -0.921 . . . . 0.0 109.898 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.458 ' HB3' ' HA ' ' A' ' 11' ' ' THR . 11.4 t80 -47.98 -49.9 29.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.175 -0.953 . . . . 0.0 109.419 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 1.3 t -139.08 93.73 10.18 Favored Pre-proline 0 C--N 1.301 -1.522 0 O-C-N 121.408 -0.807 . . . . 0.0 110.249 -179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -94.53 -75.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 1 C-N-CA 126.342 4.695 . . . . 0.0 108.988 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -68.18 -19.05 64.75 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.488 ' O ' HG21 ' A' ' 22' ' ' VAL . 3.5 t -82.03 -20.64 10.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.487 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 0.7 OUTLIER -71.78 -50.82 26.49 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.43 -53.57 53.01 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.81 -46.18 50.78 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.099 0.952 . . . . 0.0 108.781 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.488 HG21 ' O ' ' A' ' 18' ' ' VAL . 2.1 t -45.05 -43.18 2.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.281 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.455 ' HA ' ' HB2' ' A' ' 26' ' ' TYR . 30.1 mm -68.99 -36.94 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.125 -0.984 . . . . 0.0 109.371 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.03 -50.03 70.09 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.158 -0.964 . . . . 0.0 108.419 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.8 mm -71.63 -26.54 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.469 ' O ' ' HB3' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -73.38 -15.56 61.36 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 178.553 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.441 ' HA ' HD22 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -89.76 -36.02 15.39 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.11 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.13 -56.83 8.3 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.617 0.722 . . . . 0.0 109.785 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.17 -50.22 74.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.666 -0.646 . . . . 0.0 111.009 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.576 ' CD1' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -67.84 5.74 0.81 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.43 -0.793 . . . . 0.0 111.821 -177.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.573 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -36.91 -48.45 1.93 Allowed Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.727 -1.233 . . . . 0.0 110.875 179.756 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 31' ' ' SER . 41.2 Cg_endo -87.84 -34.06 0.12 Allowed 'Trans proline' 0 N--CA 1.502 1.977 1 C-N-CA 126.304 4.669 . . . . 0.0 111.303 -179.361 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.503 ' HB1' ' HA ' ' A' ' 30' ' ' LEU . . . -58.86 -15.14 11.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.02 -1.05 . . . . 0.0 110.306 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.502 HD11 HG22 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -37.92 -47.81 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.389 -0.819 . . . . 0.0 111.02 -179.016 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.479 ' O ' HG21 ' A' ' 35' ' ' THR . 13.0 t -91.71 42.51 1.11 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.085 -1.009 . . . . 0.0 109.379 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.495 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 25.2 p90 -79.88 157.02 27.05 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.458 -0.776 . . . . 0.0 109.638 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.67 61.7 0.43 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 39' ' ' LEU . . . 121.24 85.06 0.81 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -45.42 167.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -1.119 . . . . 0.0 109.35 179.849 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -86.61 -57.96 2.79 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.151 -0.968 . . . . 0.0 109.517 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.43 -14.42 43.0 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -75.45 -53.07 9.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.233 -1.157 . . . . 0.0 109.537 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.467 179.957 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . 0.474 ' O ' ' HB2' ' A' ' 2' ' ' ARG . . . . . . . . 0 C--O 1.215 -0.753 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 1' ' ' ACE . 1.1 mpt_? 61.87 14.37 6.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.863 . . . . 0.0 109.459 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.691 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 19.5 p90 -93.38 -26.45 0.27 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.355 -0.84 . . . . 0.0 112.395 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.691 ' CD ' ' N ' ' A' ' 3' ' ' TYR . 41.3 Cg_endo -78.99 -46.2 0.11 Allowed 'Trans proline' 0 N--CA 1.507 2.278 0 C-N-CA 124.489 3.459 . . . . 0.0 111.441 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -90.16 -32.89 16.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.868 -1.145 . . . . 0.0 110.749 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.474 ' O ' ' HB2' ' A' ' 9' ' ' ASP . 0.7 OUTLIER -89.99 -56.36 3.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.026 -1.046 . . . . 0.0 111.097 -178.645 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.531 HD22 ' CG2' ' A' ' 11' ' ' THR . 0.0 OUTLIER -62.34 -45.34 93.63 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.897 -1.127 . . . . 0.0 110.527 -178.823 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.3 t -44.37 -23.46 0.11 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.09 -1.006 . . . . 0.0 110.432 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 6' ' ' TYR . 0.7 OUTLIER -49.06 -70.4 0.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.013 -1.054 . . . . 0.0 110.538 -179.323 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.3 mt -88.57 -21.38 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.117 -0.99 . . . . 0.0 110.769 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.531 ' CG2' HD22 ' A' ' 7' ' ' LEU . 7.2 p -90.53 30.93 1.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.912 -1.117 . . . . 0.0 109.889 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -72.09 -41.1 67.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.271 -0.893 . . . . 0.0 109.934 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.441 ' O ' ' HD3' ' A' ' 16' ' ' PRO . . . -60.24 -23.14 63.83 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.147 -0.971 . . . . 0.0 109.671 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.412 ' HB3' ' O ' ' A' ' 11' ' ' THR . 2.9 t80 -46.48 -40.05 11.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.325 -0.859 . . . . 0.0 109.561 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.3 83.65 49.52 Favored Pre-proline 0 C--N 1.301 -1.5 0 O-C-N 121.168 -0.958 . . . . 0.0 109.992 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 13' ' ' ALA . 43.4 Cg_endo -87.77 -61.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.72 1 C-N-CA 126.041 4.494 . . . . 0.0 109.565 179.469 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -54.23 -53.31 55.27 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.22 -0.925 . . . . 0.0 108.734 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -55.4 -39.26 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.505 -0.747 . . . . 0.0 109.105 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.488 ' CD1' ' C ' ' A' ' 19' ' ' LEU . 2.0 tm? -47.49 -49.17 26.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.856 -1.153 . . . . 0.0 109.024 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.85 -51.14 70.84 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.464 -0.773 . . . . 0.0 109.317 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.52 -56.13 9.17 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.769 0.795 . . . . 0.0 109.944 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 44.7 t -51.25 -37.26 17.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 O-C-N 121.708 -0.62 . . . . 0.0 110.248 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -77.23 -26.62 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.114 -0.991 . . . . 0.0 110.249 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -66.17 -34.87 79.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.064 -1.022 . . . . 0.0 108.584 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.4 mm -81.29 -31.13 11.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.508 ' O ' ' HB3' ' A' ' 30' ' ' LEU . 6.1 m-85 -67.72 -28.21 67.46 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.514 ' O ' ' CB ' ' A' ' 31' ' ' SER . 5.0 t80 -74.4 -37.04 63.49 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.4 -59.27 4.19 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.279 0.561 . . . . 0.0 110.507 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.465 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -89.38 -54.04 4.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.293 -0.879 . . . . 0.0 111.201 -178.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.541 ' HG ' ' CB ' ' A' ' 33' ' ' ALA . 1.8 tp -75.85 16.69 0.38 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.269 -0.894 . . . . 0.0 111.238 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.587 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -57.22 -47.14 99.55 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 120.785 -1.197 . . . . 0.0 110.621 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 31' ' ' SER . 42.7 Cg_endo -87.99 -31.35 0.21 Allowed 'Trans proline' 0 N--CA 1.502 1.976 1 C-N-CA 126.352 4.701 . . . . 0.0 111.186 -178.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.541 ' CB ' ' HG ' ' A' ' 30' ' ' LEU . . . -43.84 -33.52 1.34 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.083 -1.011 . . . . 0.0 109.557 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.0 mp -69.69 -46.54 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.291 -0.88 . . . . 0.0 109.432 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.84 -15.09 61.38 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.271 -0.893 . . . . 0.0 109.435 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -79.22 -96.76 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.166 -0.959 . . . . 0.0 109.461 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.4 51.91 0.04 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.2 68.72 0.23 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.91 1.62 17.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.326 -1.103 . . . . 0.0 109.834 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.08 -69.37 0.58 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.065 -1.022 . . . . 0.0 109.597 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.83 98.69 0.65 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.14 -59.31 2.76 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.199 -1.177 . . . . 0.0 109.28 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.373 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.69 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.3 122.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.9 . . . . 0.0 109.286 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.55 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 2.7 p90 -158.75 64.45 2.7 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.294 -0.879 . . . . 0.0 109.427 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 3' ' ' TYR . 43.3 Cg_endo -89.75 -72.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.758 1 C-N-CA 126.219 4.613 . . . . 0.0 110.232 -179.787 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.437 ' O ' ' HB3' ' A' ' 9' ' ' ASP . 0.1 OUTLIER -42.51 -27.61 0.17 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.36 -0.837 . . . . 0.0 110.026 -179.738 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.478 ' O ' ' OD2' ' A' ' 9' ' ' ASP . 2.0 t80 -57.59 -50.05 74.38 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.207 -0.933 . . . . 0.0 110.417 -179.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.57 -42.41 10.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.79 -1.194 . . . . 0.0 110.711 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.3 m -78.36 17.96 0.59 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.226 -0.921 . . . . 0.0 111.232 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.478 ' OD2' ' O ' ' A' ' 6' ' ' TYR . 2.5 p30 -88.64 -104.77 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.583 -1.323 . . . . 0.0 109.444 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.0 mp -90.64 -37.19 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.858 -1.151 . . . . 0.0 109.76 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.429 ' O ' HD13 ' A' ' 19' ' ' LEU . 6.3 p -62.69 -11.21 15.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.137 -0.977 . . . . 0.0 109.732 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -63.74 -57.51 9.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.177 -0.952 . . . . 0.0 109.994 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 14' ' ' PHE . . . -102.88 -51.02 3.37 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.093 -1.004 . . . . 0.0 110.043 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.448 ' C ' ' O ' ' A' ' 13' ' ' ALA . 69.2 t80 -41.78 -36.56 1.04 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.299 -0.876 . . . . 0.0 109.448 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.6 OUTLIER -139.09 87.03 14.32 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.432 -0.793 . . . . 0.0 109.261 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -94.86 -73.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.638 1 C-N-CA 126.472 4.781 . . . . 0.0 109.933 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.518 ' HG3' ' N ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -60.39 -25.28 65.78 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.512 -0.743 . . . . 0.0 109.144 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.518 ' N ' ' HG3' ' A' ' 17' ' ' GLN . 2.7 t -84.46 -23.41 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.38 -0.825 . . . . 0.0 109.448 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 15' ' ' SER . 1.6 tt -63.29 -45.06 93.19 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.891 -1.131 . . . . 0.0 108.547 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.02 -54.91 12.65 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.441 -0.787 . . . . 0.0 109.222 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -46.16 -57.44 4.51 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.714 0.768 . . . . 0.0 109.393 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.6 t -45.24 -46.24 3.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.482 ' O ' ' N ' ' A' ' 26' ' ' TYR . 11.8 mm -61.51 -56.11 20.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.418 -0.801 . . . . 0.0 109.83 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.462 ' C ' ' O ' ' A' ' 23' ' ' ILE . 1.8 t80 -38.2 -38.62 0.36 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.24 -0.912 . . . . 0.0 109.452 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.7 mt -75.32 -45.7 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.517 ' O ' ' N ' ' A' ' 28' ' ' ALA . 4.2 m-30 -55.46 -69.9 0.12 Allowed 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.536 ' O ' ' CB ' ' A' ' 31' ' ' SER . 0.1 OUTLIER -35.24 -32.53 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.881 0.848 . . . . 0.0 109.52 177.859 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 26' ' ' TYR . . . -64.36 -60.43 3.19 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.649 -0.657 . . . . 0.0 110.498 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.23 -63.29 1.28 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.075 -1.016 . . . . 0.0 112.341 -178.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.484 HD13 ' CD1' ' A' ' 34' ' ' ILE . 0.3 OUTLIER -89.68 37.05 0.86 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.021 -1.05 . . . . 0.0 110.191 -177.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.551 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -49.62 -51.07 62.58 Favored Pre-proline 0 C--N 1.297 -1.687 0 O-C-N 121.601 -0.687 . . . . 0.0 110.242 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.558 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 44.2 Cg_endo -90.62 0.18 5.15 Favored 'Trans proline' 0 N--CA 1.501 1.948 1 C-N-CA 126.533 4.822 . . . . 0.0 111.282 -178.846 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.455 ' CB ' ' HB2' ' A' ' 30' ' ' LEU . . . -82.43 -68.54 0.69 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.988 -1.07 . . . . 0.0 109.816 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.484 ' CD1' HD13 ' A' ' 30' ' ' LEU . 5.3 mt -53.72 -61.28 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.901 . . . . 0.0 109.504 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -44.45 -31.74 1.17 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.17 -0.956 . . . . 0.0 109.654 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.558 ' CD1' ' O ' ' A' ' 32' ' ' PRO . 9.9 m-85 -87.88 83.95 7.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.266 -0.897 . . . . 0.0 109.556 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.38 98.9 0.11 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 127.0 -12.92 6.78 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.95 143.48 2.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -1.157 . . . . 0.0 109.679 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.9 tt -90.41 -28.01 18.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 109.298 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 164.64 -66.72 0.22 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -89.52 -64.57 1.12 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.339 -1.095 . . . . 0.0 109.356 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.482 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.723 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.436 ' O ' ' CD2' ' A' ' 3' ' ' TYR . 1.3 mtt85 -94.94 81.91 3.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.524 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.436 ' CD2' ' O ' ' A' ' 2' ' ' ARG . 33.0 m-85 -154.35 79.54 4.94 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.363 -0.835 . . . . 0.0 109.243 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -85.69 -86.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.819 1 C-N-CA 126.03 4.486 . . . . 0.0 110.514 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -72.23 -25.81 61.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.183 -0.948 . . . . 0.0 109.916 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -59.14 -54.21 49.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.194 -0.941 . . . . 0.0 109.773 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.43 ' O ' ' C ' ' A' ' 8' ' ' SER . 0.1 OUTLIER -75.65 -47.72 25.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.912 . . . . 0.0 109.759 -179.77 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 7' ' ' LEU . 29.6 t -42.74 -26.67 0.14 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.304 -0.872 . . . . 0.0 109.912 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 7' ' ' LEU . 0.4 OUTLIER -63.32 -51.8 64.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.242 -0.911 . . . . 0.0 109.884 -179.691 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.82 -35.95 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.186 -0.946 . . . . 0.0 109.926 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.402 ' OG1' ' HA ' ' A' ' 8' ' ' SER . 34.1 p -81.61 7.25 12.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -0.96 . . . . 0.0 109.844 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -76.37 -3.06 34.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.117 -0.99 . . . . 0.0 109.721 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.486 ' O ' ' HD2' ' A' ' 16' ' ' PRO . . . -97.64 5.71 49.01 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.151 -0.968 . . . . 0.0 109.77 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -90.72 19.35 5.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.193 -0.942 . . . . 0.0 109.383 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.599 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 2.3 m -83.9 -44.6 0.78 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.235 -0.915 . . . . 0.0 110.524 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 15' ' ' SER . 41.8 Cg_endo -82.29 -47.38 0.06 OUTLIER 'Trans proline' 0 N--CA 1.5 1.885 1 C-N-CA 125.472 4.114 . . . . 0.0 109.746 -179.876 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -51.6 -34.98 39.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 0.0 109.018 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.428 ' O ' ' C ' ' A' ' 19' ' ' LEU . 52.2 t -72.95 -43.24 59.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.343 -0.848 . . . . 0.0 109.329 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 18' ' ' VAL . 4.4 tt -45.09 -49.04 11.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.143 -0.973 . . . . 0.0 108.595 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 21' ' ' ALA . . . -54.69 -51.38 65.71 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' A' ' 22' ' ' VAL . . . -44.53 -54.37 6.11 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.81 0.814 . . . . 0.0 109.016 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 41.3 t -43.47 -52.8 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.769 -0.582 . . . . 0.0 109.532 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.3 mt -56.67 -43.82 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.082 -1.011 . . . . 0.0 108.722 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.16 -37.79 16.46 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.451 HG21 ' HB2' ' A' ' 29' ' ' ALA . 74.1 mt -72.21 -43.72 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.485 ' HA ' ' HB2' ' A' ' 30' ' ' LEU . 18.5 t80 -52.58 -23.95 7.37 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.518 ' O ' ' CB ' ' A' ' 31' ' ' SER . 3.8 t80 -89.25 -34.21 16.7 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 122.021 0.915 . . . . 0.0 108.644 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.11 -70.08 0.7 Allowed 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.286 0.565 . . . . 0.0 111.478 -178.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.456 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -79.23 -60.58 2.31 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.283 -0.886 . . . . 0.0 112.29 -177.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 26' ' ' TYR . 38.9 mt -84.2 27.35 0.69 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.922 -1.111 . . . . 0.0 110.715 -178.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.566 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -81.73 -50.82 0.87 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.069 -1.019 . . . . 0.0 109.944 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.566 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 42.8 Cg_endo -91.43 -15.23 1.51 Allowed 'Trans proline' 0 N--CA 1.5 1.862 1 C-N-CA 126.57 4.847 . . . . 0.0 110.75 -179.255 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.467 ' HB1' ' HA ' ' A' ' 30' ' ' LEU . . . -53.27 -24.63 11.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 110.163 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -71.61 -73.17 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.18 -0.95 . . . . 0.0 110.084 -179.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.9 m -57.77 -55.98 27.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 110.136 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.79 110.29 0.5 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.336 -0.852 . . . . 0.0 109.599 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.68 176.6 45.53 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 39' ' ' LEU . . . 175.88 -39.23 0.1 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.4 ' O ' ' O ' ' A' ' 38' ' ' GLY . 5.0 mp -60.79 -111.91 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.328 -1.101 . . . . 0.0 109.233 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.468 ' O ' ' C ' ' A' ' 41' ' ' GLY . 0.9 OUTLIER -104.1 -85.86 0.46 Allowed 'General case' 0 N--CA 1.485 1.317 0 O-C-N 120.824 -1.172 . . . . 0.0 108.828 179.614 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 40' ' ' LEU . . . 36.91 37.76 0.26 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -88.12 28.12 1.11 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.163 -1.198 . . . . 0.0 109.647 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.2 mttp . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 118.06 -0.972 . . . . 0.0 109.285 179.882 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.766 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.572 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 1.8 mmp_? -109.2 124.66 51.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.299 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.572 ' CG ' ' O ' ' A' ' 2' ' ' ARG . 8.7 p90 40.94 76.44 0.5 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.329 -0.857 . . . . 0.0 109.774 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.455 ' O ' ' HB3' ' A' ' 8' ' ' SER . 42.1 Cg_endo -88.39 -48.49 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.805 1 C-N-CA 126.282 4.655 . . . . 0.0 110.165 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -65.47 -10.74 36.8 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.182 -0.949 . . . . 0.0 109.45 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.402 ' O ' HD13 ' A' ' 10' ' ' ILE . 3.3 m-85 -88.02 -71.42 0.58 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.36 -0.837 . . . . 0.0 110.452 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 9' ' ' ASP . 1.4 tp -75.5 -56.13 5.0 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.198 -0.939 . . . . 0.0 110.545 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.455 ' HB3' ' O ' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -42.16 -25.62 0.08 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.262 -0.899 . . . . 0.0 110.398 -179.297 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 7' ' ' LEU . 2.7 m-20 -79.63 -44.14 21.52 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.026 -1.046 . . . . 0.0 110.398 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.402 HD13 ' O ' ' A' ' 6' ' ' TYR . 7.8 mt -64.48 -30.41 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.082 -1.011 . . . . 0.0 110.309 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.6 p -83.47 -42.41 16.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.006 -1.059 . . . . 0.0 110.186 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 8' ' ' SER . 0.6 OUTLIER -81.72 3.59 25.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.094 -1.004 . . . . 0.0 110.37 -179.158 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.512 ' HB2' ' CB ' ' A' ' 17' ' ' GLN . . . -93.09 19.84 7.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.068 -1.02 . . . . 0.0 109.814 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.414 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 28.5 t80 -91.32 22.32 3.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.193 -0.942 . . . . 0.0 110.364 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.488 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 0.2 OUTLIER -169.21 -53.01 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.336 0 O-C-N 120.903 -1.123 . . . . 0.0 111.058 -179.459 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.488 ' HD3' ' CB ' ' A' ' 15' ' ' SER . 38.9 Cg_endo -82.23 -23.72 4.2 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 125.004 3.803 . . . . 0.0 110.116 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.512 ' CB ' ' HB2' ' A' ' 13' ' ' ALA . 3.8 tm0? -71.4 -14.8 62.28 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.2 t -84.46 -33.11 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.464 -0.772 . . . . 0.0 109.205 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.471 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 2.3 tp -65.35 -53.67 40.2 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.17 -51.05 65.57 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.426 ' O ' ' C ' ' A' ' 22' ' ' VAL . . . -43.93 -53.86 5.82 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.868 0.842 . . . . 0.0 108.853 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 16.5 t -42.76 -47.61 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 121.782 -0.574 . . . . 0.0 109.527 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.3 mt -66.75 -38.73 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.054 -1.029 . . . . 0.0 109.568 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.82 -39.33 62.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.965 -1.085 . . . . 0.0 108.58 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.4 mt -67.75 -38.27 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -61.84 -21.13 64.39 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.581 ' CG ' HD22 ' A' ' 30' ' ' LEU . 2.0 t80 -73.62 -36.03 65.42 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 177.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.36 -49.3 78.36 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.555 ' O ' ' CD ' ' A' ' 32' ' ' PRO . . . -63.81 -44.24 93.87 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.404 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.581 HD22 ' CG ' ' A' ' 27' ' ' PHE . 0.8 OUTLIER -48.79 -12.01 0.04 OUTLIER 'General case' 0 N--CA 1.509 2.481 0 O-C-N 121.766 -0.584 . . . . 0.0 112.029 -178.503 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.486 ' C ' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -28.73 -50.55 0.25 Allowed Pre-proline 0 N--CA 1.502 2.144 0 O-C-N 121.382 -0.824 . . . . 0.0 112.709 -178.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.555 ' CD ' ' O ' ' A' ' 29' ' ' ALA . 38.0 Cg_endo -85.88 -32.17 0.28 Allowed 'Trans proline' 0 N--CA 1.501 1.958 1 C-N-CA 126.028 4.485 . . . . 0.0 110.757 -178.85 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.462 ' O ' ' C ' ' A' ' 34' ' ' ILE . . . -50.86 -21.53 1.74 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.238 -0.914 . . . . 0.0 109.421 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.462 ' C ' ' O ' ' A' ' 33' ' ' ALA . 3.9 tp -39.75 -37.8 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.616 -0.677 . . . . 0.0 109.206 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -57.14 11.96 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -53.13 119.81 5.16 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.15 -178.62 49.47 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 170.3 42.9 0.03 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 pp -84.22 152.9 23.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -1.116 . . . . 0.0 109.561 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.9 -84.67 0.49 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.333 -0.854 . . . . 0.0 109.375 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 53.77 -139.56 35.87 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -62.53 -33.36 74.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -1.155 . . . . 0.0 109.557 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.433 179.857 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.769 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -51.76 178.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 0.0 109.528 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.73 94.81 4.33 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.297 -0.877 . . . . 0.0 109.457 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -84.16 -40.12 0.1 Allowed 'Trans proline' 0 N--CA 1.5 1.901 1 C-N-CA 125.87 4.38 . . . . 0.0 110.252 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.477 ' HB3' ' OD2' ' A' ' 9' ' ' ASP . 0.1 OUTLIER -66.79 -30.27 70.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.101 -0.999 . . . . 0.0 109.199 179.747 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.455 ' HA ' ' HB2' ' A' ' 9' ' ' ASP . 31.4 t80 -45.58 -40.43 8.79 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.467 -0.771 . . . . 0.0 109.975 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.481 ' O ' ' OG1' ' A' ' 11' ' ' THR . 9.6 mp -52.39 -55.7 19.93 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.684 -0.635 . . . . 0.0 109.958 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.68 10.69 24.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -0.853 . . . . 0.0 110.282 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.477 ' OD2' ' HB3' ' A' ' 5' ' ' TYR . 97.9 m-20 -90.39 -73.46 0.52 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.101 -0.999 . . . . 0.0 110.766 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.7 mm -76.38 -15.04 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.223 -0.923 . . . . 0.0 110.977 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 7' ' ' LEU . 3.6 p -63.27 -10.32 15.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.882 -1.136 . . . . 0.0 109.814 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.55 -38.67 39.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.064 -1.022 . . . . 0.0 109.865 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.58 -22.75 53.84 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.146 -0.971 . . . . 0.0 109.861 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.62 ' CE2' ' NE2' ' A' ' 17' ' ' GLN . 1.6 m-30 -90.27 31.41 1.01 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.136 -0.978 . . . . 0.0 109.433 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.6 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 0.5 OUTLIER -54.38 -45.65 99.25 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.419 -0.801 . . . . 0.0 110.063 179.86 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 15' ' ' SER . 40.8 Cg_endo -82.23 -26.7 2.67 Favored 'Trans proline' 0 N--CA 1.502 1.987 1 C-N-CA 125.577 4.185 . . . . 0.0 109.955 -179.783 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.62 ' NE2' ' CE2' ' A' ' 14' ' ' PHE . 0.4 OUTLIER -75.59 -21.24 58.0 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.281 -0.887 . . . . 0.0 109.112 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 14' ' ' PHE . 98.0 t -88.75 -46.63 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.334 -0.854 . . . . 0.0 109.398 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.425 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 0.2 OUTLIER -54.27 -49.28 69.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.986 -1.071 . . . . 0.0 108.451 179.389 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 21' ' ' ALA . . . -56.22 -53.54 56.0 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 20' ' ' ALA . . . -41.01 -52.29 3.16 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.943 0.877 . . . . 0.0 109.386 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 9.4 t -47.65 -49.61 9.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.972 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.1 mt -67.5 -31.09 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.029 -1.044 . . . . 0.0 110.158 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.65 -39.39 58.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.971 -1.08 . . . . 0.0 108.995 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.9 mm -72.69 -44.97 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.267 -0.896 . . . . 0.0 108.957 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.484 ' CD1' ' O ' ' A' ' 26' ' ' TYR . 13.1 t80 -58.46 -20.61 46.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.096 -1.003 . . . . 0.0 108.349 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.461 ' O ' ' OG ' ' A' ' 31' ' ' SER . 0.2 OUTLIER -90.9 -31.0 16.58 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.84 0.828 . . . . 0.0 109.14 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.28 -71.37 0.41 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.354 0.597 . . . . 0.0 110.827 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.48 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -77.53 -50.69 12.08 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.4 -0.813 . . . . 0.0 111.007 -178.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.478 ' HA ' ' HB1' ' A' ' 33' ' ' ALA . 0.4 OUTLIER -77.39 18.57 0.4 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.401 -0.812 . . . . 0.0 111.247 -178.56 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.573 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -68.13 -52.64 22.09 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.613 -1.304 . . . . 0.0 109.996 -179.812 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.573 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 44.6 Cg_endo -93.54 -12.18 1.38 Allowed 'Trans proline' 0 N--CA 1.5 1.903 1 C-N-CA 126.561 4.841 . . . . 0.0 110.545 -179.6 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.478 ' HB1' ' HA ' ' A' ' 30' ' ' LEU . . . -70.38 -21.69 62.84 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.322 -0.861 . . . . 0.0 110.06 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.469 ' C ' ' O ' ' A' ' 33' ' ' ALA . 0.4 OUTLIER -35.08 -50.25 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.833 -0.542 . . . . 0.0 110.525 -179.354 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.9 p -82.45 -46.39 13.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.089 -1.007 . . . . 0.0 109.545 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 36' ' ' PHE . 2.8 m-85 -86.56 65.68 9.14 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.342 -0.849 . . . . 0.0 109.625 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.72 162.36 28.96 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 155.29 -50.39 0.47 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.437 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 0.8 OUTLIER -89.71 151.31 21.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -1.145 . . . . 0.0 109.314 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.37 -19.19 17.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.144 -0.972 . . . . 0.0 109.452 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 152.7 -94.94 0.15 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.27 21.74 3.15 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.303 -1.116 . . . . 0.0 109.402 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.2 mttt . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.955 -1.022 . . . . 0.0 109.522 179.996 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.793 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.406 ' O ' ' HB2' ' A' ' 3' ' ' TYR . 2.5 ttp180 -154.18 69.24 0.77 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 109.55 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.406 ' HB2' ' O ' ' A' ' 2' ' ' ARG . 78.5 m-85 59.24 83.62 0.21 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.24 -0.913 . . . . 0.0 109.452 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -87.51 -77.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.858 1 C-N-CA 126.074 4.516 . . . . 0.0 110.654 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.425 ' O ' ' C ' ' A' ' 6' ' ' TYR . 68.4 m-85 -80.88 -35.59 32.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.238 -0.914 . . . . 0.0 110.164 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.471 ' O ' ' HB2' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -43.12 -36.63 1.74 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.142 -0.974 . . . . 0.0 109.738 -179.749 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.16 -48.7 80.66 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.334 -0.854 . . . . 0.0 110.091 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.424 ' O ' HG21 ' A' ' 11' ' ' THR . 27.7 t -61.35 -11.62 10.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.158 -0.964 . . . . 0.0 110.185 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 6' ' ' TYR . 3.8 m-20 -84.75 -34.33 22.88 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.154 -0.966 . . . . 0.0 110.173 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 48.6 mm -64.63 -39.71 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.188 -0.945 . . . . 0.0 110.482 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.502 ' CG2' ' N ' ' A' ' 12' ' ' ASP . 14.5 t -60.4 -48.19 82.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.09 -1.006 . . . . 0.0 109.743 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.502 ' N ' ' CG2' ' A' ' 11' ' ' THR . 7.6 p-10 -81.41 0.73 36.2 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.003 -1.061 . . . . 0.0 109.02 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.95 37.62 1.5 Allowed 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.37 -0.831 . . . . 0.0 108.967 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.443 ' O ' ' CD2' ' A' ' 14' ' ' PHE . 4.1 p90 -82.52 17.27 1.81 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.434 -0.791 . . . . 0.0 109.973 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -117.57 89.27 31.99 Favored Pre-proline 0 N--CA 1.485 1.32 0 O-C-N 121.216 -0.928 . . . . 0.0 108.653 179.465 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -82.11 -48.57 0.05 OUTLIER 'Trans proline' 0 N--CA 1.501 1.959 1 C-N-CA 125.96 4.44 . . . . 0.0 109.857 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.57 -26.14 60.69 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.34 -0.85 . . . . 0.0 108.922 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.414 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 74.5 t -87.91 -26.55 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.485 -0.759 . . . . 0.0 109.56 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 15' ' ' SER . 0.7 OUTLIER -68.32 -54.18 19.15 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.137 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.64 -49.53 72.62 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.61 -55.05 18.1 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.751 0.786 . . . . 0.0 109.979 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 64.0 t -52.71 -40.74 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.687 -0.633 . . . . 0.0 110.442 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.425 HD11 ' O ' ' A' ' 19' ' ' LEU . 4.3 mt -77.85 -20.42 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.11 -0.994 . . . . 0.0 110.262 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.84 -46.96 85.46 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.242 -0.911 . . . . 0.0 108.659 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.8 mp -72.6 -34.49 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.302 -0.873 . . . . 0.0 108.921 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.551 ' O ' ' CD2' ' A' ' 30' ' ' LEU . 2.3 m-85 -65.29 -27.54 68.7 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -74.89 -43.6 53.46 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.12 -56.33 21.08 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.442 0.639 . . . . 0.0 109.938 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.61 -56.54 5.66 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.546 -0.721 . . . . 0.0 110.987 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.574 ' CD1' ' O ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -80.37 23.14 0.51 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.164 -0.96 . . . . 0.0 110.535 -178.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.564 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -38.22 -48.89 3.29 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.045 -1.034 . . . . 0.0 110.665 179.828 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 31' ' ' SER . 41.8 Cg_endo -89.42 -24.1 0.72 Allowed 'Trans proline' 0 N--CA 1.502 1.972 1 C-N-CA 126.546 4.831 . . . . 0.0 111.413 -179.22 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.547 ' CB ' ' HB2' ' A' ' 30' ' ' LEU . . . -62.78 -21.81 66.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.917 -1.114 . . . . 0.0 110.055 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.475 HG21 ' N ' ' A' ' 35' ' ' THR . 5.5 tt -54.38 -25.65 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.156 -0.965 . . . . 0.0 109.602 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.475 ' N ' HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -72.09 -35.74 69.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.051 -1.03 . . . . 0.0 109.388 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.45 ' C ' ' O ' ' A' ' 35' ' ' THR . 46.1 t80 -40.06 -51.04 2.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.555 -0.716 . . . . 0.0 109.82 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.97 92.24 0.5 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.06 44.88 0.63 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -177.33 5.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.167 -1.196 . . . . 0.0 109.332 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -52.84 -51.47 60.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 109.408 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.75 -129.25 6.62 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 11.3 mt-10 -81.66 -31.76 32.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.104 -1.233 . . . . 0.0 109.334 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.415 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.726 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -172.42 100.22 0.15 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.172 -0.955 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.492 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 8.9 m-85 -83.44 170.09 15.37 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.257 -0.902 . . . . 0.0 109.127 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.492 ' HD2' ' HB3' ' A' ' 3' ' ' TYR . 40.9 Cg_endo -81.25 -76.48 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.988 1 C-N-CA 125.536 4.158 . . . . 0.0 110.721 -179.602 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -55.09 -18.3 5.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.124 -0.985 . . . . 0.0 109.685 -179.681 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.469 ' HB2' ' HB2' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -75.72 -41.5 53.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 0.0 109.465 179.938 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 3' ' ' TYR . 19.6 mt -46.66 -42.53 16.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.424 -0.798 . . . . 0.0 109.826 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 12' ' ' ASP . 46.7 m -55.41 -44.14 75.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.915 . . . . 0.0 109.826 -179.641 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 6' ' ' TYR . 0.8 OUTLIER -47.77 -45.95 29.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.199 -0.938 . . . . 0.0 109.982 -179.623 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.449 HD11 HG22 ' A' ' 10' ' ' ILE . 19.4 mm -69.84 -50.01 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.181 -0.95 . . . . 0.0 109.927 -179.467 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.0 p -83.28 11.47 6.62 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.026 -1.046 . . . . 0.0 109.68 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 8' ' ' SER . 8.6 t0 -90.5 -32.04 16.51 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.197 -0.939 . . . . 0.0 109.499 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.9 -45.78 93.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.339 -0.851 . . . . 0.0 109.771 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -81.56 -15.24 55.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.905 . . . . 0.0 110.058 -179.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.403 ' OG ' ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -138.98 81.65 21.3 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.028 -1.045 . . . . 0.0 109.989 -179.701 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -91.05 -66.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.865 1 C-N-CA 126.424 4.75 . . . . 0.0 109.646 179.555 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -59.21 -41.49 88.71 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.374 -0.829 . . . . 0.0 108.776 179.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.403 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 2.5 t -65.74 -24.63 34.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.147 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.476 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 1.6 tt -58.75 -54.04 51.55 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.374 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.82 -53.59 46.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.106 -0.996 . . . . 0.0 108.607 179.131 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -44.05 -52.16 7.32 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.841 0.829 . . . . 0.0 109.32 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 38.1 t -44.0 -46.84 2.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 121.902 -0.499 . . . . 0.0 109.802 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.407 ' O ' ' C ' ' A' ' 24' ' ' PHE . 16.6 mt -61.75 -44.02 98.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.961 . . . . 0.0 109.39 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' ILE . 5.6 t80 -46.41 -45.36 17.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.935 . . . . 0.0 108.892 179.645 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.3 mm -68.9 -42.55 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.4 -0.812 . . . . 0.0 108.825 179.369 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.426 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.7 t80 -58.7 -18.81 34.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.998 -1.064 . . . . 0.0 108.349 179.028 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.82 -33.58 15.63 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.881 0.848 . . . . 0.0 108.91 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.564 ' O ' ' CD ' ' A' ' 32' ' ' PRO . . . -71.15 -62.37 1.42 Allowed 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.196 0.522 . . . . 0.0 110.743 -179.285 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.514 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -64.96 -49.74 69.14 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.417 -0.802 . . . . 0.0 111.563 -178.473 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.534 ' CD1' ' O ' ' A' ' 30' ' ' LEU . 3.4 tm? -44.02 -21.99 0.05 Allowed 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.246 -0.909 . . . . 0.0 110.932 -178.173 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.683 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -82.41 -64.16 0.26 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.522 -1.362 . . . . 0.0 110.593 -179.608 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.683 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 42.8 Cg_endo -91.25 20.74 0.88 Allowed 'Trans proline' 0 N--CA 1.498 1.787 1 C-N-CA 125.719 4.279 . . . . 0.0 110.056 179.949 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.453 ' O ' ' C ' ' A' ' 34' ' ' ILE . . . -73.66 -45.28 53.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.225 -0.922 . . . . 0.0 109.536 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.453 ' C ' ' O ' ' A' ' 33' ' ' ALA . 1.7 mp -40.57 -48.97 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.563 -0.71 . . . . 0.0 109.69 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.27 -44.32 92.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.381 -0.824 . . . . 0.0 109.926 -179.677 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -64.8 153.26 40.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.229 -0.919 . . . . 0.0 109.372 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -130.86 17.66 5.18 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.15 -52.73 4.16 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.19 -23.92 65.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.325 -1.103 . . . . 0.0 109.599 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.518 HD23 ' N ' ' A' ' 40' ' ' LEU . 1.5 mm? -101.57 2.09 38.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.185 -0.947 . . . . 0.0 109.573 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -74.39 88.0 0.71 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -81.17 -21.57 39.6 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.303 -1.116 . . . . 0.0 109.397 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.481 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.489 ' OG ' ' HB ' ' A' ' 18' ' ' VAL . 8.0 t . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -92.9 -69.32 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.704 1 C-N-CA 126.207 4.605 . . . . 0.0 110.299 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -58.17 -50.89 71.95 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.318 -0.864 . . . . 0.0 108.723 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.489 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 98.4 t -59.34 -22.42 22.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 19' ' ' LEU . 13.4 tp -60.17 -57.55 12.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.063 -1.023 . . . . 0.0 108.832 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.68 -51.1 61.75 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.328 -0.858 . . . . 0.0 109.343 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.86 -55.38 11.86 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.69 0.757 . . . . 0.0 109.561 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.6 t -50.39 -34.46 11.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 121.807 -0.558 . . . . 0.0 109.535 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mt -71.46 -37.88 66.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.336 -0.852 . . . . 0.0 108.78 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -57.08 -41.03 78.11 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 25' ' ' ILE . 35.3 mt -73.74 -32.96 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.503 ' HA ' ' HB2' ' A' ' 30' ' ' LEU . 32.8 t80 -63.84 -22.38 66.89 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -90.11 -31.79 16.95 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.57 -72.07 0.5 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.215 0.531 . . . . 0.0 111.339 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.83 -51.61 9.49 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.163 -0.961 . . . . 0.0 111.781 -177.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.507 ' HG ' ' HB3' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -78.13 24.57 0.24 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.38 -0.825 . . . . 0.0 111.167 -178.207 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.552 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -65.79 -49.56 58.74 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 120.96 -1.087 . . . . 0.0 110.477 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 31' ' ' SER . 43.2 Cg_endo -90.91 -21.45 0.72 Allowed 'Trans proline' 0 N--CA 1.503 2.033 1 C-N-CA 126.553 4.835 . . . . 0.0 111.54 -178.839 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.507 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.724 0 O-C-N 120.941 -1.099 . . . . 0.0 110.244 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.524 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 3.6 t . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 120.708 0.289 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 15' ' ' SER . 41.9 Cg_endo -86.26 -48.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.773 1 C-N-CA 125.98 4.454 . . . . 0.0 110.091 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -59.79 -43.41 94.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.201 -0.937 . . . . 0.0 108.772 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.44 ' O ' ' C ' ' A' ' 19' ' ' LEU . 73.6 t -71.6 -49.03 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.859 ' O ' HD13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -44.95 -42.76 8.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.106 -0.996 . . . . 0.0 108.358 179.309 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.92 -48.71 77.63 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.87 -56.82 13.04 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.682 0.754 . . . . 0.0 109.927 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 43.8 t -54.37 -25.21 13.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.446 -0.784 . . . . 0.0 109.201 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.859 HD13 ' O ' ' A' ' 19' ' ' LEU . 1.6 mp -82.26 -31.73 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.476 -0.765 . . . . 0.0 109.081 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -52.12 -50.98 60.61 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.1 mt -67.88 -34.87 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.67 ' O ' HD12 ' A' ' 30' ' ' LEU . 3.4 t80 -61.84 -19.44 62.59 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.463 ' HA ' ' HB2' ' A' ' 30' ' ' LEU . 1.8 t80 -85.65 -40.05 16.61 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.494 ' O ' ' OG ' ' A' ' 31' ' ' SER . . . -46.86 -53.07 12.9 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.89 -42.45 81.2 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.969 0.89 . . . . 0.0 109.515 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.67 HD12 ' O ' ' A' ' 26' ' ' TYR . 73.0 mt -70.44 15.33 0.1 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.63 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.583 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.9 OUTLIER -39.25 -48.24 4.38 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 120.872 -1.143 . . . . 0.0 111.17 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 31' ' ' SER . 39.0 Cg_endo -87.0 -23.47 1.55 Allowed 'Trans proline' 0 N--CA 1.502 2.003 1 C-N-CA 126.388 4.725 . . . . 0.0 111.421 -178.63 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.546 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.756 0 O-C-N 121.069 -1.019 . . . . 0.0 109.882 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.422 ' OG ' ' HB ' ' A' ' 18' ' ' VAL . 2.9 t . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -86.35 -53.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.704 1 C-N-CA 126.094 4.53 . . . . 0.0 110.136 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.405 ' HG3' ' N ' ' A' ' 18' ' ' VAL . 6.1 pt20 -57.56 -20.22 30.67 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.104 -0.998 . . . . 0.0 109.201 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.422 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 3.4 t -90.12 -57.17 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.448 -0.783 . . . . 0.0 109.425 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 18' ' ' VAL . 29.6 mt -47.22 -46.99 24.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.997 -1.064 . . . . 0.0 108.5 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.5 ' O ' ' C ' ' A' ' 21' ' ' ALA . . . -59.27 -56.39 22.72 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 20' ' ' ALA . . . -37.46 -49.66 1.04 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 122.192 0.996 . . . . 0.0 109.267 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.8 t -57.26 -66.56 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.749 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.582 ' O ' ' N ' ' A' ' 25' ' ' ILE . 0.7 OUTLIER -69.1 -55.29 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 120.947 -1.096 . . . . 0.0 110.276 -179.096 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.883 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 2.4 t80 -28.72 -38.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.35 0.595 . . . . 0.0 109.68 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.582 ' N ' ' O ' ' A' ' 23' ' ' ILE . 25.5 mt -77.32 -54.66 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.529 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.8 OUTLIER -61.26 -66.9 0.46 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.19 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.539 ' O ' ' CB ' ' A' ' 31' ' ' SER . 0.1 OUTLIER -39.2 -41.9 0.91 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.472 0.653 . . . . 0.0 109.244 177.909 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.883 ' HB2' ' O ' ' A' ' 24' ' ' PHE . . . -53.9 -51.44 63.71 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.626 0.727 . . . . 0.0 110.931 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.403 ' HB3' HD12 ' A' ' 30' ' ' LEU . . . -52.17 -58.06 7.75 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.537 -0.727 . . . . 0.0 110.849 -178.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.403 HD12 ' HB3' ' A' ' 29' ' ' ALA . 2.6 mp -106.07 38.86 1.92 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 0.0 110.736 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.604 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -90.93 -56.79 0.25 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.985 -1.072 . . . . 0.0 110.786 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.604 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 45.2 Cg_endo -93.36 -17.3 0.66 Allowed 'Trans proline' 0 N--CA 1.501 1.964 1 C-N-CA 126.279 4.652 . . . . 0.0 111.882 -177.87 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.006 -1.059 . . . . 0.0 110.916 -178.511 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.499 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 4.6 t . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.486 ' O ' ' HB3' ' A' ' 19' ' ' LEU . 45.7 Cg_endo -92.59 -69.52 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.733 1 C-N-CA 126.353 4.702 . . . . 0.0 109.845 179.579 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -57.45 -49.37 76.49 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.3 t -61.04 -23.49 30.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.499 ' HB2' ' O ' ' A' ' 15' ' ' SER . 6.2 tp -58.69 -54.16 50.18 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.88 -1.137 . . . . 0.0 108.63 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.0 -54.59 44.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.427 -0.795 . . . . 0.0 109.8 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.14 -55.69 7.97 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.881 0.848 . . . . 0.0 110.042 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.505 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 28.8 t -55.2 -41.01 58.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 O-C-N 121.802 -0.562 . . . . 0.0 109.875 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 19' ' ' LEU . 46.7 mm -72.11 -22.1 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.416 -0.802 . . . . 0.0 110.201 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -63.61 -52.31 61.45 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.5 mt -74.62 -26.99 20.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.549 ' O ' ' CG ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -70.15 -20.19 63.16 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.075 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.486 ' HA ' ' HB2' ' A' ' 30' ' ' LEU . 10.0 t80 -83.23 -44.37 15.07 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.29 -51.94 30.75 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.023 0.916 . . . . 0.0 108.676 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.536 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -74.1 -41.24 61.95 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.772 0.796 . . . . 0.0 109.955 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 1.016 HD13 ' CB ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -60.63 -0.03 0.24 Allowed 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.152 -178.51 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.565 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -35.35 -49.0 1.24 Allowed Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.028 -1.045 . . . . 0.0 110.547 -179.629 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 31' ' ' SER . 44.4 Cg_endo -91.48 -23.67 0.44 Allowed 'Trans proline' 0 N--CA 1.502 1.992 1 C-N-CA 126.533 4.822 . . . . 0.0 111.363 -179.422 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 1.016 ' CB ' HD13 ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.198 -0.939 . . . . 0.0 110.847 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 1.5 t . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -86.91 -61.24 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.781 1 C-N-CA 125.986 4.457 . . . . 0.0 110.062 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.09 -31.07 62.9 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.388 -0.82 . . . . 0.0 109.128 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.486 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 5.5 t -89.33 -40.31 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.441 -0.787 . . . . 0.0 110.491 -179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' A' ' 15' ' ' SER . 33.6 tp -57.73 -56.28 23.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.574 -1.329 . . . . 0.0 108.488 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.434 ' O ' ' C ' ' A' ' 21' ' ' ALA . . . -55.24 -55.23 33.69 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.494 -0.754 . . . . 0.0 109.429 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 20' ' ' ALA . . . -42.24 -52.66 4.37 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.944 0.878 . . . . 0.0 109.692 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.7 t -48.65 -55.0 3.71 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 121.173 0.511 . . . . 0.0 110.377 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 25' ' ' ILE . 45.7 mm -63.49 -54.46 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.097 -1.002 . . . . 0.0 110.778 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.523 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -32.71 -36.08 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.643 -0.661 . . . . 0.0 109.661 -179.552 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.744 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 43.4 mt -76.5 -53.98 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.405 -0.809 . . . . 0.0 109.058 178.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.479 ' O ' ' N ' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -57.58 -64.9 0.74 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.92 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.491 ' O ' ' OG ' ' A' ' 31' ' ' SER . 0.1 OUTLIER -39.33 -29.3 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.715 0.769 . . . . 0.0 109.236 177.898 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.744 ' HB3' ' O ' ' A' ' 25' ' ' ILE . . . -63.65 -62.27 1.77 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.538 -0.726 . . . . 0.0 111.202 -178.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.62 -66.76 0.9 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.179 -0.951 . . . . 0.0 112.883 -177.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.571 ' H ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -91.15 36.96 0.92 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.132 -0.98 . . . . 0.0 110.557 -177.326 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.644 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -47.09 -62.79 1.75 Allowed Pre-proline 0 C--N 1.295 -1.788 0 O-C-N 121.199 -0.938 . . . . 0.0 110.878 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.644 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 49.7 Cg_endo -98.88 -0.48 1.03 Allowed 'Trans proline' 0 N--CA 1.501 1.968 1 C-N-CA 126.347 4.698 . . . . 0.0 111.337 -178.337 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.533 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.008 -1.057 . . . . 0.0 110.541 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -91.69 -66.97 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.755 1 C-N-CA 126.374 4.716 . . . . 0.0 110.645 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.36 -42.26 86.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -0.903 . . . . 0.0 109.466 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.0 t -73.11 -19.09 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.372 -0.83 . . . . 0.0 109.155 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 15' ' ' SER . 0.4 OUTLIER -65.36 -47.11 77.56 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.069 -1.02 . . . . 0.0 108.81 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.86 -53.35 18.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.388 -0.82 . . . . 0.0 109.132 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.53 -55.77 10.17 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.895 0.855 . . . . 0.0 109.532 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.7 t -51.73 -47.92 38.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 O-C-N 121.789 -0.569 . . . . 0.0 109.519 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.485 ' O ' ' HB2' ' A' ' 27' ' ' PHE . 22.9 mm -64.54 -26.32 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 110.114 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -64.58 -36.49 84.41 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 120.515 -1.366 . . . . 0.0 108.141 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.615 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 17.3 mt -74.82 -41.88 46.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.497 ' O ' ' N ' ' A' ' 28' ' ' ALA . 6.4 m-85 -60.62 -64.22 1.03 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.632 ' HA ' ' CB ' ' A' ' 31' ' ' SER . 0.8 OUTLIER -37.07 -31.33 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.97 0.89 . . . . 0.0 109.099 177.087 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 25' ' ' ILE . . . -75.24 -53.83 8.14 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.7 -89.38 0.18 Allowed 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.875 -1.141 . . . . 0.0 113.633 -175.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.37 35.26 3.12 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.505 -0.747 . . . . 0.0 112.802 -175.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.632 ' CB ' ' HA ' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -71.14 -48.2 13.59 Favored Pre-proline 0 C--N 1.293 -1.866 0 O-C-N 120.665 -1.272 . . . . 0.0 109.614 179.152 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 31' ' ' SER . 40.3 Cg_endo -86.29 16.76 1.89 Allowed 'Trans proline' 0 C--N 1.303 -1.819 1 C-N-CA 126.307 4.671 . . . . 0.0 110.498 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.444 0 O-C-N 121.221 -0.925 . . . . 0.0 109.258 179.681 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.545 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.545 ' HD3' ' N ' ' A' ' 15' ' ' SER . 43.5 Cg_endo -91.01 -65.09 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.765 1 C-N-CA 126.13 4.553 . . . . 0.0 109.88 179.694 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -60.47 -27.01 67.21 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.367 -0.833 . . . . 0.0 109.056 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.492 ' O ' HG23 ' A' ' 22' ' ' VAL . 41.2 t -73.39 -26.82 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.326 -0.859 . . . . 0.0 109.554 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.04 -52.81 37.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.058 -1.026 . . . . 0.0 108.32 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.09 -47.16 61.95 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.88 -54.59 27.49 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.608 0.718 . . . . 0.0 109.362 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 18' ' ' VAL . 89.7 t -48.93 -31.22 3.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.524 -0.735 . . . . 0.0 109.28 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.532 ' HA ' ' HB2' ' A' ' 26' ' ' TYR . 82.0 mt -78.47 -36.17 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.408 -0.807 . . . . 0.0 109.565 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.63 -43.33 97.64 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mt -76.0 -31.29 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.532 ' HB2' ' HA ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -67.55 -19.15 65.25 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.284 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -85.75 -38.59 18.07 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.507 ' O ' ' OG ' ' A' ' 31' ' ' SER . . . -51.17 -50.53 58.82 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.585 0.707 . . . . 0.0 109.749 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.516 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -76.34 -47.79 22.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.606 -0.684 . . . . 0.0 110.642 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 1.033 HD13 ' HB3' ' A' ' 33' ' ' ALA . 4.4 mm? -66.08 3.71 0.81 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.614 -0.679 . . . . 0.0 112.042 -178.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.552 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -45.99 -53.98 18.98 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 120.445 -1.41 . . . . 0.0 111.068 -179.083 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.552 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 42.9 Cg_endo -92.48 -17.7 0.82 Allowed 'Trans proline' 0 N--CA 1.501 1.914 1 C-N-CA 126.397 4.731 . . . . 0.0 111.751 -178.319 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 1.033 ' HB3' HD13 ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.68 0 O-C-N 120.779 -1.201 . . . . 0.0 110.156 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.489 ' OG ' ' HB ' ' A' ' 18' ' ' VAL . 16.3 t . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -89.99 -64.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.757 1 C-N-CA 126.234 4.622 . . . . 0.0 110.034 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -55.7 -59.22 5.16 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.489 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 25.4 t -51.55 -24.96 4.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 15' ' ' SER . 0.2 OUTLIER -63.38 -53.16 56.89 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.214 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.85 -50.54 70.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.478 -0.764 . . . . 0.0 109.006 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.24 -55.59 10.12 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.752 0.787 . . . . 0.0 109.768 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.2 t -55.65 -38.73 51.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 O-C-N 121.71 -0.619 . . . . 0.0 109.601 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 19' ' ' LEU . 22.7 mt -69.19 -26.81 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.237 -0.915 . . . . 0.0 109.449 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -60.76 -41.51 95.6 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.1 mt -72.4 -41.02 64.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -61.56 -22.8 65.49 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.471 ' O ' ' CB ' ' A' ' 31' ' ' SER . 0.2 OUTLIER -84.62 -29.3 25.86 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 122.044 0.926 . . . . 0.0 108.577 179.416 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.7 -61.81 1.63 Allowed 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.802 -0.561 . . . . 0.0 111.1 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.36 -62.08 1.51 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.038 -1.039 . . . . 0.0 112.708 -177.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.536 ' HA ' ' HB2' ' A' ' 33' ' ' ALA . 10.4 mt -83.11 26.17 0.64 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.961 -1.087 . . . . 0.0 111.417 -177.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.564 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -58.13 -51.52 81.17 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 120.826 -1.172 . . . . 0.0 109.541 179.472 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.564 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 46.3 Cg_endo -94.45 -9.87 1.49 Allowed 'Trans proline' 0 N--CA 1.498 1.786 1 C-N-CA 126.71 4.94 . . . . 0.0 110.533 -179.375 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.536 ' HB2' ' HA ' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.287 -0.883 . . . . 0.0 110.156 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.514 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.777 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -89.7 -65.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.763 1 C-N-CA 126.143 4.562 . . . . 0.0 109.752 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -55.48 -51.26 67.56 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.478 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 72.4 t -62.1 -23.4 31.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.628 -0.67 . . . . 0.0 109.303 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.514 ' HB2' ' O ' ' A' ' 15' ' ' SER . 3.9 tp -56.89 -58.02 9.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.151 -0.968 . . . . 0.0 108.694 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.591 ' HA ' HD12 ' A' ' 23' ' ' ILE . . . -51.77 -53.59 38.09 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -44.67 -52.48 8.2 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 122.036 0.922 . . . . 0.0 109.68 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.8 t -49.94 -49.9 20.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.235 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.591 HD12 ' HA ' ' A' ' 20' ' ' ALA . 3.6 mt -66.96 -26.87 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -0.975 . . . . 0.0 109.832 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -54.74 -42.0 71.1 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.096 -1.002 . . . . 0.0 108.743 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.72 -44.11 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.107 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.06 -19.17 29.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.905 -1.122 . . . . 0.0 108.17 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.521 ' O ' ' CB ' ' A' ' 31' ' ' SER . 0.2 OUTLIER -90.81 -34.91 15.12 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.952 0.882 . . . . 0.0 108.74 179.555 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 31' ' ' SER . . . -76.04 -67.93 0.63 Allowed 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.395 0.617 . . . . 0.0 110.4 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.28 -56.28 24.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.389 -0.819 . . . . 0.0 110.623 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.486 HD12 ' N ' ' A' ' 30' ' ' LEU . 9.8 mp -85.13 25.59 0.96 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.347 -0.846 . . . . 0.0 110.547 -178.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.577 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -66.13 -49.52 55.51 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.075 -1.015 . . . . 0.0 110.046 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 31' ' ' SER . 42.8 Cg_endo -91.1 -5.76 4.1 Favored 'Trans proline' 0 C--N 1.303 -1.821 1 C-N-CA 126.557 4.838 . . . . 0.0 111.186 -179.097 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.023 -1.048 . . . . 0.0 109.647 -179.862 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.513 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.397 0 CA-C-O 120.539 0.209 . . . . 0.0 111.461 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -89.77 -69.42 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.71 1 C-N-CA 126.072 4.515 . . . . 0.0 109.884 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -55.6 -46.21 77.35 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.61 ' CG1' HG23 ' A' ' 22' ' ' VAL . 47.5 t -66.72 -26.84 38.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' A' ' 15' ' ' SER . 2.7 tp -52.58 -44.14 65.72 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.473 -1.392 . . . . 0.0 108.587 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.76 -50.94 61.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.511 -0.743 . . . . 0.0 109.783 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.21 -64.48 0.85 Allowed 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 122.029 0.919 . . . . 0.0 109.285 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.61 HG23 ' CG1' ' A' ' 18' ' ' VAL . 77.3 t -51.59 -33.73 15.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.865 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.485 ' O ' ' HB2' ' A' ' 27' ' ' PHE . 82.5 mt -78.96 -26.06 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.751 -1.218 . . . . 0.0 109.559 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -57.85 -53.42 58.41 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.726 ' H ' HD12 ' A' ' 25' ' ' ILE . 5.2 mp -70.17 -36.44 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.519 ' HA ' ' HB2' ' A' ' 30' ' ' LEU . 0.5 OUTLIER -64.63 -15.58 61.44 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.588 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.485 ' HB2' ' O ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -90.18 -26.0 20.37 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.208 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.62 -79.17 0.22 Allowed 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.605 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.499 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -91.66 -56.95 2.91 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.382 -0.823 . . . . 0.0 112.83 -177.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.519 ' HB2' ' HA ' ' A' ' 26' ' ' TYR . 15.9 mt -68.93 8.91 0.46 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.142 -0.974 . . . . 0.0 112.362 -177.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.575 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.9 OUTLIER -44.35 -48.66 25.29 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 120.626 -1.296 . . . . 0.0 110.112 179.585 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 31' ' ' SER . 42.9 Cg_endo -91.84 -15.69 1.3 Allowed 'Trans proline' 0 N--CA 1.5 1.874 1 C-N-CA 126.707 4.938 . . . . 0.0 111.131 -179.198 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.438 ' HB2' ' HA ' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.69 0 O-C-N 121.063 -1.023 . . . . 0.0 110.038 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.493 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 120.775 0.321 . . . . 0.0 110.212 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.485 ' HD2' ' OE1' ' A' ' 17' ' ' GLN . 43.2 Cg_endo -89.39 -65.64 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.669 1 C-N-CA 126.236 4.624 . . . . 0.0 108.786 178.938 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.563 ' OE1' HG23 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -65.14 -26.53 68.22 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.669 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.563 HG23 ' OE1' ' A' ' 17' ' ' GLN . 22.0 t -78.04 -20.68 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.496 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 1.0 OUTLIER -64.66 -49.02 72.65 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.321 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 21' ' ' ALA . . . -62.73 -56.86 13.79 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 20' ' ' ALA . . . -42.06 -48.76 4.72 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.951 0.881 . . . . 0.0 109.185 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.641 ' HA ' HD12 ' A' ' 25' ' ' ILE . 3.4 t -44.01 -55.29 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.5 mm -54.64 -39.59 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 119.172 -1.011 . . . . 0.0 109.021 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -51.38 -40.41 59.18 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.276 -0.89 . . . . 0.0 108.755 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.641 HD12 ' HA ' ' A' ' 22' ' ' VAL . 7.1 mt -73.15 -40.22 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.313 -0.867 . . . . 0.0 108.95 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -62.84 -16.62 59.17 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.7 -36.45 15.21 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 31' ' ' SER . . . -62.08 -56.61 17.17 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.458 0.646 . . . . 0.0 110.098 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.574 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -57.21 -46.71 82.66 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.474 -0.766 . . . . 0.0 110.563 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 1.083 HD22 ' HB3' ' A' ' 33' ' ' ALA . 1.9 tm? -63.94 -1.29 1.39 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.871 -0.518 . . . . 0.0 111.675 -178.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.588 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -45.91 -57.03 8.79 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 120.832 -1.167 . . . . 0.0 112.219 -178.907 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.588 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 43.1 Cg_endo -91.1 -23.7 0.48 Allowed 'Trans proline' 0 N--CA 1.502 1.986 1 C-N-CA 126.105 4.537 . . . . 0.0 112.122 -177.408 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 1.083 ' HB3' HD22 ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.554 0 O-C-N 120.745 -1.222 . . . . 0.0 109.27 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.549 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 8.2 t . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.549 ' HD3' ' N ' ' A' ' 15' ' ' SER . 44.7 Cg_endo -89.83 -64.65 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.747 1 C-N-CA 125.893 4.395 . . . . 0.0 110.074 -179.419 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -45.07 -32.52 1.77 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.196 -0.94 . . . . 0.0 109.66 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.7 t -86.44 -46.6 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 110.504 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.534 HD23 ' CD1' ' A' ' 23' ' ' ILE . 0.9 OUTLIER -57.54 -60.23 3.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.671 -1.268 . . . . 0.0 108.482 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.59 -47.31 39.87 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.472 -0.767 . . . . 0.0 109.285 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 24' ' ' PHE . . . -49.03 -55.44 12.02 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.938 0.875 . . . . 0.0 109.786 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.1 t -55.29 -51.83 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 121.648 0.737 . . . . 0.0 109.848 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.534 ' CD1' HD23 ' A' ' 19' ' ' LEU . 5.9 mt -66.92 -15.89 20.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.225 -0.922 . . . . 0.0 109.435 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.595 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 0.1 OUTLIER -64.94 -39.75 93.97 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 179.453 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.9 mt -67.75 -45.71 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.706 ' CZ ' HD11 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -61.33 -69.94 0.21 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.599 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.586 ' HA ' ' CB ' ' A' ' 31' ' ' SER . 0.5 OUTLIER -41.34 -30.16 0.17 Allowed 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.679 0.752 . . . . 0.0 110.201 178.2 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.595 ' HB2' ' O ' ' A' ' 24' ' ' PHE . . . -73.24 -58.04 3.59 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.469 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -91.09 -73.53 0.53 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -175.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.79 ' H ' HD23 ' A' ' 30' ' ' LEU . 2.0 pt? -85.47 26.07 0.97 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.966 -1.083 . . . . 0.0 112.364 -175.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.586 ' CB ' ' HA ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -90.02 -50.6 0.36 Allowed Pre-proline 0 C--N 1.296 -1.726 0 O-C-N 120.825 -1.172 . . . . 0.0 109.919 179.108 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 31' ' ' SER . 41.7 Cg_endo -90.58 20.22 1.02 Allowed 'Trans proline' 0 C--N 1.303 -1.829 1 C-N-CA 126.565 4.844 . . . . 0.0 110.823 -179.223 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.459 0 O-C-N 121.099 -1.001 . . . . 0.0 109.706 179.918 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.593 ' O ' HD13 ' A' ' 19' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -92.43 -68.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.771 1 C-N-CA 126.392 4.728 . . . . 0.0 110.458 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -52.29 -56.53 14.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 108.867 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.46 ' O ' ' C ' ' A' ' 19' ' ' LEU . 71.9 t -58.63 -33.0 47.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.593 HD13 ' O ' ' A' ' 15' ' ' SER . 4.6 tp -44.94 -43.1 8.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.664 -1.273 . . . . 0.0 108.671 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.62 -52.94 32.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.472 -0.767 . . . . 0.0 109.615 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.5 -59.99 3.78 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 121.67 0.748 . . . . 0.0 109.597 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.8 t -51.77 -39.63 24.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 O-C-N 121.68 -0.638 . . . . 0.0 109.585 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.491 ' HA ' ' HB2' ' A' ' 26' ' ' TYR . 63.7 mt -67.15 -30.13 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.967 -1.083 . . . . 0.0 109.493 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.413 ' O ' ' HB2' ' A' ' 27' ' ' PHE . 5.2 t80 -57.27 -50.48 72.78 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.5 mt -65.98 -36.97 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.491 ' HB2' ' HA ' ' A' ' 23' ' ' ILE . 3.2 m-85 -62.78 -21.09 65.6 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.413 ' HB2' ' O ' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -81.65 -34.44 30.8 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.045 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 31' ' ' SER . . . -63.44 -56.88 12.65 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.454 0.645 . . . . 0.0 109.34 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.01 -54.95 22.39 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.535 -0.728 . . . . 0.0 110.221 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 26' ' ' TYR . 1.9 mp -81.13 22.08 0.67 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.351 -0.843 . . . . 0.0 110.593 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.601 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -61.37 -47.63 93.29 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 120.989 -1.069 . . . . 0.0 110.01 179.722 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 31' ' ' SER . 40.8 Cg_endo -89.96 -6.1 4.9 Favored 'Trans proline' 0 N--CA 1.499 1.822 1 C-N-CA 126.609 4.873 . . . . 0.0 110.853 -179.454 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.069 -1.019 . . . . 0.0 109.541 179.961 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 1.3 t . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -94.53 -75.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 1 C-N-CA 126.342 4.695 . . . . 0.0 108.988 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -68.18 -19.05 64.75 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.652 ' O ' HG23 ' A' ' 22' ' ' VAL . 3.5 t -82.03 -20.64 10.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.508 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 0.7 OUTLIER -71.78 -50.82 26.49 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.853 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.43 -53.57 53.01 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.81 -46.18 50.78 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.099 0.952 . . . . 0.0 108.781 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 18' ' ' VAL . 2.1 t -45.05 -43.18 2.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.281 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.48 ' HA ' ' HB2' ' A' ' 26' ' ' TYR . 30.1 mm -68.99 -36.94 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.125 -0.984 . . . . 0.0 109.371 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.03 -50.03 70.09 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.158 -0.964 . . . . 0.0 108.419 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.8 mm -71.63 -26.54 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.517 ' O ' HD23 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -73.38 -15.56 61.36 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 178.553 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -89.76 -36.02 15.39 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.13 -56.83 8.3 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.617 0.722 . . . . 0.0 109.785 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.427 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -60.17 -50.22 74.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.666 -0.646 . . . . 0.0 111.009 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.844 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -67.84 5.74 0.81 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.43 -0.793 . . . . 0.0 111.821 -177.973 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.573 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -36.91 -48.45 1.93 Allowed Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.727 -1.233 . . . . 0.0 110.875 179.756 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 31' ' ' SER . 41.2 Cg_endo -87.84 -34.06 0.12 Allowed 'Trans proline' 0 N--CA 1.502 1.977 1 C-N-CA 126.304 4.669 . . . . 0.0 111.303 -179.361 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.762 0 O-C-N 121.02 -1.05 . . . . 0.0 110.306 -179.559 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -87.77 -61.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.72 1 C-N-CA 126.041 4.494 . . . . 0.0 109.565 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -54.23 -53.31 55.27 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.22 -0.925 . . . . 0.0 108.734 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -55.4 -39.26 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.505 -0.747 . . . . 0.0 109.105 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.752 ' O ' HD13 ' A' ' 19' ' ' LEU . 2.0 tm? -47.49 -49.17 26.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.856 -1.153 . . . . 0.0 109.024 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.85 -51.14 70.84 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.464 -0.773 . . . . 0.0 109.317 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.52 -56.13 9.17 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.769 0.795 . . . . 0.0 109.944 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 44.7 t -51.25 -37.26 17.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 O-C-N 121.708 -0.62 . . . . 0.0 110.248 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -77.23 -26.62 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.114 -0.991 . . . . 0.0 110.249 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -66.17 -34.87 79.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.064 -1.022 . . . . 0.0 108.584 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.4 mm -81.29 -31.13 11.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.521 ' O ' ' HB3' ' A' ' 30' ' ' LEU . 6.1 m-85 -67.72 -28.21 67.46 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.514 ' O ' ' CB ' ' A' ' 31' ' ' SER . 5.0 t80 -74.4 -37.04 63.49 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.4 -59.27 4.19 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.279 0.561 . . . . 0.0 110.507 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.49 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -89.38 -54.04 4.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.293 -0.879 . . . . 0.0 111.201 -178.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 1.004 ' HG ' ' HB3' ' A' ' 33' ' ' ALA . 1.8 tp -75.85 16.69 0.38 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.269 -0.894 . . . . 0.0 111.238 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.587 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -57.22 -47.14 99.55 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 120.785 -1.197 . . . . 0.0 110.621 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 31' ' ' SER . 42.7 Cg_endo -87.99 -31.35 0.21 Allowed 'Trans proline' 0 N--CA 1.502 1.976 1 C-N-CA 126.352 4.701 . . . . 0.0 111.186 -178.858 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 1.004 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.083 -1.011 . . . . 0.0 109.557 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.512 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.484 1.252 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -94.86 -73.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.638 1 C-N-CA 126.472 4.781 . . . . 0.0 109.933 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.506 ' HG3' ' N ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -60.39 -25.28 65.78 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.512 -0.743 . . . . 0.0 109.144 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.506 ' N ' ' HG3' ' A' ' 17' ' ' GLN . 2.7 t -84.46 -23.41 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.38 -0.825 . . . . 0.0 109.448 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.512 ' HB2' ' O ' ' A' ' 15' ' ' SER . 1.6 tt -63.29 -45.06 93.19 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.891 -1.131 . . . . 0.0 108.547 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.02 -54.91 12.65 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.441 -0.787 . . . . 0.0 109.222 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -46.16 -57.44 4.51 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.714 0.768 . . . . 0.0 109.393 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.6 t -45.24 -46.24 3.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.482 ' O ' ' N ' ' A' ' 26' ' ' TYR . 11.8 mm -61.51 -56.11 20.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.418 -0.801 . . . . 0.0 109.83 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.462 ' C ' ' O ' ' A' ' 23' ' ' ILE . 1.8 t80 -38.2 -38.62 0.36 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.24 -0.912 . . . . 0.0 109.452 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.713 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 18.7 mt -75.32 -45.7 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.517 ' O ' ' N ' ' A' ' 28' ' ' ALA . 4.2 m-30 -55.46 -69.9 0.12 Allowed 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.536 ' O ' ' CB ' ' A' ' 31' ' ' SER . 0.1 OUTLIER -35.24 -32.53 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.881 0.848 . . . . 0.0 109.52 177.859 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' A' ' 25' ' ' ILE . . . -64.36 -60.43 3.19 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.649 -0.657 . . . . 0.0 110.498 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.23 -63.29 1.28 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.075 -1.016 . . . . 0.0 112.341 -178.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.908 ' HB2' ' HB3' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -89.68 37.05 0.86 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.021 -1.05 . . . . 0.0 110.191 -177.965 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.541 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -49.62 -51.07 62.58 Favored Pre-proline 0 C--N 1.297 -1.687 0 O-C-N 121.601 -0.687 . . . . 0.0 110.242 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.541 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 44.2 Cg_endo -90.62 0.18 5.15 Favored 'Trans proline' 0 N--CA 1.501 1.948 1 C-N-CA 126.533 4.822 . . . . 0.0 111.282 -178.846 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.908 ' HB3' ' HB2' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 120.988 -1.07 . . . . 0.0 109.816 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.599 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 2.3 m . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 110.524 -0.176 . . . . 0.0 110.524 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 15' ' ' SER . 41.8 Cg_endo -82.29 -47.38 0.06 OUTLIER 'Trans proline' 0 N--CA 1.5 1.885 1 C-N-CA 125.472 4.114 . . . . 0.0 109.746 -179.876 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -51.6 -34.98 39.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 0.0 109.018 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 52.2 t -72.95 -43.24 59.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.343 -0.848 . . . . 0.0 109.329 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.431 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 4.4 tt -45.09 -49.04 11.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.143 -0.973 . . . . 0.0 108.595 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 21' ' ' ALA . . . -54.69 -51.38 65.71 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 18' ' ' VAL . . . -44.53 -54.37 6.11 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.81 0.814 . . . . 0.0 109.016 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 41.3 t -43.47 -52.8 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.769 -0.582 . . . . 0.0 109.532 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.3 mt -56.67 -43.82 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.082 -1.011 . . . . 0.0 108.722 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.16 -37.79 16.46 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.491 ' CG2' ' HB3' ' A' ' 29' ' ' ALA . 74.1 mt -72.21 -43.72 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.509 ' HA ' ' HB2' ' A' ' 30' ' ' LEU . 18.5 t80 -52.58 -23.95 7.37 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.518 ' O ' ' CB ' ' A' ' 31' ' ' SER . 3.8 t80 -89.25 -34.21 16.7 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 122.021 0.915 . . . . 0.0 108.644 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.11 -70.08 0.7 Allowed 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.286 0.565 . . . . 0.0 111.478 -178.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.491 ' HB3' ' CG2' ' A' ' 25' ' ' ILE . . . -79.23 -60.58 2.31 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.283 -0.886 . . . . 0.0 112.29 -177.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 26' ' ' TYR . 38.9 mt -84.2 27.35 0.69 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.922 -1.111 . . . . 0.0 110.715 -178.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.559 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -81.73 -50.82 0.87 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.069 -1.019 . . . . 0.0 109.944 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.559 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 42.8 Cg_endo -91.43 -15.23 1.51 Allowed 'Trans proline' 0 N--CA 1.5 1.862 1 C-N-CA 126.57 4.847 . . . . 0.0 110.75 -179.255 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 110.163 -179.623 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.492 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.003 -0.046 . . . . 0.0 111.058 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.492 ' HD3' ' CB ' ' A' ' 15' ' ' SER . 38.9 Cg_endo -82.23 -23.72 4.2 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 125.004 3.803 . . . . 0.0 110.116 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -71.4 -14.8 62.28 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.2 t -84.46 -33.11 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.464 -0.772 . . . . 0.0 109.205 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.479 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 2.3 tp -65.35 -53.67 40.2 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.17 -51.05 65.57 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.426 ' O ' ' C ' ' A' ' 22' ' ' VAL . . . -43.93 -53.86 5.82 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.868 0.842 . . . . 0.0 108.853 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 16.5 t -42.76 -47.61 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 121.782 -0.574 . . . . 0.0 109.527 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.3 mt -66.75 -38.73 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.054 -1.029 . . . . 0.0 109.568 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.82 -39.33 62.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.965 -1.085 . . . . 0.0 108.58 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.521 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 4.4 mt -67.75 -38.27 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -61.84 -21.13 64.39 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 1.094 ' HA ' HD23 ' A' ' 30' ' ' LEU . 2.0 t80 -73.62 -36.03 65.42 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 177.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 25' ' ' ILE . . . -59.36 -49.3 78.36 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.3 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.563 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -63.81 -44.24 93.87 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.404 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 1.094 HD23 ' HA ' ' A' ' 27' ' ' PHE . 0.8 OUTLIER -48.79 -12.01 0.04 OUTLIER 'General case' 0 N--CA 1.509 2.481 0 O-C-N 121.766 -0.584 . . . . 0.0 112.029 -178.503 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.486 ' C ' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -28.73 -50.55 0.25 Allowed Pre-proline 0 N--CA 1.502 2.144 0 O-C-N 121.382 -0.824 . . . . 0.0 112.709 -178.953 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.563 ' HD2' ' O ' ' A' ' 29' ' ' ALA . 38.0 Cg_endo -85.88 -32.17 0.28 Allowed 'Trans proline' 0 N--CA 1.501 1.958 1 C-N-CA 126.028 4.485 . . . . 0.0 110.757 -178.85 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.238 -0.914 . . . . 0.0 109.421 179.038 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.6 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 15' ' ' SER . 40.8 Cg_endo -82.23 -26.7 2.67 Favored 'Trans proline' 0 N--CA 1.502 1.987 1 C-N-CA 125.577 4.185 . . . . 0.0 109.955 -179.783 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.59 -21.24 58.0 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.281 -0.887 . . . . 0.0 109.112 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.0 t -88.75 -46.63 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.334 -0.854 . . . . 0.0 109.398 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.433 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 0.2 OUTLIER -54.27 -49.28 69.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.986 -1.071 . . . . 0.0 108.451 179.389 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 21' ' ' ALA . . . -56.22 -53.54 56.0 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 20' ' ' ALA . . . -41.01 -52.29 3.16 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.943 0.877 . . . . 0.0 109.386 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.433 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 9.4 t -47.65 -49.61 9.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.972 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.1 mt -67.5 -31.09 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.029 -1.044 . . . . 0.0 110.158 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.65 -39.39 58.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.971 -1.08 . . . . 0.0 108.995 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.9 mm -72.69 -44.97 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.267 -0.896 . . . . 0.0 108.957 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.484 ' CD1' ' O ' ' A' ' 26' ' ' TYR . 13.1 t80 -58.46 -20.61 46.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.096 -1.003 . . . . 0.0 108.349 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.409 ' O ' ' CB ' ' A' ' 31' ' ' SER . 0.2 OUTLIER -90.9 -31.0 16.58 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.84 0.828 . . . . 0.0 109.14 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.28 -71.37 0.41 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.354 0.597 . . . . 0.0 110.827 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.507 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -77.53 -50.69 12.08 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.4 -0.813 . . . . 0.0 111.007 -178.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -77.39 18.57 0.4 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.401 -0.812 . . . . 0.0 111.247 -178.56 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.562 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -68.13 -52.64 22.09 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.613 -1.304 . . . . 0.0 109.996 -179.812 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.562 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 44.6 Cg_endo -93.54 -12.18 1.38 Allowed 'Trans proline' 0 N--CA 1.5 1.903 1 C-N-CA 126.561 4.841 . . . . 0.0 110.545 -179.6 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.432 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.675 0 O-C-N 121.322 -0.861 . . . . 0.0 110.06 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -82.11 -48.57 0.05 OUTLIER 'Trans proline' 0 N--CA 1.501 1.959 1 C-N-CA 125.96 4.44 . . . . 0.0 109.857 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.57 -26.14 60.69 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.34 -0.85 . . . . 0.0 108.922 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.548 ' O ' HG23 ' A' ' 22' ' ' VAL . 74.5 t -87.91 -26.55 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.485 -0.759 . . . . 0.0 109.56 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.754 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.7 OUTLIER -68.32 -54.18 19.15 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.137 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.64 -49.53 72.62 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.403 ' O ' HD12 ' A' ' 25' ' ' ILE . . . -50.61 -55.05 18.1 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.751 0.786 . . . . 0.0 109.979 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 18' ' ' VAL . 64.0 t -52.71 -40.74 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.687 -0.633 . . . . 0.0 110.442 -179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.754 HD12 ' O ' ' A' ' 19' ' ' LEU . 4.3 mt -77.85 -20.42 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.11 -0.994 . . . . 0.0 110.262 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.84 -46.96 85.46 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.242 -0.911 . . . . 0.0 108.659 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.406 HD12 ' H ' ' A' ' 25' ' ' ILE . 3.8 mp -72.6 -34.49 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.302 -0.873 . . . . 0.0 108.921 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.773 ' O ' HD23 ' A' ' 30' ' ' LEU . 2.3 m-85 -65.29 -27.54 68.7 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -74.89 -43.6 53.46 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.12 -56.33 21.08 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.442 0.639 . . . . 0.0 109.938 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.61 -56.54 5.66 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.546 -0.721 . . . . 0.0 110.987 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.861 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -80.37 23.14 0.51 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.164 -0.96 . . . . 0.0 110.535 -178.993 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.564 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -38.22 -48.89 3.29 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.045 -1.034 . . . . 0.0 110.665 179.828 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 31' ' ' SER . 41.8 Cg_endo -89.42 -24.1 0.72 Allowed 'Trans proline' 0 N--CA 1.502 1.972 1 C-N-CA 126.546 4.831 . . . . 0.0 111.413 -179.22 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.835 ' HB3' ' HB2' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.597 0 O-C-N 120.917 -1.114 . . . . 0.0 110.055 -179.389 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.418 ' OG ' ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -91.05 -66.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.865 1 C-N-CA 126.424 4.75 . . . . 0.0 109.646 179.555 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -59.21 -41.49 88.71 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.374 -0.829 . . . . 0.0 108.776 179.504 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.418 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 2.5 t -65.74 -24.63 34.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.147 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.485 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 1.6 tt -58.75 -54.04 51.55 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.374 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.82 -53.59 46.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.106 -0.996 . . . . 0.0 108.607 179.131 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -44.05 -52.16 7.32 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.841 0.829 . . . . 0.0 109.32 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 38.1 t -44.0 -46.84 2.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 121.902 -0.499 . . . . 0.0 109.802 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.407 ' O ' ' C ' ' A' ' 24' ' ' PHE . 16.6 mt -61.75 -44.02 98.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.961 . . . . 0.0 109.39 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' ILE . 5.6 t80 -46.41 -45.36 17.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.935 . . . . 0.0 108.892 179.645 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.3 mm -68.9 -42.55 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.4 -0.812 . . . . 0.0 108.825 179.369 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.451 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.7 t80 -58.7 -18.81 34.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.998 -1.064 . . . . 0.0 108.349 179.028 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.82 -33.58 15.63 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.881 0.848 . . . . 0.0 108.91 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.564 ' O ' ' CD ' ' A' ' 32' ' ' PRO . . . -71.15 -62.37 1.42 Allowed 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.196 0.522 . . . . 0.0 110.743 -179.285 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.563 ' O ' ' HB2' ' A' ' 33' ' ' ALA . . . -64.96 -49.74 69.14 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.417 -0.802 . . . . 0.0 111.563 -178.473 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 1.007 ' O ' HD13 ' A' ' 30' ' ' LEU . 3.4 tm? -44.02 -21.99 0.05 Allowed 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.246 -0.909 . . . . 0.0 110.932 -178.173 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.688 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -82.41 -64.16 0.26 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.522 -1.362 . . . . 0.0 110.593 -179.608 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.688 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 42.8 Cg_endo -91.25 20.74 0.88 Allowed 'Trans proline' 0 N--CA 1.498 1.787 1 C-N-CA 125.719 4.279 . . . . 0.0 110.056 179.949 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.225 -0.922 . . . . 0.0 109.536 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.742 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.587 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 8.2 mtp180 -90.48 -102.13 0.1 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.457 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.587 ' CG ' ' O ' ' A' ' 2' ' ' ARG . 57.6 m-85 -161.55 86.32 1.64 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 120.961 -1.087 . . . . 0.0 109.454 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -87.73 -78.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.802 1 C-N-CA 126.086 4.524 . . . . 0.0 110.221 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -69.83 -28.91 66.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.243 -0.911 . . . . 0.0 109.422 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.487 ' O ' ' HB2' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -48.27 -41.24 27.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -0.838 . . . . 0.0 109.685 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.452 ' HA ' HD13 ' A' ' 7' ' ' LEU . 3.4 mm? -67.58 -39.05 84.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.961 . . . . 0.0 109.88 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.4 p -84.05 18.17 2.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.316 -0.865 . . . . 0.0 110.065 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 6' ' ' TYR . 0.9 OUTLIER -86.5 -58.56 2.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.123 -0.986 . . . . 0.0 109.802 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -28.27 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.205 -0.934 . . . . 0.0 109.439 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.459 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 73.9 p -85.27 24.18 1.18 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.365 -0.834 . . . . 0.0 110.016 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 12' ' ' ASP . 15.3 t70 -90.59 8.81 32.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.036 -1.04 . . . . 0.0 110.019 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.09 -17.62 14.43 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.021 -1.049 . . . . 0.0 109.75 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.507 ' CD1' ' C ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -76.96 1.74 16.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.259 -0.901 . . . . 0.0 110.103 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.489 ' OG ' ' HB ' ' A' ' 18' ' ' VAL . 8.0 t -146.41 94.52 4.8 Favored Pre-proline 0 N--CA 1.487 1.399 0 O-C-N 121.12 -0.988 . . . . 0.0 110.073 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -92.9 -69.32 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.704 1 C-N-CA 126.207 4.605 . . . . 0.0 110.299 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -58.17 -50.89 71.95 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.318 -0.864 . . . . 0.0 108.723 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.489 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 98.4 t -59.34 -22.42 22.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 19' ' ' LEU . 13.4 tp -60.17 -57.55 12.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.063 -1.023 . . . . 0.0 108.832 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.68 -51.1 61.75 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.328 -0.858 . . . . 0.0 109.343 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.86 -55.38 11.86 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.69 0.757 . . . . 0.0 109.561 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.6 t -50.39 -34.46 11.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 121.807 -0.558 . . . . 0.0 109.535 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mt -71.46 -37.88 66.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.336 -0.852 . . . . 0.0 108.78 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -57.08 -41.03 78.11 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 25' ' ' ILE . 35.3 mt -73.74 -32.96 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.532 ' OH ' ' CG2' ' A' ' 34' ' ' ILE . 32.8 t80 -63.84 -22.38 66.89 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -90.11 -31.79 16.95 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.57 -72.07 0.5 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.215 0.531 . . . . 0.0 111.339 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.83 -51.61 9.49 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.163 -0.961 . . . . 0.0 111.781 -177.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.507 ' HG ' ' HB3' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -78.13 24.57 0.24 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.38 -0.825 . . . . 0.0 111.167 -178.207 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.552 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -65.79 -49.56 58.74 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 120.96 -1.087 . . . . 0.0 110.477 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 31' ' ' SER . 43.2 Cg_endo -90.91 -21.45 0.72 Allowed 'Trans proline' 0 N--CA 1.503 2.033 1 C-N-CA 126.553 4.835 . . . . 0.0 111.54 -178.839 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.507 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . . . -61.78 -28.44 69.46 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.941 -1.099 . . . . 0.0 110.244 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.532 ' CG2' ' OH ' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -42.98 -63.87 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.159 -0.963 . . . . 0.0 110.758 -179.424 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.8 t -74.32 -28.08 61.0 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.153 -0.967 . . . . 0.0 111.269 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.82 123.01 24.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.764 -1.21 . . . . 0.0 110.161 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.44 128.55 2.03 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 170.09 -67.8 0.15 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.3 mt -73.6 94.35 2.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.166 -1.197 . . . . 0.0 109.604 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 pp -105.23 12.13 32.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.272 -0.893 . . . . 0.0 109.567 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -146.0 67.05 0.41 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.71 -25.57 19.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.316 -1.108 . . . . 0.0 109.278 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 43' ' ' LYS . 11.0 tttt . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.433 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.735 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.548 ' O ' ' CD2' ' A' ' 3' ' ' TYR . 21.3 mtt-85 -137.23 132.66 34.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 109.602 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.573 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER 164.93 -49.77 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.178 -0.951 . . . . 0.0 109.295 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 3' ' ' TYR . 42.7 Cg_endo -86.25 -38.22 0.09 OUTLIER 'Trans proline' 0 N--CA 1.499 1.803 1 C-N-CA 126.049 4.5 . . . . 0.0 109.708 179.479 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.42 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 48.2 t80 -81.04 -18.73 45.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.418 -0.801 . . . . 0.0 109.001 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.15 -38.57 83.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.523 -0.735 . . . . 0.0 109.986 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.765 ' HA ' HD12 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -56.35 -52.41 64.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.352 -0.843 . . . . 0.0 110.061 -179.449 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 t -51.91 -21.6 3.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.201 -0.937 . . . . 0.0 110.019 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.85 -50.27 6.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.096 -1.003 . . . . 0.0 110.049 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.865 HG23 ' CD2' ' A' ' 14' ' ' PHE . 5.2 mt -55.47 -15.55 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.044 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.535 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 7.6 p -89.16 -37.06 15.32 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.997 -1.064 . . . . 0.0 110.058 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -91.68 -66.78 0.9 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.117 -0.99 . . . . 0.0 111.494 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.09 -10.83 60.0 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.212 -0.93 . . . . 0.0 112.08 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.865 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -90.35 11.29 21.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.456 -1.402 . . . . 0.0 110.561 -179.1 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.524 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 3.6 t 35.49 63.0 2.37 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.479 -0.763 . . . . 0.0 110.267 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.535 ' CG ' ' O ' ' A' ' 11' ' ' THR . 41.9 Cg_endo -86.26 -48.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.773 1 C-N-CA 125.98 4.454 . . . . 0.0 110.091 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -59.79 -43.41 94.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.201 -0.937 . . . . 0.0 108.772 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.44 ' O ' ' C ' ' A' ' 19' ' ' LEU . 73.6 t -71.6 -49.03 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.859 ' O ' HD13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -44.95 -42.76 8.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.106 -0.996 . . . . 0.0 108.358 179.309 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.92 -48.71 77.63 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.87 -56.82 13.04 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.682 0.754 . . . . 0.0 109.927 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 43.8 t -54.37 -25.21 13.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.446 -0.784 . . . . 0.0 109.201 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.859 HD13 ' O ' ' A' ' 19' ' ' LEU . 1.6 mp -82.26 -31.73 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.476 -0.765 . . . . 0.0 109.081 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -52.12 -50.98 60.61 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.1 mt -67.88 -34.87 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.67 ' O ' HD12 ' A' ' 30' ' ' LEU . 3.4 t80 -61.84 -19.44 62.59 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.463 ' HA ' ' HB2' ' A' ' 30' ' ' LEU . 1.8 t80 -85.65 -40.05 16.61 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.494 ' O ' ' OG ' ' A' ' 31' ' ' SER . . . -46.86 -53.07 12.9 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.89 -42.45 81.2 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.969 0.89 . . . . 0.0 109.515 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.67 HD12 ' O ' ' A' ' 26' ' ' TYR . 73.0 mt -70.44 15.33 0.1 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.63 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.583 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.9 OUTLIER -39.25 -48.24 4.38 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 120.872 -1.143 . . . . 0.0 111.17 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 31' ' ' SER . 39.0 Cg_endo -87.0 -23.47 1.55 Allowed 'Trans proline' 0 N--CA 1.502 2.003 1 C-N-CA 126.388 4.725 . . . . 0.0 111.421 -178.63 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.546 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . -68.12 -13.36 62.16 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.069 -1.019 . . . . 0.0 109.882 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.528 ' CD1' ' O ' ' A' ' 31' ' ' SER . 85.4 mt -29.69 -37.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-O 120.945 0.402 . . . . 0.0 111.037 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 33' ' ' ALA . 29.1 m -75.08 -50.42 16.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.046 -1.034 . . . . 0.0 109.809 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.437 ' C ' ' O ' ' A' ' 35' ' ' THR . 32.5 t80 -39.56 -49.11 2.14 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.575 -0.703 . . . . 0.0 109.888 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 34' ' ' ILE . . . -125.63 -170.17 12.99 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.56 ' O ' HD13 ' A' ' 40' ' ' LEU . . . 152.97 -47.74 0.55 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.415 ' C ' HD13 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -49.67 119.55 3.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.058 -1.26 . . . . 0.0 109.322 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.56 HD13 ' O ' ' A' ' 38' ' ' GLY . 0.8 OUTLIER -99.89 -40.52 7.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 109.315 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 116.0 -10.75 17.91 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.531 ' O ' ' CG ' ' A' ' 43' ' ' LYS . 47.0 tp10 -69.76 -56.25 7.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.298 -1.119 . . . . 0.0 109.728 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.531 ' CG ' ' O ' ' A' ' 42' ' ' GLU . 2.6 ptmm? . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.768 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.688 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.452 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 2.6 tpp85 -109.1 -63.9 1.3 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.237 -0.914 . . . . 0.0 109.328 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.452 ' CG ' ' O ' ' A' ' 2' ' ' ARG . 1.7 m-85 -167.02 70.81 1.02 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.235 -0.916 . . . . 0.0 109.584 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.513 ' HD2' ' CD2' ' A' ' 5' ' ' TYR . 43.2 Cg_endo -86.97 -31.43 0.25 Allowed 'Trans proline' 0 C--N 1.303 -1.838 1 C-N-CA 126.21 4.606 . . . . 0.0 110.234 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.571 ' CD1' ' N ' ' A' ' 6' ' ' TYR . 33.5 p90 -90.21 -47.93 7.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.904 . . . . 0.0 110.09 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.571 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -59.47 -48.04 83.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.23 -0.919 . . . . 0.0 109.551 -179.805 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.434 ' O ' HD13 ' A' ' 7' ' ' LEU . 0.1 OUTLIER -63.78 -41.97 97.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.744 -179.775 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -81.82 16.39 1.85 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.264 -0.898 . . . . 0.0 110.19 -179.559 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.42 ' CG ' ' O ' ' A' ' 5' ' ' TYR . 80.7 m-20 -90.19 -109.77 0.08 Allowed 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.883 -1.136 . . . . 0.0 109.641 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.571 ' O ' HD13 ' A' ' 10' ' ' ILE . 0.4 OUTLIER -91.92 -38.01 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.894 -1.129 . . . . 0.0 110.085 -179.626 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.457 ' HA ' ' HB2' ' A' ' 14' ' ' PHE . 43.5 p -67.5 -0.94 4.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.48 -0.763 . . . . 0.0 110.908 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.478 ' O ' ' HG3' ' A' ' 16' ' ' PRO . 2.5 t0 -74.22 -37.15 63.92 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.704 -1.248 . . . . 0.0 110.023 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.22 9.34 34.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.123 -0.986 . . . . 0.0 110.147 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.457 ' HB2' ' HA ' ' A' ' 11' ' ' THR . 0.5 OUTLIER -90.33 -79.6 0.34 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.974 -1.079 . . . . 0.0 109.852 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.422 ' OG ' ' HB ' ' A' ' 18' ' ' VAL . 2.9 t -144.97 77.42 13.18 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.43 -0.794 . . . . 0.0 109.086 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.478 ' HG3' ' O ' ' A' ' 12' ' ' ASP . 41.6 Cg_endo -86.35 -53.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.704 1 C-N-CA 126.094 4.53 . . . . 0.0 110.136 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.405 ' HG3' ' N ' ' A' ' 18' ' ' VAL . 6.1 pt20 -57.56 -20.22 30.67 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.104 -0.998 . . . . 0.0 109.201 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.422 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 3.4 t -90.12 -57.17 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.448 -0.783 . . . . 0.0 109.425 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 18' ' ' VAL . 29.6 mt -47.22 -46.99 24.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.997 -1.064 . . . . 0.0 108.5 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.5 ' O ' ' C ' ' A' ' 21' ' ' ALA . . . -59.27 -56.39 22.72 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 20' ' ' ALA . . . -37.46 -49.66 1.04 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 122.192 0.996 . . . . 0.0 109.267 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.8 t -57.26 -66.56 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.749 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.582 ' O ' ' N ' ' A' ' 25' ' ' ILE . 0.7 OUTLIER -69.1 -55.29 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 120.947 -1.096 . . . . 0.0 110.276 -179.096 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.883 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 2.4 t80 -28.72 -38.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.35 0.595 . . . . 0.0 109.68 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.582 ' N ' ' O ' ' A' ' 23' ' ' ILE . 25.5 mt -77.32 -54.66 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.529 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.8 OUTLIER -61.26 -66.9 0.46 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.19 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.539 ' O ' ' CB ' ' A' ' 31' ' ' SER . 0.1 OUTLIER -39.2 -41.9 0.91 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.472 0.653 . . . . 0.0 109.244 177.909 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.883 ' HB2' ' O ' ' A' ' 24' ' ' PHE . . . -53.9 -51.44 63.71 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.626 0.727 . . . . 0.0 110.931 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.403 ' HB3' HD12 ' A' ' 30' ' ' LEU . . . -52.17 -58.06 7.75 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.537 -0.727 . . . . 0.0 110.849 -178.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.403 HD12 ' HB3' ' A' ' 29' ' ' ALA . 2.6 mp -106.07 38.86 1.92 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 0.0 110.736 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.604 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -90.93 -56.79 0.25 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.985 -1.072 . . . . 0.0 110.786 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.604 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 45.2 Cg_endo -93.36 -17.3 0.66 Allowed 'Trans proline' 0 N--CA 1.501 1.964 1 C-N-CA 126.279 4.652 . . . . 0.0 111.882 -177.87 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.02 -50.03 74.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.006 -1.059 . . . . 0.0 110.916 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.436 HG23 ' N ' ' A' ' 35' ' ' THR . 0.5 OUTLIER -75.95 -39.37 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.05 -1.031 . . . . 0.0 110.943 -178.726 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.436 ' N ' HG23 ' A' ' 34' ' ' ILE . 9.9 t -90.67 28.92 1.4 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.882 -1.136 . . . . 0.0 110.508 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' A' ' 32' ' ' PRO . 3.6 t80 -89.41 103.59 16.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.983 -1.073 . . . . 0.0 109.671 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 127.89 110.04 1.55 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 117.95 -38.35 2.96 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.575 ' O ' HD12 ' A' ' 39' ' ' LEU . 0.9 OUTLIER -52.03 114.13 1.22 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.195 -1.179 . . . . 0.0 109.8 -179.803 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.34 15.1 29.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.308 -0.87 . . . . 0.0 109.329 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 137.16 126.98 2.56 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -73.96 -62.63 1.43 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -1.183 . . . . 0.0 109.937 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.0 tptt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.658 -179.779 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.741 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -109.8 -71.4 0.76 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 0.0 109.505 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.681 ' CD2' HD13 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -175.44 59.84 0.2 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.203 -0.935 . . . . 0.0 109.476 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.585 ' HD3' ' N ' ' A' ' 3' ' ' TYR . 44.0 Cg_endo -91.89 -63.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.733 1 C-N-CA 125.991 4.461 . . . . 0.0 110.617 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.569 ' CE2' ' OD2' ' A' ' 9' ' ' ASP . 69.2 t80 -78.71 -23.81 45.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.489 -0.757 . . . . 0.0 110.319 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -74.79 -45.1 45.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.154 -0.966 . . . . 0.0 110.492 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.681 HD13 ' CD2' ' A' ' 3' ' ' TYR . 3.7 tp -84.42 -40.14 18.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.171 -0.956 . . . . 0.0 110.294 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.534 ' HA ' HG22 ' A' ' 11' ' ' THR . 9.9 t -83.75 25.26 0.8 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.336 -0.852 . . . . 0.0 110.492 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.569 ' OD2' ' CE2' ' A' ' 5' ' ' TYR . 0.6 OUTLIER -89.97 -68.32 0.79 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.0 -1.063 . . . . 0.0 109.958 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.7 mm -89.7 -25.13 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.113 -0.992 . . . . 0.0 110.207 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.534 HG22 ' HA ' ' A' ' 8' ' ' SER . 6.7 t -64.82 -32.38 74.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.096 -1.003 . . . . 0.0 110.015 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -74.35 -5.38 41.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.081 -1.012 . . . . 0.0 109.853 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.07 -59.99 2.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.211 -0.931 . . . . 0.0 109.828 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -81.45 5.71 16.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.27 -0.894 . . . . 0.0 110.043 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.499 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 4.6 t -148.38 76.17 10.19 Favored Pre-proline 0 C--N 1.305 -1.366 0 O-C-N 121.013 -1.055 . . . . 0.0 109.849 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.486 ' O ' ' HB3' ' A' ' 19' ' ' LEU . 45.7 Cg_endo -92.59 -69.52 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.733 1 C-N-CA 126.353 4.702 . . . . 0.0 109.845 179.579 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -57.45 -49.37 76.49 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.3 t -61.04 -23.49 30.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.499 ' HB2' ' O ' ' A' ' 15' ' ' SER . 6.2 tp -58.69 -54.16 50.18 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.88 -1.137 . . . . 0.0 108.63 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.0 -54.59 44.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.427 -0.795 . . . . 0.0 109.8 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.14 -55.69 7.97 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.881 0.848 . . . . 0.0 110.042 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.505 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 28.8 t -55.2 -41.01 58.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 O-C-N 121.802 -0.562 . . . . 0.0 109.875 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 19' ' ' LEU . 46.7 mm -72.11 -22.1 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.416 -0.802 . . . . 0.0 110.201 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -63.61 -52.31 61.45 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.5 mt -74.62 -26.99 20.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.549 ' O ' ' CG ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -70.15 -20.19 63.16 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.075 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.486 ' HA ' ' HB2' ' A' ' 30' ' ' LEU . 10.0 t80 -83.23 -44.37 15.07 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.29 -51.94 30.75 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.023 0.916 . . . . 0.0 108.676 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.536 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -74.1 -41.24 61.95 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.772 0.796 . . . . 0.0 109.955 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.016 HD13 ' CB ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -60.63 -0.03 0.24 Allowed 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.152 -178.51 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.565 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -35.35 -49.0 1.24 Allowed Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.028 -1.045 . . . . 0.0 110.547 -179.629 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 31' ' ' SER . 44.4 Cg_endo -91.48 -23.67 0.44 Allowed 'Trans proline' 0 N--CA 1.502 1.992 1 C-N-CA 126.533 4.822 . . . . 0.0 111.363 -179.422 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 1.016 ' CB ' HD13 ' A' ' 30' ' ' LEU . . . -80.66 -4.25 53.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.198 -0.939 . . . . 0.0 110.847 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.426 ' C ' ' O ' ' A' ' 33' ' ' ALA . 1.1 pt -41.59 -26.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 O-C-N 121.293 -0.88 . . . . 0.0 110.514 -178.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.426 ' N ' ' O ' ' A' ' 33' ' ' ALA . 11.6 t -81.87 -37.51 26.81 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.556 -1.34 . . . . 0.0 109.641 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -50.72 -31.86 17.83 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.125 -0.984 . . . . 0.0 108.623 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -103.88 82.32 0.37 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -131.95 3.83 5.3 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.413 ' N ' ' CD2' ' A' ' 39' ' ' LEU . 3.9 mm? -84.74 7.93 18.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.312 -1.111 . . . . 0.0 109.774 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.13 -65.88 0.94 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.969 . . . . 0.0 109.395 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -46.64 140.0 7.01 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -73.26 -11.91 60.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -1.186 . . . . 0.0 109.386 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.468 179.956 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ACE . . . . . 0.801 ' H1 ' ' HE1' ' A' ' 3' ' ' TYR . . . . . . . . 0 C--O 1.215 -0.744 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.539 ' C ' ' CG ' ' A' ' 3' ' ' TYR . 0.3 OUTLIER -118.68 -76.84 0.57 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 109.712 . . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.801 ' HE1' ' H1 ' ' A' ' 1' ' ' ACE . 1.0 OUTLIER 37.59 87.08 0.12 Allowed Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.394 -0.816 . . . . 0.0 110.078 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -86.53 -71.62 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.92 1 C-N-CA 126.05 4.5 . . . . 0.0 110.626 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.49 ' O ' ' OD1' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -74.8 -33.99 62.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.199 -0.938 . . . . 0.0 110.036 -179.439 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.455 ' O ' ' OD1' ' A' ' 9' ' ' ASP . 12.2 t80 -41.66 -42.7 2.59 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.388 -0.82 . . . . 0.0 109.891 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.24 -39.1 71.86 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.431 -0.793 . . . . 0.0 110.803 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.79 -14.52 59.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.188 -0.945 . . . . 0.0 111.501 -178.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -90.68 -66.82 0.89 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.54 -1.35 . . . . 0.0 110.606 -179.501 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.464 ' CG2' ' N ' ' A' ' 11' ' ' THR . 1.8 tt -38.66 -40.95 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 121.484 0.659 . . . . 0.0 110.072 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.464 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 30.7 p -76.38 -42.12 45.61 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.481 -0.762 . . . . 0.0 109.914 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -79.27 5.45 12.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.079 -1.013 . . . . 0.0 109.869 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.07 -20.77 29.88 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.107 -0.996 . . . . 0.0 109.488 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.564 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -81.9 4.76 21.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.217 -0.927 . . . . 0.0 109.401 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 1.5 t -121.46 86.29 43.94 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -86.91 -61.24 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.781 1 C-N-CA 125.986 4.457 . . . . 0.0 110.062 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.09 -31.07 62.9 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.388 -0.82 . . . . 0.0 109.128 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.486 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 5.5 t -89.33 -40.31 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.441 -0.787 . . . . 0.0 110.491 -179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' A' ' 15' ' ' SER . 33.6 tp -57.73 -56.28 23.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.574 -1.329 . . . . 0.0 108.488 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.434 ' O ' ' C ' ' A' ' 21' ' ' ALA . . . -55.24 -55.23 33.69 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.494 -0.754 . . . . 0.0 109.429 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 20' ' ' ALA . . . -42.24 -52.66 4.37 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.944 0.878 . . . . 0.0 109.692 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.7 t -48.65 -55.0 3.71 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 121.173 0.511 . . . . 0.0 110.377 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 25' ' ' ILE . 45.7 mm -63.49 -54.46 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.097 -1.002 . . . . 0.0 110.778 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.523 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -32.71 -36.08 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.643 -0.661 . . . . 0.0 109.661 -179.552 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.744 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 43.4 mt -76.5 -53.98 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.405 -0.809 . . . . 0.0 109.058 178.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.479 ' O ' ' N ' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -57.58 -64.9 0.74 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.92 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.491 ' O ' ' OG ' ' A' ' 31' ' ' SER . 0.1 OUTLIER -39.33 -29.3 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.715 0.769 . . . . 0.0 109.236 177.898 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.744 ' HB3' ' O ' ' A' ' 25' ' ' ILE . . . -63.65 -62.27 1.77 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.538 -0.726 . . . . 0.0 111.202 -178.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.62 -66.76 0.9 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.179 -0.951 . . . . 0.0 112.883 -177.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.571 ' H ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -91.15 36.96 0.92 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.132 -0.98 . . . . 0.0 110.557 -177.326 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.644 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -47.09 -62.79 1.75 Allowed Pre-proline 0 C--N 1.295 -1.788 0 O-C-N 121.199 -0.938 . . . . 0.0 110.878 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.644 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 49.7 Cg_endo -98.88 -0.48 1.03 Allowed 'Trans proline' 0 N--CA 1.501 1.968 1 C-N-CA 126.347 4.698 . . . . 0.0 111.337 -178.337 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.533 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . -63.6 -59.14 5.0 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.008 -1.057 . . . . 0.0 110.541 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.8 tt -62.32 -22.81 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 110.716 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.64 -19.8 24.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.889 -1.132 . . . . 0.0 110.129 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -90.08 149.29 22.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.131 -0.981 . . . . 0.0 109.983 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.66 123.16 4.95 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -105.11 18.35 42.74 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.2 mp -70.25 -16.36 63.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.371 -1.076 . . . . 0.0 109.703 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.88 -41.72 83.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.164 -0.96 . . . . 0.0 109.596 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 124.58 29.45 1.07 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.93 -19.98 66.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.217 -1.167 . . . . 0.0 109.294 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.7 tppt? . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.348 179.795 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.696 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.409 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 6.9 ttm180 -138.74 132.95 31.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.265 -0.897 . . . . 0.0 109.434 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.492 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 2.6 m-30 -108.61 104.7 55.15 Favored Pre-proline 0 N--CA 1.487 1.389 0 O-C-N 121.22 -0.925 . . . . 0.0 109.441 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 8' ' ' SER . 42.0 Cg_endo -85.87 -35.4 0.14 Allowed 'Trans proline' 0 N--CA 1.5 1.866 1 C-N-CA 125.914 4.409 . . . . 0.0 110.508 -179.78 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.409 ' O ' ' HB3' ' A' ' 9' ' ' ASP . 27.6 m-85 -86.25 -19.41 29.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -0.961 . . . . 0.0 109.884 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.492 ' HB3' ' HB3' ' A' ' 3' ' ' TYR . 33.8 t80 -78.12 -45.5 23.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.887 . . . . 0.0 109.716 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 12' ' ' ASP . 6.7 mt -86.59 -39.66 15.95 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.386 -0.821 . . . . 0.0 110.402 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 4' ' ' PRO . 8.4 m -81.84 16.25 1.91 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.124 -0.985 . . . . 0.0 111.046 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.478 ' OD2' ' O ' ' A' ' 6' ' ' TYR . 4.1 p30 -88.88 -107.8 0.08 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.759 -1.213 . . . . 0.0 109.276 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.3 mt -90.38 -29.46 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 120.833 -1.167 . . . . 0.0 109.274 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 58.2 p -90.26 30.94 1.04 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.324 -0.86 . . . . 0.0 109.355 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.466 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 55.8 t0 -74.6 -70.06 0.42 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.0 109.834 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.54 11.08 34.75 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.217 -0.927 . . . . 0.0 109.783 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -73.23 -65.39 0.81 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.237 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -143.21 77.6 15.66 Favored Pre-proline 0 C--N 1.299 -1.597 0 O-C-N 121.432 -0.793 . . . . 0.0 108.979 179.646 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -91.69 -66.97 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.755 1 C-N-CA 126.374 4.716 . . . . 0.0 110.645 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.36 -42.26 86.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -0.903 . . . . 0.0 109.466 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.0 t -73.11 -19.09 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.372 -0.83 . . . . 0.0 109.155 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 15' ' ' SER . 0.4 OUTLIER -65.36 -47.11 77.56 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.069 -1.02 . . . . 0.0 108.81 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.86 -53.35 18.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.388 -0.82 . . . . 0.0 109.132 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.53 -55.77 10.17 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.895 0.855 . . . . 0.0 109.532 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.7 t -51.73 -47.92 38.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 O-C-N 121.789 -0.569 . . . . 0.0 109.519 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.485 ' O ' ' HB2' ' A' ' 27' ' ' PHE . 22.9 mm -64.54 -26.32 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 110.114 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -64.58 -36.49 84.41 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 120.515 -1.366 . . . . 0.0 108.141 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.615 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 17.3 mt -74.82 -41.88 46.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.497 ' O ' ' N ' ' A' ' 28' ' ' ALA . 6.4 m-85 -60.62 -64.22 1.03 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.632 ' HA ' ' CB ' ' A' ' 31' ' ' SER . 0.8 OUTLIER -37.07 -31.33 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.97 0.89 . . . . 0.0 109.099 177.087 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 25' ' ' ILE . . . -75.24 -53.83 8.14 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.7 -89.38 0.18 Allowed 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.875 -1.141 . . . . 0.0 113.633 -175.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.37 35.26 3.12 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.505 -0.747 . . . . 0.0 112.802 -175.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.632 ' CB ' ' HA ' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -71.14 -48.2 13.59 Favored Pre-proline 0 C--N 1.293 -1.866 0 O-C-N 120.665 -1.272 . . . . 0.0 109.614 179.152 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 31' ' ' SER . 40.3 Cg_endo -86.29 16.76 1.89 Allowed 'Trans proline' 0 C--N 1.303 -1.819 1 C-N-CA 126.307 4.671 . . . . 0.0 110.498 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.99 -57.89 2.7 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.221 -0.925 . . . . 0.0 109.258 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.0 mt -78.03 -51.15 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.204 -0.935 . . . . 0.0 109.149 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.412 ' O ' ' C ' ' A' ' 36' ' ' PHE . 39.4 p -68.83 -5.93 23.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.131 -0.981 . . . . 0.0 109.746 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 32' ' ' PRO . 16.1 t80 -42.37 132.09 3.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.32 -0.863 . . . . 0.0 109.645 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -70.53 85.66 0.34 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -136.83 9.8 3.94 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.601 HD12 ' H ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER -59.59 -172.84 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.217 -1.166 . . . . 0.0 109.508 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.53 ' H ' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -105.35 37.76 2.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.23 -0.919 . . . . 0.0 109.319 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.601 ' H ' HD12 ' A' ' 39' ' ' LEU . . . -126.19 5.31 7.76 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -41.1 27.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.216 -1.167 . . . . 0.0 109.386 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.479 ' CD ' ' O ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.409 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ACE . . . . . 0.778 ' H1 ' ' CZ ' ' A' ' 3' ' ' TYR . . . . . . . . 0 C--O 1.214 -0.776 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -122.03 81.64 1.85 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.904 . . . . 0.0 109.442 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.778 ' CZ ' ' H1 ' ' A' ' 1' ' ' ACE . 0.2 OUTLIER -154.85 77.73 5.06 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.382 -0.824 . . . . 0.0 109.209 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -86.14 -57.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.499 1.809 1 C-N-CA 126.094 4.529 . . . . 0.0 110.344 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -52.81 -22.34 5.26 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.229 -0.919 . . . . 0.0 109.381 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.463 ' O ' ' CG ' ' A' ' 9' ' ' ASP . 3.6 t80 -59.1 -45.37 91.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.359 -0.838 . . . . 0.0 109.298 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.469 ' O ' ' OD1' ' A' ' 9' ' ' ASP . 0.1 OUTLIER -71.29 -32.63 68.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.2 -0.938 . . . . 0.0 109.358 179.739 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.535 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 0.3 OUTLIER -58.11 -9.38 1.4 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.683 -0.636 . . . . 0.0 111.24 -179.342 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 0.9 OUTLIER -53.08 -90.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.798 -1.189 . . . . 0.0 110.881 -178.928 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.52 -22.14 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.081 -1.012 . . . . 0.0 111.179 -178.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.535 ' OG1' ' HA ' ' A' ' 8' ' ' SER . 40.0 p -67.0 -7.49 22.87 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.549 -1.344 . . . . 0.0 109.929 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 9' ' ' ASP . 16.3 p-10 -90.96 -1.09 57.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.098 -1.001 . . . . 0.0 110.288 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.75 -19.48 21.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.077 -1.014 . . . . 0.0 110.042 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -84.26 -21.15 31.2 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.192 -0.943 . . . . 0.0 109.748 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.545 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 0.3 OUTLIER -143.75 62.25 10.6 Favored Pre-proline 0 N--CA 1.487 1.377 0 O-C-N 121.123 -0.986 . . . . 0.0 110.111 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.545 ' HD3' ' N ' ' A' ' 15' ' ' SER . 43.5 Cg_endo -91.01 -65.09 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.765 1 C-N-CA 126.13 4.553 . . . . 0.0 109.88 179.694 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -60.47 -27.01 67.21 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.367 -0.833 . . . . 0.0 109.056 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.492 ' O ' HG23 ' A' ' 22' ' ' VAL . 41.2 t -73.39 -26.82 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.326 -0.859 . . . . 0.0 109.554 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.04 -52.81 37.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.058 -1.026 . . . . 0.0 108.32 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.09 -47.16 61.95 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.88 -54.59 27.49 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.608 0.718 . . . . 0.0 109.362 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 18' ' ' VAL . 89.7 t -48.93 -31.22 3.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.524 -0.735 . . . . 0.0 109.28 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.532 ' HA ' ' HB2' ' A' ' 26' ' ' TYR . 82.0 mt -78.47 -36.17 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.408 -0.807 . . . . 0.0 109.565 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.63 -43.33 97.64 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mt -76.0 -31.29 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.532 ' HB2' ' HA ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -67.55 -19.15 65.25 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.284 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -85.75 -38.59 18.07 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.507 ' O ' ' OG ' ' A' ' 31' ' ' SER . . . -51.17 -50.53 58.82 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.585 0.707 . . . . 0.0 109.749 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.516 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -76.34 -47.79 22.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.606 -0.684 . . . . 0.0 110.642 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.033 HD13 ' HB3' ' A' ' 33' ' ' ALA . 4.4 mm? -66.08 3.71 0.81 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.614 -0.679 . . . . 0.0 112.042 -178.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.552 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -45.99 -53.98 18.98 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 120.445 -1.41 . . . . 0.0 111.068 -179.083 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.552 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 42.9 Cg_endo -92.48 -17.7 0.82 Allowed 'Trans proline' 0 N--CA 1.501 1.914 1 C-N-CA 126.397 4.731 . . . . 0.0 111.751 -178.319 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 1.033 ' HB3' HD13 ' A' ' 30' ' ' LEU . . . -77.56 -28.13 51.71 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.779 -1.201 . . . . 0.0 110.156 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -53.67 -38.82 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.116 -0.99 . . . . 0.0 109.824 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.425 HG23 ' CD1' ' A' ' 36' ' ' PHE . 3.5 t -90.33 -19.25 24.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.973 . . . . 0.0 110.019 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.472 ' HB2' ' HA ' ' A' ' 33' ' ' ALA . 6.9 m-30 -78.84 -94.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.096 -1.003 . . . . 0.0 110.06 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -103.54 -172.68 25.84 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 126.37 82.75 0.45 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.528 HD23 ' N ' ' A' ' 39' ' ' LEU . 2.2 pt? -47.1 147.93 1.3 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -1.172 . . . . 0.0 109.448 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 41' ' ' GLY . 1.9 tp -86.77 -71.59 0.55 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.884 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 40' ' ' LEU . . . 44.92 -152.05 0.69 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -70.28 -13.92 62.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.026 -1.279 . . . . 0.0 109.126 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.466 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.728 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -158.75 28.12 0.22 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.554 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -70.03 -49.63 18.5 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 0.0 109.772 -179.703 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' A' ' 3' ' ' TYR . 42.2 Cg_endo -86.68 -35.17 0.12 Allowed 'Trans proline' 0 N--CA 1.501 1.913 1 C-N-CA 125.964 4.443 . . . . 0.0 110.862 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -69.14 -12.78 61.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.028 -1.045 . . . . 0.0 109.778 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.26 -64.7 0.97 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.168 -0.957 . . . . 0.0 109.721 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.433 ' O ' ' OG1' ' A' ' 11' ' ' THR . 15.3 mt -72.17 -38.19 69.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.342 -0.849 . . . . 0.0 109.941 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.498 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -81.23 21.77 0.71 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.402 -0.811 . . . . 0.0 110.426 -179.471 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.79 -65.95 0.95 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.811 -1.181 . . . . 0.0 109.676 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 11' ' ' THR . 5.2 tt -90.22 -38.02 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.323 -0.86 . . . . 0.0 109.873 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 7' ' ' LEU . 67.7 p -82.84 23.64 0.81 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.514 -0.741 . . . . 0.0 110.393 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.498 ' HB3' ' O ' ' A' ' 8' ' ' SER . 3.5 p-10 -69.89 -48.72 57.58 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.893 -1.13 . . . . 0.0 109.672 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.419 ' N ' ' CG ' ' A' ' 12' ' ' ASP . . . -106.23 -15.67 14.79 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.109 -0.994 . . . . 0.0 110.06 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -82.98 -60.42 2.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.064 -1.022 . . . . 0.0 110.298 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.489 ' OG ' ' HB ' ' A' ' 18' ' ' VAL . 16.3 t -123.81 87.4 52.77 Favored Pre-proline 0 C--N 1.301 -1.541 0 O-C-N 121.289 -0.882 . . . . 0.0 109.774 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -89.99 -64.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.757 1 C-N-CA 126.234 4.622 . . . . 0.0 110.034 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -55.7 -59.22 5.16 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.489 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 25.4 t -51.55 -24.96 4.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 15' ' ' SER . 0.2 OUTLIER -63.38 -53.16 56.89 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.214 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.85 -50.54 70.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.478 -0.764 . . . . 0.0 109.006 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.24 -55.59 10.12 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.752 0.787 . . . . 0.0 109.768 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.2 t -55.65 -38.73 51.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 O-C-N 121.71 -0.619 . . . . 0.0 109.601 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 19' ' ' LEU . 22.7 mt -69.19 -26.81 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.237 -0.915 . . . . 0.0 109.449 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -60.76 -41.51 95.6 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.1 mt -72.4 -41.02 64.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -61.56 -22.8 65.49 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.471 ' O ' ' CB ' ' A' ' 31' ' ' SER . 0.2 OUTLIER -84.62 -29.3 25.86 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 122.044 0.926 . . . . 0.0 108.577 179.416 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.7 -61.81 1.63 Allowed 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.802 -0.561 . . . . 0.0 111.1 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.36 -62.08 1.51 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.038 -1.039 . . . . 0.0 112.708 -177.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.536 ' HA ' ' HB2' ' A' ' 33' ' ' ALA . 10.4 mt -83.11 26.17 0.64 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.961 -1.087 . . . . 0.0 111.417 -177.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.564 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -58.13 -51.52 81.17 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 120.826 -1.172 . . . . 0.0 109.541 179.472 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.564 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 46.3 Cg_endo -94.45 -9.87 1.49 Allowed 'Trans proline' 0 N--CA 1.498 1.786 1 C-N-CA 126.71 4.94 . . . . 0.0 110.533 -179.375 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.536 ' HB2' ' HA ' ' A' ' 30' ' ' LEU . . . -42.78 -25.92 0.11 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.287 -0.883 . . . . 0.0 110.156 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.49 HG22 ' N ' ' A' ' 35' ' ' THR . 1.8 mp -38.56 -75.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.514 -0.741 . . . . 0.0 110.434 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.49 ' N ' HG22 ' A' ' 34' ' ' ILE . 1.7 t -83.93 -27.26 28.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.008 -1.058 . . . . 0.0 110.245 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -79.55 134.29 36.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.016 -1.052 . . . . 0.0 109.691 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.99 98.81 0.19 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 153.12 83.75 0.04 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 pp -83.09 137.07 34.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.351 -1.088 . . . . 0.0 109.797 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.745 ' C ' HD13 ' A' ' 40' ' ' LEU . 3.5 tm? -105.16 -58.44 1.89 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.302 -0.874 . . . . 0.0 108.922 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.73 148.22 16.97 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -69.27 -39.6 78.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -1.147 . . . . 0.0 109.248 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.463 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.718 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -90.0 -171.0 2.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.893 . . . . 0.0 109.384 . . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.551 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.1 OUTLIER 169.4 -50.28 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.904 . . . . 0.0 110.231 179.579 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.551 ' CD ' ' N ' ' A' ' 3' ' ' TYR . 41.5 Cg_endo -85.33 -29.6 0.61 Allowed 'Trans proline' 0 N--CA 1.501 1.963 1 C-N-CA 126.028 4.485 . . . . 0.0 111.246 -179.177 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -74.33 -12.73 60.61 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.936 -1.103 . . . . 0.0 109.733 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -68.69 -50.35 51.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 110.262 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.6 -41.31 88.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.18 -0.95 . . . . 0.0 109.93 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.63 -31.54 25.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.156 -0.965 . . . . 0.0 109.608 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -76.43 -32.98 58.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.243 -0.911 . . . . 0.0 109.712 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.8 mm -59.77 -17.37 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.15 -0.969 . . . . 0.0 110.165 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.41 ' OG1' ' N ' ' A' ' 12' ' ' ASP . 9.1 p -90.41 -58.75 2.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.101 -1.0 . . . . 0.0 110.539 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.41 ' N ' ' OG1' ' A' ' 11' ' ' THR . 1.5 t0 -59.89 -43.32 94.85 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.15 -0.969 . . . . 0.0 110.326 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.487 ' O ' ' C ' ' A' ' 14' ' ' PHE . . . -101.14 43.68 1.05 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.292 -0.88 . . . . 0.0 108.686 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.487 ' C ' ' O ' ' A' ' 13' ' ' ALA . 1.0 OUTLIER -34.88 -36.18 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.111 0.482 . . . . 0.0 109.743 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.514 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.4 OUTLIER 34.58 94.29 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.994 -0.441 . . . . 0.0 110.443 179.117 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -89.7 -65.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.763 1 C-N-CA 126.143 4.562 . . . . 0.0 109.752 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -55.48 -51.26 67.56 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.478 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 72.4 t -62.1 -23.4 31.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.628 -0.67 . . . . 0.0 109.303 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.514 ' HB2' ' O ' ' A' ' 15' ' ' SER . 3.9 tp -56.89 -58.02 9.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.151 -0.968 . . . . 0.0 108.694 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.591 ' HA ' HD12 ' A' ' 23' ' ' ILE . . . -51.77 -53.59 38.09 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -44.67 -52.48 8.2 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 122.036 0.922 . . . . 0.0 109.68 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.8 t -49.94 -49.9 20.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.235 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.591 HD12 ' HA ' ' A' ' 20' ' ' ALA . 3.6 mt -66.96 -26.87 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -0.975 . . . . 0.0 109.832 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -54.74 -42.0 71.1 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.096 -1.002 . . . . 0.0 108.743 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.72 -44.11 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.107 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.06 -19.17 29.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.905 -1.122 . . . . 0.0 108.17 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.521 ' O ' ' CB ' ' A' ' 31' ' ' SER . 0.2 OUTLIER -90.81 -34.91 15.12 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.952 0.882 . . . . 0.0 108.74 179.555 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 31' ' ' SER . . . -76.04 -67.93 0.63 Allowed 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.395 0.617 . . . . 0.0 110.4 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.28 -56.28 24.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.389 -0.819 . . . . 0.0 110.623 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.707 ' O ' HG23 ' A' ' 34' ' ' ILE . 9.8 mp -85.13 25.59 0.96 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.347 -0.846 . . . . 0.0 110.547 -178.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.577 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -66.13 -49.52 55.51 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.075 -1.015 . . . . 0.0 110.046 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 31' ' ' SER . 42.8 Cg_endo -91.1 -5.76 4.1 Favored 'Trans proline' 0 C--N 1.303 -1.821 1 C-N-CA 126.557 4.838 . . . . 0.0 111.186 -179.097 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.88 -27.26 25.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.023 -1.048 . . . . 0.0 109.647 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.707 HG23 ' O ' ' A' ' 30' ' ' LEU . 27.1 pt -67.6 -35.16 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.331 -0.855 . . . . 0.0 109.793 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.514 ' N ' HG13 ' A' ' 34' ' ' ILE . 10.3 t -86.91 13.96 8.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.188 -0.945 . . . . 0.0 109.44 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.49 ' CD1' ' C ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -89.93 -10.73 44.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.299 -0.876 . . . . 0.0 109.056 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.47 ' O ' ' CE1' ' A' ' 36' ' ' PHE . . . 87.41 88.11 1.09 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -142.94 23.98 2.27 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.712 HD23 ' N ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -79.19 -70.87 0.47 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.217 -1.166 . . . . 0.0 108.853 179.584 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.7 mt -105.79 -57.49 2.03 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.257 -0.902 . . . . 0.0 109.74 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -151.14 -130.69 1.71 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.49 ' C ' ' CG ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -86.7 -75.57 0.39 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.317 -1.108 . . . . 0.0 109.647 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.49 ' CG ' ' C ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.537 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.726 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.02 151.35 21.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.235 -0.916 . . . . 0.0 109.535 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.421 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.9 OUTLIER 51.42 67.75 3.92 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.298 -0.876 . . . . 0.0 109.689 179.752 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.421 ' HD3' ' N ' ' A' ' 3' ' ' TYR . 41.8 Cg_endo -86.62 -88.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.775 1 C-N-CA 126.078 4.518 . . . . 0.0 110.186 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.468 ' O ' ' HB2' ' A' ' 9' ' ' ASP . 26.1 m-85 -68.06 -20.29 64.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -0.899 . . . . 0.0 109.743 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -66.4 -62.19 1.6 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.342 -0.849 . . . . 0.0 110.499 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.734 HD23 ' C ' ' A' ' 7' ' ' LEU . 6.6 tt -62.72 -54.11 44.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.336 -0.852 . . . . 0.0 110.751 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.439 ' C ' HG22 ' A' ' 11' ' ' THR . 0.5 OUTLIER -55.82 -14.33 2.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.066 -1.021 . . . . 0.0 110.707 -179.103 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -90.17 -46.25 8.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.959 -1.088 . . . . 0.0 110.496 -179.264 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.475 ' O ' HG22 ' A' ' 10' ' ' ILE . 50.0 mt -68.52 -5.43 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.136 -0.977 . . . . 0.0 110.672 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.439 HG22 ' C ' ' A' ' 8' ' ' SER . 1.7 t -86.75 -46.89 9.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.868 -1.145 . . . . 0.0 110.838 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.25 -24.31 20.98 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.78 -1.2 . . . . 0.0 109.566 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.68 41.62 1.36 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.351 -0.843 . . . . 0.0 109.129 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.533 ' O ' ' O ' ' A' ' 15' ' ' SER . 5.3 t80 -51.76 -59.91 3.77 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.283 -0.886 . . . . 0.0 108.881 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.533 ' O ' ' O ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER 20.91 104.75 0.01 OUTLIER Pre-proline 0 N--CA 1.507 2.397 0 C-N-CA 122.255 0.222 . . . . 0.0 111.461 179.072 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -89.77 -69.42 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.71 1 C-N-CA 126.072 4.515 . . . . 0.0 109.884 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -55.6 -46.21 77.35 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.61 ' CG1' HG23 ' A' ' 22' ' ' VAL . 47.5 t -66.72 -26.84 38.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' A' ' 15' ' ' SER . 2.7 tp -52.58 -44.14 65.72 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.473 -1.392 . . . . 0.0 108.587 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.76 -50.94 61.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.511 -0.743 . . . . 0.0 109.783 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.21 -64.48 0.85 Allowed 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 122.029 0.919 . . . . 0.0 109.285 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.61 HG23 ' CG1' ' A' ' 18' ' ' VAL . 77.3 t -51.59 -33.73 15.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.865 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.485 ' O ' ' HB2' ' A' ' 27' ' ' PHE . 82.5 mt -78.96 -26.06 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.751 -1.218 . . . . 0.0 109.559 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -57.85 -53.42 58.41 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.726 ' H ' HD12 ' A' ' 25' ' ' ILE . 5.2 mp -70.17 -36.44 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.519 ' HA ' ' HB2' ' A' ' 30' ' ' LEU . 0.5 OUTLIER -64.63 -15.58 61.44 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.588 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.485 ' HB2' ' O ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -90.18 -26.0 20.37 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.208 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.62 -79.17 0.22 Allowed 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.605 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.499 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -91.66 -56.95 2.91 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.382 -0.823 . . . . 0.0 112.83 -177.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.519 ' HB2' ' HA ' ' A' ' 26' ' ' TYR . 15.9 mt -68.93 8.91 0.46 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.142 -0.974 . . . . 0.0 112.362 -177.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.575 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.9 OUTLIER -44.35 -48.66 25.29 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 120.626 -1.296 . . . . 0.0 110.112 179.585 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 31' ' ' SER . 42.9 Cg_endo -91.84 -15.69 1.3 Allowed 'Trans proline' 0 N--CA 1.5 1.874 1 C-N-CA 126.707 4.938 . . . . 0.0 111.131 -179.198 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.471 ' O ' ' C ' ' A' ' 34' ' ' ILE . . . -50.72 -21.59 1.69 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.063 -1.023 . . . . 0.0 110.038 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.471 ' C ' ' O ' ' A' ' 33' ' ' ALA . 72.6 mt -34.84 -74.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.765 -0.585 . . . . 0.0 110.755 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.461 HG23 ' N ' ' A' ' 36' ' ' PHE . 14.7 t -70.72 -37.73 73.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.16 -0.963 . . . . 0.0 110.058 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.461 ' N ' HG23 ' A' ' 35' ' ' THR . 6.0 m-85 -73.75 178.09 5.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.257 -0.902 . . . . 0.0 109.827 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 54.94 62.53 6.17 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 40' ' ' LEU . . . 117.16 86.47 1.19 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -46.75 89.99 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.518 -0.99 . . . . 0.0 109.487 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.547 ' N ' ' O ' ' A' ' 38' ' ' GLY . 2.7 mp -106.22 31.1 5.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 109.858 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.37 -90.85 1.74 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -57.59 -53.03 62.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.408 -1.054 . . . . 0.0 109.728 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.644 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ACE . . . . . 0.603 ' H1 ' ' HG3' ' A' ' 4' ' ' PRO . . . . . . . . 0 C--O 1.216 -0.698 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.81 -49.76 28.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.88 . . . . 0.0 109.449 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.57 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 4.1 p90 -162.03 59.91 1.05 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.173 -0.954 . . . . 0.0 109.914 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.603 ' HG3' ' H1 ' ' A' ' 1' ' ' ACE . 45.4 Cg_endo -90.9 -16.33 1.49 Allowed 'Trans proline' 0 N--CA 1.499 1.81 1 C-N-CA 126.004 4.469 . . . . 0.0 109.993 179.748 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.435 ' O ' ' OD1' ' A' ' 9' ' ' ASP . 17.8 t80 -81.94 -16.6 49.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.445 -0.784 . . . . 0.0 110.19 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -70.92 -57.03 4.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.162 -0.962 . . . . 0.0 110.197 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 8' ' ' SER . 0.2 OUTLIER -70.78 -45.67 64.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.195 -0.941 . . . . 0.0 110.185 -179.279 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.465 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 8.5 m -43.71 -25.74 0.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.202 -0.937 . . . . 0.0 109.949 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 5' ' ' TYR . 59.3 m-20 -50.87 -63.7 1.04 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.13 -0.981 . . . . 0.0 110.408 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 56.0 mt -64.3 -43.92 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.124 -0.985 . . . . 0.0 110.283 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.465 ' OG1' ' HA ' ' A' ' 8' ' ' SER . 26.2 p -69.1 -3.12 12.08 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.13 -0.982 . . . . 0.0 109.944 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -64.17 -44.09 93.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.069 -1.019 . . . . 0.0 110.028 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.69 -6.98 18.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.064 -1.022 . . . . 0.0 109.941 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -89.25 -7.15 56.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.156 -0.965 . . . . 0.0 109.896 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.493 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 0.5 OUTLIER -135.88 91.87 17.17 Favored Pre-proline 0 C--N 1.306 -1.318 0 O-C-N 120.996 -1.065 . . . . 0.0 110.212 -179.612 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.485 ' HD2' ' OE1' ' A' ' 17' ' ' GLN . 43.2 Cg_endo -89.39 -65.64 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.669 1 C-N-CA 126.236 4.624 . . . . 0.0 108.786 178.938 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.563 ' OE1' HG23 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -65.14 -26.53 68.22 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.669 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.563 HG23 ' OE1' ' A' ' 17' ' ' GLN . 22.0 t -78.04 -20.68 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.496 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 1.0 OUTLIER -64.66 -49.02 72.65 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.321 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 21' ' ' ALA . . . -62.73 -56.86 13.79 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 20' ' ' ALA . . . -42.06 -48.76 4.72 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.951 0.881 . . . . 0.0 109.185 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.641 ' HA ' HD12 ' A' ' 25' ' ' ILE . 3.4 t -44.01 -55.29 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.5 mm -54.64 -39.59 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 119.172 -1.011 . . . . 0.0 109.021 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -51.38 -40.41 59.18 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.276 -0.89 . . . . 0.0 108.755 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.641 HD12 ' HA ' ' A' ' 22' ' ' VAL . 7.1 mt -73.15 -40.22 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.313 -0.867 . . . . 0.0 108.95 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -62.84 -16.62 59.17 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.7 -36.45 15.21 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 31' ' ' SER . . . -62.08 -56.61 17.17 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.458 0.646 . . . . 0.0 110.098 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.574 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -57.21 -46.71 82.66 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.474 -0.766 . . . . 0.0 110.563 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.083 HD22 ' HB3' ' A' ' 33' ' ' ALA . 1.9 tm? -63.94 -1.29 1.39 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.871 -0.518 . . . . 0.0 111.675 -178.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.588 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -45.91 -57.03 8.79 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 120.832 -1.167 . . . . 0.0 112.219 -178.907 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.588 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 43.1 Cg_endo -91.1 -23.7 0.48 Allowed 'Trans proline' 0 N--CA 1.502 1.986 1 C-N-CA 126.105 4.537 . . . . 0.0 112.122 -177.408 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 1.083 ' HB3' HD22 ' A' ' 30' ' ' LEU . . . -64.31 -23.9 67.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.745 -1.222 . . . . 0.0 109.27 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.969 HD13 ' O ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -61.02 -24.42 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.562 -0.711 . . . . 0.0 110.19 -179.594 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 m -79.48 -22.5 43.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.963 -1.086 . . . . 0.0 109.627 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -51.44 109.09 0.31 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.211 -0.93 . . . . 0.0 109.514 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -165.71 34.56 0.25 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 128.27 77.29 0.21 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.475 HD13 ' HA ' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -81.38 -75.83 0.27 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.365 -1.079 . . . . 0.0 109.742 -179.716 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 41' ' ' GLY . 9.6 mt -86.72 -55.04 4.04 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.302 -0.874 . . . . 0.0 109.614 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 40' ' ' LEU . . . 61.2 129.25 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.409 ' C ' ' HD3' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -57.53 -17.56 14.45 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.241 -1.153 . . . . 0.0 109.501 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.409 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.199 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.753 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -102.29 149.45 24.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.146 -0.971 . . . . 0.0 109.636 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -79.39 121.98 83.46 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.358 -0.839 . . . . 0.0 109.501 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -85.54 -83.28 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.809 1 C-N-CA 125.638 4.225 . . . . 0.0 109.977 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -77.28 -39.33 48.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.125 -0.985 . . . . 0.0 109.306 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.463 ' O ' ' HB2' ' A' ' 9' ' ' ASP . 22.9 m-85 -50.09 -41.04 47.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.263 -0.898 . . . . 0.0 109.285 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.413 ' O ' ' OG1' ' A' ' 11' ' ' THR . 3.6 tp -58.89 -45.81 89.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.438 -0.789 . . . . 0.0 109.845 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.18 24.13 0.68 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.19 -0.944 . . . . 0.0 110.571 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 6' ' ' TYR . 3.5 m-20 -90.15 -105.08 0.09 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.864 -1.148 . . . . 0.0 110.247 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.8 mt -91.06 -1.27 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.995 -1.065 . . . . 0.0 111.106 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 7' ' ' LEU . 7.5 p -70.08 -8.46 49.6 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.802 -1.186 . . . . 0.0 110.093 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.92 -26.05 31.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.064 -1.022 . . . . 0.0 109.615 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.02 -11.58 58.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.345 -0.847 . . . . 0.0 109.684 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.467 ' O ' ' C ' ' A' ' 15' ' ' SER . 0.9 OUTLIER -87.31 -4.11 59.05 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.176 -0.953 . . . . 0.0 109.713 -179.869 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.549 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 8.2 t 36.23 59.93 3.22 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.653 -0.654 . . . . 0.0 110.063 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.549 ' HD3' ' N ' ' A' ' 15' ' ' SER . 44.7 Cg_endo -89.83 -64.65 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.747 1 C-N-CA 125.893 4.395 . . . . 0.0 110.074 -179.419 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -45.07 -32.52 1.77 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.196 -0.94 . . . . 0.0 109.66 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.7 t -86.44 -46.6 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 110.504 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.534 HD23 ' CD1' ' A' ' 23' ' ' ILE . 0.9 OUTLIER -57.54 -60.23 3.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.671 -1.268 . . . . 0.0 108.482 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.59 -47.31 39.87 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.472 -0.767 . . . . 0.0 109.285 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 24' ' ' PHE . . . -49.03 -55.44 12.02 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.938 0.875 . . . . 0.0 109.786 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.1 t -55.29 -51.83 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 121.648 0.737 . . . . 0.0 109.848 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.534 ' CD1' HD23 ' A' ' 19' ' ' LEU . 5.9 mt -66.92 -15.89 20.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.225 -0.922 . . . . 0.0 109.435 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.595 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 0.1 OUTLIER -64.94 -39.75 93.97 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 179.453 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.9 mt -67.75 -45.71 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.706 ' CZ ' HD11 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -61.33 -69.94 0.21 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.599 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.586 ' HA ' ' CB ' ' A' ' 31' ' ' SER . 0.5 OUTLIER -41.34 -30.16 0.17 Allowed 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.679 0.752 . . . . 0.0 110.201 178.2 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.595 ' HB2' ' O ' ' A' ' 24' ' ' PHE . . . -73.24 -58.04 3.59 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.469 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -91.09 -73.53 0.53 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -175.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.79 ' H ' HD23 ' A' ' 30' ' ' LEU . 2.0 pt? -85.47 26.07 0.97 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.966 -1.083 . . . . 0.0 112.364 -175.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.586 ' CB ' ' HA ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -90.02 -50.6 0.36 Allowed Pre-proline 0 C--N 1.296 -1.726 0 O-C-N 120.825 -1.172 . . . . 0.0 109.919 179.108 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 31' ' ' SER . 41.7 Cg_endo -90.58 20.22 1.02 Allowed 'Trans proline' 0 C--N 1.303 -1.829 1 C-N-CA 126.565 4.844 . . . . 0.0 110.823 -179.223 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.27 -81.55 0.34 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.099 -1.001 . . . . 0.0 109.706 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.4 mt -67.45 -49.4 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.472 -0.767 . . . . 0.0 109.529 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 98.4 m -58.99 -20.36 52.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.899 . . . . 0.0 109.496 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.496 ' HB2' ' O ' ' A' ' 32' ' ' PRO . 2.0 t80 -51.03 106.19 0.12 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.301 -0.874 . . . . 0.0 109.574 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 175.41 -64.53 0.1 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 126.99 74.35 0.2 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.423 HD12 ' H ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -88.49 -120.0 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.167 -1.196 . . . . 0.0 109.04 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 41' ' ' GLY . 10.9 tp -66.71 -63.63 1.03 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.638 -1.289 . . . . 0.0 109.164 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 40' ' ' LEU . . . 43.59 92.27 0.01 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -55.63 -18.96 8.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.284 -1.127 . . . . 0.0 109.587 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.501 179.958 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.751 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.86 166.77 21.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 109.431 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.549 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 4.3 m-85 44.92 61.37 11.86 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 109.768 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.549 ' HD3' ' N ' ' A' ' 3' ' ' TYR . 43.6 Cg_endo -89.86 -52.16 0.02 OUTLIER 'Trans proline' 0 N--CA 1.5 1.897 1 C-N-CA 126.008 4.472 . . . . 0.0 110.282 180.0 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -45.8 -36.36 5.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -0.843 . . . . 0.0 110.086 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -89.91 -46.07 8.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.116 -0.99 . . . . 0.0 110.164 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 8' ' ' SER . 0.5 OUTLIER -76.59 -63.71 1.28 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.181 -0.95 . . . . 0.0 110.27 -179.319 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.434 ' O ' ' CG ' ' A' ' 12' ' ' ASP . 74.2 m -42.13 -29.74 0.25 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.261 -0.899 . . . . 0.0 109.951 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.5 -80.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.163 -0.96 . . . . 0.0 109.99 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -63.52 -30.55 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.236 -0.915 . . . . 0.0 110.037 -179.267 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.417 ' OG1' ' HA ' ' A' ' 8' ' ' SER . 16.7 p -90.32 34.21 0.88 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.144 -0.973 . . . . 0.0 109.334 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.434 ' CG ' ' O ' ' A' ' 8' ' ' SER . 8.8 m-20 -78.39 -74.64 0.26 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.353 -0.842 . . . . 0.0 109.994 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.4 -22.01 12.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 110.694 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.56 -3.6 15.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.01 -1.056 . . . . 0.0 110.239 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.593 ' O ' HD13 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -149.86 72.29 9.58 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 120.991 -1.068 . . . . 0.0 109.839 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -92.43 -68.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.771 1 C-N-CA 126.392 4.728 . . . . 0.0 110.458 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -52.29 -56.53 14.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 108.867 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.46 ' O ' ' C ' ' A' ' 19' ' ' LEU . 71.9 t -58.63 -33.0 47.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.593 HD13 ' O ' ' A' ' 15' ' ' SER . 4.6 tp -44.94 -43.1 8.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.664 -1.273 . . . . 0.0 108.671 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.62 -52.94 32.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.472 -0.767 . . . . 0.0 109.615 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.5 -59.99 3.78 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 121.67 0.748 . . . . 0.0 109.597 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.8 t -51.77 -39.63 24.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 O-C-N 121.68 -0.638 . . . . 0.0 109.585 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.491 ' HA ' ' HB2' ' A' ' 26' ' ' TYR . 63.7 mt -67.15 -30.13 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.967 -1.083 . . . . 0.0 109.493 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.413 ' O ' ' HB2' ' A' ' 27' ' ' PHE . 5.2 t80 -57.27 -50.48 72.78 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.5 mt -65.98 -36.97 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.491 ' HB2' ' HA ' ' A' ' 23' ' ' ILE . 3.2 m-85 -62.78 -21.09 65.6 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.413 ' HB2' ' O ' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -81.65 -34.44 30.8 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.045 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 31' ' ' SER . . . -63.44 -56.88 12.65 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.454 0.645 . . . . 0.0 109.34 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.01 -54.95 22.39 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.535 -0.728 . . . . 0.0 110.221 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 26' ' ' TYR . 1.9 mp -81.13 22.08 0.67 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.351 -0.843 . . . . 0.0 110.593 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.601 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -61.37 -47.63 93.29 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 120.989 -1.069 . . . . 0.0 110.01 179.722 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 31' ' ' SER . 40.8 Cg_endo -89.96 -6.1 4.9 Favored 'Trans proline' 0 N--CA 1.499 1.822 1 C-N-CA 126.609 4.873 . . . . 0.0 110.853 -179.454 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.62 -31.34 52.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.069 -1.019 . . . . 0.0 109.541 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.5 pt -90.51 -29.7 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 109.496 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.402 ' OG1' ' HA ' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -75.53 -22.4 57.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.124 -0.985 . . . . 0.0 109.183 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -46.4 -65.54 0.54 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 109.017 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 61.54 68.63 1.58 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 178.6 32.03 0.05 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mp -90.24 85.82 6.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.209 -1.171 . . . . 0.0 109.83 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.507 HD22 ' N ' ' A' ' 40' ' ' LEU . 3.3 mm? -79.77 -31.76 40.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.118 -0.989 . . . . 0.0 109.571 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 56.88 168.92 0.1 OUTLIER Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 43' ' ' LYS . 6.7 mt-10 -76.1 -23.57 54.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.326 -1.102 . . . . 0.0 109.703 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 42' ' ' GLU . 1.5 tmmt? . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.645 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.756 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.492 ' O ' ' N ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -127.61 -48.93 1.39 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.875 . . . . 0.0 109.563 . . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.447 ' C ' ' O ' ' A' ' 2' ' ' ARG . 2.2 m-30 -40.03 96.89 0.12 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.504 -0.748 . . . . 0.0 110.054 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.492 ' N ' ' O ' ' A' ' 2' ' ' ARG . 43.0 Cg_endo -88.5 -25.34 0.74 Allowed 'Trans proline' 0 C--N 1.304 -1.806 1 C-N-CA 126.24 4.627 . . . . 0.0 110.26 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -90.47 -11.31 40.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.275 -0.891 . . . . 0.0 109.494 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.47 ' O ' ' OD2' ' A' ' 9' ' ' ASP . 2.6 t80 -89.81 -43.32 10.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 110.117 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 7' ' ' LEU . 2.0 mm? -87.74 -38.23 15.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 110.455 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 4' ' ' PRO . 19.3 m -83.12 19.97 1.34 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.208 -0.933 . . . . 0.0 110.945 -178.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.47 ' OD2' ' O ' ' A' ' 6' ' ' TYR . 6.3 p30 -90.54 -109.48 0.09 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.726 -1.234 . . . . 0.0 109.557 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.1 mm -90.96 -25.93 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.795 -1.191 . . . . 0.0 109.987 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.492 ' HA ' ' HB3' ' A' ' 14' ' ' PHE . 76.4 p -56.39 -29.86 62.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 110.109 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 9' ' ' ASP . 5.2 p-10 -47.19 -37.35 10.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.064 -1.022 . . . . 0.0 109.417 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -97.91 -27.18 14.39 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.226 -0.921 . . . . 0.0 109.898 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.492 ' HB3' ' HA ' ' A' ' 11' ' ' THR . 11.4 t80 -47.98 -49.9 29.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.175 -0.953 . . . . 0.0 109.419 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 1.3 t -139.08 93.73 10.18 Favored Pre-proline 0 C--N 1.301 -1.522 0 O-C-N 121.408 -0.807 . . . . 0.0 110.249 -179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -94.53 -75.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 1 C-N-CA 126.342 4.695 . . . . 0.0 108.988 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -68.18 -19.05 64.75 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.652 ' O ' HG23 ' A' ' 22' ' ' VAL . 3.5 t -82.03 -20.64 10.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.508 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 0.7 OUTLIER -71.78 -50.82 26.49 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.853 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.43 -53.57 53.01 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.81 -46.18 50.78 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.099 0.952 . . . . 0.0 108.781 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 18' ' ' VAL . 2.1 t -45.05 -43.18 2.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.281 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.48 ' HA ' ' HB2' ' A' ' 26' ' ' TYR . 30.1 mm -68.99 -36.94 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.125 -0.984 . . . . 0.0 109.371 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.03 -50.03 70.09 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.158 -0.964 . . . . 0.0 108.419 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.8 mm -71.63 -26.54 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.517 ' O ' HD23 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -73.38 -15.56 61.36 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 178.553 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -89.76 -36.02 15.39 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.13 -56.83 8.3 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.617 0.722 . . . . 0.0 109.785 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.427 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -60.17 -50.22 74.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.666 -0.646 . . . . 0.0 111.009 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.844 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -67.84 5.74 0.81 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.43 -0.793 . . . . 0.0 111.821 -177.973 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.573 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -36.91 -48.45 1.93 Allowed Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.727 -1.233 . . . . 0.0 110.875 179.756 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 31' ' ' SER . 41.2 Cg_endo -87.84 -34.06 0.12 Allowed 'Trans proline' 0 N--CA 1.502 1.977 1 C-N-CA 126.304 4.669 . . . . 0.0 111.303 -179.361 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.489 ' O ' ' HB3' ' A' ' 36' ' ' PHE . . . -58.86 -15.14 11.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.02 -1.05 . . . . 0.0 110.306 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.748 ' C ' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -37.92 -47.81 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.389 -0.819 . . . . 0.0 111.02 -179.016 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.619 ' N ' HG23 ' A' ' 34' ' ' ILE . 13.0 t -91.71 42.51 1.11 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.085 -1.009 . . . . 0.0 109.379 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.489 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 25.2 p90 -79.88 157.02 27.05 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.458 -0.776 . . . . 0.0 109.638 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.67 61.7 0.43 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 39' ' ' LEU . . . 121.24 85.06 0.81 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -45.42 167.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -1.119 . . . . 0.0 109.35 179.849 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -86.61 -57.96 2.79 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.151 -0.968 . . . . 0.0 109.517 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.43 -14.42 43.0 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -75.45 -53.07 9.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.233 -1.157 . . . . 0.0 109.537 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.467 179.957 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ACE . . . . . 0.472 ' O ' ' HB2' ' A' ' 2' ' ' ARG . . . . . . . . 0 C--O 1.215 -0.753 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 1' ' ' ACE . 1.1 mpt_? 61.87 14.37 6.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.863 . . . . 0.0 109.459 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.691 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 19.5 p90 -93.38 -26.45 0.27 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.355 -0.84 . . . . 0.0 112.395 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.691 ' CD ' ' N ' ' A' ' 3' ' ' TYR . 41.3 Cg_endo -78.99 -46.2 0.11 Allowed 'Trans proline' 0 N--CA 1.507 2.278 0 C-N-CA 124.489 3.459 . . . . 0.0 111.441 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -90.16 -32.89 16.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.868 -1.145 . . . . 0.0 110.749 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.481 ' O ' ' HB2' ' A' ' 9' ' ' ASP . 0.7 OUTLIER -89.99 -56.36 3.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.026 -1.046 . . . . 0.0 111.097 -178.645 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.042 HD23 HG21 ' A' ' 11' ' ' THR . 0.0 OUTLIER -62.34 -45.34 93.63 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.897 -1.127 . . . . 0.0 110.527 -178.823 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.3 t -44.37 -23.46 0.11 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.09 -1.006 . . . . 0.0 110.432 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 6' ' ' TYR . 0.7 OUTLIER -49.06 -70.4 0.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.013 -1.054 . . . . 0.0 110.538 -179.323 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.3 mt -88.57 -21.38 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.117 -0.99 . . . . 0.0 110.769 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . 1.042 HG21 HD23 ' A' ' 7' ' ' LEU . 7.2 p -90.53 30.93 1.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.912 -1.117 . . . . 0.0 109.889 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -72.09 -41.1 67.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.271 -0.893 . . . . 0.0 109.934 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.422 ' O ' ' HD3' ' A' ' 16' ' ' PRO . . . -60.24 -23.14 63.83 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.147 -0.971 . . . . 0.0 109.671 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.432 ' HB3' ' O ' ' A' ' 11' ' ' THR . 2.9 t80 -46.48 -40.05 11.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.325 -0.859 . . . . 0.0 109.561 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.3 83.65 49.52 Favored Pre-proline 0 C--N 1.301 -1.5 0 O-C-N 121.168 -0.958 . . . . 0.0 109.992 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 13' ' ' ALA . 43.4 Cg_endo -87.77 -61.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.72 1 C-N-CA 126.041 4.494 . . . . 0.0 109.565 179.469 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -54.23 -53.31 55.27 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.22 -0.925 . . . . 0.0 108.734 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -55.4 -39.26 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.505 -0.747 . . . . 0.0 109.105 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.752 HD13 ' O ' ' A' ' 19' ' ' LEU . 2.0 tm? -47.49 -49.17 26.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.856 -1.153 . . . . 0.0 109.024 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.85 -51.14 70.84 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.464 -0.773 . . . . 0.0 109.317 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.52 -56.13 9.17 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.769 0.795 . . . . 0.0 109.944 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 44.7 t -51.25 -37.26 17.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 O-C-N 121.708 -0.62 . . . . 0.0 110.248 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -77.23 -26.62 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.114 -0.991 . . . . 0.0 110.249 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -66.17 -34.87 79.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.064 -1.022 . . . . 0.0 108.584 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.4 mm -81.29 -31.13 11.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.521 ' O ' ' HB3' ' A' ' 30' ' ' LEU . 6.1 m-85 -67.72 -28.21 67.46 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.514 ' O ' ' CB ' ' A' ' 31' ' ' SER . 5.0 t80 -74.4 -37.04 63.49 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.4 -59.27 4.19 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.279 0.561 . . . . 0.0 110.507 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.49 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -89.38 -54.04 4.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.293 -0.879 . . . . 0.0 111.201 -178.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.004 ' HG ' ' HB3' ' A' ' 33' ' ' ALA . 1.8 tp -75.85 16.69 0.38 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.269 -0.894 . . . . 0.0 111.238 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.587 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -57.22 -47.14 99.55 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 120.785 -1.197 . . . . 0.0 110.621 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 31' ' ' SER . 42.7 Cg_endo -87.99 -31.35 0.21 Allowed 'Trans proline' 0 N--CA 1.502 1.976 1 C-N-CA 126.352 4.701 . . . . 0.0 111.186 -178.858 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 1.004 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . . . -43.84 -33.52 1.34 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.083 -1.011 . . . . 0.0 109.557 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.582 HD12 ' O ' ' A' ' 30' ' ' LEU . 2.0 mp -69.69 -46.54 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.291 -0.88 . . . . 0.0 109.432 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.84 -15.09 61.38 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.271 -0.893 . . . . 0.0 109.435 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -79.22 -96.76 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.166 -0.959 . . . . 0.0 109.461 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.4 51.91 0.04 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.2 68.72 0.23 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.91 1.62 17.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.326 -1.103 . . . . 0.0 109.834 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.08 -69.37 0.58 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.065 -1.022 . . . . 0.0 109.597 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.83 98.69 0.65 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.14 -59.31 2.76 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.199 -1.177 . . . . 0.0 109.28 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.373 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.69 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.3 122.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.9 . . . . 0.0 109.286 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.55 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 2.7 p90 -158.75 64.45 2.7 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.294 -0.879 . . . . 0.0 109.427 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.519 ' HD3' ' N ' ' A' ' 3' ' ' TYR . 43.3 Cg_endo -89.75 -72.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.758 1 C-N-CA 126.219 4.613 . . . . 0.0 110.232 -179.787 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.418 ' O ' ' HB3' ' A' ' 9' ' ' ASP . 0.1 OUTLIER -42.51 -27.61 0.17 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.36 -0.837 . . . . 0.0 110.026 -179.738 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.478 ' O ' ' OD2' ' A' ' 9' ' ' ASP . 2.0 t80 -57.59 -50.05 74.38 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.207 -0.933 . . . . 0.0 110.417 -179.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.57 -42.41 10.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.79 -1.194 . . . . 0.0 110.711 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.3 m -78.36 17.96 0.59 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.226 -0.921 . . . . 0.0 111.232 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.478 ' OD2' ' O ' ' A' ' 6' ' ' TYR . 2.5 p30 -88.64 -104.77 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.583 -1.323 . . . . 0.0 109.444 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.574 ' N ' HD12 ' A' ' 10' ' ' ILE . 2.0 mp -90.64 -37.19 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.858 -1.151 . . . . 0.0 109.76 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.494 ' O ' HD12 ' A' ' 19' ' ' LEU . 6.3 p -62.69 -11.21 15.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.137 -0.977 . . . . 0.0 109.732 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -63.74 -57.51 9.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.177 -0.952 . . . . 0.0 109.994 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 14' ' ' PHE . . . -102.88 -51.02 3.37 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.093 -1.004 . . . . 0.0 110.043 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.448 ' C ' ' O ' ' A' ' 13' ' ' ALA . 69.2 t80 -41.78 -36.56 1.04 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.299 -0.876 . . . . 0.0 109.448 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.512 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.6 OUTLIER -139.09 87.03 14.32 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.432 -0.793 . . . . 0.0 109.261 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -94.86 -73.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.638 1 C-N-CA 126.472 4.781 . . . . 0.0 109.933 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.506 ' HG3' ' N ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -60.39 -25.28 65.78 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.512 -0.743 . . . . 0.0 109.144 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.506 ' N ' ' HG3' ' A' ' 17' ' ' GLN . 2.7 t -84.46 -23.41 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.38 -0.825 . . . . 0.0 109.448 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.512 ' HB2' ' O ' ' A' ' 15' ' ' SER . 1.6 tt -63.29 -45.06 93.19 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.891 -1.131 . . . . 0.0 108.547 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.02 -54.91 12.65 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.441 -0.787 . . . . 0.0 109.222 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -46.16 -57.44 4.51 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.714 0.768 . . . . 0.0 109.393 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.6 t -45.24 -46.24 3.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.482 ' O ' ' N ' ' A' ' 26' ' ' TYR . 11.8 mm -61.51 -56.11 20.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.418 -0.801 . . . . 0.0 109.83 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.462 ' C ' ' O ' ' A' ' 23' ' ' ILE . 1.8 t80 -38.2 -38.62 0.36 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.24 -0.912 . . . . 0.0 109.452 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.713 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 18.7 mt -75.32 -45.7 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.517 ' O ' ' N ' ' A' ' 28' ' ' ALA . 4.2 m-30 -55.46 -69.9 0.12 Allowed 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.536 ' O ' ' CB ' ' A' ' 31' ' ' SER . 0.1 OUTLIER -35.24 -32.53 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.881 0.848 . . . . 0.0 109.52 177.859 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' A' ' 25' ' ' ILE . . . -64.36 -60.43 3.19 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.649 -0.657 . . . . 0.0 110.498 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.23 -63.29 1.28 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.075 -1.016 . . . . 0.0 112.341 -178.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.908 ' HB2' ' HB3' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -89.68 37.05 0.86 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.021 -1.05 . . . . 0.0 110.191 -177.965 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.541 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -49.62 -51.07 62.58 Favored Pre-proline 0 C--N 1.297 -1.687 0 O-C-N 121.601 -0.687 . . . . 0.0 110.242 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.558 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 44.2 Cg_endo -90.62 0.18 5.15 Favored 'Trans proline' 0 N--CA 1.501 1.948 1 C-N-CA 126.533 4.822 . . . . 0.0 111.282 -178.846 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.908 ' HB3' ' HB2' ' A' ' 30' ' ' LEU . . . -82.43 -68.54 0.69 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.988 -1.07 . . . . 0.0 109.816 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.789 HD12 HD12 ' A' ' 30' ' ' LEU . 5.3 mt -53.72 -61.28 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.901 . . . . 0.0 109.504 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -44.45 -31.74 1.17 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.17 -0.956 . . . . 0.0 109.654 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.558 ' CD1' ' O ' ' A' ' 32' ' ' PRO . 9.9 m-85 -87.88 83.95 7.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.266 -0.897 . . . . 0.0 109.556 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.38 98.9 0.11 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 127.0 -12.92 6.78 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.95 143.48 2.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -1.157 . . . . 0.0 109.679 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.9 tt -90.41 -28.01 18.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 109.298 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 164.64 -66.72 0.22 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -89.52 -64.57 1.12 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.339 -1.095 . . . . 0.0 109.356 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.482 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.723 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.436 ' O ' ' CD2' ' A' ' 3' ' ' TYR . 1.3 mtt85 -94.94 81.91 3.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.524 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.452 ' HB3' HD12 ' A' ' 7' ' ' LEU . 33.0 m-85 -154.35 79.54 4.94 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.363 -0.835 . . . . 0.0 109.243 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -85.69 -86.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.819 1 C-N-CA 126.03 4.486 . . . . 0.0 110.514 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -72.23 -25.81 61.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.183 -0.948 . . . . 0.0 109.916 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -59.14 -54.21 49.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.194 -0.941 . . . . 0.0 109.773 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.452 HD12 ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -75.65 -47.72 25.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.912 . . . . 0.0 109.759 -179.77 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 7' ' ' LEU . 29.6 t -42.74 -26.67 0.14 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.304 -0.872 . . . . 0.0 109.912 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 7' ' ' LEU . 0.4 OUTLIER -63.32 -51.8 64.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.242 -0.911 . . . . 0.0 109.884 -179.691 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.82 -35.95 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.186 -0.946 . . . . 0.0 109.926 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.414 ' OG1' ' HA ' ' A' ' 8' ' ' SER . 34.1 p -81.61 7.25 12.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -0.96 . . . . 0.0 109.844 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -76.37 -3.06 34.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.117 -0.99 . . . . 0.0 109.721 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.502 ' O ' ' HD2' ' A' ' 16' ' ' PRO . . . -97.64 5.71 49.01 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.151 -0.968 . . . . 0.0 109.77 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -90.72 19.35 5.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.193 -0.942 . . . . 0.0 109.383 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.599 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 2.3 m -83.9 -44.6 0.78 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.235 -0.915 . . . . 0.0 110.524 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 15' ' ' SER . 41.8 Cg_endo -82.29 -47.38 0.06 OUTLIER 'Trans proline' 0 N--CA 1.5 1.885 1 C-N-CA 125.472 4.114 . . . . 0.0 109.746 -179.876 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -51.6 -34.98 39.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 0.0 109.018 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 52.2 t -72.95 -43.24 59.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.343 -0.848 . . . . 0.0 109.329 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.431 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 4.4 tt -45.09 -49.04 11.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.143 -0.973 . . . . 0.0 108.595 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 21' ' ' ALA . . . -54.69 -51.38 65.71 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 18' ' ' VAL . . . -44.53 -54.37 6.11 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.81 0.814 . . . . 0.0 109.016 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 41.3 t -43.47 -52.8 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.769 -0.582 . . . . 0.0 109.532 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.3 mt -56.67 -43.82 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.082 -1.011 . . . . 0.0 108.722 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.16 -37.79 16.46 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.491 ' CG2' ' HB3' ' A' ' 29' ' ' ALA . 74.1 mt -72.21 -43.72 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.509 ' HA ' ' HB2' ' A' ' 30' ' ' LEU . 18.5 t80 -52.58 -23.95 7.37 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.518 ' O ' ' CB ' ' A' ' 31' ' ' SER . 3.8 t80 -89.25 -34.21 16.7 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 122.021 0.915 . . . . 0.0 108.644 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.11 -70.08 0.7 Allowed 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.286 0.565 . . . . 0.0 111.478 -178.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.491 ' HB3' ' CG2' ' A' ' 25' ' ' ILE . . . -79.23 -60.58 2.31 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.283 -0.886 . . . . 0.0 112.29 -177.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 26' ' ' TYR . 38.9 mt -84.2 27.35 0.69 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.922 -1.111 . . . . 0.0 110.715 -178.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.559 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -81.73 -50.82 0.87 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.069 -1.019 . . . . 0.0 109.944 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.559 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 42.8 Cg_endo -91.43 -15.23 1.51 Allowed 'Trans proline' 0 N--CA 1.5 1.862 1 C-N-CA 126.57 4.847 . . . . 0.0 110.75 -179.255 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.27 -24.63 11.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 110.163 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -71.61 -73.17 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.18 -0.95 . . . . 0.0 110.084 -179.366 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.9 m -57.77 -55.98 27.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 110.136 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.79 110.29 0.5 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.336 -0.852 . . . . 0.0 109.599 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.68 176.6 45.53 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 39' ' ' LEU . . . 175.88 -39.23 0.1 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.772 ' H ' HD12 ' A' ' 39' ' ' LEU . 5.0 mp -60.79 -111.91 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.328 -1.101 . . . . 0.0 109.233 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.468 ' O ' ' C ' ' A' ' 41' ' ' GLY . 0.9 OUTLIER -104.1 -85.86 0.46 Allowed 'General case' 0 N--CA 1.485 1.317 0 O-C-N 120.824 -1.172 . . . . 0.0 108.828 179.614 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 40' ' ' LEU . . . 36.91 37.76 0.26 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -88.12 28.12 1.11 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.163 -1.198 . . . . 0.0 109.647 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.2 mttp . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 118.06 -0.972 . . . . 0.0 109.285 179.882 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.766 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.572 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 1.8 mmp_? -109.2 124.66 51.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.299 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.572 ' CG ' ' O ' ' A' ' 2' ' ' ARG . 8.7 p90 40.94 76.44 0.5 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.329 -0.857 . . . . 0.0 109.774 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.449 ' O ' ' HB3' ' A' ' 8' ' ' SER . 42.1 Cg_endo -88.39 -48.49 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.805 1 C-N-CA 126.282 4.655 . . . . 0.0 110.165 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -65.47 -10.74 36.8 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.182 -0.949 . . . . 0.0 109.45 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -88.02 -71.42 0.58 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.36 -0.837 . . . . 0.0 110.452 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.582 ' HA ' HD12 ' A' ' 10' ' ' ILE . 1.4 tp -75.5 -56.13 5.0 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.198 -0.939 . . . . 0.0 110.545 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.449 ' HB3' ' O ' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -42.16 -25.62 0.08 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.262 -0.899 . . . . 0.0 110.398 -179.297 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 7' ' ' LEU . 2.7 m-20 -79.63 -44.14 21.52 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.026 -1.046 . . . . 0.0 110.398 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.582 HD12 ' HA ' ' A' ' 7' ' ' LEU . 7.8 mt -64.48 -30.41 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.082 -1.011 . . . . 0.0 110.309 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.6 p -83.47 -42.41 16.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.006 -1.059 . . . . 0.0 110.186 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 8' ' ' SER . 0.6 OUTLIER -81.72 3.59 25.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.094 -1.004 . . . . 0.0 110.37 -179.158 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.691 ' HB1' ' CB ' ' A' ' 17' ' ' GLN . . . -93.09 19.84 7.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.068 -1.02 . . . . 0.0 109.814 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.414 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 28.5 t80 -91.32 22.32 3.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.193 -0.942 . . . . 0.0 110.364 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.492 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 0.2 OUTLIER -169.21 -53.01 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.336 0 O-C-N 120.903 -1.123 . . . . 0.0 111.058 -179.459 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.492 ' HD3' ' CB ' ' A' ' 15' ' ' SER . 38.9 Cg_endo -82.23 -23.72 4.2 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 125.004 3.803 . . . . 0.0 110.116 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.691 ' CB ' ' HB1' ' A' ' 13' ' ' ALA . 3.8 tm0? -71.4 -14.8 62.28 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.2 t -84.46 -33.11 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.464 -0.772 . . . . 0.0 109.205 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.479 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 2.3 tp -65.35 -53.67 40.2 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.17 -51.05 65.57 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.426 ' O ' ' C ' ' A' ' 22' ' ' VAL . . . -43.93 -53.86 5.82 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.868 0.842 . . . . 0.0 108.853 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 16.5 t -42.76 -47.61 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 121.782 -0.574 . . . . 0.0 109.527 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.3 mt -66.75 -38.73 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.054 -1.029 . . . . 0.0 109.568 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.82 -39.33 62.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.965 -1.085 . . . . 0.0 108.58 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.521 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 4.4 mt -67.75 -38.27 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -61.84 -21.13 64.39 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 1.094 ' HA ' HD23 ' A' ' 30' ' ' LEU . 2.0 t80 -73.62 -36.03 65.42 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 177.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 25' ' ' ILE . . . -59.36 -49.3 78.36 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.563 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -63.81 -44.24 93.87 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.404 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.094 HD23 ' HA ' ' A' ' 27' ' ' PHE . 0.8 OUTLIER -48.79 -12.01 0.04 OUTLIER 'General case' 0 N--CA 1.509 2.481 0 O-C-N 121.766 -0.584 . . . . 0.0 112.029 -178.503 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.486 ' C ' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -28.73 -50.55 0.25 Allowed Pre-proline 0 N--CA 1.502 2.144 0 O-C-N 121.382 -0.824 . . . . 0.0 112.709 -178.953 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.563 ' HD2' ' O ' ' A' ' 29' ' ' ALA . 38.0 Cg_endo -85.88 -32.17 0.28 Allowed 'Trans proline' 0 N--CA 1.501 1.958 1 C-N-CA 126.028 4.485 . . . . 0.0 110.757 -178.85 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.462 ' O ' ' C ' ' A' ' 34' ' ' ILE . . . -50.86 -21.53 1.74 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.238 -0.914 . . . . 0.0 109.421 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.462 ' C ' ' O ' ' A' ' 33' ' ' ALA . 3.9 tp -39.75 -37.8 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.616 -0.677 . . . . 0.0 109.206 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.41 ' N ' HG23 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -53.76 -57.14 11.96 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.581 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -53.13 119.81 5.16 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.15 -178.62 49.47 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 170.3 42.9 0.03 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 pp -84.22 152.9 23.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -1.116 . . . . 0.0 109.561 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.512 HD23 ' N ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -104.9 -84.67 0.49 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.333 -0.854 . . . . 0.0 109.375 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 53.77 -139.56 35.87 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -62.53 -33.36 74.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -1.155 . . . . 0.0 109.557 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.433 179.857 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.769 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -51.76 178.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 0.0 109.528 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.73 94.81 4.33 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.297 -0.877 . . . . 0.0 109.457 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -84.16 -40.12 0.1 Allowed 'Trans proline' 0 N--CA 1.5 1.901 1 C-N-CA 125.87 4.38 . . . . 0.0 110.252 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.479 ' HB3' ' OD2' ' A' ' 9' ' ' ASP . 0.1 OUTLIER -66.79 -30.27 70.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.101 -0.999 . . . . 0.0 109.199 179.747 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.478 ' HA ' ' HB2' ' A' ' 9' ' ' ASP . 31.4 t80 -45.58 -40.43 8.79 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.467 -0.771 . . . . 0.0 109.975 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.453 ' O ' ' CG2' ' A' ' 11' ' ' THR . 9.6 mp -52.39 -55.7 19.93 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.684 -0.635 . . . . 0.0 109.958 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.68 10.69 24.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -0.853 . . . . 0.0 110.282 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.479 ' OD2' ' HB3' ' A' ' 5' ' ' TYR . 97.9 m-20 -90.39 -73.46 0.52 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.101 -0.999 . . . . 0.0 110.766 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.7 mm -76.38 -15.04 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.223 -0.923 . . . . 0.0 110.977 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.453 ' CG2' ' O ' ' A' ' 7' ' ' LEU . 3.6 p -63.27 -10.32 15.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.882 -1.136 . . . . 0.0 109.814 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.55 -38.67 39.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.064 -1.022 . . . . 0.0 109.865 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.58 -22.75 53.84 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.146 -0.971 . . . . 0.0 109.861 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.62 ' CE2' ' NE2' ' A' ' 17' ' ' GLN . 1.6 m-30 -90.27 31.41 1.01 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.136 -0.978 . . . . 0.0 109.433 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.6 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 0.5 OUTLIER -54.38 -45.65 99.25 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.419 -0.801 . . . . 0.0 110.063 179.86 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 15' ' ' SER . 40.8 Cg_endo -82.23 -26.7 2.67 Favored 'Trans proline' 0 N--CA 1.502 1.987 1 C-N-CA 125.577 4.185 . . . . 0.0 109.955 -179.783 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.62 ' NE2' ' CE2' ' A' ' 14' ' ' PHE . 0.4 OUTLIER -75.59 -21.24 58.0 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.281 -0.887 . . . . 0.0 109.112 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 14' ' ' PHE . 98.0 t -88.75 -46.63 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.334 -0.854 . . . . 0.0 109.398 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.433 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 0.2 OUTLIER -54.27 -49.28 69.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.986 -1.071 . . . . 0.0 108.451 179.389 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 21' ' ' ALA . . . -56.22 -53.54 56.0 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 20' ' ' ALA . . . -41.01 -52.29 3.16 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.943 0.877 . . . . 0.0 109.386 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.433 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 9.4 t -47.65 -49.61 9.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.972 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.1 mt -67.5 -31.09 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.029 -1.044 . . . . 0.0 110.158 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.65 -39.39 58.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.971 -1.08 . . . . 0.0 108.995 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.9 mm -72.69 -44.97 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.267 -0.896 . . . . 0.0 108.957 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.484 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 13.1 t80 -58.46 -20.61 46.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.096 -1.003 . . . . 0.0 108.349 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.409 ' O ' ' CB ' ' A' ' 31' ' ' SER . 0.2 OUTLIER -90.9 -31.0 16.58 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.84 0.828 . . . . 0.0 109.14 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.28 -71.37 0.41 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.354 0.597 . . . . 0.0 110.827 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.507 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -77.53 -50.69 12.08 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.4 -0.813 . . . . 0.0 111.007 -178.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -77.39 18.57 0.4 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.401 -0.812 . . . . 0.0 111.247 -178.56 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.562 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -68.13 -52.64 22.09 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.613 -1.304 . . . . 0.0 109.996 -179.812 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.562 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 44.6 Cg_endo -93.54 -12.18 1.38 Allowed 'Trans proline' 0 N--CA 1.5 1.903 1 C-N-CA 126.561 4.841 . . . . 0.0 110.545 -179.6 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.469 ' O ' ' C ' ' A' ' 34' ' ' ILE . . . -70.38 -21.69 62.84 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.322 -0.861 . . . . 0.0 110.06 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.6 HD12 HG23 ' A' ' 35' ' ' THR . 0.4 OUTLIER -35.08 -50.25 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.833 -0.542 . . . . 0.0 110.525 -179.354 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.6 HG23 HD12 ' A' ' 34' ' ' ILE . 17.9 p -82.45 -46.39 13.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.089 -1.007 . . . . 0.0 109.545 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.446 ' N ' ' CD1' ' A' ' 36' ' ' PHE . 2.8 m-85 -86.56 65.68 9.14 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.342 -0.849 . . . . 0.0 109.625 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.72 162.36 28.96 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 155.29 -50.39 0.47 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.685 HD23 ' H ' ' A' ' 39' ' ' LEU . 0.8 OUTLIER -89.71 151.31 21.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -1.145 . . . . 0.0 109.314 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.37 -19.19 17.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.144 -0.972 . . . . 0.0 109.452 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 152.7 -94.94 0.15 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.27 21.74 3.15 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.303 -1.116 . . . . 0.0 109.402 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.2 mttt . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.955 -1.022 . . . . 0.0 109.522 179.996 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.793 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 -154.18 69.24 0.77 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 109.55 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 59.24 83.62 0.21 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.24 -0.913 . . . . 0.0 109.452 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -87.51 -77.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.858 1 C-N-CA 126.074 4.516 . . . . 0.0 110.654 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.425 ' O ' ' C ' ' A' ' 6' ' ' TYR . 68.4 m-85 -80.88 -35.59 32.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.238 -0.914 . . . . 0.0 110.164 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.474 ' O ' ' HB2' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -43.12 -36.63 1.74 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.142 -0.974 . . . . 0.0 109.738 -179.749 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.16 -48.7 80.66 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.334 -0.854 . . . . 0.0 110.091 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.455 ' O ' HG22 ' A' ' 11' ' ' THR . 27.7 t -61.35 -11.62 10.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.158 -0.964 . . . . 0.0 110.185 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.488 ' HA ' ' OD1' ' A' ' 12' ' ' ASP . 3.8 m-20 -84.75 -34.33 22.88 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.154 -0.966 . . . . 0.0 110.173 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 48.6 mm -64.63 -39.71 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.188 -0.945 . . . . 0.0 110.482 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.606 HG23 ' N ' ' A' ' 12' ' ' ASP . 14.5 t -60.4 -48.19 82.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.09 -1.006 . . . . 0.0 109.743 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.606 ' N ' HG23 ' A' ' 11' ' ' THR . 7.6 p-10 -81.41 0.73 36.2 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.003 -1.061 . . . . 0.0 109.02 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.95 37.62 1.5 Allowed 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.37 -0.831 . . . . 0.0 108.967 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.443 ' O ' ' CD2' ' A' ' 14' ' ' PHE . 4.1 p90 -82.52 17.27 1.81 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.434 -0.791 . . . . 0.0 109.973 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -117.57 89.27 31.99 Favored Pre-proline 0 N--CA 1.485 1.32 0 O-C-N 121.216 -0.928 . . . . 0.0 108.653 179.465 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 14' ' ' PHE . 42.0 Cg_endo -82.11 -48.57 0.05 OUTLIER 'Trans proline' 0 N--CA 1.501 1.959 1 C-N-CA 125.96 4.44 . . . . 0.0 109.857 -179.582 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.57 -26.14 60.69 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.34 -0.85 . . . . 0.0 108.922 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.548 ' O ' HG23 ' A' ' 22' ' ' VAL . 74.5 t -87.91 -26.55 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.485 -0.759 . . . . 0.0 109.56 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.754 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.7 OUTLIER -68.32 -54.18 19.15 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.137 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.64 -49.53 72.62 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.403 ' O ' HD12 ' A' ' 25' ' ' ILE . . . -50.61 -55.05 18.1 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.751 0.786 . . . . 0.0 109.979 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 18' ' ' VAL . 64.0 t -52.71 -40.74 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.687 -0.633 . . . . 0.0 110.442 -179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.754 HD12 ' O ' ' A' ' 19' ' ' LEU . 4.3 mt -77.85 -20.42 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.11 -0.994 . . . . 0.0 110.262 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.84 -46.96 85.46 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.242 -0.911 . . . . 0.0 108.659 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.406 ' H ' HD12 ' A' ' 25' ' ' ILE . 3.8 mp -72.6 -34.49 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.302 -0.873 . . . . 0.0 108.921 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.773 ' O ' HD23 ' A' ' 30' ' ' LEU . 2.3 m-85 -65.29 -27.54 68.7 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -74.89 -43.6 53.46 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.12 -56.33 21.08 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.442 0.639 . . . . 0.0 109.938 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.61 -56.54 5.66 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.546 -0.721 . . . . 0.0 110.987 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.861 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -80.37 23.14 0.51 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.164 -0.96 . . . . 0.0 110.535 -178.993 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.564 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -38.22 -48.89 3.29 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.045 -1.034 . . . . 0.0 110.665 179.828 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 31' ' ' SER . 41.8 Cg_endo -89.42 -24.1 0.72 Allowed 'Trans proline' 0 N--CA 1.502 1.972 1 C-N-CA 126.546 4.831 . . . . 0.0 111.413 -179.22 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.835 ' HB3' ' HB2' ' A' ' 30' ' ' LEU . . . -62.78 -21.81 66.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.917 -1.114 . . . . 0.0 110.055 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.5 tt -54.38 -25.65 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.156 -0.965 . . . . 0.0 109.602 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -72.09 -35.74 69.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.051 -1.03 . . . . 0.0 109.388 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.45 ' C ' ' O ' ' A' ' 35' ' ' THR . 46.1 t80 -40.06 -51.04 2.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.555 -0.716 . . . . 0.0 109.82 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.97 92.24 0.5 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.06 44.88 0.63 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -177.33 5.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.167 -1.196 . . . . 0.0 109.332 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.517 ' HA ' HD13 ' A' ' 40' ' ' LEU . 4.0 mm? -52.84 -51.47 60.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 109.408 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.75 -129.25 6.62 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 11.3 mt-10 -81.66 -31.76 32.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.104 -1.233 . . . . 0.0 109.334 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.415 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.726 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -172.42 100.22 0.15 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.172 -0.955 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.52 ' HB2' ' HB2' ' A' ' 6' ' ' TYR . 8.9 m-85 -83.44 170.09 15.37 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.257 -0.902 . . . . 0.0 109.127 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' A' ' 3' ' ' TYR . 40.9 Cg_endo -81.25 -76.48 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.988 1 C-N-CA 125.536 4.158 . . . . 0.0 110.721 -179.602 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -55.09 -18.3 5.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.124 -0.985 . . . . 0.0 109.685 -179.681 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.52 ' HB2' ' HB2' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -75.72 -41.5 53.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 0.0 109.465 179.938 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 7' ' ' LEU . 19.6 mt -46.66 -42.53 16.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.424 -0.798 . . . . 0.0 109.826 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 12' ' ' ASP . 46.7 m -55.41 -44.14 75.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.915 . . . . 0.0 109.826 -179.641 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 6' ' ' TYR . 0.8 OUTLIER -47.77 -45.95 29.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.199 -0.938 . . . . 0.0 109.982 -179.623 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.43 HD13 ' HA ' ' A' ' 10' ' ' ILE . 19.4 mm -69.84 -50.01 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.181 -0.95 . . . . 0.0 109.927 -179.467 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.0 p -83.28 11.47 6.62 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.026 -1.046 . . . . 0.0 109.68 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 8' ' ' SER . 8.6 t0 -90.5 -32.04 16.51 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.197 -0.939 . . . . 0.0 109.499 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.9 -45.78 93.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.339 -0.851 . . . . 0.0 109.771 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -81.56 -15.24 55.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.905 . . . . 0.0 110.058 -179.581 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.418 ' OG ' ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -138.98 81.65 21.3 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.028 -1.045 . . . . 0.0 109.989 -179.701 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -91.05 -66.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.865 1 C-N-CA 126.424 4.75 . . . . 0.0 109.646 179.555 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -59.21 -41.49 88.71 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.374 -0.829 . . . . 0.0 108.776 179.504 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.418 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 2.5 t -65.74 -24.63 34.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.147 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.485 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 1.6 tt -58.75 -54.04 51.55 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.374 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.82 -53.59 46.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.106 -0.996 . . . . 0.0 108.607 179.131 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -44.05 -52.16 7.32 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.841 0.829 . . . . 0.0 109.32 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 38.1 t -44.0 -46.84 2.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 121.902 -0.499 . . . . 0.0 109.802 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.407 ' O ' ' C ' ' A' ' 24' ' ' PHE . 16.6 mt -61.75 -44.02 98.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.961 . . . . 0.0 109.39 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' ILE . 5.6 t80 -46.41 -45.36 17.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.935 . . . . 0.0 108.892 179.645 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.3 mm -68.9 -42.55 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.4 -0.812 . . . . 0.0 108.825 179.369 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.451 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.7 t80 -58.7 -18.81 34.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.998 -1.064 . . . . 0.0 108.349 179.028 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.82 -33.58 15.63 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.881 0.848 . . . . 0.0 108.91 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.564 ' O ' ' CD ' ' A' ' 32' ' ' PRO . . . -71.15 -62.37 1.42 Allowed 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.196 0.522 . . . . 0.0 110.743 -179.285 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.563 ' O ' ' HB2' ' A' ' 33' ' ' ALA . . . -64.96 -49.74 69.14 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.417 -0.802 . . . . 0.0 111.563 -178.473 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.007 ' O ' HD13 ' A' ' 30' ' ' LEU . 3.4 tm? -44.02 -21.99 0.05 Allowed 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.246 -0.909 . . . . 0.0 110.932 -178.173 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.688 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -82.41 -64.16 0.26 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.522 -1.362 . . . . 0.0 110.593 -179.608 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.688 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 42.8 Cg_endo -91.25 20.74 0.88 Allowed 'Trans proline' 0 N--CA 1.498 1.787 1 C-N-CA 125.719 4.279 . . . . 0.0 110.056 179.949 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -73.66 -45.28 53.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.225 -0.922 . . . . 0.0 109.536 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.453 ' C ' ' O ' ' A' ' 33' ' ' ALA . 1.7 mp -40.57 -48.97 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.563 -0.71 . . . . 0.0 109.69 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.27 -44.32 92.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.381 -0.824 . . . . 0.0 109.926 -179.677 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -64.8 153.26 40.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.229 -0.919 . . . . 0.0 109.372 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -130.86 17.66 5.18 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.15 -52.73 4.16 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.19 -23.92 65.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.325 -1.103 . . . . 0.0 109.599 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.644 ' N ' HD22 ' A' ' 40' ' ' LEU . 1.5 mm? -101.57 2.09 38.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.185 -0.947 . . . . 0.0 109.573 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -74.39 88.0 0.71 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -81.17 -21.57 39.6 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.303 -1.116 . . . . 0.0 109.397 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.481 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.489 ' OG ' ' HB ' ' A' ' 18' ' ' VAL . 8.0 t . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -92.9 -69.32 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.704 1 C-N-CA 126.207 4.605 . . . . 0.0 110.299 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -58.17 -50.89 71.95 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.318 -0.864 . . . . 0.0 108.723 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.489 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 98.4 t -59.34 -22.42 22.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 19' ' ' LEU . 13.4 tp -60.17 -57.55 12.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.063 -1.023 . . . . 0.0 108.832 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.68 -51.1 61.75 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.328 -0.858 . . . . 0.0 109.343 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.86 -55.38 11.86 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.69 0.757 . . . . 0.0 109.561 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.6 t -50.39 -34.46 11.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 121.807 -0.558 . . . . 0.0 109.535 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mt -71.46 -37.88 66.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.336 -0.852 . . . . 0.0 108.78 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -57.08 -41.03 78.11 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 25' ' ' ILE . 35.3 mt -73.74 -32.96 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.503 ' HA ' ' HB2' ' A' ' 30' ' ' LEU . 32.8 t80 -63.84 -22.38 66.89 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -90.11 -31.79 16.95 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.57 -72.07 0.5 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.215 0.531 . . . . 0.0 111.339 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.83 -51.61 9.49 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.163 -0.961 . . . . 0.0 111.781 -177.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.507 ' HG ' ' HB3' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -78.13 24.57 0.24 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.38 -0.825 . . . . 0.0 111.167 -178.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.552 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -65.79 -49.56 58.74 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 120.96 -1.087 . . . . 0.0 110.477 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 31' ' ' SER . 43.2 Cg_endo -90.91 -21.45 0.72 Allowed 'Trans proline' 0 N--CA 1.503 2.033 1 C-N-CA 126.553 4.835 . . . . 0.0 111.54 -178.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.507 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.724 0 O-C-N 120.941 -1.099 . . . . 0.0 110.244 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.524 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 3.6 t . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 120.708 0.289 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 15' ' ' SER . 41.9 Cg_endo -86.26 -48.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.773 1 C-N-CA 125.98 4.454 . . . . 0.0 110.091 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -59.79 -43.41 94.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.201 -0.937 . . . . 0.0 108.772 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.44 ' O ' ' C ' ' A' ' 19' ' ' LEU . 73.6 t -71.6 -49.03 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.859 ' O ' HD13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -44.95 -42.76 8.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.106 -0.996 . . . . 0.0 108.358 179.309 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.92 -48.71 77.63 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.87 -56.82 13.04 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.682 0.754 . . . . 0.0 109.927 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 43.8 t -54.37 -25.21 13.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.446 -0.784 . . . . 0.0 109.201 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.859 HD13 ' O ' ' A' ' 19' ' ' LEU . 1.6 mp -82.26 -31.73 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.476 -0.765 . . . . 0.0 109.081 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -52.12 -50.98 60.61 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.1 mt -67.88 -34.87 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.67 ' O ' HD12 ' A' ' 30' ' ' LEU . 3.4 t80 -61.84 -19.44 62.59 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.463 ' HA ' ' HB2' ' A' ' 30' ' ' LEU . 1.8 t80 -85.65 -40.05 16.61 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.494 ' O ' ' OG ' ' A' ' 31' ' ' SER . . . -46.86 -53.07 12.9 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.89 -42.45 81.2 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.969 0.89 . . . . 0.0 109.515 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.67 HD12 ' O ' ' A' ' 26' ' ' TYR . 73.0 mt -70.44 15.33 0.1 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.63 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.583 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.9 OUTLIER -39.25 -48.24 4.38 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 120.872 -1.143 . . . . 0.0 111.17 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 31' ' ' SER . 39.0 Cg_endo -87.0 -23.47 1.55 Allowed 'Trans proline' 0 N--CA 1.502 2.003 1 C-N-CA 126.388 4.725 . . . . 0.0 111.421 -178.63 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.546 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.756 0 O-C-N 121.069 -1.019 . . . . 0.0 109.882 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.422 ' OG ' ' HB ' ' A' ' 18' ' ' VAL . 2.9 t . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -86.35 -53.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.704 1 C-N-CA 126.094 4.53 . . . . 0.0 110.136 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.405 ' HG3' ' N ' ' A' ' 18' ' ' VAL . 6.1 pt20 -57.56 -20.22 30.67 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.104 -0.998 . . . . 0.0 109.201 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.422 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 3.4 t -90.12 -57.17 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.448 -0.783 . . . . 0.0 109.425 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 18' ' ' VAL . 29.6 mt -47.22 -46.99 24.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.997 -1.064 . . . . 0.0 108.5 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.5 ' O ' ' C ' ' A' ' 21' ' ' ALA . . . -59.27 -56.39 22.72 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 20' ' ' ALA . . . -37.46 -49.66 1.04 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 122.192 0.996 . . . . 0.0 109.267 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.8 t -57.26 -66.56 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.749 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.582 ' O ' ' N ' ' A' ' 25' ' ' ILE . 0.7 OUTLIER -69.1 -55.29 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 120.947 -1.096 . . . . 0.0 110.276 -179.096 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.883 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 2.4 t80 -28.72 -38.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.35 0.595 . . . . 0.0 109.68 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.582 ' N ' ' O ' ' A' ' 23' ' ' ILE . 25.5 mt -77.32 -54.66 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.529 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.8 OUTLIER -61.26 -66.9 0.46 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.19 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.539 ' O ' ' CB ' ' A' ' 31' ' ' SER . 0.1 OUTLIER -39.2 -41.9 0.91 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.472 0.653 . . . . 0.0 109.244 177.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.883 ' HB2' ' O ' ' A' ' 24' ' ' PHE . . . -53.9 -51.44 63.71 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.626 0.727 . . . . 0.0 110.931 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.403 ' HB3' HD12 ' A' ' 30' ' ' LEU . . . -52.17 -58.06 7.75 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.537 -0.727 . . . . 0.0 110.849 -178.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.403 HD12 ' HB3' ' A' ' 29' ' ' ALA . 2.6 mp -106.07 38.86 1.92 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 0.0 110.736 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.604 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -90.93 -56.79 0.25 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.985 -1.072 . . . . 0.0 110.786 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.604 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 45.2 Cg_endo -93.36 -17.3 0.66 Allowed 'Trans proline' 0 N--CA 1.501 1.964 1 C-N-CA 126.279 4.652 . . . . 0.0 111.882 -177.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.006 -1.059 . . . . 0.0 110.916 -178.511 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.499 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 4.6 t . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.486 ' O ' ' HB3' ' A' ' 19' ' ' LEU . 45.7 Cg_endo -92.59 -69.52 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.733 1 C-N-CA 126.353 4.702 . . . . 0.0 109.845 179.579 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -57.45 -49.37 76.49 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.3 t -61.04 -23.49 30.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.499 ' HB2' ' O ' ' A' ' 15' ' ' SER . 6.2 tp -58.69 -54.16 50.18 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.88 -1.137 . . . . 0.0 108.63 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.0 -54.59 44.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.427 -0.795 . . . . 0.0 109.8 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.14 -55.69 7.97 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.881 0.848 . . . . 0.0 110.042 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.505 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 28.8 t -55.2 -41.01 58.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 O-C-N 121.802 -0.562 . . . . 0.0 109.875 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 19' ' ' LEU . 46.7 mm -72.11 -22.1 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.416 -0.802 . . . . 0.0 110.201 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -63.61 -52.31 61.45 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.5 mt -74.62 -26.99 20.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.549 ' O ' ' CG ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -70.15 -20.19 63.16 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.075 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.486 ' HA ' ' HB2' ' A' ' 30' ' ' LEU . 10.0 t80 -83.23 -44.37 15.07 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.29 -51.94 30.75 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.023 0.916 . . . . 0.0 108.676 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.536 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -74.1 -41.24 61.95 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.772 0.796 . . . . 0.0 109.955 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 1.016 HD13 ' CB ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -60.63 -0.03 0.24 Allowed 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.152 -178.51 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.565 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -35.35 -49.0 1.24 Allowed Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.028 -1.045 . . . . 0.0 110.547 -179.629 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 31' ' ' SER . 44.4 Cg_endo -91.48 -23.67 0.44 Allowed 'Trans proline' 0 N--CA 1.502 1.992 1 C-N-CA 126.533 4.822 . . . . 0.0 111.363 -179.422 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 1.016 ' CB ' HD13 ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.198 -0.939 . . . . 0.0 110.847 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 1.5 t . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -86.91 -61.24 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.781 1 C-N-CA 125.986 4.457 . . . . 0.0 110.062 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.09 -31.07 62.9 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.388 -0.82 . . . . 0.0 109.128 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.486 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 5.5 t -89.33 -40.31 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.441 -0.787 . . . . 0.0 110.491 -179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' A' ' 15' ' ' SER . 33.6 tp -57.73 -56.28 23.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.574 -1.329 . . . . 0.0 108.488 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.434 ' O ' ' C ' ' A' ' 21' ' ' ALA . . . -55.24 -55.23 33.69 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.494 -0.754 . . . . 0.0 109.429 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 20' ' ' ALA . . . -42.24 -52.66 4.37 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.944 0.878 . . . . 0.0 109.692 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.7 t -48.65 -55.0 3.71 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 121.173 0.511 . . . . 0.0 110.377 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 25' ' ' ILE . 45.7 mm -63.49 -54.46 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.097 -1.002 . . . . 0.0 110.778 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.523 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -32.71 -36.08 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.643 -0.661 . . . . 0.0 109.661 -179.552 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.744 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 43.4 mt -76.5 -53.98 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.405 -0.809 . . . . 0.0 109.058 178.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.479 ' O ' ' N ' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -57.58 -64.9 0.74 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.491 ' O ' ' OG ' ' A' ' 31' ' ' SER . 0.1 OUTLIER -39.33 -29.3 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.715 0.769 . . . . 0.0 109.236 177.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.744 ' HB3' ' O ' ' A' ' 25' ' ' ILE . . . -63.65 -62.27 1.77 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.538 -0.726 . . . . 0.0 111.202 -178.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.62 -66.76 0.9 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.179 -0.951 . . . . 0.0 112.883 -177.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.571 ' H ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -91.15 36.96 0.92 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.132 -0.98 . . . . 0.0 110.557 -177.326 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.644 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -47.09 -62.79 1.75 Allowed Pre-proline 0 C--N 1.295 -1.788 0 O-C-N 121.199 -0.938 . . . . 0.0 110.878 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.644 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 49.7 Cg_endo -98.88 -0.48 1.03 Allowed 'Trans proline' 0 N--CA 1.501 1.968 1 C-N-CA 126.347 4.698 . . . . 0.0 111.337 -178.337 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.533 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.008 -1.057 . . . . 0.0 110.541 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -91.69 -66.97 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.755 1 C-N-CA 126.374 4.716 . . . . 0.0 110.645 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.36 -42.26 86.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -0.903 . . . . 0.0 109.466 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.0 t -73.11 -19.09 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.372 -0.83 . . . . 0.0 109.155 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 15' ' ' SER . 0.4 OUTLIER -65.36 -47.11 77.56 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.069 -1.02 . . . . 0.0 108.81 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.86 -53.35 18.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.388 -0.82 . . . . 0.0 109.132 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.53 -55.77 10.17 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.895 0.855 . . . . 0.0 109.532 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.7 t -51.73 -47.92 38.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 O-C-N 121.789 -0.569 . . . . 0.0 109.519 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.485 ' O ' ' HB2' ' A' ' 27' ' ' PHE . 22.9 mm -64.54 -26.32 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 110.114 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -64.58 -36.49 84.41 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 120.515 -1.366 . . . . 0.0 108.141 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.615 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 17.3 mt -74.82 -41.88 46.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.497 ' O ' ' N ' ' A' ' 28' ' ' ALA . 6.4 m-85 -60.62 -64.22 1.03 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.632 ' HA ' ' CB ' ' A' ' 31' ' ' SER . 0.8 OUTLIER -37.07 -31.33 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.97 0.89 . . . . 0.0 109.099 177.087 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 25' ' ' ILE . . . -75.24 -53.83 8.14 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.7 -89.38 0.18 Allowed 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.875 -1.141 . . . . 0.0 113.633 -175.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.37 35.26 3.12 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.505 -0.747 . . . . 0.0 112.802 -175.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.632 ' CB ' ' HA ' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -71.14 -48.2 13.59 Favored Pre-proline 0 C--N 1.293 -1.866 0 O-C-N 120.665 -1.272 . . . . 0.0 109.614 179.152 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 31' ' ' SER . 40.3 Cg_endo -86.29 16.76 1.89 Allowed 'Trans proline' 0 C--N 1.303 -1.819 1 C-N-CA 126.307 4.671 . . . . 0.0 110.498 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.444 0 O-C-N 121.221 -0.925 . . . . 0.0 109.258 179.681 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.545 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.545 ' HD3' ' N ' ' A' ' 15' ' ' SER . 43.5 Cg_endo -91.01 -65.09 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.765 1 C-N-CA 126.13 4.553 . . . . 0.0 109.88 179.694 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -60.47 -27.01 67.21 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.367 -0.833 . . . . 0.0 109.056 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.492 ' O ' HG23 ' A' ' 22' ' ' VAL . 41.2 t -73.39 -26.82 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.326 -0.859 . . . . 0.0 109.554 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.04 -52.81 37.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.058 -1.026 . . . . 0.0 108.32 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.09 -47.16 61.95 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.88 -54.59 27.49 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.608 0.718 . . . . 0.0 109.362 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 18' ' ' VAL . 89.7 t -48.93 -31.22 3.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.524 -0.735 . . . . 0.0 109.28 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.532 ' HA ' ' HB2' ' A' ' 26' ' ' TYR . 82.0 mt -78.47 -36.17 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.408 -0.807 . . . . 0.0 109.565 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.63 -43.33 97.64 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mt -76.0 -31.29 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.532 ' HB2' ' HA ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -67.55 -19.15 65.25 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.284 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -85.75 -38.59 18.07 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.507 ' O ' ' OG ' ' A' ' 31' ' ' SER . . . -51.17 -50.53 58.82 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.585 0.707 . . . . 0.0 109.749 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.516 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -76.34 -47.79 22.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.606 -0.684 . . . . 0.0 110.642 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 1.033 HD13 ' HB3' ' A' ' 33' ' ' ALA . 4.4 mm? -66.08 3.71 0.81 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.614 -0.679 . . . . 0.0 112.042 -178.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.552 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -45.99 -53.98 18.98 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 120.445 -1.41 . . . . 0.0 111.068 -179.083 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.552 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 42.9 Cg_endo -92.48 -17.7 0.82 Allowed 'Trans proline' 0 N--CA 1.501 1.914 1 C-N-CA 126.397 4.731 . . . . 0.0 111.751 -178.319 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 1.033 ' HB3' HD13 ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.68 0 O-C-N 120.779 -1.201 . . . . 0.0 110.156 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.489 ' OG ' ' HB ' ' A' ' 18' ' ' VAL . 16.3 t . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -89.99 -64.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.757 1 C-N-CA 126.234 4.622 . . . . 0.0 110.034 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -55.7 -59.22 5.16 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.489 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 25.4 t -51.55 -24.96 4.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 15' ' ' SER . 0.2 OUTLIER -63.38 -53.16 56.89 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.214 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.85 -50.54 70.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.478 -0.764 . . . . 0.0 109.006 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.24 -55.59 10.12 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.752 0.787 . . . . 0.0 109.768 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.2 t -55.65 -38.73 51.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 O-C-N 121.71 -0.619 . . . . 0.0 109.601 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 19' ' ' LEU . 22.7 mt -69.19 -26.81 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.237 -0.915 . . . . 0.0 109.449 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -60.76 -41.51 95.6 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.1 mt -72.4 -41.02 64.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -61.56 -22.8 65.49 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.471 ' O ' ' CB ' ' A' ' 31' ' ' SER . 0.2 OUTLIER -84.62 -29.3 25.86 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 122.044 0.926 . . . . 0.0 108.577 179.416 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.7 -61.81 1.63 Allowed 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.802 -0.561 . . . . 0.0 111.1 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.36 -62.08 1.51 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.038 -1.039 . . . . 0.0 112.708 -177.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.536 ' HA ' ' HB2' ' A' ' 33' ' ' ALA . 10.4 mt -83.11 26.17 0.64 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.961 -1.087 . . . . 0.0 111.417 -177.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.564 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -58.13 -51.52 81.17 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 120.826 -1.172 . . . . 0.0 109.541 179.472 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.564 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 46.3 Cg_endo -94.45 -9.87 1.49 Allowed 'Trans proline' 0 N--CA 1.498 1.786 1 C-N-CA 126.71 4.94 . . . . 0.0 110.533 -179.375 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.536 ' HB2' ' HA ' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.287 -0.883 . . . . 0.0 110.156 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.514 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.777 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -89.7 -65.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.763 1 C-N-CA 126.143 4.562 . . . . 0.0 109.752 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -55.48 -51.26 67.56 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.478 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 72.4 t -62.1 -23.4 31.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.628 -0.67 . . . . 0.0 109.303 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.514 ' HB2' ' O ' ' A' ' 15' ' ' SER . 3.9 tp -56.89 -58.02 9.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.151 -0.968 . . . . 0.0 108.694 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.591 ' HA ' HD12 ' A' ' 23' ' ' ILE . . . -51.77 -53.59 38.09 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -44.67 -52.48 8.2 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 122.036 0.922 . . . . 0.0 109.68 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.8 t -49.94 -49.9 20.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.235 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.591 HD12 ' HA ' ' A' ' 20' ' ' ALA . 3.6 mt -66.96 -26.87 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -0.975 . . . . 0.0 109.832 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -54.74 -42.0 71.1 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.096 -1.002 . . . . 0.0 108.743 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.72 -44.11 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.107 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.06 -19.17 29.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.905 -1.122 . . . . 0.0 108.17 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.521 ' O ' ' CB ' ' A' ' 31' ' ' SER . 0.2 OUTLIER -90.81 -34.91 15.12 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.952 0.882 . . . . 0.0 108.74 179.555 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 31' ' ' SER . . . -76.04 -67.93 0.63 Allowed 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.395 0.617 . . . . 0.0 110.4 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.28 -56.28 24.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.389 -0.819 . . . . 0.0 110.623 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.486 HD12 ' N ' ' A' ' 30' ' ' LEU . 9.8 mp -85.13 25.59 0.96 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.347 -0.846 . . . . 0.0 110.547 -178.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.577 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -66.13 -49.52 55.51 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.075 -1.015 . . . . 0.0 110.046 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 31' ' ' SER . 42.8 Cg_endo -91.1 -5.76 4.1 Favored 'Trans proline' 0 C--N 1.303 -1.821 1 C-N-CA 126.557 4.838 . . . . 0.0 111.186 -179.097 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.023 -1.048 . . . . 0.0 109.647 -179.862 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.513 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.397 0 CA-C-O 120.539 0.209 . . . . 0.0 111.461 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -89.77 -69.42 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.71 1 C-N-CA 126.072 4.515 . . . . 0.0 109.884 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -55.6 -46.21 77.35 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.61 ' CG1' HG23 ' A' ' 22' ' ' VAL . 47.5 t -66.72 -26.84 38.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' A' ' 15' ' ' SER . 2.7 tp -52.58 -44.14 65.72 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.473 -1.392 . . . . 0.0 108.587 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.76 -50.94 61.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.511 -0.743 . . . . 0.0 109.783 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.21 -64.48 0.85 Allowed 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 122.029 0.919 . . . . 0.0 109.285 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.61 HG23 ' CG1' ' A' ' 18' ' ' VAL . 77.3 t -51.59 -33.73 15.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.865 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.485 ' O ' ' HB2' ' A' ' 27' ' ' PHE . 82.5 mt -78.96 -26.06 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.751 -1.218 . . . . 0.0 109.559 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -57.85 -53.42 58.41 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.726 ' H ' HD12 ' A' ' 25' ' ' ILE . 5.2 mp -70.17 -36.44 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.519 ' HA ' ' HB2' ' A' ' 30' ' ' LEU . 0.5 OUTLIER -64.63 -15.58 61.44 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.588 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.485 ' HB2' ' O ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -90.18 -26.0 20.37 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.208 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.62 -79.17 0.22 Allowed 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.605 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.499 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -91.66 -56.95 2.91 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.382 -0.823 . . . . 0.0 112.83 -177.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.519 ' HB2' ' HA ' ' A' ' 26' ' ' TYR . 15.9 mt -68.93 8.91 0.46 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.142 -0.974 . . . . 0.0 112.362 -177.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.575 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.9 OUTLIER -44.35 -48.66 25.29 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 120.626 -1.296 . . . . 0.0 110.112 179.585 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 31' ' ' SER . 42.9 Cg_endo -91.84 -15.69 1.3 Allowed 'Trans proline' 0 N--CA 1.5 1.874 1 C-N-CA 126.707 4.938 . . . . 0.0 111.131 -179.198 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.438 ' HB2' ' HA ' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.69 0 O-C-N 121.063 -1.023 . . . . 0.0 110.038 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.493 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 120.775 0.321 . . . . 0.0 110.212 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.485 ' HD2' ' OE1' ' A' ' 17' ' ' GLN . 43.2 Cg_endo -89.39 -65.64 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.669 1 C-N-CA 126.236 4.624 . . . . 0.0 108.786 178.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.563 ' OE1' HG23 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -65.14 -26.53 68.22 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.669 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.563 HG23 ' OE1' ' A' ' 17' ' ' GLN . 22.0 t -78.04 -20.68 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.496 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 1.0 OUTLIER -64.66 -49.02 72.65 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.321 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 21' ' ' ALA . . . -62.73 -56.86 13.79 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 20' ' ' ALA . . . -42.06 -48.76 4.72 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.951 0.881 . . . . 0.0 109.185 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.641 ' HA ' HD12 ' A' ' 25' ' ' ILE . 3.4 t -44.01 -55.29 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.5 mm -54.64 -39.59 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 119.172 -1.011 . . . . 0.0 109.021 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -51.38 -40.41 59.18 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.276 -0.89 . . . . 0.0 108.755 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.641 HD12 ' HA ' ' A' ' 22' ' ' VAL . 7.1 mt -73.15 -40.22 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.313 -0.867 . . . . 0.0 108.95 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -62.84 -16.62 59.17 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.7 -36.45 15.21 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 31' ' ' SER . . . -62.08 -56.61 17.17 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.458 0.646 . . . . 0.0 110.098 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.574 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -57.21 -46.71 82.66 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.474 -0.766 . . . . 0.0 110.563 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 1.083 HD22 ' HB3' ' A' ' 33' ' ' ALA . 1.9 tm? -63.94 -1.29 1.39 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.871 -0.518 . . . . 0.0 111.675 -178.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.588 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -45.91 -57.03 8.79 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 120.832 -1.167 . . . . 0.0 112.219 -178.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.588 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 43.1 Cg_endo -91.1 -23.7 0.48 Allowed 'Trans proline' 0 N--CA 1.502 1.986 1 C-N-CA 126.105 4.537 . . . . 0.0 112.122 -177.408 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 1.083 ' HB3' HD22 ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.554 0 O-C-N 120.745 -1.222 . . . . 0.0 109.27 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.549 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 8.2 t . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.549 ' HD3' ' N ' ' A' ' 15' ' ' SER . 44.7 Cg_endo -89.83 -64.65 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.747 1 C-N-CA 125.893 4.395 . . . . 0.0 110.074 -179.419 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -45.07 -32.52 1.77 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.196 -0.94 . . . . 0.0 109.66 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.7 t -86.44 -46.6 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 110.504 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.534 HD23 ' CD1' ' A' ' 23' ' ' ILE . 0.9 OUTLIER -57.54 -60.23 3.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.671 -1.268 . . . . 0.0 108.482 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.59 -47.31 39.87 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.472 -0.767 . . . . 0.0 109.285 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 24' ' ' PHE . . . -49.03 -55.44 12.02 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.938 0.875 . . . . 0.0 109.786 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.1 t -55.29 -51.83 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 121.648 0.737 . . . . 0.0 109.848 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.534 ' CD1' HD23 ' A' ' 19' ' ' LEU . 5.9 mt -66.92 -15.89 20.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.225 -0.922 . . . . 0.0 109.435 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.595 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 0.1 OUTLIER -64.94 -39.75 93.97 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 179.453 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.9 mt -67.75 -45.71 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.706 ' CZ ' HD11 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -61.33 -69.94 0.21 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.599 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.586 ' HA ' ' CB ' ' A' ' 31' ' ' SER . 0.5 OUTLIER -41.34 -30.16 0.17 Allowed 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.679 0.752 . . . . 0.0 110.201 178.2 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.595 ' HB2' ' O ' ' A' ' 24' ' ' PHE . . . -73.24 -58.04 3.59 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.469 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -91.09 -73.53 0.53 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -175.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.79 ' H ' HD23 ' A' ' 30' ' ' LEU . 2.0 pt? -85.47 26.07 0.97 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.966 -1.083 . . . . 0.0 112.364 -175.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.586 ' CB ' ' HA ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -90.02 -50.6 0.36 Allowed Pre-proline 0 C--N 1.296 -1.726 0 O-C-N 120.825 -1.172 . . . . 0.0 109.919 179.108 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 31' ' ' SER . 41.7 Cg_endo -90.58 20.22 1.02 Allowed 'Trans proline' 0 C--N 1.303 -1.829 1 C-N-CA 126.565 4.844 . . . . 0.0 110.823 -179.223 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.459 0 O-C-N 121.099 -1.001 . . . . 0.0 109.706 179.918 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.593 ' O ' HD13 ' A' ' 19' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -92.43 -68.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.771 1 C-N-CA 126.392 4.728 . . . . 0.0 110.458 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -52.29 -56.53 14.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 108.867 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.46 ' O ' ' C ' ' A' ' 19' ' ' LEU . 71.9 t -58.63 -33.0 47.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.593 HD13 ' O ' ' A' ' 15' ' ' SER . 4.6 tp -44.94 -43.1 8.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.664 -1.273 . . . . 0.0 108.671 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.62 -52.94 32.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.472 -0.767 . . . . 0.0 109.615 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.5 -59.99 3.78 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 121.67 0.748 . . . . 0.0 109.597 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.8 t -51.77 -39.63 24.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 O-C-N 121.68 -0.638 . . . . 0.0 109.585 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.491 ' HA ' ' HB2' ' A' ' 26' ' ' TYR . 63.7 mt -67.15 -30.13 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.967 -1.083 . . . . 0.0 109.493 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.413 ' O ' ' HB2' ' A' ' 27' ' ' PHE . 5.2 t80 -57.27 -50.48 72.78 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.5 mt -65.98 -36.97 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.491 ' HB2' ' HA ' ' A' ' 23' ' ' ILE . 3.2 m-85 -62.78 -21.09 65.6 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.413 ' HB2' ' O ' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -81.65 -34.44 30.8 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.045 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 31' ' ' SER . . . -63.44 -56.88 12.65 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.454 0.645 . . . . 0.0 109.34 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.01 -54.95 22.39 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.535 -0.728 . . . . 0.0 110.221 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 26' ' ' TYR . 1.9 mp -81.13 22.08 0.67 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.351 -0.843 . . . . 0.0 110.593 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.601 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -61.37 -47.63 93.29 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 120.989 -1.069 . . . . 0.0 110.01 179.722 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 31' ' ' SER . 40.8 Cg_endo -89.96 -6.1 4.9 Favored 'Trans proline' 0 N--CA 1.499 1.822 1 C-N-CA 126.609 4.873 . . . . 0.0 110.853 -179.454 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.069 -1.019 . . . . 0.0 109.541 179.961 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 1.3 t . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -94.53 -75.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 1 C-N-CA 126.342 4.695 . . . . 0.0 108.988 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -68.18 -19.05 64.75 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.652 ' O ' HG23 ' A' ' 22' ' ' VAL . 3.5 t -82.03 -20.64 10.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.508 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 0.7 OUTLIER -71.78 -50.82 26.49 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.43 -53.57 53.01 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.81 -46.18 50.78 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.099 0.952 . . . . 0.0 108.781 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 18' ' ' VAL . 2.1 t -45.05 -43.18 2.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.281 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.48 ' HA ' ' HB2' ' A' ' 26' ' ' TYR . 30.1 mm -68.99 -36.94 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.125 -0.984 . . . . 0.0 109.371 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.03 -50.03 70.09 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.158 -0.964 . . . . 0.0 108.419 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.8 mm -71.63 -26.54 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.517 ' O ' HD23 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -73.38 -15.56 61.36 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 178.553 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -89.76 -36.02 15.39 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.13 -56.83 8.3 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.617 0.722 . . . . 0.0 109.785 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.427 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -60.17 -50.22 74.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.666 -0.646 . . . . 0.0 111.009 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.844 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -67.84 5.74 0.81 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.43 -0.793 . . . . 0.0 111.821 -177.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.573 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -36.91 -48.45 1.93 Allowed Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.727 -1.233 . . . . 0.0 110.875 179.756 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 31' ' ' SER . 41.2 Cg_endo -87.84 -34.06 0.12 Allowed 'Trans proline' 0 N--CA 1.502 1.977 1 C-N-CA 126.304 4.669 . . . . 0.0 111.303 -179.361 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.762 0 O-C-N 121.02 -1.05 . . . . 0.0 110.306 -179.559 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -87.77 -61.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.72 1 C-N-CA 126.041 4.494 . . . . 0.0 109.565 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -54.23 -53.31 55.27 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.22 -0.925 . . . . 0.0 108.734 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -55.4 -39.26 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.505 -0.747 . . . . 0.0 109.105 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.752 ' O ' HD13 ' A' ' 19' ' ' LEU . 2.0 tm? -47.49 -49.17 26.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.856 -1.153 . . . . 0.0 109.024 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.85 -51.14 70.84 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.464 -0.773 . . . . 0.0 109.317 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.52 -56.13 9.17 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.769 0.795 . . . . 0.0 109.944 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 44.7 t -51.25 -37.26 17.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 O-C-N 121.708 -0.62 . . . . 0.0 110.248 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -77.23 -26.62 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.114 -0.991 . . . . 0.0 110.249 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -66.17 -34.87 79.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.064 -1.022 . . . . 0.0 108.584 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.4 mm -81.29 -31.13 11.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.521 ' O ' ' HB3' ' A' ' 30' ' ' LEU . 6.1 m-85 -67.72 -28.21 67.46 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.514 ' O ' ' CB ' ' A' ' 31' ' ' SER . 5.0 t80 -74.4 -37.04 63.49 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.4 -59.27 4.19 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.279 0.561 . . . . 0.0 110.507 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.49 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -89.38 -54.04 4.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.293 -0.879 . . . . 0.0 111.201 -178.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 1.004 ' HG ' ' HB3' ' A' ' 33' ' ' ALA . 1.8 tp -75.85 16.69 0.38 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.269 -0.894 . . . . 0.0 111.238 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.587 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -57.22 -47.14 99.55 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 120.785 -1.197 . . . . 0.0 110.621 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 31' ' ' SER . 42.7 Cg_endo -87.99 -31.35 0.21 Allowed 'Trans proline' 0 N--CA 1.502 1.976 1 C-N-CA 126.352 4.701 . . . . 0.0 111.186 -178.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 1.004 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.083 -1.011 . . . . 0.0 109.557 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.512 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.484 1.252 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -94.86 -73.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.638 1 C-N-CA 126.472 4.781 . . . . 0.0 109.933 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.506 ' HG3' ' N ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -60.39 -25.28 65.78 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.512 -0.743 . . . . 0.0 109.144 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.506 ' N ' ' HG3' ' A' ' 17' ' ' GLN . 2.7 t -84.46 -23.41 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.38 -0.825 . . . . 0.0 109.448 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.512 ' HB2' ' O ' ' A' ' 15' ' ' SER . 1.6 tt -63.29 -45.06 93.19 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.891 -1.131 . . . . 0.0 108.547 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.02 -54.91 12.65 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.441 -0.787 . . . . 0.0 109.222 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -46.16 -57.44 4.51 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.714 0.768 . . . . 0.0 109.393 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.6 t -45.24 -46.24 3.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.482 ' O ' ' N ' ' A' ' 26' ' ' TYR . 11.8 mm -61.51 -56.11 20.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.418 -0.801 . . . . 0.0 109.83 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.462 ' C ' ' O ' ' A' ' 23' ' ' ILE . 1.8 t80 -38.2 -38.62 0.36 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.24 -0.912 . . . . 0.0 109.452 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.713 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 18.7 mt -75.32 -45.7 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.517 ' O ' ' N ' ' A' ' 28' ' ' ALA . 4.2 m-30 -55.46 -69.9 0.12 Allowed 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.536 ' O ' ' CB ' ' A' ' 31' ' ' SER . 0.1 OUTLIER -35.24 -32.53 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.881 0.848 . . . . 0.0 109.52 177.859 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' A' ' 25' ' ' ILE . . . -64.36 -60.43 3.19 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.649 -0.657 . . . . 0.0 110.498 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.23 -63.29 1.28 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.075 -1.016 . . . . 0.0 112.341 -178.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.908 ' HB2' ' HB3' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -89.68 37.05 0.86 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.021 -1.05 . . . . 0.0 110.191 -177.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.541 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -49.62 -51.07 62.58 Favored Pre-proline 0 C--N 1.297 -1.687 0 O-C-N 121.601 -0.687 . . . . 0.0 110.242 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.541 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 44.2 Cg_endo -90.62 0.18 5.15 Favored 'Trans proline' 0 N--CA 1.501 1.948 1 C-N-CA 126.533 4.822 . . . . 0.0 111.282 -178.846 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.908 ' HB3' ' HB2' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 120.988 -1.07 . . . . 0.0 109.816 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.599 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 2.3 m . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 110.524 -0.176 . . . . 0.0 110.524 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 15' ' ' SER . 41.8 Cg_endo -82.29 -47.38 0.06 OUTLIER 'Trans proline' 0 N--CA 1.5 1.885 1 C-N-CA 125.472 4.114 . . . . 0.0 109.746 -179.876 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -51.6 -34.98 39.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 0.0 109.018 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 52.2 t -72.95 -43.24 59.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.343 -0.848 . . . . 0.0 109.329 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.431 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 4.4 tt -45.09 -49.04 11.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.143 -0.973 . . . . 0.0 108.595 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 21' ' ' ALA . . . -54.69 -51.38 65.71 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 18' ' ' VAL . . . -44.53 -54.37 6.11 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.81 0.814 . . . . 0.0 109.016 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 41.3 t -43.47 -52.8 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.769 -0.582 . . . . 0.0 109.532 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.3 mt -56.67 -43.82 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.082 -1.011 . . . . 0.0 108.722 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.16 -37.79 16.46 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.491 ' CG2' ' HB3' ' A' ' 29' ' ' ALA . 74.1 mt -72.21 -43.72 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.509 ' HA ' ' HB2' ' A' ' 30' ' ' LEU . 18.5 t80 -52.58 -23.95 7.37 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.518 ' O ' ' CB ' ' A' ' 31' ' ' SER . 3.8 t80 -89.25 -34.21 16.7 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 122.021 0.915 . . . . 0.0 108.644 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.11 -70.08 0.7 Allowed 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.286 0.565 . . . . 0.0 111.478 -178.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.491 ' HB3' ' CG2' ' A' ' 25' ' ' ILE . . . -79.23 -60.58 2.31 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.283 -0.886 . . . . 0.0 112.29 -177.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 26' ' ' TYR . 38.9 mt -84.2 27.35 0.69 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.922 -1.111 . . . . 0.0 110.715 -178.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.559 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -81.73 -50.82 0.87 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.069 -1.019 . . . . 0.0 109.944 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.559 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 42.8 Cg_endo -91.43 -15.23 1.51 Allowed 'Trans proline' 0 N--CA 1.5 1.862 1 C-N-CA 126.57 4.847 . . . . 0.0 110.75 -179.255 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 110.163 -179.623 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.492 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.003 -0.046 . . . . 0.0 111.058 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.492 ' HD3' ' CB ' ' A' ' 15' ' ' SER . 38.9 Cg_endo -82.23 -23.72 4.2 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 125.004 3.803 . . . . 0.0 110.116 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -71.4 -14.8 62.28 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.2 t -84.46 -33.11 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.464 -0.772 . . . . 0.0 109.205 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.479 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 2.3 tp -65.35 -53.67 40.2 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.17 -51.05 65.57 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.426 ' O ' ' C ' ' A' ' 22' ' ' VAL . . . -43.93 -53.86 5.82 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.868 0.842 . . . . 0.0 108.853 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 16.5 t -42.76 -47.61 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 121.782 -0.574 . . . . 0.0 109.527 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.3 mt -66.75 -38.73 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.054 -1.029 . . . . 0.0 109.568 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.82 -39.33 62.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.965 -1.085 . . . . 0.0 108.58 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.521 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 4.4 mt -67.75 -38.27 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -61.84 -21.13 64.39 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 1.094 ' HA ' HD23 ' A' ' 30' ' ' LEU . 2.0 t80 -73.62 -36.03 65.42 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 177.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 25' ' ' ILE . . . -59.36 -49.3 78.36 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.563 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -63.81 -44.24 93.87 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.404 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 1.094 HD23 ' HA ' ' A' ' 27' ' ' PHE . 0.8 OUTLIER -48.79 -12.01 0.04 OUTLIER 'General case' 0 N--CA 1.509 2.481 0 O-C-N 121.766 -0.584 . . . . 0.0 112.029 -178.503 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.486 ' C ' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -28.73 -50.55 0.25 Allowed Pre-proline 0 N--CA 1.502 2.144 0 O-C-N 121.382 -0.824 . . . . 0.0 112.709 -178.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.563 ' HD2' ' O ' ' A' ' 29' ' ' ALA . 38.0 Cg_endo -85.88 -32.17 0.28 Allowed 'Trans proline' 0 N--CA 1.501 1.958 1 C-N-CA 126.028 4.485 . . . . 0.0 110.757 -178.85 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.238 -0.914 . . . . 0.0 109.421 179.038 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.6 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 15' ' ' SER . 40.8 Cg_endo -82.23 -26.7 2.67 Favored 'Trans proline' 0 N--CA 1.502 1.987 1 C-N-CA 125.577 4.185 . . . . 0.0 109.955 -179.783 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.59 -21.24 58.0 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.281 -0.887 . . . . 0.0 109.112 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.0 t -88.75 -46.63 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.334 -0.854 . . . . 0.0 109.398 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.433 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 0.2 OUTLIER -54.27 -49.28 69.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.986 -1.071 . . . . 0.0 108.451 179.389 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 21' ' ' ALA . . . -56.22 -53.54 56.0 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 20' ' ' ALA . . . -41.01 -52.29 3.16 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.943 0.877 . . . . 0.0 109.386 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.433 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 9.4 t -47.65 -49.61 9.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.972 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.1 mt -67.5 -31.09 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.029 -1.044 . . . . 0.0 110.158 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.65 -39.39 58.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.971 -1.08 . . . . 0.0 108.995 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.9 mm -72.69 -44.97 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.267 -0.896 . . . . 0.0 108.957 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.484 ' CD1' ' O ' ' A' ' 26' ' ' TYR . 13.1 t80 -58.46 -20.61 46.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.096 -1.003 . . . . 0.0 108.349 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.409 ' O ' ' CB ' ' A' ' 31' ' ' SER . 0.2 OUTLIER -90.9 -31.0 16.58 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.84 0.828 . . . . 0.0 109.14 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.28 -71.37 0.41 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.354 0.597 . . . . 0.0 110.827 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.507 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -77.53 -50.69 12.08 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.4 -0.813 . . . . 0.0 111.007 -178.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -77.39 18.57 0.4 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.401 -0.812 . . . . 0.0 111.247 -178.56 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.562 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -68.13 -52.64 22.09 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.613 -1.304 . . . . 0.0 109.996 -179.812 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.562 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 44.6 Cg_endo -93.54 -12.18 1.38 Allowed 'Trans proline' 0 N--CA 1.5 1.903 1 C-N-CA 126.561 4.841 . . . . 0.0 110.545 -179.6 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.432 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.675 0 O-C-N 121.322 -0.861 . . . . 0.0 110.06 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -82.11 -48.57 0.05 OUTLIER 'Trans proline' 0 N--CA 1.501 1.959 1 C-N-CA 125.96 4.44 . . . . 0.0 109.857 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.57 -26.14 60.69 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.34 -0.85 . . . . 0.0 108.922 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.548 ' O ' HG23 ' A' ' 22' ' ' VAL . 74.5 t -87.91 -26.55 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.485 -0.759 . . . . 0.0 109.56 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.754 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.7 OUTLIER -68.32 -54.18 19.15 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.137 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.64 -49.53 72.62 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.403 ' O ' HD12 ' A' ' 25' ' ' ILE . . . -50.61 -55.05 18.1 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.751 0.786 . . . . 0.0 109.979 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 18' ' ' VAL . 64.0 t -52.71 -40.74 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.687 -0.633 . . . . 0.0 110.442 -179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.754 HD12 ' O ' ' A' ' 19' ' ' LEU . 4.3 mt -77.85 -20.42 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.11 -0.994 . . . . 0.0 110.262 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.84 -46.96 85.46 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.242 -0.911 . . . . 0.0 108.659 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.406 HD12 ' H ' ' A' ' 25' ' ' ILE . 3.8 mp -72.6 -34.49 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.302 -0.873 . . . . 0.0 108.921 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.773 ' O ' HD23 ' A' ' 30' ' ' LEU . 2.3 m-85 -65.29 -27.54 68.7 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -74.89 -43.6 53.46 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.12 -56.33 21.08 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.442 0.639 . . . . 0.0 109.938 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.61 -56.54 5.66 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.546 -0.721 . . . . 0.0 110.987 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.861 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -80.37 23.14 0.51 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.164 -0.96 . . . . 0.0 110.535 -178.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.564 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -38.22 -48.89 3.29 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.045 -1.034 . . . . 0.0 110.665 179.828 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 31' ' ' SER . 41.8 Cg_endo -89.42 -24.1 0.72 Allowed 'Trans proline' 0 N--CA 1.502 1.972 1 C-N-CA 126.546 4.831 . . . . 0.0 111.413 -179.22 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.835 ' HB3' ' HB2' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.597 0 O-C-N 120.917 -1.114 . . . . 0.0 110.055 -179.389 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.418 ' OG ' ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -91.05 -66.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.865 1 C-N-CA 126.424 4.75 . . . . 0.0 109.646 179.555 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -59.21 -41.49 88.71 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.374 -0.829 . . . . 0.0 108.776 179.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.418 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 2.5 t -65.74 -24.63 34.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.147 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.485 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 1.6 tt -58.75 -54.04 51.55 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.374 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.82 -53.59 46.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.106 -0.996 . . . . 0.0 108.607 179.131 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -44.05 -52.16 7.32 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.841 0.829 . . . . 0.0 109.32 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 38.1 t -44.0 -46.84 2.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 121.902 -0.499 . . . . 0.0 109.802 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.407 ' O ' ' C ' ' A' ' 24' ' ' PHE . 16.6 mt -61.75 -44.02 98.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.961 . . . . 0.0 109.39 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' ILE . 5.6 t80 -46.41 -45.36 17.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.935 . . . . 0.0 108.892 179.645 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.3 mm -68.9 -42.55 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.4 -0.812 . . . . 0.0 108.825 179.369 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.451 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.7 t80 -58.7 -18.81 34.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.998 -1.064 . . . . 0.0 108.349 179.028 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.82 -33.58 15.63 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.881 0.848 . . . . 0.0 108.91 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.564 ' O ' ' CD ' ' A' ' 32' ' ' PRO . . . -71.15 -62.37 1.42 Allowed 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.196 0.522 . . . . 0.0 110.743 -179.285 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.563 ' O ' ' HB2' ' A' ' 33' ' ' ALA . . . -64.96 -49.74 69.14 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.417 -0.802 . . . . 0.0 111.563 -178.473 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 1.007 ' O ' HD13 ' A' ' 30' ' ' LEU . 3.4 tm? -44.02 -21.99 0.05 Allowed 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.246 -0.909 . . . . 0.0 110.932 -178.173 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.688 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -82.41 -64.16 0.26 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.522 -1.362 . . . . 0.0 110.593 -179.608 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.688 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 42.8 Cg_endo -91.25 20.74 0.88 Allowed 'Trans proline' 0 N--CA 1.498 1.787 1 C-N-CA 125.719 4.279 . . . . 0.0 110.056 179.949 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.225 -0.922 . . . . 0.0 109.536 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.742 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.587 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 8.2 mtp180 -90.48 -102.13 0.1 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.457 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.587 ' CG ' ' O ' ' A' ' 2' ' ' ARG . 57.6 m-85 -161.55 86.32 1.64 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 120.961 -1.087 . . . . 0.0 109.454 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -87.73 -78.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.802 1 C-N-CA 126.086 4.524 . . . . 0.0 110.221 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -69.83 -28.91 66.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.243 -0.911 . . . . 0.0 109.422 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.487 ' O ' ' HB2' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -48.27 -41.24 27.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -0.838 . . . . 0.0 109.685 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.452 ' HA ' HD13 ' A' ' 7' ' ' LEU . 3.4 mm? -67.58 -39.05 84.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.961 . . . . 0.0 109.88 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.4 p -84.05 18.17 2.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.316 -0.865 . . . . 0.0 110.065 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 6' ' ' TYR . 0.9 OUTLIER -86.5 -58.56 2.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.123 -0.986 . . . . 0.0 109.802 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -28.27 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.205 -0.934 . . . . 0.0 109.439 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.459 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 73.9 p -85.27 24.18 1.18 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.365 -0.834 . . . . 0.0 110.016 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 12' ' ' ASP . 15.3 t70 -90.59 8.81 32.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.036 -1.04 . . . . 0.0 110.019 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.09 -17.62 14.43 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.021 -1.049 . . . . 0.0 109.75 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.507 ' CD1' ' C ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -76.96 1.74 16.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.259 -0.901 . . . . 0.0 110.103 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.489 ' OG ' ' HB ' ' A' ' 18' ' ' VAL . 8.0 t -146.41 94.52 4.8 Favored Pre-proline 0 N--CA 1.487 1.399 0 O-C-N 121.12 -0.988 . . . . 0.0 110.073 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -92.9 -69.32 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.704 1 C-N-CA 126.207 4.605 . . . . 0.0 110.299 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -58.17 -50.89 71.95 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.318 -0.864 . . . . 0.0 108.723 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.489 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 98.4 t -59.34 -22.42 22.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 19' ' ' LEU . 13.4 tp -60.17 -57.55 12.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.063 -1.023 . . . . 0.0 108.832 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.68 -51.1 61.75 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.328 -0.858 . . . . 0.0 109.343 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.86 -55.38 11.86 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.69 0.757 . . . . 0.0 109.561 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.6 t -50.39 -34.46 11.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 121.807 -0.558 . . . . 0.0 109.535 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mt -71.46 -37.88 66.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.336 -0.852 . . . . 0.0 108.78 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -57.08 -41.03 78.11 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 25' ' ' ILE . 35.3 mt -73.74 -32.96 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.532 ' OH ' ' CG2' ' A' ' 34' ' ' ILE . 32.8 t80 -63.84 -22.38 66.89 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -90.11 -31.79 16.95 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.57 -72.07 0.5 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.215 0.531 . . . . 0.0 111.339 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.83 -51.61 9.49 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.163 -0.961 . . . . 0.0 111.781 -177.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.507 ' HG ' ' HB3' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -78.13 24.57 0.24 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.38 -0.825 . . . . 0.0 111.167 -178.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.552 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -65.79 -49.56 58.74 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 120.96 -1.087 . . . . 0.0 110.477 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 31' ' ' SER . 43.2 Cg_endo -90.91 -21.45 0.72 Allowed 'Trans proline' 0 N--CA 1.503 2.033 1 C-N-CA 126.553 4.835 . . . . 0.0 111.54 -178.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.507 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . . . -61.78 -28.44 69.46 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.941 -1.099 . . . . 0.0 110.244 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.532 ' CG2' ' OH ' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -42.98 -63.87 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.159 -0.963 . . . . 0.0 110.758 -179.424 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.8 t -74.32 -28.08 61.0 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.153 -0.967 . . . . 0.0 111.269 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.82 123.01 24.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.764 -1.21 . . . . 0.0 110.161 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.44 128.55 2.03 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 170.09 -67.8 0.15 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.3 mt -73.6 94.35 2.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.166 -1.197 . . . . 0.0 109.604 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 pp -105.23 12.13 32.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.272 -0.893 . . . . 0.0 109.567 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -146.0 67.05 0.41 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.71 -25.57 19.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.316 -1.108 . . . . 0.0 109.278 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 43' ' ' LYS . 11.0 tttt . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.433 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.735 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.548 ' O ' ' CD2' ' A' ' 3' ' ' TYR . 21.3 mtt-85 -137.23 132.66 34.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 109.602 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.573 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER 164.93 -49.77 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.178 -0.951 . . . . 0.0 109.295 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 3' ' ' TYR . 42.7 Cg_endo -86.25 -38.22 0.09 OUTLIER 'Trans proline' 0 N--CA 1.499 1.803 1 C-N-CA 126.049 4.5 . . . . 0.0 109.708 179.479 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.42 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 48.2 t80 -81.04 -18.73 45.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.418 -0.801 . . . . 0.0 109.001 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.15 -38.57 83.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.523 -0.735 . . . . 0.0 109.986 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.765 ' HA ' HD12 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -56.35 -52.41 64.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.352 -0.843 . . . . 0.0 110.061 -179.449 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 t -51.91 -21.6 3.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.201 -0.937 . . . . 0.0 110.019 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.85 -50.27 6.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.096 -1.003 . . . . 0.0 110.049 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.865 HG23 ' CD2' ' A' ' 14' ' ' PHE . 5.2 mt -55.47 -15.55 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.044 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.535 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 7.6 p -89.16 -37.06 15.32 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.997 -1.064 . . . . 0.0 110.058 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -91.68 -66.78 0.9 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.117 -0.99 . . . . 0.0 111.494 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.09 -10.83 60.0 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.212 -0.93 . . . . 0.0 112.08 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.865 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -90.35 11.29 21.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.456 -1.402 . . . . 0.0 110.561 -179.1 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.524 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 3.6 t 35.49 63.0 2.37 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.479 -0.763 . . . . 0.0 110.267 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.535 ' CG ' ' O ' ' A' ' 11' ' ' THR . 41.9 Cg_endo -86.26 -48.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.773 1 C-N-CA 125.98 4.454 . . . . 0.0 110.091 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -59.79 -43.41 94.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.201 -0.937 . . . . 0.0 108.772 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.44 ' O ' ' C ' ' A' ' 19' ' ' LEU . 73.6 t -71.6 -49.03 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.859 ' O ' HD13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -44.95 -42.76 8.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.106 -0.996 . . . . 0.0 108.358 179.309 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.92 -48.71 77.63 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.87 -56.82 13.04 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.682 0.754 . . . . 0.0 109.927 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 43.8 t -54.37 -25.21 13.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.446 -0.784 . . . . 0.0 109.201 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.859 HD13 ' O ' ' A' ' 19' ' ' LEU . 1.6 mp -82.26 -31.73 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.476 -0.765 . . . . 0.0 109.081 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -52.12 -50.98 60.61 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.1 mt -67.88 -34.87 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.67 ' O ' HD12 ' A' ' 30' ' ' LEU . 3.4 t80 -61.84 -19.44 62.59 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.463 ' HA ' ' HB2' ' A' ' 30' ' ' LEU . 1.8 t80 -85.65 -40.05 16.61 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.494 ' O ' ' OG ' ' A' ' 31' ' ' SER . . . -46.86 -53.07 12.9 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.89 -42.45 81.2 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.969 0.89 . . . . 0.0 109.515 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.67 HD12 ' O ' ' A' ' 26' ' ' TYR . 73.0 mt -70.44 15.33 0.1 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.63 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.583 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.9 OUTLIER -39.25 -48.24 4.38 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 120.872 -1.143 . . . . 0.0 111.17 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 31' ' ' SER . 39.0 Cg_endo -87.0 -23.47 1.55 Allowed 'Trans proline' 0 N--CA 1.502 2.003 1 C-N-CA 126.388 4.725 . . . . 0.0 111.421 -178.63 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.546 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . -68.12 -13.36 62.16 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.069 -1.019 . . . . 0.0 109.882 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.528 ' CD1' ' O ' ' A' ' 31' ' ' SER . 85.4 mt -29.69 -37.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-O 120.945 0.402 . . . . 0.0 111.037 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 33' ' ' ALA . 29.1 m -75.08 -50.42 16.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.046 -1.034 . . . . 0.0 109.809 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.437 ' C ' ' O ' ' A' ' 35' ' ' THR . 32.5 t80 -39.56 -49.11 2.14 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.575 -0.703 . . . . 0.0 109.888 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 34' ' ' ILE . . . -125.63 -170.17 12.99 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.56 ' O ' HD13 ' A' ' 40' ' ' LEU . . . 152.97 -47.74 0.55 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.415 ' C ' HD13 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -49.67 119.55 3.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.058 -1.26 . . . . 0.0 109.322 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.56 HD13 ' O ' ' A' ' 38' ' ' GLY . 0.8 OUTLIER -99.89 -40.52 7.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 109.315 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 116.0 -10.75 17.91 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.531 ' O ' ' CG ' ' A' ' 43' ' ' LYS . 47.0 tp10 -69.76 -56.25 7.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.298 -1.119 . . . . 0.0 109.728 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.531 ' CG ' ' O ' ' A' ' 42' ' ' GLU . 2.6 ptmm? . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.768 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.688 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.452 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 2.6 tpp85 -109.1 -63.9 1.3 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.237 -0.914 . . . . 0.0 109.328 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.452 ' CG ' ' O ' ' A' ' 2' ' ' ARG . 1.7 m-85 -167.02 70.81 1.02 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.235 -0.916 . . . . 0.0 109.584 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.513 ' HD2' ' CD2' ' A' ' 5' ' ' TYR . 43.2 Cg_endo -86.97 -31.43 0.25 Allowed 'Trans proline' 0 C--N 1.303 -1.838 1 C-N-CA 126.21 4.606 . . . . 0.0 110.234 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.571 ' CD1' ' N ' ' A' ' 6' ' ' TYR . 33.5 p90 -90.21 -47.93 7.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.904 . . . . 0.0 110.09 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.571 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -59.47 -48.04 83.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.23 -0.919 . . . . 0.0 109.551 -179.805 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.434 ' O ' HD13 ' A' ' 7' ' ' LEU . 0.1 OUTLIER -63.78 -41.97 97.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.744 -179.775 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -81.82 16.39 1.85 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.264 -0.898 . . . . 0.0 110.19 -179.559 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.42 ' CG ' ' O ' ' A' ' 5' ' ' TYR . 80.7 m-20 -90.19 -109.77 0.08 Allowed 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.883 -1.136 . . . . 0.0 109.641 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.571 ' O ' HD13 ' A' ' 10' ' ' ILE . 0.4 OUTLIER -91.92 -38.01 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.894 -1.129 . . . . 0.0 110.085 -179.626 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.457 ' HA ' ' HB2' ' A' ' 14' ' ' PHE . 43.5 p -67.5 -0.94 4.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.48 -0.763 . . . . 0.0 110.908 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.478 ' O ' ' HG3' ' A' ' 16' ' ' PRO . 2.5 t0 -74.22 -37.15 63.92 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.704 -1.248 . . . . 0.0 110.023 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.22 9.34 34.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.123 -0.986 . . . . 0.0 110.147 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.457 ' HB2' ' HA ' ' A' ' 11' ' ' THR . 0.5 OUTLIER -90.33 -79.6 0.34 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.974 -1.079 . . . . 0.0 109.852 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.422 ' OG ' ' HB ' ' A' ' 18' ' ' VAL . 2.9 t -144.97 77.42 13.18 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.43 -0.794 . . . . 0.0 109.086 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.478 ' HG3' ' O ' ' A' ' 12' ' ' ASP . 41.6 Cg_endo -86.35 -53.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.704 1 C-N-CA 126.094 4.53 . . . . 0.0 110.136 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.405 ' HG3' ' N ' ' A' ' 18' ' ' VAL . 6.1 pt20 -57.56 -20.22 30.67 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.104 -0.998 . . . . 0.0 109.201 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.422 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 3.4 t -90.12 -57.17 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.448 -0.783 . . . . 0.0 109.425 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 18' ' ' VAL . 29.6 mt -47.22 -46.99 24.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.997 -1.064 . . . . 0.0 108.5 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.5 ' O ' ' C ' ' A' ' 21' ' ' ALA . . . -59.27 -56.39 22.72 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 20' ' ' ALA . . . -37.46 -49.66 1.04 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 122.192 0.996 . . . . 0.0 109.267 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.8 t -57.26 -66.56 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.749 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.582 ' O ' ' N ' ' A' ' 25' ' ' ILE . 0.7 OUTLIER -69.1 -55.29 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 120.947 -1.096 . . . . 0.0 110.276 -179.096 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.883 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 2.4 t80 -28.72 -38.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.35 0.595 . . . . 0.0 109.68 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.582 ' N ' ' O ' ' A' ' 23' ' ' ILE . 25.5 mt -77.32 -54.66 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.529 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.8 OUTLIER -61.26 -66.9 0.46 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.19 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.539 ' O ' ' CB ' ' A' ' 31' ' ' SER . 0.1 OUTLIER -39.2 -41.9 0.91 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.472 0.653 . . . . 0.0 109.244 177.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.883 ' HB2' ' O ' ' A' ' 24' ' ' PHE . . . -53.9 -51.44 63.71 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.626 0.727 . . . . 0.0 110.931 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.403 ' HB3' HD12 ' A' ' 30' ' ' LEU . . . -52.17 -58.06 7.75 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.537 -0.727 . . . . 0.0 110.849 -178.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.403 HD12 ' HB3' ' A' ' 29' ' ' ALA . 2.6 mp -106.07 38.86 1.92 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 0.0 110.736 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.604 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -90.93 -56.79 0.25 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.985 -1.072 . . . . 0.0 110.786 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.604 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 45.2 Cg_endo -93.36 -17.3 0.66 Allowed 'Trans proline' 0 N--CA 1.501 1.964 1 C-N-CA 126.279 4.652 . . . . 0.0 111.882 -177.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.02 -50.03 74.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.006 -1.059 . . . . 0.0 110.916 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.436 HG23 ' N ' ' A' ' 35' ' ' THR . 0.5 OUTLIER -75.95 -39.37 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.05 -1.031 . . . . 0.0 110.943 -178.726 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.436 ' N ' HG23 ' A' ' 34' ' ' ILE . 9.9 t -90.67 28.92 1.4 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.882 -1.136 . . . . 0.0 110.508 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' A' ' 32' ' ' PRO . 3.6 t80 -89.41 103.59 16.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.983 -1.073 . . . . 0.0 109.671 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 127.89 110.04 1.55 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 117.95 -38.35 2.96 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.575 ' O ' HD12 ' A' ' 39' ' ' LEU . 0.9 OUTLIER -52.03 114.13 1.22 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.195 -1.179 . . . . 0.0 109.8 -179.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.34 15.1 29.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.308 -0.87 . . . . 0.0 109.329 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 137.16 126.98 2.56 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -73.96 -62.63 1.43 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -1.183 . . . . 0.0 109.937 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.0 tptt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.658 -179.779 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.741 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -109.8 -71.4 0.76 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 0.0 109.505 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.681 ' CD2' HD13 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -175.44 59.84 0.2 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.203 -0.935 . . . . 0.0 109.476 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.585 ' HD3' ' N ' ' A' ' 3' ' ' TYR . 44.0 Cg_endo -91.89 -63.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.733 1 C-N-CA 125.991 4.461 . . . . 0.0 110.617 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.569 ' CE2' ' OD2' ' A' ' 9' ' ' ASP . 69.2 t80 -78.71 -23.81 45.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.489 -0.757 . . . . 0.0 110.319 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -74.79 -45.1 45.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.154 -0.966 . . . . 0.0 110.492 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.681 HD13 ' CD2' ' A' ' 3' ' ' TYR . 3.7 tp -84.42 -40.14 18.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.171 -0.956 . . . . 0.0 110.294 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.534 ' HA ' HG22 ' A' ' 11' ' ' THR . 9.9 t -83.75 25.26 0.8 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.336 -0.852 . . . . 0.0 110.492 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.569 ' OD2' ' CE2' ' A' ' 5' ' ' TYR . 0.6 OUTLIER -89.97 -68.32 0.79 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.0 -1.063 . . . . 0.0 109.958 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.7 mm -89.7 -25.13 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.113 -0.992 . . . . 0.0 110.207 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.534 HG22 ' HA ' ' A' ' 8' ' ' SER . 6.7 t -64.82 -32.38 74.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.096 -1.003 . . . . 0.0 110.015 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -74.35 -5.38 41.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.081 -1.012 . . . . 0.0 109.853 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.07 -59.99 2.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.211 -0.931 . . . . 0.0 109.828 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -81.45 5.71 16.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.27 -0.894 . . . . 0.0 110.043 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.499 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 4.6 t -148.38 76.17 10.19 Favored Pre-proline 0 C--N 1.305 -1.366 0 O-C-N 121.013 -1.055 . . . . 0.0 109.849 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.486 ' O ' ' HB3' ' A' ' 19' ' ' LEU . 45.7 Cg_endo -92.59 -69.52 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.733 1 C-N-CA 126.353 4.702 . . . . 0.0 109.845 179.579 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -57.45 -49.37 76.49 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.3 t -61.04 -23.49 30.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.499 ' HB2' ' O ' ' A' ' 15' ' ' SER . 6.2 tp -58.69 -54.16 50.18 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.88 -1.137 . . . . 0.0 108.63 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.0 -54.59 44.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.427 -0.795 . . . . 0.0 109.8 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.14 -55.69 7.97 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.881 0.848 . . . . 0.0 110.042 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.505 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 28.8 t -55.2 -41.01 58.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 O-C-N 121.802 -0.562 . . . . 0.0 109.875 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 19' ' ' LEU . 46.7 mm -72.11 -22.1 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.416 -0.802 . . . . 0.0 110.201 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -63.61 -52.31 61.45 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.5 mt -74.62 -26.99 20.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.549 ' O ' ' CG ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -70.15 -20.19 63.16 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.075 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.486 ' HA ' ' HB2' ' A' ' 30' ' ' LEU . 10.0 t80 -83.23 -44.37 15.07 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.29 -51.94 30.75 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.023 0.916 . . . . 0.0 108.676 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.536 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -74.1 -41.24 61.95 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.772 0.796 . . . . 0.0 109.955 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.016 HD13 ' CB ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -60.63 -0.03 0.24 Allowed 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.152 -178.51 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.565 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -35.35 -49.0 1.24 Allowed Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.028 -1.045 . . . . 0.0 110.547 -179.629 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 31' ' ' SER . 44.4 Cg_endo -91.48 -23.67 0.44 Allowed 'Trans proline' 0 N--CA 1.502 1.992 1 C-N-CA 126.533 4.822 . . . . 0.0 111.363 -179.422 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 1.016 ' CB ' HD13 ' A' ' 30' ' ' LEU . . . -80.66 -4.25 53.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.198 -0.939 . . . . 0.0 110.847 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.426 ' C ' ' O ' ' A' ' 33' ' ' ALA . 1.1 pt -41.59 -26.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 O-C-N 121.293 -0.88 . . . . 0.0 110.514 -178.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.426 ' N ' ' O ' ' A' ' 33' ' ' ALA . 11.6 t -81.87 -37.51 26.81 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.556 -1.34 . . . . 0.0 109.641 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -50.72 -31.86 17.83 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.125 -0.984 . . . . 0.0 108.623 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -103.88 82.32 0.37 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -131.95 3.83 5.3 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.413 ' N ' ' CD2' ' A' ' 39' ' ' LEU . 3.9 mm? -84.74 7.93 18.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.312 -1.111 . . . . 0.0 109.774 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.13 -65.88 0.94 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.969 . . . . 0.0 109.395 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -46.64 140.0 7.01 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -73.26 -11.91 60.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -1.186 . . . . 0.0 109.386 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.468 179.956 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . 0.801 ' H1 ' ' HE1' ' A' ' 3' ' ' TYR . . . . . . . . 0 C--O 1.215 -0.744 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.539 ' C ' ' CG ' ' A' ' 3' ' ' TYR . 0.3 OUTLIER -118.68 -76.84 0.57 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 109.712 . . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.801 ' HE1' ' H1 ' ' A' ' 1' ' ' ACE . 1.0 OUTLIER 37.59 87.08 0.12 Allowed Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.394 -0.816 . . . . 0.0 110.078 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -86.53 -71.62 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.92 1 C-N-CA 126.05 4.5 . . . . 0.0 110.626 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.49 ' O ' ' OD1' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -74.8 -33.99 62.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.199 -0.938 . . . . 0.0 110.036 -179.439 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.455 ' O ' ' OD1' ' A' ' 9' ' ' ASP . 12.2 t80 -41.66 -42.7 2.59 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.388 -0.82 . . . . 0.0 109.891 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.24 -39.1 71.86 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.431 -0.793 . . . . 0.0 110.803 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.79 -14.52 59.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.188 -0.945 . . . . 0.0 111.501 -178.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -90.68 -66.82 0.89 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.54 -1.35 . . . . 0.0 110.606 -179.501 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.464 ' CG2' ' N ' ' A' ' 11' ' ' THR . 1.8 tt -38.66 -40.95 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 121.484 0.659 . . . . 0.0 110.072 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.464 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 30.7 p -76.38 -42.12 45.61 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.481 -0.762 . . . . 0.0 109.914 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -79.27 5.45 12.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.079 -1.013 . . . . 0.0 109.869 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.07 -20.77 29.88 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.107 -0.996 . . . . 0.0 109.488 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.564 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -81.9 4.76 21.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.217 -0.927 . . . . 0.0 109.401 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 1.5 t -121.46 86.29 43.94 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -86.91 -61.24 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.781 1 C-N-CA 125.986 4.457 . . . . 0.0 110.062 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.09 -31.07 62.9 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.388 -0.82 . . . . 0.0 109.128 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.486 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 5.5 t -89.33 -40.31 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.441 -0.787 . . . . 0.0 110.491 -179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' A' ' 15' ' ' SER . 33.6 tp -57.73 -56.28 23.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.574 -1.329 . . . . 0.0 108.488 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.434 ' O ' ' C ' ' A' ' 21' ' ' ALA . . . -55.24 -55.23 33.69 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.494 -0.754 . . . . 0.0 109.429 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 20' ' ' ALA . . . -42.24 -52.66 4.37 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.944 0.878 . . . . 0.0 109.692 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.7 t -48.65 -55.0 3.71 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 121.173 0.511 . . . . 0.0 110.377 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 25' ' ' ILE . 45.7 mm -63.49 -54.46 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.097 -1.002 . . . . 0.0 110.778 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.523 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -32.71 -36.08 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.643 -0.661 . . . . 0.0 109.661 -179.552 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.744 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 43.4 mt -76.5 -53.98 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.405 -0.809 . . . . 0.0 109.058 178.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.479 ' O ' ' N ' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -57.58 -64.9 0.74 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.491 ' O ' ' OG ' ' A' ' 31' ' ' SER . 0.1 OUTLIER -39.33 -29.3 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.715 0.769 . . . . 0.0 109.236 177.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.744 ' HB3' ' O ' ' A' ' 25' ' ' ILE . . . -63.65 -62.27 1.77 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.538 -0.726 . . . . 0.0 111.202 -178.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.62 -66.76 0.9 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.179 -0.951 . . . . 0.0 112.883 -177.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.571 ' H ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -91.15 36.96 0.92 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.132 -0.98 . . . . 0.0 110.557 -177.326 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.644 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -47.09 -62.79 1.75 Allowed Pre-proline 0 C--N 1.295 -1.788 0 O-C-N 121.199 -0.938 . . . . 0.0 110.878 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.644 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 49.7 Cg_endo -98.88 -0.48 1.03 Allowed 'Trans proline' 0 N--CA 1.501 1.968 1 C-N-CA 126.347 4.698 . . . . 0.0 111.337 -178.337 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.533 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . -63.6 -59.14 5.0 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.008 -1.057 . . . . 0.0 110.541 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.8 tt -62.32 -22.81 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 110.716 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.64 -19.8 24.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.889 -1.132 . . . . 0.0 110.129 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -90.08 149.29 22.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.131 -0.981 . . . . 0.0 109.983 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.66 123.16 4.95 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -105.11 18.35 42.74 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.2 mp -70.25 -16.36 63.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.371 -1.076 . . . . 0.0 109.703 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.88 -41.72 83.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.164 -0.96 . . . . 0.0 109.596 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 124.58 29.45 1.07 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.93 -19.98 66.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.217 -1.167 . . . . 0.0 109.294 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.7 tppt? . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.348 179.795 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.696 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.409 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 6.9 ttm180 -138.74 132.95 31.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.265 -0.897 . . . . 0.0 109.434 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.492 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 2.6 m-30 -108.61 104.7 55.15 Favored Pre-proline 0 N--CA 1.487 1.389 0 O-C-N 121.22 -0.925 . . . . 0.0 109.441 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 8' ' ' SER . 42.0 Cg_endo -85.87 -35.4 0.14 Allowed 'Trans proline' 0 N--CA 1.5 1.866 1 C-N-CA 125.914 4.409 . . . . 0.0 110.508 -179.78 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.409 ' O ' ' HB3' ' A' ' 9' ' ' ASP . 27.6 m-85 -86.25 -19.41 29.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -0.961 . . . . 0.0 109.884 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.492 ' HB3' ' HB3' ' A' ' 3' ' ' TYR . 33.8 t80 -78.12 -45.5 23.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.887 . . . . 0.0 109.716 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 12' ' ' ASP . 6.7 mt -86.59 -39.66 15.95 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.386 -0.821 . . . . 0.0 110.402 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 4' ' ' PRO . 8.4 m -81.84 16.25 1.91 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.124 -0.985 . . . . 0.0 111.046 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.478 ' OD2' ' O ' ' A' ' 6' ' ' TYR . 4.1 p30 -88.88 -107.8 0.08 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.759 -1.213 . . . . 0.0 109.276 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.3 mt -90.38 -29.46 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 120.833 -1.167 . . . . 0.0 109.274 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 58.2 p -90.26 30.94 1.04 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.324 -0.86 . . . . 0.0 109.355 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.466 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 55.8 t0 -74.6 -70.06 0.42 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.0 109.834 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.54 11.08 34.75 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.217 -0.927 . . . . 0.0 109.783 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -73.23 -65.39 0.81 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.237 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -143.21 77.6 15.66 Favored Pre-proline 0 C--N 1.299 -1.597 0 O-C-N 121.432 -0.793 . . . . 0.0 108.979 179.646 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -91.69 -66.97 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.755 1 C-N-CA 126.374 4.716 . . . . 0.0 110.645 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.36 -42.26 86.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -0.903 . . . . 0.0 109.466 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.0 t -73.11 -19.09 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.372 -0.83 . . . . 0.0 109.155 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 15' ' ' SER . 0.4 OUTLIER -65.36 -47.11 77.56 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.069 -1.02 . . . . 0.0 108.81 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.86 -53.35 18.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.388 -0.82 . . . . 0.0 109.132 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.53 -55.77 10.17 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.895 0.855 . . . . 0.0 109.532 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.7 t -51.73 -47.92 38.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 O-C-N 121.789 -0.569 . . . . 0.0 109.519 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.485 ' O ' ' HB2' ' A' ' 27' ' ' PHE . 22.9 mm -64.54 -26.32 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 110.114 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -64.58 -36.49 84.41 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 120.515 -1.366 . . . . 0.0 108.141 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.615 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 17.3 mt -74.82 -41.88 46.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.497 ' O ' ' N ' ' A' ' 28' ' ' ALA . 6.4 m-85 -60.62 -64.22 1.03 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.632 ' HA ' ' CB ' ' A' ' 31' ' ' SER . 0.8 OUTLIER -37.07 -31.33 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.97 0.89 . . . . 0.0 109.099 177.087 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 25' ' ' ILE . . . -75.24 -53.83 8.14 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.7 -89.38 0.18 Allowed 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.875 -1.141 . . . . 0.0 113.633 -175.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.37 35.26 3.12 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.505 -0.747 . . . . 0.0 112.802 -175.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.632 ' CB ' ' HA ' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -71.14 -48.2 13.59 Favored Pre-proline 0 C--N 1.293 -1.866 0 O-C-N 120.665 -1.272 . . . . 0.0 109.614 179.152 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 31' ' ' SER . 40.3 Cg_endo -86.29 16.76 1.89 Allowed 'Trans proline' 0 C--N 1.303 -1.819 1 C-N-CA 126.307 4.671 . . . . 0.0 110.498 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.99 -57.89 2.7 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.221 -0.925 . . . . 0.0 109.258 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.0 mt -78.03 -51.15 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.204 -0.935 . . . . 0.0 109.149 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.412 ' O ' ' C ' ' A' ' 36' ' ' PHE . 39.4 p -68.83 -5.93 23.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.131 -0.981 . . . . 0.0 109.746 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 32' ' ' PRO . 16.1 t80 -42.37 132.09 3.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.32 -0.863 . . . . 0.0 109.645 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -70.53 85.66 0.34 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -136.83 9.8 3.94 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.601 HD12 ' H ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER -59.59 -172.84 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.217 -1.166 . . . . 0.0 109.508 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.53 ' H ' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -105.35 37.76 2.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.23 -0.919 . . . . 0.0 109.319 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.601 ' H ' HD12 ' A' ' 39' ' ' LEU . . . -126.19 5.31 7.76 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -41.1 27.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.216 -1.167 . . . . 0.0 109.386 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.479 ' CD ' ' O ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.409 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . 0.778 ' H1 ' ' CZ ' ' A' ' 3' ' ' TYR . . . . . . . . 0 C--O 1.214 -0.776 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -122.03 81.64 1.85 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.904 . . . . 0.0 109.442 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.778 ' CZ ' ' H1 ' ' A' ' 1' ' ' ACE . 0.2 OUTLIER -154.85 77.73 5.06 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.382 -0.824 . . . . 0.0 109.209 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -86.14 -57.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.499 1.809 1 C-N-CA 126.094 4.529 . . . . 0.0 110.344 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -52.81 -22.34 5.26 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.229 -0.919 . . . . 0.0 109.381 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.463 ' O ' ' CG ' ' A' ' 9' ' ' ASP . 3.6 t80 -59.1 -45.37 91.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.359 -0.838 . . . . 0.0 109.298 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.469 ' O ' ' OD1' ' A' ' 9' ' ' ASP . 0.1 OUTLIER -71.29 -32.63 68.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.2 -0.938 . . . . 0.0 109.358 179.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.535 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 0.3 OUTLIER -58.11 -9.38 1.4 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.683 -0.636 . . . . 0.0 111.24 -179.342 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 0.9 OUTLIER -53.08 -90.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.798 -1.189 . . . . 0.0 110.881 -178.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.52 -22.14 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.081 -1.012 . . . . 0.0 111.179 -178.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.535 ' OG1' ' HA ' ' A' ' 8' ' ' SER . 40.0 p -67.0 -7.49 22.87 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.549 -1.344 . . . . 0.0 109.929 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 9' ' ' ASP . 16.3 p-10 -90.96 -1.09 57.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.098 -1.001 . . . . 0.0 110.288 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.75 -19.48 21.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.077 -1.014 . . . . 0.0 110.042 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -84.26 -21.15 31.2 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.192 -0.943 . . . . 0.0 109.748 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.545 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 0.3 OUTLIER -143.75 62.25 10.6 Favored Pre-proline 0 N--CA 1.487 1.377 0 O-C-N 121.123 -0.986 . . . . 0.0 110.111 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.545 ' HD3' ' N ' ' A' ' 15' ' ' SER . 43.5 Cg_endo -91.01 -65.09 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.765 1 C-N-CA 126.13 4.553 . . . . 0.0 109.88 179.694 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -60.47 -27.01 67.21 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.367 -0.833 . . . . 0.0 109.056 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.492 ' O ' HG23 ' A' ' 22' ' ' VAL . 41.2 t -73.39 -26.82 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.326 -0.859 . . . . 0.0 109.554 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.04 -52.81 37.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.058 -1.026 . . . . 0.0 108.32 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.09 -47.16 61.95 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.88 -54.59 27.49 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.608 0.718 . . . . 0.0 109.362 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 18' ' ' VAL . 89.7 t -48.93 -31.22 3.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.524 -0.735 . . . . 0.0 109.28 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.532 ' HA ' ' HB2' ' A' ' 26' ' ' TYR . 82.0 mt -78.47 -36.17 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.408 -0.807 . . . . 0.0 109.565 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.63 -43.33 97.64 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mt -76.0 -31.29 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.532 ' HB2' ' HA ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -67.55 -19.15 65.25 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.284 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -85.75 -38.59 18.07 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.507 ' O ' ' OG ' ' A' ' 31' ' ' SER . . . -51.17 -50.53 58.82 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.585 0.707 . . . . 0.0 109.749 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.516 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -76.34 -47.79 22.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.606 -0.684 . . . . 0.0 110.642 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.033 HD13 ' HB3' ' A' ' 33' ' ' ALA . 4.4 mm? -66.08 3.71 0.81 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.614 -0.679 . . . . 0.0 112.042 -178.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.552 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -45.99 -53.98 18.98 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 120.445 -1.41 . . . . 0.0 111.068 -179.083 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.552 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 42.9 Cg_endo -92.48 -17.7 0.82 Allowed 'Trans proline' 0 N--CA 1.501 1.914 1 C-N-CA 126.397 4.731 . . . . 0.0 111.751 -178.319 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 1.033 ' HB3' HD13 ' A' ' 30' ' ' LEU . . . -77.56 -28.13 51.71 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.779 -1.201 . . . . 0.0 110.156 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -53.67 -38.82 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.116 -0.99 . . . . 0.0 109.824 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.425 HG23 ' CD1' ' A' ' 36' ' ' PHE . 3.5 t -90.33 -19.25 24.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.973 . . . . 0.0 110.019 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.472 ' HB2' ' HA ' ' A' ' 33' ' ' ALA . 6.9 m-30 -78.84 -94.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.096 -1.003 . . . . 0.0 110.06 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -103.54 -172.68 25.84 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 126.37 82.75 0.45 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.528 HD23 ' N ' ' A' ' 39' ' ' LEU . 2.2 pt? -47.1 147.93 1.3 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -1.172 . . . . 0.0 109.448 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 41' ' ' GLY . 1.9 tp -86.77 -71.59 0.55 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.884 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 40' ' ' LEU . . . 44.92 -152.05 0.69 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -70.28 -13.92 62.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.026 -1.279 . . . . 0.0 109.126 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.466 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.728 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -158.75 28.12 0.22 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.554 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -70.03 -49.63 18.5 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 0.0 109.772 -179.703 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' A' ' 3' ' ' TYR . 42.2 Cg_endo -86.68 -35.17 0.12 Allowed 'Trans proline' 0 N--CA 1.501 1.913 1 C-N-CA 125.964 4.443 . . . . 0.0 110.862 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -69.14 -12.78 61.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.028 -1.045 . . . . 0.0 109.778 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.26 -64.7 0.97 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.168 -0.957 . . . . 0.0 109.721 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.433 ' O ' ' OG1' ' A' ' 11' ' ' THR . 15.3 mt -72.17 -38.19 69.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.342 -0.849 . . . . 0.0 109.941 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.498 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -81.23 21.77 0.71 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.402 -0.811 . . . . 0.0 110.426 -179.471 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.79 -65.95 0.95 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.811 -1.181 . . . . 0.0 109.676 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 11' ' ' THR . 5.2 tt -90.22 -38.02 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.323 -0.86 . . . . 0.0 109.873 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 7' ' ' LEU . 67.7 p -82.84 23.64 0.81 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.514 -0.741 . . . . 0.0 110.393 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.498 ' HB3' ' O ' ' A' ' 8' ' ' SER . 3.5 p-10 -69.89 -48.72 57.58 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.893 -1.13 . . . . 0.0 109.672 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.419 ' N ' ' CG ' ' A' ' 12' ' ' ASP . . . -106.23 -15.67 14.79 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.109 -0.994 . . . . 0.0 110.06 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -82.98 -60.42 2.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.064 -1.022 . . . . 0.0 110.298 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.489 ' OG ' ' HB ' ' A' ' 18' ' ' VAL . 16.3 t -123.81 87.4 52.77 Favored Pre-proline 0 C--N 1.301 -1.541 0 O-C-N 121.289 -0.882 . . . . 0.0 109.774 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -89.99 -64.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.757 1 C-N-CA 126.234 4.622 . . . . 0.0 110.034 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -55.7 -59.22 5.16 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.489 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 25.4 t -51.55 -24.96 4.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 15' ' ' SER . 0.2 OUTLIER -63.38 -53.16 56.89 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.214 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.85 -50.54 70.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.478 -0.764 . . . . 0.0 109.006 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.24 -55.59 10.12 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.752 0.787 . . . . 0.0 109.768 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.2 t -55.65 -38.73 51.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 O-C-N 121.71 -0.619 . . . . 0.0 109.601 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 19' ' ' LEU . 22.7 mt -69.19 -26.81 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.237 -0.915 . . . . 0.0 109.449 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -60.76 -41.51 95.6 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.1 mt -72.4 -41.02 64.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -61.56 -22.8 65.49 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.471 ' O ' ' CB ' ' A' ' 31' ' ' SER . 0.2 OUTLIER -84.62 -29.3 25.86 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 122.044 0.926 . . . . 0.0 108.577 179.416 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.7 -61.81 1.63 Allowed 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.802 -0.561 . . . . 0.0 111.1 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.36 -62.08 1.51 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.038 -1.039 . . . . 0.0 112.708 -177.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.536 ' HA ' ' HB2' ' A' ' 33' ' ' ALA . 10.4 mt -83.11 26.17 0.64 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.961 -1.087 . . . . 0.0 111.417 -177.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.564 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -58.13 -51.52 81.17 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 120.826 -1.172 . . . . 0.0 109.541 179.472 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.564 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 46.3 Cg_endo -94.45 -9.87 1.49 Allowed 'Trans proline' 0 N--CA 1.498 1.786 1 C-N-CA 126.71 4.94 . . . . 0.0 110.533 -179.375 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.536 ' HB2' ' HA ' ' A' ' 30' ' ' LEU . . . -42.78 -25.92 0.11 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.287 -0.883 . . . . 0.0 110.156 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.49 HG22 ' N ' ' A' ' 35' ' ' THR . 1.8 mp -38.56 -75.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.514 -0.741 . . . . 0.0 110.434 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.49 ' N ' HG22 ' A' ' 34' ' ' ILE . 1.7 t -83.93 -27.26 28.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.008 -1.058 . . . . 0.0 110.245 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -79.55 134.29 36.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.016 -1.052 . . . . 0.0 109.691 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.99 98.81 0.19 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 153.12 83.75 0.04 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 pp -83.09 137.07 34.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.351 -1.088 . . . . 0.0 109.797 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.745 ' C ' HD13 ' A' ' 40' ' ' LEU . 3.5 tm? -105.16 -58.44 1.89 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.302 -0.874 . . . . 0.0 108.922 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.73 148.22 16.97 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -69.27 -39.6 78.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -1.147 . . . . 0.0 109.248 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.463 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.718 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -90.0 -171.0 2.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.893 . . . . 0.0 109.384 . . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.551 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.1 OUTLIER 169.4 -50.28 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.904 . . . . 0.0 110.231 179.579 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.551 ' CD ' ' N ' ' A' ' 3' ' ' TYR . 41.5 Cg_endo -85.33 -29.6 0.61 Allowed 'Trans proline' 0 N--CA 1.501 1.963 1 C-N-CA 126.028 4.485 . . . . 0.0 111.246 -179.177 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -74.33 -12.73 60.61 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.936 -1.103 . . . . 0.0 109.733 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -68.69 -50.35 51.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 110.262 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.6 -41.31 88.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.18 -0.95 . . . . 0.0 109.93 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.63 -31.54 25.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.156 -0.965 . . . . 0.0 109.608 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -76.43 -32.98 58.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.243 -0.911 . . . . 0.0 109.712 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.8 mm -59.77 -17.37 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.15 -0.969 . . . . 0.0 110.165 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.41 ' OG1' ' N ' ' A' ' 12' ' ' ASP . 9.1 p -90.41 -58.75 2.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.101 -1.0 . . . . 0.0 110.539 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.41 ' N ' ' OG1' ' A' ' 11' ' ' THR . 1.5 t0 -59.89 -43.32 94.85 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.15 -0.969 . . . . 0.0 110.326 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.487 ' O ' ' C ' ' A' ' 14' ' ' PHE . . . -101.14 43.68 1.05 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.292 -0.88 . . . . 0.0 108.686 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.487 ' C ' ' O ' ' A' ' 13' ' ' ALA . 1.0 OUTLIER -34.88 -36.18 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.111 0.482 . . . . 0.0 109.743 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.514 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.4 OUTLIER 34.58 94.29 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.994 -0.441 . . . . 0.0 110.443 179.117 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -89.7 -65.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.763 1 C-N-CA 126.143 4.562 . . . . 0.0 109.752 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -55.48 -51.26 67.56 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.478 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 72.4 t -62.1 -23.4 31.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.628 -0.67 . . . . 0.0 109.303 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.514 ' HB2' ' O ' ' A' ' 15' ' ' SER . 3.9 tp -56.89 -58.02 9.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.151 -0.968 . . . . 0.0 108.694 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.591 ' HA ' HD12 ' A' ' 23' ' ' ILE . . . -51.77 -53.59 38.09 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -44.67 -52.48 8.2 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 122.036 0.922 . . . . 0.0 109.68 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.8 t -49.94 -49.9 20.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.235 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.591 HD12 ' HA ' ' A' ' 20' ' ' ALA . 3.6 mt -66.96 -26.87 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -0.975 . . . . 0.0 109.832 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -54.74 -42.0 71.1 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.096 -1.002 . . . . 0.0 108.743 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.72 -44.11 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.107 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.06 -19.17 29.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.905 -1.122 . . . . 0.0 108.17 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.521 ' O ' ' CB ' ' A' ' 31' ' ' SER . 0.2 OUTLIER -90.81 -34.91 15.12 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.952 0.882 . . . . 0.0 108.74 179.555 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 31' ' ' SER . . . -76.04 -67.93 0.63 Allowed 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.395 0.617 . . . . 0.0 110.4 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.28 -56.28 24.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.389 -0.819 . . . . 0.0 110.623 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.707 ' O ' HG23 ' A' ' 34' ' ' ILE . 9.8 mp -85.13 25.59 0.96 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.347 -0.846 . . . . 0.0 110.547 -178.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.577 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -66.13 -49.52 55.51 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.075 -1.015 . . . . 0.0 110.046 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 31' ' ' SER . 42.8 Cg_endo -91.1 -5.76 4.1 Favored 'Trans proline' 0 C--N 1.303 -1.821 1 C-N-CA 126.557 4.838 . . . . 0.0 111.186 -179.097 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.88 -27.26 25.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.023 -1.048 . . . . 0.0 109.647 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.707 HG23 ' O ' ' A' ' 30' ' ' LEU . 27.1 pt -67.6 -35.16 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.331 -0.855 . . . . 0.0 109.793 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.514 ' N ' HG13 ' A' ' 34' ' ' ILE . 10.3 t -86.91 13.96 8.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.188 -0.945 . . . . 0.0 109.44 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.49 ' CD1' ' C ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -89.93 -10.73 44.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.299 -0.876 . . . . 0.0 109.056 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.47 ' O ' ' CE1' ' A' ' 36' ' ' PHE . . . 87.41 88.11 1.09 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -142.94 23.98 2.27 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.712 HD23 ' N ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -79.19 -70.87 0.47 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.217 -1.166 . . . . 0.0 108.853 179.584 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.7 mt -105.79 -57.49 2.03 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.257 -0.902 . . . . 0.0 109.74 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -151.14 -130.69 1.71 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.49 ' C ' ' CG ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -86.7 -75.57 0.39 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.317 -1.108 . . . . 0.0 109.647 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.49 ' CG ' ' C ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.537 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.726 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.02 151.35 21.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.235 -0.916 . . . . 0.0 109.535 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.421 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.9 OUTLIER 51.42 67.75 3.92 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.298 -0.876 . . . . 0.0 109.689 179.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.421 ' HD3' ' N ' ' A' ' 3' ' ' TYR . 41.8 Cg_endo -86.62 -88.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.775 1 C-N-CA 126.078 4.518 . . . . 0.0 110.186 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.468 ' O ' ' HB2' ' A' ' 9' ' ' ASP . 26.1 m-85 -68.06 -20.29 64.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -0.899 . . . . 0.0 109.743 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -66.4 -62.19 1.6 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.342 -0.849 . . . . 0.0 110.499 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.734 HD23 ' C ' ' A' ' 7' ' ' LEU . 6.6 tt -62.72 -54.11 44.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.336 -0.852 . . . . 0.0 110.751 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.439 ' C ' HG22 ' A' ' 11' ' ' THR . 0.5 OUTLIER -55.82 -14.33 2.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.066 -1.021 . . . . 0.0 110.707 -179.103 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -90.17 -46.25 8.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.959 -1.088 . . . . 0.0 110.496 -179.264 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.475 ' O ' HG22 ' A' ' 10' ' ' ILE . 50.0 mt -68.52 -5.43 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.136 -0.977 . . . . 0.0 110.672 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.439 HG22 ' C ' ' A' ' 8' ' ' SER . 1.7 t -86.75 -46.89 9.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.868 -1.145 . . . . 0.0 110.838 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.25 -24.31 20.98 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.78 -1.2 . . . . 0.0 109.566 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.68 41.62 1.36 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.351 -0.843 . . . . 0.0 109.129 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.533 ' O ' ' O ' ' A' ' 15' ' ' SER . 5.3 t80 -51.76 -59.91 3.77 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.283 -0.886 . . . . 0.0 108.881 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.533 ' O ' ' O ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER 20.91 104.75 0.01 OUTLIER Pre-proline 0 N--CA 1.507 2.397 0 C-N-CA 122.255 0.222 . . . . 0.0 111.461 179.072 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -89.77 -69.42 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.71 1 C-N-CA 126.072 4.515 . . . . 0.0 109.884 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -55.6 -46.21 77.35 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.61 ' CG1' HG23 ' A' ' 22' ' ' VAL . 47.5 t -66.72 -26.84 38.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' A' ' 15' ' ' SER . 2.7 tp -52.58 -44.14 65.72 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.473 -1.392 . . . . 0.0 108.587 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.76 -50.94 61.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.511 -0.743 . . . . 0.0 109.783 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.21 -64.48 0.85 Allowed 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 122.029 0.919 . . . . 0.0 109.285 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.61 HG23 ' CG1' ' A' ' 18' ' ' VAL . 77.3 t -51.59 -33.73 15.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.865 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.485 ' O ' ' HB2' ' A' ' 27' ' ' PHE . 82.5 mt -78.96 -26.06 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.751 -1.218 . . . . 0.0 109.559 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -57.85 -53.42 58.41 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.726 ' H ' HD12 ' A' ' 25' ' ' ILE . 5.2 mp -70.17 -36.44 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.519 ' HA ' ' HB2' ' A' ' 30' ' ' LEU . 0.5 OUTLIER -64.63 -15.58 61.44 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.588 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.485 ' HB2' ' O ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -90.18 -26.0 20.37 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.208 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.62 -79.17 0.22 Allowed 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.605 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.499 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -91.66 -56.95 2.91 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.382 -0.823 . . . . 0.0 112.83 -177.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.519 ' HB2' ' HA ' ' A' ' 26' ' ' TYR . 15.9 mt -68.93 8.91 0.46 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.142 -0.974 . . . . 0.0 112.362 -177.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.575 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.9 OUTLIER -44.35 -48.66 25.29 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 120.626 -1.296 . . . . 0.0 110.112 179.585 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 31' ' ' SER . 42.9 Cg_endo -91.84 -15.69 1.3 Allowed 'Trans proline' 0 N--CA 1.5 1.874 1 C-N-CA 126.707 4.938 . . . . 0.0 111.131 -179.198 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.471 ' O ' ' C ' ' A' ' 34' ' ' ILE . . . -50.72 -21.59 1.69 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.063 -1.023 . . . . 0.0 110.038 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.471 ' C ' ' O ' ' A' ' 33' ' ' ALA . 72.6 mt -34.84 -74.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.765 -0.585 . . . . 0.0 110.755 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.461 HG23 ' N ' ' A' ' 36' ' ' PHE . 14.7 t -70.72 -37.73 73.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.16 -0.963 . . . . 0.0 110.058 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.461 ' N ' HG23 ' A' ' 35' ' ' THR . 6.0 m-85 -73.75 178.09 5.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.257 -0.902 . . . . 0.0 109.827 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 54.94 62.53 6.17 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 40' ' ' LEU . . . 117.16 86.47 1.19 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -46.75 89.99 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.518 -0.99 . . . . 0.0 109.487 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.547 ' N ' ' O ' ' A' ' 38' ' ' GLY . 2.7 mp -106.22 31.1 5.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 109.858 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.37 -90.85 1.74 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -57.59 -53.03 62.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.408 -1.054 . . . . 0.0 109.728 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.644 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . 0.603 ' H1 ' ' HG3' ' A' ' 4' ' ' PRO . . . . . . . . 0 C--O 1.216 -0.698 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.81 -49.76 28.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.88 . . . . 0.0 109.449 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.57 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 4.1 p90 -162.03 59.91 1.05 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.173 -0.954 . . . . 0.0 109.914 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.603 ' HG3' ' H1 ' ' A' ' 1' ' ' ACE . 45.4 Cg_endo -90.9 -16.33 1.49 Allowed 'Trans proline' 0 N--CA 1.499 1.81 1 C-N-CA 126.004 4.469 . . . . 0.0 109.993 179.748 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.435 ' O ' ' OD1' ' A' ' 9' ' ' ASP . 17.8 t80 -81.94 -16.6 49.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.445 -0.784 . . . . 0.0 110.19 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -70.92 -57.03 4.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.162 -0.962 . . . . 0.0 110.197 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 8' ' ' SER . 0.2 OUTLIER -70.78 -45.67 64.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.195 -0.941 . . . . 0.0 110.185 -179.279 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.465 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 8.5 m -43.71 -25.74 0.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.202 -0.937 . . . . 0.0 109.949 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 5' ' ' TYR . 59.3 m-20 -50.87 -63.7 1.04 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.13 -0.981 . . . . 0.0 110.408 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 56.0 mt -64.3 -43.92 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.124 -0.985 . . . . 0.0 110.283 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.465 ' OG1' ' HA ' ' A' ' 8' ' ' SER . 26.2 p -69.1 -3.12 12.08 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.13 -0.982 . . . . 0.0 109.944 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -64.17 -44.09 93.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.069 -1.019 . . . . 0.0 110.028 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.69 -6.98 18.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.064 -1.022 . . . . 0.0 109.941 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -89.25 -7.15 56.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.156 -0.965 . . . . 0.0 109.896 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.493 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 0.5 OUTLIER -135.88 91.87 17.17 Favored Pre-proline 0 C--N 1.306 -1.318 0 O-C-N 120.996 -1.065 . . . . 0.0 110.212 -179.612 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.485 ' HD2' ' OE1' ' A' ' 17' ' ' GLN . 43.2 Cg_endo -89.39 -65.64 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.669 1 C-N-CA 126.236 4.624 . . . . 0.0 108.786 178.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.563 ' OE1' HG23 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -65.14 -26.53 68.22 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.669 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.563 HG23 ' OE1' ' A' ' 17' ' ' GLN . 22.0 t -78.04 -20.68 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.496 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 1.0 OUTLIER -64.66 -49.02 72.65 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.321 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 21' ' ' ALA . . . -62.73 -56.86 13.79 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 20' ' ' ALA . . . -42.06 -48.76 4.72 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.951 0.881 . . . . 0.0 109.185 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.641 ' HA ' HD12 ' A' ' 25' ' ' ILE . 3.4 t -44.01 -55.29 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.5 mm -54.64 -39.59 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 119.172 -1.011 . . . . 0.0 109.021 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -51.38 -40.41 59.18 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.276 -0.89 . . . . 0.0 108.755 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.641 HD12 ' HA ' ' A' ' 22' ' ' VAL . 7.1 mt -73.15 -40.22 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.313 -0.867 . . . . 0.0 108.95 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -62.84 -16.62 59.17 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.7 -36.45 15.21 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 31' ' ' SER . . . -62.08 -56.61 17.17 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.458 0.646 . . . . 0.0 110.098 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.574 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -57.21 -46.71 82.66 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.474 -0.766 . . . . 0.0 110.563 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.083 HD22 ' HB3' ' A' ' 33' ' ' ALA . 1.9 tm? -63.94 -1.29 1.39 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.871 -0.518 . . . . 0.0 111.675 -178.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.588 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -45.91 -57.03 8.79 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 120.832 -1.167 . . . . 0.0 112.219 -178.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.588 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 43.1 Cg_endo -91.1 -23.7 0.48 Allowed 'Trans proline' 0 N--CA 1.502 1.986 1 C-N-CA 126.105 4.537 . . . . 0.0 112.122 -177.408 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 1.083 ' HB3' HD22 ' A' ' 30' ' ' LEU . . . -64.31 -23.9 67.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.745 -1.222 . . . . 0.0 109.27 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.969 HD13 ' O ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -61.02 -24.42 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.562 -0.711 . . . . 0.0 110.19 -179.594 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 m -79.48 -22.5 43.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.963 -1.086 . . . . 0.0 109.627 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -51.44 109.09 0.31 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.211 -0.93 . . . . 0.0 109.514 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -165.71 34.56 0.25 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 128.27 77.29 0.21 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.475 HD13 ' HA ' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -81.38 -75.83 0.27 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.365 -1.079 . . . . 0.0 109.742 -179.716 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 41' ' ' GLY . 9.6 mt -86.72 -55.04 4.04 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.302 -0.874 . . . . 0.0 109.614 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 40' ' ' LEU . . . 61.2 129.25 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.409 ' C ' ' HD3' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -57.53 -17.56 14.45 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.241 -1.153 . . . . 0.0 109.501 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.409 ' HD3' ' C ' ' A' ' 42' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.199 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.753 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -102.29 149.45 24.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.146 -0.971 . . . . 0.0 109.636 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -79.39 121.98 83.46 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.358 -0.839 . . . . 0.0 109.501 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -85.54 -83.28 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.809 1 C-N-CA 125.638 4.225 . . . . 0.0 109.977 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -77.28 -39.33 48.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.125 -0.985 . . . . 0.0 109.306 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.463 ' O ' ' HB2' ' A' ' 9' ' ' ASP . 22.9 m-85 -50.09 -41.04 47.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.263 -0.898 . . . . 0.0 109.285 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.413 ' O ' ' OG1' ' A' ' 11' ' ' THR . 3.6 tp -58.89 -45.81 89.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.438 -0.789 . . . . 0.0 109.845 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.18 24.13 0.68 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.19 -0.944 . . . . 0.0 110.571 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 6' ' ' TYR . 3.5 m-20 -90.15 -105.08 0.09 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.864 -1.148 . . . . 0.0 110.247 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.8 mt -91.06 -1.27 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.995 -1.065 . . . . 0.0 111.106 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 7' ' ' LEU . 7.5 p -70.08 -8.46 49.6 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.802 -1.186 . . . . 0.0 110.093 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.92 -26.05 31.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.064 -1.022 . . . . 0.0 109.615 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.02 -11.58 58.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.345 -0.847 . . . . 0.0 109.684 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.467 ' O ' ' C ' ' A' ' 15' ' ' SER . 0.9 OUTLIER -87.31 -4.11 59.05 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.176 -0.953 . . . . 0.0 109.713 -179.869 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.549 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 8.2 t 36.23 59.93 3.22 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.653 -0.654 . . . . 0.0 110.063 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.549 ' HD3' ' N ' ' A' ' 15' ' ' SER . 44.7 Cg_endo -89.83 -64.65 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.747 1 C-N-CA 125.893 4.395 . . . . 0.0 110.074 -179.419 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -45.07 -32.52 1.77 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.196 -0.94 . . . . 0.0 109.66 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.7 t -86.44 -46.6 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 110.504 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.534 HD23 ' CD1' ' A' ' 23' ' ' ILE . 0.9 OUTLIER -57.54 -60.23 3.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.671 -1.268 . . . . 0.0 108.482 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.59 -47.31 39.87 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.472 -0.767 . . . . 0.0 109.285 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 24' ' ' PHE . . . -49.03 -55.44 12.02 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.938 0.875 . . . . 0.0 109.786 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.1 t -55.29 -51.83 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 121.648 0.737 . . . . 0.0 109.848 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.534 ' CD1' HD23 ' A' ' 19' ' ' LEU . 5.9 mt -66.92 -15.89 20.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.225 -0.922 . . . . 0.0 109.435 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.595 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 0.1 OUTLIER -64.94 -39.75 93.97 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 179.453 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.9 mt -67.75 -45.71 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.706 ' CZ ' HD11 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -61.33 -69.94 0.21 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.599 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.586 ' HA ' ' CB ' ' A' ' 31' ' ' SER . 0.5 OUTLIER -41.34 -30.16 0.17 Allowed 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.679 0.752 . . . . 0.0 110.201 178.2 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.595 ' HB2' ' O ' ' A' ' 24' ' ' PHE . . . -73.24 -58.04 3.59 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.469 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -91.09 -73.53 0.53 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -175.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.79 ' H ' HD23 ' A' ' 30' ' ' LEU . 2.0 pt? -85.47 26.07 0.97 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.966 -1.083 . . . . 0.0 112.364 -175.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.586 ' CB ' ' HA ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -90.02 -50.6 0.36 Allowed Pre-proline 0 C--N 1.296 -1.726 0 O-C-N 120.825 -1.172 . . . . 0.0 109.919 179.108 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 31' ' ' SER . 41.7 Cg_endo -90.58 20.22 1.02 Allowed 'Trans proline' 0 C--N 1.303 -1.829 1 C-N-CA 126.565 4.844 . . . . 0.0 110.823 -179.223 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.27 -81.55 0.34 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.099 -1.001 . . . . 0.0 109.706 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.4 mt -67.45 -49.4 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.472 -0.767 . . . . 0.0 109.529 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 98.4 m -58.99 -20.36 52.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.899 . . . . 0.0 109.496 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.496 ' HB2' ' O ' ' A' ' 32' ' ' PRO . 2.0 t80 -51.03 106.19 0.12 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.301 -0.874 . . . . 0.0 109.574 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 175.41 -64.53 0.1 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 126.99 74.35 0.2 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.423 HD12 ' H ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -88.49 -120.0 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.167 -1.196 . . . . 0.0 109.04 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 41' ' ' GLY . 10.9 tp -66.71 -63.63 1.03 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.638 -1.289 . . . . 0.0 109.164 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 40' ' ' LEU . . . 43.59 92.27 0.01 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -55.63 -18.96 8.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.284 -1.127 . . . . 0.0 109.587 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.501 179.958 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.751 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.86 166.77 21.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 109.431 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.549 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 4.3 m-85 44.92 61.37 11.86 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 109.768 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.549 ' HD3' ' N ' ' A' ' 3' ' ' TYR . 43.6 Cg_endo -89.86 -52.16 0.02 OUTLIER 'Trans proline' 0 N--CA 1.5 1.897 1 C-N-CA 126.008 4.472 . . . . 0.0 110.282 180.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -45.8 -36.36 5.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -0.843 . . . . 0.0 110.086 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -89.91 -46.07 8.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.116 -0.99 . . . . 0.0 110.164 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 8' ' ' SER . 0.5 OUTLIER -76.59 -63.71 1.28 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.181 -0.95 . . . . 0.0 110.27 -179.319 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.434 ' O ' ' CG ' ' A' ' 12' ' ' ASP . 74.2 m -42.13 -29.74 0.25 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.261 -0.899 . . . . 0.0 109.951 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.5 -80.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.163 -0.96 . . . . 0.0 109.99 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -63.52 -30.55 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.236 -0.915 . . . . 0.0 110.037 -179.267 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.417 ' OG1' ' HA ' ' A' ' 8' ' ' SER . 16.7 p -90.32 34.21 0.88 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.144 -0.973 . . . . 0.0 109.334 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.434 ' CG ' ' O ' ' A' ' 8' ' ' SER . 8.8 m-20 -78.39 -74.64 0.26 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.353 -0.842 . . . . 0.0 109.994 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.4 -22.01 12.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 110.694 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.56 -3.6 15.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.01 -1.056 . . . . 0.0 110.239 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.593 ' O ' HD13 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -149.86 72.29 9.58 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 120.991 -1.068 . . . . 0.0 109.839 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -92.43 -68.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.771 1 C-N-CA 126.392 4.728 . . . . 0.0 110.458 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -52.29 -56.53 14.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 108.867 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.46 ' O ' ' C ' ' A' ' 19' ' ' LEU . 71.9 t -58.63 -33.0 47.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.593 HD13 ' O ' ' A' ' 15' ' ' SER . 4.6 tp -44.94 -43.1 8.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.664 -1.273 . . . . 0.0 108.671 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.62 -52.94 32.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.472 -0.767 . . . . 0.0 109.615 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.5 -59.99 3.78 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 121.67 0.748 . . . . 0.0 109.597 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.8 t -51.77 -39.63 24.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 O-C-N 121.68 -0.638 . . . . 0.0 109.585 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.491 ' HA ' ' HB2' ' A' ' 26' ' ' TYR . 63.7 mt -67.15 -30.13 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.967 -1.083 . . . . 0.0 109.493 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.413 ' O ' ' HB2' ' A' ' 27' ' ' PHE . 5.2 t80 -57.27 -50.48 72.78 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.5 mt -65.98 -36.97 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.491 ' HB2' ' HA ' ' A' ' 23' ' ' ILE . 3.2 m-85 -62.78 -21.09 65.6 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.413 ' HB2' ' O ' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -81.65 -34.44 30.8 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.045 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 31' ' ' SER . . . -63.44 -56.88 12.65 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.454 0.645 . . . . 0.0 109.34 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.01 -54.95 22.39 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.535 -0.728 . . . . 0.0 110.221 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 26' ' ' TYR . 1.9 mp -81.13 22.08 0.67 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.351 -0.843 . . . . 0.0 110.593 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.601 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -61.37 -47.63 93.29 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 120.989 -1.069 . . . . 0.0 110.01 179.722 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 31' ' ' SER . 40.8 Cg_endo -89.96 -6.1 4.9 Favored 'Trans proline' 0 N--CA 1.499 1.822 1 C-N-CA 126.609 4.873 . . . . 0.0 110.853 -179.454 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.62 -31.34 52.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.069 -1.019 . . . . 0.0 109.541 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.5 pt -90.51 -29.7 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 109.496 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.402 ' OG1' ' HA ' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -75.53 -22.4 57.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.124 -0.985 . . . . 0.0 109.183 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -46.4 -65.54 0.54 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 109.017 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 61.54 68.63 1.58 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 178.6 32.03 0.05 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mp -90.24 85.82 6.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.209 -1.171 . . . . 0.0 109.83 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.507 HD22 ' N ' ' A' ' 40' ' ' LEU . 3.3 mm? -79.77 -31.76 40.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.118 -0.989 . . . . 0.0 109.571 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 56.88 168.92 0.1 OUTLIER Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 43' ' ' LYS . 6.7 mt-10 -76.1 -23.57 54.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.326 -1.102 . . . . 0.0 109.703 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 42' ' ' GLU . 1.5 tmmt? . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.645 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.756 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.492 ' O ' ' N ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -127.61 -48.93 1.39 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.875 . . . . 0.0 109.563 . . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.447 ' C ' ' O ' ' A' ' 2' ' ' ARG . 2.2 m-30 -40.03 96.89 0.12 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.504 -0.748 . . . . 0.0 110.054 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.492 ' N ' ' O ' ' A' ' 2' ' ' ARG . 43.0 Cg_endo -88.5 -25.34 0.74 Allowed 'Trans proline' 0 C--N 1.304 -1.806 1 C-N-CA 126.24 4.627 . . . . 0.0 110.26 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -90.47 -11.31 40.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.275 -0.891 . . . . 0.0 109.494 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.47 ' O ' ' OD2' ' A' ' 9' ' ' ASP . 2.6 t80 -89.81 -43.32 10.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 110.117 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 7' ' ' LEU . 2.0 mm? -87.74 -38.23 15.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 110.455 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 4' ' ' PRO . 19.3 m -83.12 19.97 1.34 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.208 -0.933 . . . . 0.0 110.945 -178.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.47 ' OD2' ' O ' ' A' ' 6' ' ' TYR . 6.3 p30 -90.54 -109.48 0.09 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.726 -1.234 . . . . 0.0 109.557 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.1 mm -90.96 -25.93 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.795 -1.191 . . . . 0.0 109.987 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.492 ' HA ' ' HB3' ' A' ' 14' ' ' PHE . 76.4 p -56.39 -29.86 62.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 110.109 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 9' ' ' ASP . 5.2 p-10 -47.19 -37.35 10.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.064 -1.022 . . . . 0.0 109.417 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -97.91 -27.18 14.39 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.226 -0.921 . . . . 0.0 109.898 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.492 ' HB3' ' HA ' ' A' ' 11' ' ' THR . 11.4 t80 -47.98 -49.9 29.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.175 -0.953 . . . . 0.0 109.419 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 1.3 t -139.08 93.73 10.18 Favored Pre-proline 0 C--N 1.301 -1.522 0 O-C-N 121.408 -0.807 . . . . 0.0 110.249 -179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -94.53 -75.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 1 C-N-CA 126.342 4.695 . . . . 0.0 108.988 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -68.18 -19.05 64.75 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.652 ' O ' HG23 ' A' ' 22' ' ' VAL . 3.5 t -82.03 -20.64 10.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.508 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 0.7 OUTLIER -71.78 -50.82 26.49 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.43 -53.57 53.01 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.81 -46.18 50.78 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.099 0.952 . . . . 0.0 108.781 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 18' ' ' VAL . 2.1 t -45.05 -43.18 2.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.281 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.48 ' HA ' ' HB2' ' A' ' 26' ' ' TYR . 30.1 mm -68.99 -36.94 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.125 -0.984 . . . . 0.0 109.371 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.03 -50.03 70.09 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.158 -0.964 . . . . 0.0 108.419 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.8 mm -71.63 -26.54 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.517 ' O ' HD23 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -73.38 -15.56 61.36 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 178.553 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -89.76 -36.02 15.39 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.13 -56.83 8.3 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.617 0.722 . . . . 0.0 109.785 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.427 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -60.17 -50.22 74.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.666 -0.646 . . . . 0.0 111.009 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.844 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -67.84 5.74 0.81 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.43 -0.793 . . . . 0.0 111.821 -177.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.573 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -36.91 -48.45 1.93 Allowed Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.727 -1.233 . . . . 0.0 110.875 179.756 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 31' ' ' SER . 41.2 Cg_endo -87.84 -34.06 0.12 Allowed 'Trans proline' 0 N--CA 1.502 1.977 1 C-N-CA 126.304 4.669 . . . . 0.0 111.303 -179.361 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.489 ' O ' ' HB3' ' A' ' 36' ' ' PHE . . . -58.86 -15.14 11.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.02 -1.05 . . . . 0.0 110.306 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.748 ' C ' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -37.92 -47.81 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.389 -0.819 . . . . 0.0 111.02 -179.016 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.619 ' N ' HG23 ' A' ' 34' ' ' ILE . 13.0 t -91.71 42.51 1.11 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.085 -1.009 . . . . 0.0 109.379 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.489 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 25.2 p90 -79.88 157.02 27.05 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.458 -0.776 . . . . 0.0 109.638 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.67 61.7 0.43 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 39' ' ' LEU . . . 121.24 85.06 0.81 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -45.42 167.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -1.119 . . . . 0.0 109.35 179.849 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -86.61 -57.96 2.79 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.151 -0.968 . . . . 0.0 109.517 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.43 -14.42 43.0 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -75.45 -53.07 9.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.233 -1.157 . . . . 0.0 109.537 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.467 179.957 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . 0.472 ' O ' ' HB2' ' A' ' 2' ' ' ARG . . . . . . . . 0 C--O 1.215 -0.753 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 1' ' ' ACE . 1.1 mpt_? 61.87 14.37 6.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.863 . . . . 0.0 109.459 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.691 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 19.5 p90 -93.38 -26.45 0.27 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.355 -0.84 . . . . 0.0 112.395 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.691 ' CD ' ' N ' ' A' ' 3' ' ' TYR . 41.3 Cg_endo -78.99 -46.2 0.11 Allowed 'Trans proline' 0 N--CA 1.507 2.278 0 C-N-CA 124.489 3.459 . . . . 0.0 111.441 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -90.16 -32.89 16.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.868 -1.145 . . . . 0.0 110.749 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.481 ' O ' ' HB2' ' A' ' 9' ' ' ASP . 0.7 OUTLIER -89.99 -56.36 3.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.026 -1.046 . . . . 0.0 111.097 -178.645 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.042 HD23 HG21 ' A' ' 11' ' ' THR . 0.0 OUTLIER -62.34 -45.34 93.63 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.897 -1.127 . . . . 0.0 110.527 -178.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.3 t -44.37 -23.46 0.11 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.09 -1.006 . . . . 0.0 110.432 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 6' ' ' TYR . 0.7 OUTLIER -49.06 -70.4 0.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.013 -1.054 . . . . 0.0 110.538 -179.323 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.3 mt -88.57 -21.38 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.117 -0.99 . . . . 0.0 110.769 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 1.042 HG21 HD23 ' A' ' 7' ' ' LEU . 7.2 p -90.53 30.93 1.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.912 -1.117 . . . . 0.0 109.889 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -72.09 -41.1 67.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.271 -0.893 . . . . 0.0 109.934 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.422 ' O ' ' HD3' ' A' ' 16' ' ' PRO . . . -60.24 -23.14 63.83 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.147 -0.971 . . . . 0.0 109.671 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.432 ' HB3' ' O ' ' A' ' 11' ' ' THR . 2.9 t80 -46.48 -40.05 11.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.325 -0.859 . . . . 0.0 109.561 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.3 83.65 49.52 Favored Pre-proline 0 C--N 1.301 -1.5 0 O-C-N 121.168 -0.958 . . . . 0.0 109.992 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 13' ' ' ALA . 43.4 Cg_endo -87.77 -61.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.72 1 C-N-CA 126.041 4.494 . . . . 0.0 109.565 179.469 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -54.23 -53.31 55.27 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.22 -0.925 . . . . 0.0 108.734 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -55.4 -39.26 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.505 -0.747 . . . . 0.0 109.105 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.752 HD13 ' O ' ' A' ' 19' ' ' LEU . 2.0 tm? -47.49 -49.17 26.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.856 -1.153 . . . . 0.0 109.024 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.85 -51.14 70.84 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.464 -0.773 . . . . 0.0 109.317 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.52 -56.13 9.17 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.769 0.795 . . . . 0.0 109.944 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 44.7 t -51.25 -37.26 17.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 O-C-N 121.708 -0.62 . . . . 0.0 110.248 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -77.23 -26.62 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.114 -0.991 . . . . 0.0 110.249 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -66.17 -34.87 79.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.064 -1.022 . . . . 0.0 108.584 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.4 mm -81.29 -31.13 11.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.521 ' O ' ' HB3' ' A' ' 30' ' ' LEU . 6.1 m-85 -67.72 -28.21 67.46 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.514 ' O ' ' CB ' ' A' ' 31' ' ' SER . 5.0 t80 -74.4 -37.04 63.49 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.4 -59.27 4.19 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.279 0.561 . . . . 0.0 110.507 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.49 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -89.38 -54.04 4.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.293 -0.879 . . . . 0.0 111.201 -178.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.004 ' HG ' ' HB3' ' A' ' 33' ' ' ALA . 1.8 tp -75.85 16.69 0.38 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.269 -0.894 . . . . 0.0 111.238 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.587 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -57.22 -47.14 99.55 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 120.785 -1.197 . . . . 0.0 110.621 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 31' ' ' SER . 42.7 Cg_endo -87.99 -31.35 0.21 Allowed 'Trans proline' 0 N--CA 1.502 1.976 1 C-N-CA 126.352 4.701 . . . . 0.0 111.186 -178.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 1.004 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . . . -43.84 -33.52 1.34 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.083 -1.011 . . . . 0.0 109.557 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.582 HD12 ' O ' ' A' ' 30' ' ' LEU . 2.0 mp -69.69 -46.54 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.291 -0.88 . . . . 0.0 109.432 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.84 -15.09 61.38 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.271 -0.893 . . . . 0.0 109.435 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -79.22 -96.76 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.166 -0.959 . . . . 0.0 109.461 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.4 51.91 0.04 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.2 68.72 0.23 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.91 1.62 17.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.326 -1.103 . . . . 0.0 109.834 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.08 -69.37 0.58 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.065 -1.022 . . . . 0.0 109.597 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.83 98.69 0.65 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.14 -59.31 2.76 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.199 -1.177 . . . . 0.0 109.28 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.373 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.69 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.3 122.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.9 . . . . 0.0 109.286 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.55 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 2.7 p90 -158.75 64.45 2.7 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.294 -0.879 . . . . 0.0 109.427 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.519 ' HD3' ' N ' ' A' ' 3' ' ' TYR . 43.3 Cg_endo -89.75 -72.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.758 1 C-N-CA 126.219 4.613 . . . . 0.0 110.232 -179.787 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.418 ' O ' ' HB3' ' A' ' 9' ' ' ASP . 0.1 OUTLIER -42.51 -27.61 0.17 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.36 -0.837 . . . . 0.0 110.026 -179.738 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.478 ' O ' ' OD2' ' A' ' 9' ' ' ASP . 2.0 t80 -57.59 -50.05 74.38 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.207 -0.933 . . . . 0.0 110.417 -179.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.57 -42.41 10.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.79 -1.194 . . . . 0.0 110.711 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.3 m -78.36 17.96 0.59 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.226 -0.921 . . . . 0.0 111.232 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.478 ' OD2' ' O ' ' A' ' 6' ' ' TYR . 2.5 p30 -88.64 -104.77 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.583 -1.323 . . . . 0.0 109.444 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.574 ' N ' HD12 ' A' ' 10' ' ' ILE . 2.0 mp -90.64 -37.19 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.858 -1.151 . . . . 0.0 109.76 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.494 ' O ' HD12 ' A' ' 19' ' ' LEU . 6.3 p -62.69 -11.21 15.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.137 -0.977 . . . . 0.0 109.732 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -63.74 -57.51 9.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.177 -0.952 . . . . 0.0 109.994 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 14' ' ' PHE . . . -102.88 -51.02 3.37 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.093 -1.004 . . . . 0.0 110.043 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.448 ' C ' ' O ' ' A' ' 13' ' ' ALA . 69.2 t80 -41.78 -36.56 1.04 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.299 -0.876 . . . . 0.0 109.448 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.512 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.6 OUTLIER -139.09 87.03 14.32 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.432 -0.793 . . . . 0.0 109.261 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -94.86 -73.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.638 1 C-N-CA 126.472 4.781 . . . . 0.0 109.933 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.506 ' HG3' ' N ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -60.39 -25.28 65.78 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.512 -0.743 . . . . 0.0 109.144 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.506 ' N ' ' HG3' ' A' ' 17' ' ' GLN . 2.7 t -84.46 -23.41 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.38 -0.825 . . . . 0.0 109.448 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.512 ' HB2' ' O ' ' A' ' 15' ' ' SER . 1.6 tt -63.29 -45.06 93.19 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.891 -1.131 . . . . 0.0 108.547 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.02 -54.91 12.65 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.441 -0.787 . . . . 0.0 109.222 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -46.16 -57.44 4.51 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.714 0.768 . . . . 0.0 109.393 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.6 t -45.24 -46.24 3.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.482 ' O ' ' N ' ' A' ' 26' ' ' TYR . 11.8 mm -61.51 -56.11 20.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.418 -0.801 . . . . 0.0 109.83 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.462 ' C ' ' O ' ' A' ' 23' ' ' ILE . 1.8 t80 -38.2 -38.62 0.36 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.24 -0.912 . . . . 0.0 109.452 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.713 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 18.7 mt -75.32 -45.7 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.517 ' O ' ' N ' ' A' ' 28' ' ' ALA . 4.2 m-30 -55.46 -69.9 0.12 Allowed 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.536 ' O ' ' CB ' ' A' ' 31' ' ' SER . 0.1 OUTLIER -35.24 -32.53 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.881 0.848 . . . . 0.0 109.52 177.859 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' A' ' 25' ' ' ILE . . . -64.36 -60.43 3.19 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.649 -0.657 . . . . 0.0 110.498 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.23 -63.29 1.28 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.075 -1.016 . . . . 0.0 112.341 -178.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.908 ' HB2' ' HB3' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -89.68 37.05 0.86 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.021 -1.05 . . . . 0.0 110.191 -177.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.541 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -49.62 -51.07 62.58 Favored Pre-proline 0 C--N 1.297 -1.687 0 O-C-N 121.601 -0.687 . . . . 0.0 110.242 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.558 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 44.2 Cg_endo -90.62 0.18 5.15 Favored 'Trans proline' 0 N--CA 1.501 1.948 1 C-N-CA 126.533 4.822 . . . . 0.0 111.282 -178.846 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.908 ' HB3' ' HB2' ' A' ' 30' ' ' LEU . . . -82.43 -68.54 0.69 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.988 -1.07 . . . . 0.0 109.816 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.789 HD12 HD12 ' A' ' 30' ' ' LEU . 5.3 mt -53.72 -61.28 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.901 . . . . 0.0 109.504 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -44.45 -31.74 1.17 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.17 -0.956 . . . . 0.0 109.654 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.558 ' CD1' ' O ' ' A' ' 32' ' ' PRO . 9.9 m-85 -87.88 83.95 7.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.266 -0.897 . . . . 0.0 109.556 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.38 98.9 0.11 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 127.0 -12.92 6.78 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.95 143.48 2.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -1.157 . . . . 0.0 109.679 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.9 tt -90.41 -28.01 18.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 109.298 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 164.64 -66.72 0.22 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -89.52 -64.57 1.12 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.339 -1.095 . . . . 0.0 109.356 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.482 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.723 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.436 ' O ' ' CD2' ' A' ' 3' ' ' TYR . 1.3 mtt85 -94.94 81.91 3.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.524 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.452 ' HB3' HD12 ' A' ' 7' ' ' LEU . 33.0 m-85 -154.35 79.54 4.94 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.363 -0.835 . . . . 0.0 109.243 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -85.69 -86.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.819 1 C-N-CA 126.03 4.486 . . . . 0.0 110.514 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -72.23 -25.81 61.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.183 -0.948 . . . . 0.0 109.916 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -59.14 -54.21 49.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.194 -0.941 . . . . 0.0 109.773 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.452 HD12 ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -75.65 -47.72 25.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.912 . . . . 0.0 109.759 -179.77 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 7' ' ' LEU . 29.6 t -42.74 -26.67 0.14 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.304 -0.872 . . . . 0.0 109.912 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 7' ' ' LEU . 0.4 OUTLIER -63.32 -51.8 64.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.242 -0.911 . . . . 0.0 109.884 -179.691 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.82 -35.95 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.186 -0.946 . . . . 0.0 109.926 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.414 ' OG1' ' HA ' ' A' ' 8' ' ' SER . 34.1 p -81.61 7.25 12.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -0.96 . . . . 0.0 109.844 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -76.37 -3.06 34.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.117 -0.99 . . . . 0.0 109.721 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.502 ' O ' ' HD2' ' A' ' 16' ' ' PRO . . . -97.64 5.71 49.01 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.151 -0.968 . . . . 0.0 109.77 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -90.72 19.35 5.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.193 -0.942 . . . . 0.0 109.383 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.599 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 2.3 m -83.9 -44.6 0.78 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.235 -0.915 . . . . 0.0 110.524 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 15' ' ' SER . 41.8 Cg_endo -82.29 -47.38 0.06 OUTLIER 'Trans proline' 0 N--CA 1.5 1.885 1 C-N-CA 125.472 4.114 . . . . 0.0 109.746 -179.876 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -51.6 -34.98 39.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 0.0 109.018 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 52.2 t -72.95 -43.24 59.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.343 -0.848 . . . . 0.0 109.329 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.431 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 4.4 tt -45.09 -49.04 11.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.143 -0.973 . . . . 0.0 108.595 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 21' ' ' ALA . . . -54.69 -51.38 65.71 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 18' ' ' VAL . . . -44.53 -54.37 6.11 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.81 0.814 . . . . 0.0 109.016 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 41.3 t -43.47 -52.8 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.769 -0.582 . . . . 0.0 109.532 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.3 mt -56.67 -43.82 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.082 -1.011 . . . . 0.0 108.722 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.16 -37.79 16.46 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.491 ' CG2' ' HB3' ' A' ' 29' ' ' ALA . 74.1 mt -72.21 -43.72 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.509 ' HA ' ' HB2' ' A' ' 30' ' ' LEU . 18.5 t80 -52.58 -23.95 7.37 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.518 ' O ' ' CB ' ' A' ' 31' ' ' SER . 3.8 t80 -89.25 -34.21 16.7 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 122.021 0.915 . . . . 0.0 108.644 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.11 -70.08 0.7 Allowed 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.286 0.565 . . . . 0.0 111.478 -178.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.491 ' HB3' ' CG2' ' A' ' 25' ' ' ILE . . . -79.23 -60.58 2.31 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.283 -0.886 . . . . 0.0 112.29 -177.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 26' ' ' TYR . 38.9 mt -84.2 27.35 0.69 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.922 -1.111 . . . . 0.0 110.715 -178.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.559 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -81.73 -50.82 0.87 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.069 -1.019 . . . . 0.0 109.944 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.559 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 42.8 Cg_endo -91.43 -15.23 1.51 Allowed 'Trans proline' 0 N--CA 1.5 1.862 1 C-N-CA 126.57 4.847 . . . . 0.0 110.75 -179.255 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.27 -24.63 11.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 110.163 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -71.61 -73.17 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.18 -0.95 . . . . 0.0 110.084 -179.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.9 m -57.77 -55.98 27.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 110.136 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.79 110.29 0.5 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.336 -0.852 . . . . 0.0 109.599 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.68 176.6 45.53 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 39' ' ' LEU . . . 175.88 -39.23 0.1 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.772 ' H ' HD12 ' A' ' 39' ' ' LEU . 5.0 mp -60.79 -111.91 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.328 -1.101 . . . . 0.0 109.233 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.468 ' O ' ' C ' ' A' ' 41' ' ' GLY . 0.9 OUTLIER -104.1 -85.86 0.46 Allowed 'General case' 0 N--CA 1.485 1.317 0 O-C-N 120.824 -1.172 . . . . 0.0 108.828 179.614 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 40' ' ' LEU . . . 36.91 37.76 0.26 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -88.12 28.12 1.11 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.163 -1.198 . . . . 0.0 109.647 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.2 mttp . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 118.06 -0.972 . . . . 0.0 109.285 179.882 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.766 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.572 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 1.8 mmp_? -109.2 124.66 51.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.299 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.572 ' CG ' ' O ' ' A' ' 2' ' ' ARG . 8.7 p90 40.94 76.44 0.5 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.329 -0.857 . . . . 0.0 109.774 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.449 ' O ' ' HB3' ' A' ' 8' ' ' SER . 42.1 Cg_endo -88.39 -48.49 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.805 1 C-N-CA 126.282 4.655 . . . . 0.0 110.165 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -65.47 -10.74 36.8 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.182 -0.949 . . . . 0.0 109.45 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -88.02 -71.42 0.58 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.36 -0.837 . . . . 0.0 110.452 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.582 ' HA ' HD12 ' A' ' 10' ' ' ILE . 1.4 tp -75.5 -56.13 5.0 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.198 -0.939 . . . . 0.0 110.545 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.449 ' HB3' ' O ' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -42.16 -25.62 0.08 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.262 -0.899 . . . . 0.0 110.398 -179.297 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 7' ' ' LEU . 2.7 m-20 -79.63 -44.14 21.52 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.026 -1.046 . . . . 0.0 110.398 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.582 HD12 ' HA ' ' A' ' 7' ' ' LEU . 7.8 mt -64.48 -30.41 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.082 -1.011 . . . . 0.0 110.309 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.6 p -83.47 -42.41 16.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.006 -1.059 . . . . 0.0 110.186 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 8' ' ' SER . 0.6 OUTLIER -81.72 3.59 25.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.094 -1.004 . . . . 0.0 110.37 -179.158 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.691 ' HB1' ' CB ' ' A' ' 17' ' ' GLN . . . -93.09 19.84 7.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.068 -1.02 . . . . 0.0 109.814 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.414 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 28.5 t80 -91.32 22.32 3.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.193 -0.942 . . . . 0.0 110.364 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.492 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 0.2 OUTLIER -169.21 -53.01 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.336 0 O-C-N 120.903 -1.123 . . . . 0.0 111.058 -179.459 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.492 ' HD3' ' CB ' ' A' ' 15' ' ' SER . 38.9 Cg_endo -82.23 -23.72 4.2 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 125.004 3.803 . . . . 0.0 110.116 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.691 ' CB ' ' HB1' ' A' ' 13' ' ' ALA . 3.8 tm0? -71.4 -14.8 62.28 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.2 t -84.46 -33.11 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.464 -0.772 . . . . 0.0 109.205 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.479 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 2.3 tp -65.35 -53.67 40.2 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.17 -51.05 65.57 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.426 ' O ' ' C ' ' A' ' 22' ' ' VAL . . . -43.93 -53.86 5.82 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.868 0.842 . . . . 0.0 108.853 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 16.5 t -42.76 -47.61 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 121.782 -0.574 . . . . 0.0 109.527 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.3 mt -66.75 -38.73 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.054 -1.029 . . . . 0.0 109.568 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.82 -39.33 62.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.965 -1.085 . . . . 0.0 108.58 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.521 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 4.4 mt -67.75 -38.27 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -61.84 -21.13 64.39 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 1.094 ' HA ' HD23 ' A' ' 30' ' ' LEU . 2.0 t80 -73.62 -36.03 65.42 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 177.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 25' ' ' ILE . . . -59.36 -49.3 78.36 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.563 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -63.81 -44.24 93.87 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.404 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.094 HD23 ' HA ' ' A' ' 27' ' ' PHE . 0.8 OUTLIER -48.79 -12.01 0.04 OUTLIER 'General case' 0 N--CA 1.509 2.481 0 O-C-N 121.766 -0.584 . . . . 0.0 112.029 -178.503 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.486 ' C ' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -28.73 -50.55 0.25 Allowed Pre-proline 0 N--CA 1.502 2.144 0 O-C-N 121.382 -0.824 . . . . 0.0 112.709 -178.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.563 ' HD2' ' O ' ' A' ' 29' ' ' ALA . 38.0 Cg_endo -85.88 -32.17 0.28 Allowed 'Trans proline' 0 N--CA 1.501 1.958 1 C-N-CA 126.028 4.485 . . . . 0.0 110.757 -178.85 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.462 ' O ' ' C ' ' A' ' 34' ' ' ILE . . . -50.86 -21.53 1.74 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.238 -0.914 . . . . 0.0 109.421 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.462 ' C ' ' O ' ' A' ' 33' ' ' ALA . 3.9 tp -39.75 -37.8 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.616 -0.677 . . . . 0.0 109.206 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.41 ' N ' HG23 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -53.76 -57.14 11.96 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.581 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -53.13 119.81 5.16 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.15 -178.62 49.47 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 170.3 42.9 0.03 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 pp -84.22 152.9 23.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -1.116 . . . . 0.0 109.561 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.512 HD23 ' N ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -104.9 -84.67 0.49 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.333 -0.854 . . . . 0.0 109.375 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 53.77 -139.56 35.87 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -62.53 -33.36 74.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -1.155 . . . . 0.0 109.557 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.433 179.857 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.769 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -51.76 178.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 0.0 109.528 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.73 94.81 4.33 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.297 -0.877 . . . . 0.0 109.457 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -84.16 -40.12 0.1 Allowed 'Trans proline' 0 N--CA 1.5 1.901 1 C-N-CA 125.87 4.38 . . . . 0.0 110.252 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.479 ' HB3' ' OD2' ' A' ' 9' ' ' ASP . 0.1 OUTLIER -66.79 -30.27 70.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.101 -0.999 . . . . 0.0 109.199 179.747 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.478 ' HA ' ' HB2' ' A' ' 9' ' ' ASP . 31.4 t80 -45.58 -40.43 8.79 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.467 -0.771 . . . . 0.0 109.975 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.453 ' O ' ' CG2' ' A' ' 11' ' ' THR . 9.6 mp -52.39 -55.7 19.93 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.684 -0.635 . . . . 0.0 109.958 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.68 10.69 24.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -0.853 . . . . 0.0 110.282 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.479 ' OD2' ' HB3' ' A' ' 5' ' ' TYR . 97.9 m-20 -90.39 -73.46 0.52 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.101 -0.999 . . . . 0.0 110.766 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.7 mm -76.38 -15.04 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.223 -0.923 . . . . 0.0 110.977 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.453 ' CG2' ' O ' ' A' ' 7' ' ' LEU . 3.6 p -63.27 -10.32 15.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.882 -1.136 . . . . 0.0 109.814 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.55 -38.67 39.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.064 -1.022 . . . . 0.0 109.865 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.58 -22.75 53.84 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.146 -0.971 . . . . 0.0 109.861 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.62 ' CE2' ' NE2' ' A' ' 17' ' ' GLN . 1.6 m-30 -90.27 31.41 1.01 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.136 -0.978 . . . . 0.0 109.433 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.6 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 0.5 OUTLIER -54.38 -45.65 99.25 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.419 -0.801 . . . . 0.0 110.063 179.86 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 15' ' ' SER . 40.8 Cg_endo -82.23 -26.7 2.67 Favored 'Trans proline' 0 N--CA 1.502 1.987 1 C-N-CA 125.577 4.185 . . . . 0.0 109.955 -179.783 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.62 ' NE2' ' CE2' ' A' ' 14' ' ' PHE . 0.4 OUTLIER -75.59 -21.24 58.0 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.281 -0.887 . . . . 0.0 109.112 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 14' ' ' PHE . 98.0 t -88.75 -46.63 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.334 -0.854 . . . . 0.0 109.398 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.433 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 0.2 OUTLIER -54.27 -49.28 69.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.986 -1.071 . . . . 0.0 108.451 179.389 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 21' ' ' ALA . . . -56.22 -53.54 56.0 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 20' ' ' ALA . . . -41.01 -52.29 3.16 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.943 0.877 . . . . 0.0 109.386 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.433 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 9.4 t -47.65 -49.61 9.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.972 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.1 mt -67.5 -31.09 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.029 -1.044 . . . . 0.0 110.158 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.65 -39.39 58.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.971 -1.08 . . . . 0.0 108.995 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.9 mm -72.69 -44.97 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.267 -0.896 . . . . 0.0 108.957 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.484 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 13.1 t80 -58.46 -20.61 46.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.096 -1.003 . . . . 0.0 108.349 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.409 ' O ' ' CB ' ' A' ' 31' ' ' SER . 0.2 OUTLIER -90.9 -31.0 16.58 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.84 0.828 . . . . 0.0 109.14 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.28 -71.37 0.41 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.354 0.597 . . . . 0.0 110.827 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.507 ' O ' ' HD2' ' A' ' 32' ' ' PRO . . . -77.53 -50.69 12.08 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.4 -0.813 . . . . 0.0 111.007 -178.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -77.39 18.57 0.4 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.401 -0.812 . . . . 0.0 111.247 -178.56 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.562 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -68.13 -52.64 22.09 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.613 -1.304 . . . . 0.0 109.996 -179.812 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.562 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 44.6 Cg_endo -93.54 -12.18 1.38 Allowed 'Trans proline' 0 N--CA 1.5 1.903 1 C-N-CA 126.561 4.841 . . . . 0.0 110.545 -179.6 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.469 ' O ' ' C ' ' A' ' 34' ' ' ILE . . . -70.38 -21.69 62.84 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.322 -0.861 . . . . 0.0 110.06 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.6 HD12 HG23 ' A' ' 35' ' ' THR . 0.4 OUTLIER -35.08 -50.25 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.833 -0.542 . . . . 0.0 110.525 -179.354 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.6 HG23 HD12 ' A' ' 34' ' ' ILE . 17.9 p -82.45 -46.39 13.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.089 -1.007 . . . . 0.0 109.545 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.446 ' N ' ' CD1' ' A' ' 36' ' ' PHE . 2.8 m-85 -86.56 65.68 9.14 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.342 -0.849 . . . . 0.0 109.625 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.72 162.36 28.96 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 155.29 -50.39 0.47 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.685 HD23 ' H ' ' A' ' 39' ' ' LEU . 0.8 OUTLIER -89.71 151.31 21.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -1.145 . . . . 0.0 109.314 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.37 -19.19 17.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.144 -0.972 . . . . 0.0 109.452 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 152.7 -94.94 0.15 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.27 21.74 3.15 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.303 -1.116 . . . . 0.0 109.402 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.2 mttt . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.955 -1.022 . . . . 0.0 109.522 179.996 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.793 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 -154.18 69.24 0.77 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 109.55 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 59.24 83.62 0.21 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.24 -0.913 . . . . 0.0 109.452 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -87.51 -77.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.858 1 C-N-CA 126.074 4.516 . . . . 0.0 110.654 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.425 ' O ' ' C ' ' A' ' 6' ' ' TYR . 68.4 m-85 -80.88 -35.59 32.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.238 -0.914 . . . . 0.0 110.164 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.474 ' O ' ' HB2' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -43.12 -36.63 1.74 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.142 -0.974 . . . . 0.0 109.738 -179.749 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.16 -48.7 80.66 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.334 -0.854 . . . . 0.0 110.091 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.455 ' O ' HG22 ' A' ' 11' ' ' THR . 27.7 t -61.35 -11.62 10.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.158 -0.964 . . . . 0.0 110.185 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.488 ' HA ' ' OD1' ' A' ' 12' ' ' ASP . 3.8 m-20 -84.75 -34.33 22.88 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.154 -0.966 . . . . 0.0 110.173 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 48.6 mm -64.63 -39.71 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.188 -0.945 . . . . 0.0 110.482 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.606 HG23 ' N ' ' A' ' 12' ' ' ASP . 14.5 t -60.4 -48.19 82.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.09 -1.006 . . . . 0.0 109.743 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.606 ' N ' HG23 ' A' ' 11' ' ' THR . 7.6 p-10 -81.41 0.73 36.2 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.003 -1.061 . . . . 0.0 109.02 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.95 37.62 1.5 Allowed 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.37 -0.831 . . . . 0.0 108.967 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.443 ' O ' ' CD2' ' A' ' 14' ' ' PHE . 4.1 p90 -82.52 17.27 1.81 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.434 -0.791 . . . . 0.0 109.973 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -117.57 89.27 31.99 Favored Pre-proline 0 N--CA 1.485 1.32 0 O-C-N 121.216 -0.928 . . . . 0.0 108.653 179.465 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 14' ' ' PHE . 42.0 Cg_endo -82.11 -48.57 0.05 OUTLIER 'Trans proline' 0 N--CA 1.501 1.959 1 C-N-CA 125.96 4.44 . . . . 0.0 109.857 -179.582 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.57 -26.14 60.69 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.34 -0.85 . . . . 0.0 108.922 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.548 ' O ' HG23 ' A' ' 22' ' ' VAL . 74.5 t -87.91 -26.55 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.485 -0.759 . . . . 0.0 109.56 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.754 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.7 OUTLIER -68.32 -54.18 19.15 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.137 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.64 -49.53 72.62 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.403 ' O ' HD12 ' A' ' 25' ' ' ILE . . . -50.61 -55.05 18.1 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.751 0.786 . . . . 0.0 109.979 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 18' ' ' VAL . 64.0 t -52.71 -40.74 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.687 -0.633 . . . . 0.0 110.442 -179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.754 HD12 ' O ' ' A' ' 19' ' ' LEU . 4.3 mt -77.85 -20.42 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.11 -0.994 . . . . 0.0 110.262 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.84 -46.96 85.46 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.242 -0.911 . . . . 0.0 108.659 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.406 ' H ' HD12 ' A' ' 25' ' ' ILE . 3.8 mp -72.6 -34.49 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.302 -0.873 . . . . 0.0 108.921 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.773 ' O ' HD23 ' A' ' 30' ' ' LEU . 2.3 m-85 -65.29 -27.54 68.7 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -74.89 -43.6 53.46 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.12 -56.33 21.08 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.442 0.639 . . . . 0.0 109.938 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.61 -56.54 5.66 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.546 -0.721 . . . . 0.0 110.987 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.861 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -80.37 23.14 0.51 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.164 -0.96 . . . . 0.0 110.535 -178.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.564 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -38.22 -48.89 3.29 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.045 -1.034 . . . . 0.0 110.665 179.828 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 31' ' ' SER . 41.8 Cg_endo -89.42 -24.1 0.72 Allowed 'Trans proline' 0 N--CA 1.502 1.972 1 C-N-CA 126.546 4.831 . . . . 0.0 111.413 -179.22 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.835 ' HB3' ' HB2' ' A' ' 30' ' ' LEU . . . -62.78 -21.81 66.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.917 -1.114 . . . . 0.0 110.055 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.5 tt -54.38 -25.65 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.156 -0.965 . . . . 0.0 109.602 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -72.09 -35.74 69.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.051 -1.03 . . . . 0.0 109.388 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.45 ' C ' ' O ' ' A' ' 35' ' ' THR . 46.1 t80 -40.06 -51.04 2.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.555 -0.716 . . . . 0.0 109.82 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.97 92.24 0.5 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.06 44.88 0.63 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -177.33 5.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.167 -1.196 . . . . 0.0 109.332 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.517 ' HA ' HD13 ' A' ' 40' ' ' LEU . 4.0 mm? -52.84 -51.47 60.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 109.408 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.75 -129.25 6.62 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 11.3 mt-10 -81.66 -31.76 32.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.104 -1.233 . . . . 0.0 109.334 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.415 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.726 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -172.42 100.22 0.15 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.172 -0.955 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.52 ' HB2' ' HB2' ' A' ' 6' ' ' TYR . 8.9 m-85 -83.44 170.09 15.37 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.257 -0.902 . . . . 0.0 109.127 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' A' ' 3' ' ' TYR . 40.9 Cg_endo -81.25 -76.48 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.988 1 C-N-CA 125.536 4.158 . . . . 0.0 110.721 -179.602 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -55.09 -18.3 5.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.124 -0.985 . . . . 0.0 109.685 -179.681 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.52 ' HB2' ' HB2' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -75.72 -41.5 53.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 0.0 109.465 179.938 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 7' ' ' LEU . 19.6 mt -46.66 -42.53 16.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.424 -0.798 . . . . 0.0 109.826 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 12' ' ' ASP . 46.7 m -55.41 -44.14 75.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.915 . . . . 0.0 109.826 -179.641 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 6' ' ' TYR . 0.8 OUTLIER -47.77 -45.95 29.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.199 -0.938 . . . . 0.0 109.982 -179.623 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.43 HD13 ' HA ' ' A' ' 10' ' ' ILE . 19.4 mm -69.84 -50.01 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.181 -0.95 . . . . 0.0 109.927 -179.467 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.0 p -83.28 11.47 6.62 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.026 -1.046 . . . . 0.0 109.68 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 8' ' ' SER . 8.6 t0 -90.5 -32.04 16.51 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.197 -0.939 . . . . 0.0 109.499 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.9 -45.78 93.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.339 -0.851 . . . . 0.0 109.771 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -81.56 -15.24 55.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.905 . . . . 0.0 110.058 -179.581 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.418 ' OG ' ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -138.98 81.65 21.3 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.028 -1.045 . . . . 0.0 109.989 -179.701 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -91.05 -66.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.865 1 C-N-CA 126.424 4.75 . . . . 0.0 109.646 179.555 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -59.21 -41.49 88.71 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.374 -0.829 . . . . 0.0 108.776 179.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.418 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 2.5 t -65.74 -24.63 34.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.147 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.485 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 1.6 tt -58.75 -54.04 51.55 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.374 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.82 -53.59 46.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.106 -0.996 . . . . 0.0 108.607 179.131 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -44.05 -52.16 7.32 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.841 0.829 . . . . 0.0 109.32 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 38.1 t -44.0 -46.84 2.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 121.902 -0.499 . . . . 0.0 109.802 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.407 ' O ' ' C ' ' A' ' 24' ' ' PHE . 16.6 mt -61.75 -44.02 98.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.961 . . . . 0.0 109.39 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' ILE . 5.6 t80 -46.41 -45.36 17.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.935 . . . . 0.0 108.892 179.645 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.3 mm -68.9 -42.55 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.4 -0.812 . . . . 0.0 108.825 179.369 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.451 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.7 t80 -58.7 -18.81 34.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.998 -1.064 . . . . 0.0 108.349 179.028 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.82 -33.58 15.63 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.881 0.848 . . . . 0.0 108.91 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.564 ' O ' ' CD ' ' A' ' 32' ' ' PRO . . . -71.15 -62.37 1.42 Allowed 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.196 0.522 . . . . 0.0 110.743 -179.285 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.563 ' O ' ' HB2' ' A' ' 33' ' ' ALA . . . -64.96 -49.74 69.14 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.417 -0.802 . . . . 0.0 111.563 -178.473 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.007 ' O ' HD13 ' A' ' 30' ' ' LEU . 3.4 tm? -44.02 -21.99 0.05 Allowed 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.246 -0.909 . . . . 0.0 110.932 -178.173 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.688 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -82.41 -64.16 0.26 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.522 -1.362 . . . . 0.0 110.593 -179.608 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.688 ' HD3' ' CB ' ' A' ' 31' ' ' SER . 42.8 Cg_endo -91.25 20.74 0.88 Allowed 'Trans proline' 0 N--CA 1.498 1.787 1 C-N-CA 125.719 4.279 . . . . 0.0 110.056 179.949 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -73.66 -45.28 53.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.225 -0.922 . . . . 0.0 109.536 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.453 ' C ' ' O ' ' A' ' 33' ' ' ALA . 1.7 mp -40.57 -48.97 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.563 -0.71 . . . . 0.0 109.69 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.27 -44.32 92.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.381 -0.824 . . . . 0.0 109.926 -179.677 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -64.8 153.26 40.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.229 -0.919 . . . . 0.0 109.372 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -130.86 17.66 5.18 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.15 -52.73 4.16 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.19 -23.92 65.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.325 -1.103 . . . . 0.0 109.599 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.644 ' N ' HD22 ' A' ' 40' ' ' LEU . 1.5 mm? -101.57 2.09 38.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.185 -0.947 . . . . 0.0 109.573 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -74.39 88.0 0.71 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -81.17 -21.57 39.6 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.303 -1.116 . . . . 0.0 109.397 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.481 179.994 . . . . . . . . 1 1 . 1 stop_ save_